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SUMMARY
CHAPTER ONE
Chapter one describes the practical consideration o f lithiation reactions and 
preparation o f organolithium reagents. It also provides reviews o f directed lithiation 
of substituted aromatics and heterocycles.
CHAPTER TWO
Chapter two describes directed lithiation and substitution of various 
A-benzylpivalamides. Lithiation o f /V-benzylpivalamide with /-BuLi in THF at low 
temperature followed by reaction with benzophenone gave a mixture o f ortho- and 
a-substitutions. Ring substitution could be achieved via bromine-lithium exchange of 
/V-(2-bromobenzyl)pivalamide followed by reactions with electrophiles. Lithiation 
and substitution o f 4-methoxy and 4-methyl derivatives with /-BuLi in THF gave 
or/Ziosubstitution. By contrast, lithiation and substitution o f the 2-methoxy derivative 
gave ring substitution, but next to the methoxy group rather than next to the 
pivaloylaminomethyl group. Under similar reaction conditions lithiation of 
A-(2-methylbenzyl)pivalamide followed by reactions with electrophiles, gave 
products substituted in the methyl group.
CHAPTER THREE
Chapter three describes lithiation and substitution o f various substituted 
jV'-benzyl-A.A-dimethylureas. Lithiation o f unsubstituted, 4-methoxy and 4-methyl 
derivatives with /-BuLi at -78 °C in THF followed by reactions with electrophiles 
gave or//?o-substitution. It was found that lithiation o f the 2-methyl derivative under 
similar conditions gave products substituted in the methyl group. By contrast, 
lithiation and substitution o f the 2-methoxy derivative with /-BuLi at -20 °C gave a 
mixture o f o'- and o-substitutions.
CHAPTER FOUR
Chapter four describes cyclization reactions o f A-(2-substituted 
benzyl)pivalamides and vV-(2-substituted benzyl)-7V,A-dimethylureas with TFAA as a 
catalyst in DCM at RT, via dehydration from the OH and hydrogen from the NH, to 
give the corresponding isoindolines in excellent yields. The procedure has been 
proven to be simple, efficient and general.
CHAPTER FIVE
Chapter five describes cyclization reactions o f A-(2-substituted benzyl)-AyV- 
dimethylureas in DCM in the presence o f TFAA to produce the corresponding 
dihydroisoquinolines in excellent yields. However, V-(2-(2-hydroxy-2- 
arylalkyl)benzyl)pivalamides are not cyclised under similar conditions. Instead, 
esterification of the hydroxyl group with TFAA or dehydration from the OH and a 
hydrogen from the CH2 at position 2, takes place to give the corresponding derivatives 
in high yields.
CHAPTER SIX
Chapter six describes a lithiation procedure that allows the production of
3-substituted isoindolin-l-ones in high yields in only one step via lithiation o f various 
substituted A-benzyl-MA-dimethylureas with /-BuLi (3.3 mole equivalents) in THF 
at 0 °C followed by reactions with various electrophiles. The procedure has been 
proven to be simple, efficient and general.
CONTENTS
Contents
CONTENTS
Page
CHAPTER ONE
DIRECTED LITHIATION OF AROMATIC COMPOUNDS
1.1 Introduction 1
1.2 Practical considerations 1
1.2.1 Choice o f solvent 1
1.2.2 Reactions at low temperatures 2
1.2.3 Inert atmospheres 3
1.2.4 Estimation o f organolithium reagents 3
1.3 Preparation o f organolithium compounds 3
1.3.1 By reaction with lithium metal 4
1.3.2 By reaction with lithium salts o f radical anions 5
1.3.3 By halogen-lithium exchange 6
1.3.4 By lithiation 7
1.4 Directed lithiation o f aromatic compounds 8
1.4.1 Directed lithiation of benzene derivatives 9
1.4.2 Directed lithiation o f naphthalene derivatives 9
1.4.3 Directed lithiation o f heterocycles 10
1.4.3.1 Directed lithiation o f pyridines 10
1.4.3.2 Directed lithiation o f quinolines 12
1.4.3.3 Directed lithiation o f pyridazines 12
1.4.3.4 Directed lithiation o f pyrimidines 13
1.4.3.5 Directed lithiation o f pyrazines 13
1.4.3.6 Directed lithiation o f cinnolines 14
1.4.3.7 Directed lithiation o f quinazolines 15
1.4.3.8 Directed lithiation o f quinoxalines 15
1.5 Conclusion 15
CHAPTER TWO
INVESTIGATION OF THE INFLUENCES OF SUBSTITUENTS ON THE 
LITHIATION SITES OF VARIOUS A-BENZYLPIVALAMIDES
2.1 Introduction 16
2.2 Synthesis o f A-benzylpivalamide (49) 18
2.3 Lithiation of A-benzylpivalamide (49) 18
2.4 Synthesis of jV-(2-bromobenzyl)pivalamide (60) 24
2.5 Bromine lithium exchange o f V-(2-bromobenzyl)pivalamide (60) 24
2.6 Synthesis of various A-benzylpivalamides 27
2.7 Directed lithiation of V-(4-methoxybenzyl)pivalamide (44) 28
2.8 Directed lithiation of V-(2-methoxybenzyl)pivalamide (46) 30
2.9 Directed lithiation of V-(4-methylbenzyl)pivalamide (68) 37
2.10 Lithiation of V-(2-methylbenzyl)pivalamide (65) 38
2.11 Conclusion 41
CHAPTER THREE
INVESTIGATION OF THE INFLUENCES OF SUBSTITUENTS ON THE 
LITHIATION SITES OF VARIOUS W'-BENZYL-AyV DIMETHYLUREAS
3.1 Introduction 42
vi
Contents
3.2 Synthesis o f A-benzyl-A, A-dimethylureas from reactions of 44
benzylamines with triphosgene followed by reactions with
dimethylamine
3.3 Synthesis o f V-benzyl-A.V-dimethylureas from reactions of 46
benzylamines with dimethylcarbamoyl chloride
3.4 Directed lithiation of V-benzyl-V.V-dimethylureas 107, 108 and 113 47
3.5 Directed lithiation o f jV'-(2-methoxybenzyl)-jV,J/V-dimethylurea (111) 51
3.6 Lithiation o f V-(2-methylbenzyl)-V,Ar-dimethylurea (114) 57
3.7 Conclusion 58
CHAPTER FOUR
SYNTHESIS OF SUBSTITUTED ISOINDOLINES
4.1 Introduction 60
4.2 Synthesis o f l,l-diphenyl-2-pivaloylisoindoline (162) 61
4.3 Synthesis o f substituted isoindolines 163-173 63
4.4 Synthesis o f V-(2-cyclohexenylbenzyl)pivalamidess 174 and 175 65
4.5 Attempted synthesis o f 1-substituted isoindolines 66
4.6 Conclusion 67
CHAPTER FIVE
SYNTHESIS OF SUBSTITUTED TETRAHYDROISOQUINOLINES
5.1 Introduction 68
5.2 Attempted cyclizations o f Ar-(2-(2-hydroxy-2-arylalkyl)benzyl)- 70
pivalamides
5.3 Synthesis o f 3-(4-methoxyphenyl)-2-dimethylaminocarbonyl-1,2,3,4- 76
tetrahydroisoquinoline (198)
5.4 Synthesis o f substituted tetrahydroisoquinolines 199 and 200 77
5.5 Synthesis o f V-(2-(2,2-diphenylvinyl)benzyl)-ACV-dimethylurea (201) 78
5.6 Attempted synthesis o f 2-unsubstituted 1,2,3,4-tetrahydroisoquinolines 80
5.7 Conclusion 81
CHAPTER SIX
SYNTHESIS OF SUBSTITUTED ISOINDOLIN-1-ONES
6.1 Introduction 82
6.2 Synthesis o f (/?*)-3-((5’*)-3-(hydroxy(4-methoxyphenyl)methyl)-4- 84
methoxyisoindolin-1 -one (139)
6.3 Synthesis of 4-methoxyisoindolin-1-one (216) 86
6.4 Synthesis of various 3-substituted 4-methoxyisoindolin-l-ones 216-224 87
6.5 Synthesis of various substituted isoindolin-1-ones 225-245 89
6.6 Attempted cyclization of V-benzylpivalamide (49) 91
6.7 Attempted synthesis of l,2-dihydroisoquinolin-3(4//)-ones 92
6.8 Conclusion 93
CHAPTER SEVEN 
EXPERIMENTAL
7.1 General experimental 94
7.2 Synthesis of A-benzylpivalamide (49) 94
7.3 Lithiation and substitution of A-benzylpivalamide (49) 95
7.4 Synthesis of V-(2-bromobenzyl)pivalamide (60) 97
vii
Contents
7.5 Synthesis o f N -^-substituted benzyl)pivalamides 57 and 62-66 via 98
bromine-lithium exchange o f iV-(2-bromobenzyl)pivalamide (60)
7.6 Synthesis o f  ^ -(substituted benzyl)pivalamides 102
7.7 Synthesis of N-(2-substituted 4-methoxybenzyl)pivalamides 71-76 via 104
directed lithiation o f Ar-(4-methoxybenzyl)pivalamide (44)
7.8 Synthesis of Ar-(4-methoxy-2-methylbenzyl)-Ar-methylpivalamide (77) 110
via directed lithiation o f /V-(4-methoxybenzyl)pivalamide (44)
7.9 Synthesis o f N-(3-substituted 2-methoxybenzyl)pivalamides 80-84 via 110
directed lithiation o f yV-(2-methoxybenzyl)pivalamide (46)
7.10 Lithiation o f 46 with /-BuLi at 0 °C followed by reaction with 117
4-anisaldehyde
7.11 Lithiation o f 46 with /-BuLi at 0 °C followed by reaction with CCL 118
7.12 Lithiation o f 46 with sec-BuLi at -78 °C followed by reaction with CO2 119
7.13 Lithiation o f 46 with sec-BuLi at 0 °C followed by reaction with CO2 119
7.14 Lithiation o f 46 with ^-BuLi at 0 °C followed by reaction with CO2 119
7.15 Synthesis o f iV-(2-substituted 4-methylbenzyl)pivalamides 89-95 via 120
directed lithiation of Ar-(4-methylbenzyl)pivalamide (68)
7.16 Synthesis o f Ar-(2,4-dimethylbenzyl)-iV-methylpivalamide (96) via 126
directed lithiation o f jV-(4-methylbenzyl)pivalamide (68)
7.17 Synthesis o f N-(2-substituted methyl)benzylpivalamides 99-106 via 126
lateral lithiation o f Ar-(2-methylbenzyl)pivalamide (65)
7.18 Synthesis of N'-benzyl-A^N-dimethylureas from reactions o f 133
benzylamines with triphosgene followed by reactions with 
dimethylamine
7.19 Synthesis of A^-benzyl-iVy/V-dimethylureas from reactions o f 140
benzylamines with dimethylcarbamoyl chloride
7.20 Synthesis o f jV'-(2-substituted benzyl)-AVV-dimethylureas 114 and 118- 140 
131 via directed lithiation o f N-benzyl-A^N-dimethylureas 107, 108 and
113
7.21 Synthesis o f Ar-ethyl-Ar-(2-ethyl-4-methoxybenzyl)-A^,Ar-dimethylurea 152
(132) via directed lithiation o f 108
7.22 Synthesis o f A^-(2-(hydroxy(4-methoxyphenyl)methyl)-6- 153
methoxybenzyO-A^Af-dimethylurea (136) and 7V-(3-(hydroxy(4- 
methoxyphenyl)methyl)-2-methoxybenzyl)-Ar,A^-dimethylurea (137) via 
lithiation of Ar-(2-methoxybenzyl)-A^,Ar-dimethylurea (111) at -20 °C
7.23 Lithiation of jV'-(2-methoxybenzyl)-iV,N-dimethylurea (111) at 0 °C 155
followed by reaction with 4-anisaldehyde
7.24 Synthesis o f A^-(2-(substituted-6-methoxybenzyl)-Ar,A^-dimethylureas 157
141,143, 145 and 147 and Ar-(3-(substituted-2-methoxybenzyl)-Ar> r- 
dimethylureas 142, 144, 146 and 148 via lithiation o f Ar-(2-methoxy- 
benzyl)-A,ALdimethylurea (111) at -2 0  °C
7.25 Synthesis of N'-(2-substituted methylbenzyl)-AyV-dimethylureas 153- 163
158 via lateral lithiation of Ar-(2-methylbenzyl)-A^,Ar-dimethylurea (114)
7.26 Synthesis o f l,l-diphenyl-2-pivaloylisoindoline (162) via cyclization o f 168 
A^-(2-(hydroxydiphenylmethyl)benzyl)pivalamide (57)
7.27 Synthesis of substituted isoindolines 163-173 170
7.28 Synthesis of iV-(2-(cyclohexenyl)pivalamides 174 and 175 179
7.29 Synthesis of A^-(2-(2-phenyl-2-trifluoroacetoxyethyl)benzyl)pivalamide 181
(188)
7.30 Synthesis of (£’)-Ar-(2-(4-methoxystyryl)benzyl)pivalamide (189) 182
viii
Contents
7.31 Synthesis o f (£')-Ar-(2-(2-phenylprop-l-enyl)benzyl)pivalamide (190) 183
7.32 Synthesis o f 3-(4-methoxyphenyl)-2-dimethylaminocarbonyl-l,2,3,4- 184
tetrahydroisoquinoline (198) via cyclization 7V'-(2-(2-hydroxy-2-(4- 
methoxyphenyl)ethy l)benzy l)-iV, jV-dimethy lurea (153)
7.33 Synthesis o f substituted tetrahydroisoquinolines 199 and 200 186
7.34 Synthesis o f Ar-(2-(2,2-diphenylvinyl)benzyl)-A^T/V-dimethylurea (201) 187
7.35 Synthesis o f (/?*)-3-((S*)-(hydroxy(4-methoxyphenyl)methyl)- 189
4-methoxyisoindolin-l-one (139)
7.36 Synthesis o f 4-methoxyisoindolin-l-one (216) 189
7.37 Synthesis o f 3-substituted 4-methoxyisoindolin-1 -ones 216-224 191
7.38 Synthesis of various substituted isoindolin-1-ones 225-245 197
FINAL CONCLUSION AND FUTURE W ORK 212
REFERENCES 213
ix
CHAPTER ONE
DIRECTED LITHIATION OF AROMATIC
COMPOUNDS
Chapter One: Directed lithiation o f aromatic compounds
C H A P T E R  O N E  
D IR E C T E D  L IT H IA T IO N  O F A R O M A T IC  C O M P O U N D S
1.1 Introduction
Electrophilic aromatic substitution reactions are o f great importance in the 
production of aromatic products, some o f which are useful intermediates for the 
synthesis o f valuable industrial, pharmaceutical, agrochemical and fine chemicals. 
However, most commercial applications still make use of methods developed many 
years ago, which commonly suffer serious disadvantages, including the requirement 
for mineral or Lewis acids as activators.1 Unfortunately, the use of such activators 
creates a number o f environmental problems. The activators may be required in more 
than stoichiometric amounts and the work-up procedure may lead to hydrolysis of 
activators and generation of large quantities o f corrosive and toxic waste by-products. 
Moreover, these reactions often lead to mixtures o f regioisomers with low selectivity.
In recent years, many efforts have been made to develop clean and 
environmentally friendly processes for the regioselective production o f specific 
products. It is well recognised that organolithium reagents can play an important role 
in such cases. Many aromatic compounds undergo lithiation ortho to a functional 
group.2' 17 The organolithium reagents in such reactions are useful intermediates for 
the synthesis o f ortho-disubstituted aromatics. Moreover, ortho-lithiation has been 
applied to more complicated heterocycles to produce derivatives that are difficult to 
prepare by other means.18'21 This review o f organolithium chemistry is not intended to 
be comprehensive, but rather to summarise the state o f the art and provide references 
to more detailed reviews and primary literature.
1.2 Practical considerations
1.2.1 Choice of solvent
Solvents used in lithiation reactions should be easily purified and free from 
water and peroxides. They usually have low-enough freezing points that enable them 
to be used at low temperature without freezing taking place. Also they should not 
themselves react with organolithium reagents.4
Aliphatic hydrocarbons are inert, and easily purified and dried. The isomeric 
butyllithiums are commercially available in these solvents. However, aryllithiums, 
methyllithium and reagents such as lithium diisopropylamide (LDA) are insoluble in
1
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aliphatic hydrocarbons in the absence o f electron-donating ligands.4 Aromatic 
hydrocarbons are also easily purified and dried, but toluene is relatively easily 
lithiated, and benzene is dangerously toxic and cannot be used at low temperatures 
because it has a high freezing point (5.5 °C). Therefore ethers are the most commonly 
used solvents for organolithium reactions. Diethyl ether (Et20) is probably the most 
commonly used solvent for lithiation reactions. It is easily purified and dried, it has an 
appropriate boiling point and a low enough freezing point. Moreover, most lithium 
reagents are soluble in diethyl ether and do not cleave the ether too rapidly.
When a more strongly Lewis-basic solvent is required, tetrahydrofuran (THF) 
is the most widely used alternative to diethyl ether. It does, however, suffer from 
some disadvantages. It is much more readily attacked by organolithium reagents than 
diethyl ether; its freezing point is only just above the temperature o f evaporating solid 
carbon dioxide. It is much less easily dried, and more hygroscopic than diethyl ether.
Mixed solvents systems are also the key to working at very low temperatures 
where it is important not only that the reaction medium should remain liquid, but also 
its viscosity should remain low. A particularly useful combination is the “Trapp 
mixture”, comprising THF/Et^O/pentane (or hexane or light petroleum) in a 4/4/1 
ratio, which can be used at very low temperatures.4
1.2.2 Reactions at low temperatures
Reactions o f organolithium reagents are often carried out at low temperatures. 
In particular it is often stated that a reaction is carried out at -78 °C, the temperature o f 
a solid carbon dioxide-acetone cooling bath. For alternative low temperatures, 
convenient cooling baths include solvents cooled to slush by stirring with liquid 
nitrogen. Some examples are listed in Table 1.1.4
Table 1.1: Solvents for cooling slush baths
Solvent Temperature of slush bath (°C)
T etrachloromethane -23
Chlorobenzene -45
Chloroform -63
Ethyl acetate -84
Hexane -94
Methanol -98
Methylcyclohexane -126
Pentane -131
2
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1.2.3 Inert atmospheres
Organolithium reagents are sensitive to moisture in the air. For most 
preparative applications involving organolithium reagents, a sufficient degree o f 
protection is achieved simply by maintaining a slight positive pressure o f an inert gas 
(nitrogen or argon) over the reaction mixture.
1.2.4 Estimation of organolithium reagents
The best established methods for estimating organolithium reagents in the
-) -> y  y
presence of lithium hydroxide or alkoxides are the Watson-" and Gilman double 
titration methods. In these methods, total base is first determined. An aliquot of the 
test solution is treated with an organic halide o f sufficient reactivity to convert the 
organolithium compound into non-basic lithium halide while leaving any hydroxide 
or alkoxides unchanged for a second titration. Gilman originally used benzyl chloride, 
but 1,2-dichloroethane and allyl bromide have been reported to be more generally 
satisfactory .“
1.3 Preparation of organolithium compounds
Several organolithium reagents are made commercially, some of them on a 
considerable scale. w-Butyllithium (//-BuLi), sec-butyllithium (5ec-BuLi) and 
/er/-butyllithium (/-BuLi) in hydrocarbon solvents, for example, are sold in tonnage 
quantities. Phenyllithium and methyllithium are highly stable in ethers at room 
temperature. A list o f the most common commercially available organolithium 
reagents is showed in Table 1.2.
Table 1.2: The most common commercially available organolithium reagents"
Organolithium reagent Solvent Concentration (M)
tt-Butyllithium
/e/7-Butyllithium
.vec-Butyllithium
Methyllithium
Phenyllithium
Hexanes
Cyclohexane
Pentane
Pentane
Cyclohexane
Diethyl ether
Cumene/tetrahydrofuran
Cyclohexane/diethyl ether
1.6, 2.5 and 10.0 
2.0 
2.0
1.5 and 1.7
1.3
1.4 
1.0
1.8
" Available from Sigma-Aldrich Chemical Company. Also, some of such reagents are 
available from Fluka and Alfa Aesar.
3
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Most organolithium compounds exist as clusters both in the solid state and in 
solution in most solvents. The tendency to aggregate is common for alkylithiums. The 
aggregates are held together by delocalised covalent bonds between lithium and the 
terminal carbon o f the alkyl chain.17 In hydrocarbon solvents lithium reagents 
aggregate to stabilise the electron deficient lithium atom and exist as dimmers, 
tetramers and hexamers. The state o f aggregation was found to be dependent on steric 
hindrance in organolithiums, so that increasing bulkiness of the organic group in 
organolithiums tends to decrease the aggregation state.4,17 Ether solvents such as 
diethyl ether or THF can provide an alternative electron density source for the lithium 
atoms.8 For example, /-BuLi is tetrameric in pentane, but becomes, at low 
temperature, dimeric in diethyl ether and monomeric in THF. Also, a coordinating 
solvent such as THF, 1,2-dimethoxyethane (DME) or N ,N ,N ’,N ’- 
tetramethylethylenediamine (TMEDA) increases the reactivity o f the organolithium 
reagents by lowing its aggregation state. The aggregation states for the most common
g
organolithium reagents in different solvents are shown in Table 1.3.
Table 1.3: Aggregation sates for 
organolithium reagents
the most common commercially available
Aggregation state in hydrocarbons Aggregation state in Et20 or THF
Hexameric Tetrameric Tetrameric Dimeric Monomeric
/7-BuLi sec-BuL\ «-BuLi sec-BuLi /-BuLL
/-BuLi MeLi /-BuLi
PhLi
PhLL
° At low temperatures (less than -100 °C).
The majority of organolithiums are prepared by the reaction o f organic halides 
with lithium metal, although halogen-lithium exchange and lithiation methods are also 
used.
1.3.1 By reaction with lithium metal
Commercially available organolithium reagents are usually produced by 
reductive lithiation of organic halides with lithium metal (Equation 1.1) at room 
temperature or above.4 However, such methods suffer serious disadvantages. For 
example, the organolithium produced (RLi) could react with alkyl halide (RX) to
4
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produce a coupled product (R-R). Also, problems could arise from the use of lithium 
metal at the required temperatures.
RX + 2  Li - »  RLi + LiX j
Equation 1.1
Alkyl chlorides are the best among alkyl halides in reductive lithiation 
reactions; rate of coupling is fast in the case o f alkyl iodides and bromides, but their 
reductions are also fast.8
It should be noted that to obtain a high yield o f organolithium compound using 
this method the following points must be taken into consideration.4 Firstly, the 
lithium used should be finely divided and free from mineral oil. Secondly, the 
presence of 1-3% of sodium in lithium could increase its reactivity towards alkyl 
halide (RX) by aiding initiation without significantly affecting the yield or properties 
of the product (RLi). However, higher concentrations o f sodium may lead to low 
product yields through formation o f coupling products (R-R; via Wurtz coupling). 
Thirdly, the organic halide should be added slowly with efficient stirring to minimise 
the formation o f coupling product. Table 1.4 shows examples of organolithiums that
A
are routinely prepared using this approach.
Table 1.4: Preparation o f organolithiums from reaction of organic halides with
lithium metal
Organolithium Organic halide Solvent Yield (%)
/7-BuLi tt-BuCl Pentane 93-98
t- BuLi t-BuCl Pentane 80
MeLi MeCl Diethyl ether 70-89
Mel Diethyl ether 82
PhLi PhBr Diethyl ether 95-99
1.3.2 By reaction with lithium salts of radical anions
The reactions of organic halides with lithium metal, leading to organolithium 
compounds, almost certainly involves electron transfer," so it is not unexpected that 
under appropriate conditions electron transfer from a radical anion to an organic 
halide, with lithium as a counter ion, may also give organolithium compounds. With 
lithium naphthalene yields are variable, but can be high with aryl chlorides.25 With
5
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lithium 4,4'-di-/er/-butylbiphenyl excellent yields are reported in several cases, and 
this reagent gives some organolithiums that are unobtainable by other methods.27
1.3.3 By halogen-lithium exchange
The general halogen-lithium exchange reaction (Equation 1.2) has features 
that make it extremely valuable for preparing organolithium compounds.
RX + R'Li  .........  -.—  RLi + R'X
Equation 1.2
The equilibrium lies towards the side having the organolithium compound 
with the organic group better able to accommodate partial carbanionic character, and 
it is thus particularly useful for preparing aryllithium compounds by reaction o f 
butyllithium with aryl halides. With iodo and bromo compounds the reaction is 
general and often proceeds remarkably rapidly even at low temperatures.4 The 
reaction is less satisfactory with chloro compounds and does not takes place at all 
with fluoro derivatives. The solvent used in such processes is normally an ether, 
though it does take place in hydrocarbon solvents, but more slowly.4
Because halogen-lithium exchange takes place rapidly under mild conditions, 
potential side-products such as alkylation o f the organolithium by the organic halide 
are not usually troublesome. However, when the desired organolithium reagent is 
warmed for subsequent reaction it can couple with the alkyl halide, producing a 
coupled product (R-R').4 If alkylation is a problem, it can be minimised by use of two 
mole equivalents of r-BuLi. In this case, halogen-lithium exchange is achieved by the 
first mole equivalent and the second reacts with the /-BuX formed to produce 
isobutane and isobutene.
Halogen-metal exchange processes may involve single electron transfer 
processes and radical intermediates (Equation 1.3) or proceed through ate complex 
formation (Equation 1.2) via nucleophilic substitution at the halogen. It is believed
that alkyl bromides react with alkyllithiums via the radical mechanism, while aryl
8 8^bromides and aryl iodides react via ate complexes as intermediates. Also, primary
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alkyl iodides react via a polar mechanism and secondary alkyl iodides react via both 
polar and radical mechanisms.8,28
R -L i- X R -L i .
Equation 1.3
R -X
cL i -R '
> ^ 0
R ^ B r - R ’
©
Li
R -L i
R’- X
intermediate 
ate complex
Halogen-lithium exchange via ate complex "intermediate"^
Equation 1.4
1.3.4 By lithiation
The replacement o f hydrogen by lithium in an organic compound (Equation 
1.5) is perhaps the most versatile method for preparing organolithium compounds.4
/■ —
RH + R'Li --------------------► RLi + R'H
Equation 1.5
The simplest lithiations (deprotonations) are those o f relatively acidic 
hydrocarbons (pKa < ca. 33) such as 1-alkynes and triarylmethanes. However, other 
compounds whose acidities are much lower are also readily lithiated.4 This happens 
when activation takes place by the presence o f an a -  or P-heteroatom that increases 
the thermodynamic and/or kinetic acidity o f a particular hydrogen atom. This type o f 
activation is very useful for the introduction o f a substituent ortho to an existing 
functional group (directed ring lithiation) or on an ortho-methyl or methylene group 
(lateral lithiation).4,8 Directed lithiation o f aromatic and heterocycles is discussed in 
detail in Section 1.4.
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1.4 Directed lithiation of aromatic compounds
Regioselective synthesis o f or/Zzo-disubstituted aromatics is one o f the 
classical problems in synthetic chemistry. Simple electrophilic substitution usually 
takes place under forcing conditions in the presence of a catalyst and often leads to 
various isomers and polysubstituted aromatics. A number o f alternative approaches 
have therefore been developed for regioselective or/Zzo-disubstitution, and ortho- 
metalation followed by electrophilic substitution is one of the most recognised and 
efficient.
Directed lithiation o f aromatic compounds 1 comprises deprotonation of a site 
ortho to a substituent that possesses a heteroatom (oxygen, nitrogen or sulfur) by use 
of a base. Such a substituent is known as a directing metallation group (DMG). The 
base, normally an alkyllithium reagent, leads to an ozYZzo-lithiated species 3 (Scheme 
1.1). Treatment o f 3 with electrophilic reagents produces ozYZzo-disubstituted products 
4."'" Apparently, complexation occurs between the substituent group (DMG) and the 
lithium reagent prior to lithiation to give 2, and this serves to bring the lithiating agent 
into closer proximity with the ortho proton, which is then selectively removed.29
DMG RLi DMG DMG-RH
DMG
Electrophile
Scheme 1.1
For a successful deprotonation to occur, the DMG must possess the somewhat 
contrary properties of being a good coordinating site for the lithium reagent and a 
poor electrophilic site for attack by the lithium reagent. The rate and regioselectivity 
o f or/Zzo-lithiation seems to be controlled not only by coordination between the 
lithium reagent and the heteroatom of the DMG but also by the acidity of the proton at 
the or/Zzo-position. It is not clear which factor has the driving force in or/Zzo-lithiation.
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However, both o f them could play a role for lithiation to be successful. For example, 
strong activators (DMG) tend to have a mixture o f the basic requirements for good 
coordination to lithium reagent and the electron-withdrawing properties required to 
cause the or^o-protons to become acidic enough to encourage deprotonation 
efficiently and rapidly.8
Groups that encourage such or//?o-lithiation include: strong activators, 
S 0 2NR2, NHCOR, CONR2, CSNHR, CONHR, OCONR2, C 0 2R, CH2NHR, 
0 CH20Me; moderate activators, OR, NR2, SR, CF3, F; and weak activators, CH2OH, 
CH(OR)2. The rapid expansion o f the list o f functionalities capable o f directing 
lithiation has made this approach an important strategy for the synthesis of various 
regiospecifically substituted benzenes and heterocycles.30'36
1.4.1 Directed lithiation of benzene derivatives
Directed lithiation o f benzene systems, containing a range o f DMGs (e.g. 
NHCOBu', N H C 02Bu', NHCONMe2, CONHR, CONR2, OCONEt2, CH2NR2, 
CH2NHCOBu', CH2N H C 02Bu', CH2NHCONMe2, OMe, SH, CF3, F, l//-tetrazol-5- 
yl, O-tetrahydropyranyl), with various lithium reagents to produce the corresponding 
disubstituted benzenes via lithium intermediates has been investigated.37'39 For 
example, N-pivaloylaniline (5) has been doubly lithiated, on nitrogen and on the 
carbon at position 2, with two equivalents o f tf-BuLi at 0 to 25 °C in a THF/Et20  
mixture for 20 h. The ortho-dilithiated intermediate 6 thus obtained has been reacted 
with electrophiles to give the corresponding 2-substituted derivatives 7 (Scheme 1.2) 
in yields of 53-78%.37
n-BuLi 
0 to 25 °CNHCOBu NHCOBu1i, Electrophile
THF/Et?0
Scheme 1.2
1.4.2 Directed lithiation of naphthalene derivatives
Directed lithiation of naphthalene containing DMGs has received limited 
attention compared to benzene derivatives. Most o f the work reported involves
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lithiation o f A.A-diethyl-l-naphthamide and A,A-diethyl-2-naphthamide.40'43 For 
example, 7V,7V-diethyl-l-naphthamide (8) has been lithiated with sec-BuLi in the 
presence o f A.A^A^A'-tetramethylethylenediamine (TMEDA) at -78 °C in THF. The 
lithium intermediate 9 thus obtained has been reacted with oxygen to give 2-hydroxy- 
jV.A-diethyl-l-naphthamides (10; Scheme 1.3).40
CONE! CONEt CONEt;
OH
sec-BuLi/TMEDA
THF, -78 °C
Scheme 1.3
1.4.3 Directed lithiation of heterocycles
The chemistry of heterocyclic compounds is extremely important for the 
synthesis of valuable bioorganic and pharmaceutical compounds. Lithiation is an 
important strategy for ortho-functionalization o f pyridines, quinolines and 
diazines.44,45 Unfortunately, in some cases such lithiation reactions with alkyllithiums 
suffer from nucleophilic addition of the lithium reagent to the azomethine (C=N) bond 
of azines, even at low temperatures. However, most reactions become completely 
chemoselective for lithiation by use o f less nucleophilic lithium reagents such as LDA 
and lithium 2,2,6,6-tetramethylpiperidide (LTMP).
1.4.3.1 Directed lithiation of pyridines
Directed lithiation of pyridines, containing various DMGs (e.g. NHCOBu', 
CONHPh, CONR2, SOBu', SOAr, C 0 2H, OCH2OEt, OMe, CF3, F, Cl) at the C-2 
position, with various lithium reagents invariably takes place at C-3 to give the 
corresponding 3-substituted derivatives after reactions o f the lithium reagents 
produced with electrophiles4649 For example, 2-(pivaloylamino)pyridine (11) has 
been lithiated, on nitrogen and on the carbon at position 3, with /7-BuLi 
(2 equivalents) in THF at 0 °C. The dilithium reagent 12 thus obtained reacted with a 
range of electrophiles to give 3-substituted 2-(pivaloylamino)pyridines 13 (Scheme 
1.4).46,47
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i, Electrophile
THF, 0 °C
NHCOBu1 Bu1 NHCOBu1
Scheme 1.4
Directed lithiation o f pyridines, containing a DMG {e.g. S 0 2NHBu', 
NHCOBu', N H C 02Bu', CONR2, OCSNEt2, SOAr, C 0 2H, OEt, OMe, F, Cl) at the 
C-3 position, with various lithium reagents takes place predominately at C-4.50’54 For 
example, 3-(pivaloylamino)pyridine (14) has been lithiated, on nitrogen and on the 
carbon at position 4, with «-BuLi (2 equivalents) in THF at -70 to -25 °C and in the 
presence o f TMEDA. The dilithium reagent 15 thus formed reacted with various 
electrophiles to give the corresponding 4-substituted 3-(pivaloylamino)pyridines 16 
(Scheme 1.5).50'52
NHCOBu NHCOBui, Electrophilen-BuLi/TMEDA
THF, -70 to -25 °C
Scheme 1.5
Similarly, directed lithiation o f pyridines, containing a DMG {e.g. NHCOBu', 
CONR2, CONHPh, C 0 2H, CH(OEt)2, OMe, Cl) at C-4, takes place at C-3 with 
various lithium reagents.46,55’57 For example, 4-(pivaloylamino)pyridine (17) has been 
lithiated, on nitrogen and on the carbon at position 3, with n-BuLi in THF at 0 °C. The 
dilithium reagent 18 obtained reacted with various electrophiles to give the 
corresponding 3-substituted 4-(pivaloylamino)pyridines 19 (Scheme 1.6).46,55
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NHCOBu NHCOBu1Bu1
i, Electrophilen-BuLi
THF, 0 °C
17
Scheme 1.6
1.4.3.2 Directed lithiation of quinolines
Directed lithiation of quinolines, containing various DMGs (e.g. NHCOBu', 
OCONEt2, CO2H, OR, Cl) at the C-2 position, has been achieved by the use of 
»-BuLi or less nucleophilic lithium reagents (e.g. LDA) at low temperatures.58'60 For 
example, or/Zio-lithiation o f 2-pivaloylaminoquinoline (20) has been achieved by use 
of n-BuLi in dry Et20 at low temperature to give the lithium reagent 21. Reactions o f 
21 with various electrophiles afforded the corresponding 3-substituted
582-pivaloylaminoquinolines 22 (Scheme 1.7) in moderate to very good yields.
/7-B uLi
Et20 (j)Li i, Electrophile 
ii, H30 + '
Bu'
-70 °C
NHCOBu1NHCOBu
20
Scheme 1.7
1.4.3.3 Directed lithiation of pyridazines
Directed lithiation of pyridazines, containing various DMGs (e.g. SO2NHBU', 
NHCOBu', OMe, 0 CH2CH20Me, Cl) at the C-3 position, has been successfully 
achieved with less nucleophilic lithium reagents such as LDA and LTMP.61-63 For 
example 3-(pivaloylamino)pyridazine (23) has been doubly lithiated, on nitrogen and 
on the carbon at position 4, with LDA or LTMP in THF at -70 °C. The dilithium 
reagent 24 obtained reacted with various electrophiles to give the corresponding 
4-substituted 3-(pivaloylamino)pyridazines 25 (Scheme 1.8).61
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NHCOBu NHCOBuBu
LDA or LTMP i. Electrophile,
THF, -70 °C
24 25
Scheme 1.8
1.4.3.4 Directed lithiation of pyrimidines
Directed lithiation o f pyrimidines, containing a DMG (e.g. OMe, F, Cl) at the 
C-4 position, mainly takes place at C-5 to give the corresponding lithium 
intermediates, which on reactions with electrophiles produce 4,5-disubstituted 
pyrimidines.64'68 For example, lithiation o f 4-methoxypyrimidine (26) with LDA or 
LTMP in THF or Et20 at 0 or -78 °C gave the 5-lithio derivative 27 which reacted 
with electrophiles to give the corresponding 5-substituted 4-methoxypyrimidines 28 
(Scheme 1.9).64'66
........ .
OMe OMe OMe
0
LDA or LTMP
& N
i, Electrophile
THF or Et20 ii, H30 +
26 27 28
Scheme 1.9
1.4.3.5 Directed lithiation of pyrazines
Directed lithiation of pyrazines, containing a DMG (e.g. NHCOBu', SO2BU', 
S02Ph, OMe, SR, F, Cl, I) at the C-2 position, invariably takes place at C-3.69’70 For 
example, 2-(pivaloylamino)pyrazine (29) has been doubly lithiated by the use o f 
alkyllithiums (/?-BuLi or /-BuLi) in THF or Et20 at -70 to 20 °C. Reactions o f the 
dilithium reagent 30 thus formed with electrophiles produced the corresponding
3-substituted 2-(pivaloylamino)pyrazines 31 (Scheme 1.10).69
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RLi/THF 
or Et20 'Li i, Electrophile.
-70 to 20 °C
NHCOBu NHCOBu1Bu1
3129
Scheme 1.10
1.4.3.6 Directed lithiation of cinnolines
3-Substituted cinnolines have been lithiated with LTMP or LDA in THF at 
low temperature at C-4. For example, 3-methoxycinnoline (32) has been lithiated at 
C-4 by use o f LTMP or LDA in THF at -75 °C to give the lithium reagent 33 which 
reacted with various electrophiles to give the corresponding 4-substituted
3-methoxycinnolines 34 (Scheme 1.11).71
OMeOMeOMe
i, ElectrophileLTMP or LDA
THF, -75 °C
Scheme 1.11
Similarly, the 4-substituted analogues have been lithiated at C-3. For example,
4-methoxycinnoline (35) has been lithiated at C-3 by use o f LTMP or LDA in THF at 
-75 °C to give the lithium reagent 36 which reacted with electrophiles to give the 
corresponding 3-substituted 4-methoxycinnolines 37 (Scheme 1.12).71
•Me
N THF, -75 °C
LTMP or LDA
36
'Me
i, Electrophile,
Me
Scheme 1.12
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1.4.3.7 Directed lithiation of quinazolines
Regioselective lithiation of various quinazoline derivatives has been
77  fi 1investigated. ' For example, directed lithiation of 3-pivaloylamino-4(3//)- 
quinazolinone (38) was achieved by the use o f LDA in THF at -7 8  °C to give the 
dilithium intermediate 39. Reactions o f 39 with various electrophiles afforded the 
corresponding 2-substituted 3-pivaloylamino-4(3//)-quinazolinones 40 (Scheme 1.13) 
in very good yields.72
NHCOBu1
LDA, THF
-78 °C
B uii, Electrophile NHCOBu1
Scheme 1.13
1.4.3.8 Directed lithiation of quinoxalines
Lithiation o f various quinoxaline derivatives has been investigated.82'84 For 
example, directed lithiation o f 2-(pivaloylamino)quinoxaline (41) was achieved by the 
use o f LTMP in THF at -78 °C to produce the dilithium reagent 42.84 Reactions o f the 
dilithium reagent 42 thus obtained with electrophiles produced the corresponding
3-substituted 2-(pivaloylamino)quinoxalines 43 (Scheme 1.14) in modest yields.84
<j>Li i, Electrophile
■^Cv , ii, H30 +
I Bu' 13
LTMP. THF,
-78 °C
NHCOBuNHCOBu1
42 43
Scheme 1.14
1.5. Conclusion
Directed lithiation offers approaches to c>r/Z7tf-di substituted aromatic products. 
Directed lithiation o f aromatic compounds by lithium reagents at low temperatures 
and reactions of the lithium reagents thus obtained with electrophiles is useful for the 
production of or/Zzo-disubstituted derivatives. The process has been applied to various 
aromatics and heterocycles to produce the corresponding or/Zzo-disubstituted 
derivatives that might be difficult to prepare by other means.
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INVESTIGATION OF THE INFLUENCES OF 
SUBSTITUENTS ON THE LITHIATION SITES OF 
VARIOUS N-BENZYLPIVALAMIDES
Chapter Two: Investigation o f the influences o f substituents on the lithiation sites o f
various N-benzylpivalamides
C H A P T E R  T W O
IN V E ST IG A T IO N  O F TH E IN F L U E N C E S O F SU B ST IT U E N T S O N  
TH E  L IT H IA T IO N  SIT ES O F V A R IO U S /V -B E N ZY L PIV A LA M ID E S
2.1 Introduction
Regioselective synthesis o f substituted aromatics is one o f the classical
problems in synthetic chemistry. Simple electrophilic substitution often leads to
various isomers and polysubstituted aromatics and may take place under forcing
conditions in the presence o f a catalyst. Lithiation of aromatics followed by
electrophilic substitution is one o f the most efficient approaches for synthesis of
*111substituted and/or modified derivatives. "
Schlosser has shown that Ar-(4-methoxybenzyl)pivalamide (44) undergoes 
selective lithiation ortho to the pivaloylaminomethyl group when treated with «-BuLi
o c
in anhydrous THF at 0 °C. Reaction o f the lithium reagent obtained with carbon 
dioxide produced the corresponding acid 45 in 64% yield (Scheme 2 .1).85
, n-BuLi, THF, 0 °CNHCOBu1
i, CO;
MeO MeO
45 (64%)44
Scheme 2.1
By contrast, V-(2-methoxybenzyl)pivalamide (46) under similar reaction 
conditions gave a mixture o f two products, one o f which involved carboxylation 
ortho- to the pivaloylaminomethyl group (47; isolated in 10% yield by fractional 
crystallization), and the other of which involved carboxylation at the side-chain (48; 
isolated in 14% yield as the methyl ester following treatment o f the residue with 
diazomethane; Scheme 2.2).85
i, n-BuLi
C 0 2H
-
c o 2h 
^  1
NHCOBuf THF, 0 ° C b f i T  NHC0Buf (l ' NHCOBuf
^ < D M e
ii, CO2
iii, H+ “' A m .  ‘
46 47(10% ) 48(14% )
Scheme 2.2
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Similarly, treatment of N-benzylpivalamide (49) in the same way gave a 
mixture of two substituted products 50 (o-substitution; isolated in 36% yield by 
fractional crystallization), and 51 (a-substitution; isolated in 20% yield as the methyl 
ester following treatment o f the residue with diazomethane; Scheme 2.3).85
COoH
i, n-BuLi 
NHCOBu' THF, 0 °C, NHCOBu1
+ii, CO;
50 (36% 51 (20%)
Scheme 2.3
The poor regioselectivity and low yields achieved in the latter reactions render 
the process unattractive as a synthetic method. However, it was not clear whether the 
lithiation reaction would proceed in the same way under different reaction conditions 
(e.g. different lithium reagents, reaction temperatures or times) or using electrophiles 
other than carbon dioxide. These interesting changes in the directing effects of the 
substituents suggested that further studies on directed lithiation o f ^/-(substituted 
benzyl)pivalamides would be worthwhile.
We therefore decided to investigate lithiation of various ^-(substituted 
benzyl)pivalamides to see if the lack of selectivity in such lithiation reactions could be 
overcome and to examine their scope o f applicability and generality. We have 
selected N-benzylpivalamides carrying bromo, methoxy and methyl substituents, as 
well as the unsubstituted case, as substrates. As shown by Schlosser, unsubstituted 
N-benzylpivalamide could be lithiated at the a-position (on the CH2) and exposition 
(ortho to amidomethyl side chain). In the case o f methoxy derivatives, three sites 
compete for lithiation: a-position (on the CH2), the o-position (ortho to amidomethyl 
side chain) and o -position (ortho to methoxy group). In the case o f methyl 
derivatives, four sites compete for lithiation: a-position (on the CH2), the o-position 
(ortho to amidomethyl side chain), on the methyl group itself and o -position (ortho to 
the methyl group), although the last one is unlikely. Therefore, the aim of the work 
represented in this chapter was to synthesise ^-(substituted benzyl)pivalamides and 
investigate their lithiation reactions, to enable convenient syntheses o f the 
corresponding substituted derivatives.
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The results, which we now report in this chapter, show consistency with the 
earlier results reported by Schlosser when «-BuLi was used as the lithium reagent at 
0 °C.85 However, variation in the site o f lithiation was observed in the case of 
Ar-(2-methoxybenzyl)pivalamide (46) when /-BuLi was used at -78 °C. As a result, we 
have been able to establish conditions for a high-yielding and general ring- 
substitution, but at the position ortho- to the methoxy group rather than ortho- to the 
pivaloylaminomethyl group for this substrate. Lithiation at this site was not reported 
at all by Simig and Schlosser under their conditions.85 Also, we found that lithiation 
o f jV-(4-methylbenzyl)pivalamide takes place smoothly ortho- to the 
pivaloylaminomethyl group, while, lithiation o f A-(2-methylbenzyl)pivalamide takes 
place on the methyl group at the 2-position.
2.2 Synthesis of TV-benzylpivalamide (49)
The first task was to synthesise A-benzylpivalamide (49) and investigate its 
lithiation reactions under various reaction conditions. A-Benzylpivalamide (49) was
Q /
prepared according to a literature procedure. Reaction with pivaloyl chloride with 
benzylamine (52) in dichloromethane (DCM) and in the presence of triethylamine 
(TEA) at 0 °C gave 49 in 92% yield after crystallization (Scheme 2.4). The structure 
o f compound 49 was confirmed by various spectroscopic techniques (see Chapter 7; 
Section 7.2).
NH f-BuCOCI/TEA N
HDCM, 1 h, 0°C
49 (92%)
Scheme 2.4
2.3 Lithiation of /V-benzylpivalamide (49)
Double lithiation o f A-benzylpivalamide (49) has been previously reported
o  C
(Scheme 2.3). However, the lithiation was not selective, giving a mixture of o- and 
a-lithiation. Therefore, double lithiation o f compound 49 was investigated under 
various reaction conditions in order to see the effect of those conditions on the 
reaction selectivity and yields o f products.
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Initially the reaction of 49 with «-BuLi (2.2 mole equivalents) was carried out 
in anhydrous THF under a nitrogen atmosphere at -7 8  °C. Initial addition of «-BuLi 
provided a yellow solution, presumably because o f formation o f the monolithium 
reagent 53, until approximately one equivalent had been added, then gave a brownish 
solution as the remaining tf-BuLi was added, presumably because o f formation o f the 
dilithium reagent. The mixture was stirred for 4 h at -78  °C. Benzophenone (1.1 mole 
equivalents) was added as a solution in anhydrous THF and the mixture was stirred 
for another 2 h (Scheme 2.5) at -78  °C. The reaction mixture was allowed to warm to 
room temperature and quenched by addition of saturated aqueous NH4C1 solution. 
The product mixture was examined by TLC and showed the formation of two minor 
new products, along with the starting material 49 and benzophenone, which were 
isolated by column chromatography (silica gel; Et20-hexane, 1:3). The starting 
material 49 was recovered in 81% yield. The two minor products (Scheme 2.5) were 
subsequently identified as Ar-(2-hydroxy-l,2,2-triphenylethyl)pivalamide (56; 4% 
yield) and Ar-(2-(hydroxydiphenylmethyl)-benzyl)pivalamide (57; 7% yield).
OLi
BuLiBuLi
49 53
OLi OLi
i, Ph2CO, 2 h
54
OHPh.
PhPhPh
57 (7-34%)
Scheme 2.5
Two mole equivalents o f rc-BuLi were necessary, the first mole to remove the 
NH proton and the second one to lithiate on the CH2 at the side-chain or on the ring at 
the 2-position to produce the dilithium reagents 54 or 55, respectively (Scheme 2.5).
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Compound 56 is the product expected from reaction o f the dilithium intermediate 54 
with benzophenone (a-substitution), while, compound 57 is the product expected 
product from the reaction of dilithium intermediate 55 with benzophenone (ortho- 
substitution).
The 'H and l3C NMR spectra o f 56 showed the absence of CH2 signals, 
indicating that lithiation took place at the CH2 o f the -C H 2NHCOBu' group. The ,3C 
signals o f the two phenyl groups originating in benzophenone appeared separately, 
verifying that they were diastereotopic. The diastereotopicity arises from creation o f a 
stereogenic carbon during lithiation at the side-chain followed by reaction with 
benzophenone. Compound 56 would o f course be present as a racemic mixture. The 
presence of CH2 signals in the NMR spectra o f 57 indicated that lithiation took place 
on the ring.
The yields o f 56 and 57 were low presumably because the lithiation reaction of 
49 with rt-BuLi at -78 °C was slow. It seems likely that longer reaction time, higher 
temperature and/or other lithiating reagent might have an effect on the yield. Fuhrer 
and Gschwend had reported that lithiation o f A-phenylpivalamide, using «-BuLi at 
25 °C, was slow and required 20 h as a reaction time to generate the or//70-lithiated 
species.37 Therefore, it seemed likely that the low yields o f the products o f lithiation 
o f 49 and treatment with an electrophile observed under the low temperature 
conditions used here were the result o f inefficient lithiation.
It was of interest to see if the reaction would proceed more rapidly with other 
lithium reagents, and we therefore attempted double lithiation of 49 using /-BuLi. It 
was found that lithiation of 49 with /-BuLi (2.2 mole equivalents) under similar 
reaction conditions to those used with «-BuLi, followed by reaction with 
benzophenone, gave 56 and 57 in slightly better yields (6 and 10%, respectively) after 
separation by column chromatography (Table 2.1; entry 1) along with 49 (69%). We 
also attempted double lithiation o f 49 using sec-BuLi under similar conditions; 
however, the yields o f 56 and 57 were very similar to those obtained using A?-BuLi as 
reagent. Therefore, we undertook a more detailed lithiation study o f 49 using /-BuLi 
as the lithium reagent.
A series of experiments was conducted to try to find conditions under which 
only one product would be obtained or to improve the yields of 56 and 57. Double 
lithiations o f 49 with 2.2 mole equivalents o f /-BuLi in THF for 2 or 4 h at 0 °C
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followed by reaction with benzophenone for 2 h at 0 °C were attempted. Under such 
conditions the yields of 56 and 57 were in the range of 34-37 and 30-34% , 
respectively (Table 2.1; entries 2 and 3), while 49 was recovered in 20-28%  yield.
o r
These results are consistent with Schlosser’s findings.
Table 2.1: Yields o f 56 and 57 formed by lithiation of 49 using /-BuLi (2.2 mole
equivalents) and reaction with benzophenone, according to Scheme 2.5
49 56 57
Yield (% )a
Entry T (°C ) t(h ) 49 56 57 overall
1 -78 4 69 (81)* 6(4)* 10(7)* 16 ( n y
2 0 2 28 34 30 64
3 0 4 20 37 34 71
4 20 2 30 40 16 56
5 20 4 30 42 17 59
a Yield o f isolated products after purification by column chromatography.
* Figures in parentheses are for similar reactions, but with w-BuLi or sec-BuLi as a 
lithium reagent (both reagents gave identical results).
The stability o f «-BuLi in diethyl ether as a solvent is ten to fifty times greater
o
than in THF at any given temperature. Generally, a temperature increase of 20 °C 
could shorten the lifetime of BuLi by a factor o f 10. It is well recognised that /-BuLi 
decomposes THF more rapidly than «-BuLi to produce ethylene and the lithium 
enolate o f acetaldehyde as the most abundant products. Therefore, it is always better
Q
to carry out lithiation reactions involving /-BuLi and THF below 0 °C. Nevertheless, 
we decided to attempt double lithiation of 49 with /-BuLi in THF at 20 °C to see what 
effect the temperature could have on both yield and selectivity o f products. Lithiations 
o f 49 with /-BuLi in THF for 2 or 4 h at 20 °C, followed by reaction with 
benzophenone for 2 h at 20 °C, were attempted. It was found that the yields of 56 and 
57 were in the range o f 40-42 and 16-17%, respectively (Table 2.1; entries 4 and 5), 
while 49 was recovered in 30% yield. It is clear that the overall yields o f products 
formed via lithiation were indeed lower at 20 °C than at 0 °C, as would be expected
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on the basis o f reaction o f the /-BuLi with the solvent. However, the overall yields, at 
56-59%, were still respectable and since 49 and benzophenone were easily recovered 
the process could be repeated to provide a higher final conversion into products after 
even 2 cycles. Alternatively, use o f a larger excess o f /-BuLi might lead to an increase 
in overall yield o f products.
More interestingly, the reaction was selective towards the side-chain lithiation 
product (56). At -78 °C the major product (albeit in very low yield) had been the ring- 
substituted product (57), while at 0 °C the two products were formed in more-or-less 
equal amounts (Table 2.1; entries 2 and 3), but at 20 °C 56 was favoured over 57 by 
around 2.5:1 (Table 2.1; entries 4 and 5). Indeed, the yield o f 56 at 20 °C was actually 
higher than at 0 °C, despite the likely reaction of the lithiating agent with THF, while 
the yield o f 57 was substantially lower. There are several possible explanations for 
these observations.
Firstly, lithiation at the ortho-position might be slow at 20 °C. However, this 
explanation is unlikely, since lithiation occurs readily enough at 0 °C.
Secondly, ortho and a-lithiations might take place at 20 °C as much as at 0 °C, 
but at the higher temperature the dilithium intermediate 58, produced in-situ from 
reaction o f 55 and benzophenone, may be unstable, dissociating back to 
benzophenone and or//7o-lithiated species 55 (Equation 2.1). The proportion of the 
adduct 58 present in the mixture when the reaction was quenched would be reflected 
in the yield of 57 obtained.
OLi
Ph Ph
58
Equation 2.1
Since the forward reaction involves ordering, it will have a negative AS 
(Equation 2.2). At higher temperature the TAS term (Equation 2.2) is greater and 
-TAS is therefore more positive, encouraging dissociation. At 0 °C the equilibrium 
position may favour association, whereas at 20 °C it may favour dissociation. This
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possibility was tested by treating 57 with /-BuLi (2 equivalents) in dry THF at 20 °C 
for 2 h. However, following work up 57 was recovered quantitatively (97%), which 
make this possibility unlikely.
AG = AH - TAS
Equation 2.2
Thirdly, at 20 °C the or//?o-lithiated species 55 might be reactive enough to 
deprotonate the solvent (THF), leading to starting material 49 that cannot react with 
benzophenone. However, if  the lithium reagent 55 is still intact at 20 °C, but the 
problem is something to do with the way it reacts with the benzophenone at the higher 
temperature, cooling it down before addition o f benzophenone would again lead to 
formation of 57. This possibility was tested by carrying out two experiments. The first 
(Experiment A) involved treatment o f 49 with /-BuLi (2 equivalents) in dry THF at 20 
°C for 2 h. The reaction mixture was then cooled down to 0 °C before benzophenone 
was added. The reaction mixture was stirred for 2 h at 0 °C, worked up and the 
product mixture was separated by column chromatography. Under such conditions the 
yields o f 56 and 57 were 41 and 18%, respectively, while 49 was recovered in 30% 
yield along with benzophenone. These results were virtually identical to those 
obtained from reactions carried out entirely at 20 °C. The second experiment 
(Experiment B) involved treatment o f 49 with /-BuLi (2 equivalents) in dry THF at 0 
°C for 2 h to give the mixture o f lithium species that led to the products recorded in 
Entry 2 o f Table 2.1. The reaction mixture was then warmed up to 20 °C before 
benzophenone was added and the reaction mixture was stirred for 2 h at 20 °C. Under 
such conditions the yields of 56 and 57 were 39 and 20%, respectively, while 49 was 
recovered in 31% yield along with benzophenone, i.e. quite similar to the results of 
Experiment A, but exhibiting a significantly lower yield of 57 than from reactions 
conducted entirely at 0 °C (Entries 2 and 3 o f Table 2.1). These results clearly 
indicated that lithium reagent 55 is not very stable at 20 °C and are consistent with its 
deprotonating the solvent to give back the starting material 49.
A fourth possibility is that the two lithium reagents 54 and 55 are capable of 
interconverting at 20 °C, presumably through a series of deprotonations and
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reprotonations, and that 54 is the thermodynamically more stable one. The lower 
overall yields would be a result o f the loss o f some /-BuLi by reaction with the THF, 
but the changed proportions o f products would reflect the net conversion o f 55 into 
54.
O f all the possibilities considered, the third possibility seems the most likely in 
view o f all the results.
Clearly, direct lithiation on the ring without lithiation on the CH2 of the 
CH:NHCOBu' group was not a realistic hope with A-benzylpivalamide (49) as 
substrate. However, ring substitution could presumably be achieved via bromine- 
lithium exchange o f yV-(2-bromobenzyl)pivalamide. Therefore, we decided to 
synthesise iV-(2-bromobenzyl)pivalamide.
2.4 Synthesis of A^-(2-bromobenzyl)pivalamide (60)
Ar-(2-Bromobenzyl)pivalamide (60) was prepared in 88% yield from reaction 
of pivaloyl chloride with 2-bromobenzylamine hydrochloride (59) in the presence 
TEA in DCM (Scheme 2.6).
NH2-HCI /-BuCOCI/TEA N
HDCM, 1 h, 0°C
60 (88%)
Scheme 2.6
With compound 60 in hand, attention was turned to investigate bromine- 
lithium exchange of 60 followed by reaction with various electrophiles in an attempt 
to produce the corresponding 2-substituted derivatives.
2.5 Bromine-lithium exchange of 7V-(2-broniobenzyl)pivalamide (60)
Halogen-lithium exchange of halogenated aromatic compounds is generally 
favoured over deprotonation (direct lithiation on the ring) at low temperatures. This 
rapid reaction allows the introduction o f a lithium atom at a specific non-activated 
position on the ring. The rate of halogen-lithium exchange in aryl halides follows the 
order, Arl > ArBr »  ArCl > ArF. Aryl chlorides and fluorides usually undergo
o
deprotonation at the position next to the halogen producing benzynes. The most
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common lithium reagents for halogen-lithium exchange are /-BuLi, «-BuLi and 
sec-BuLi; however, /-BuLi is the most favourable one.
The bromine-lithium exchange in aromatic compounds is likely to proceed 
through nucleophilic substitution at the bromine via formation o f ate complex as 
intermediate (Equation 2.3).8,87'89 Many examples of halogen-lithium exchange to 
produce the corresponding aryllithiums have been reported.8,89
A r-B r
L -
Ar-*Br—R
intermediate 
ate complex
©
Li
Ar—Li 
+
R -B r
Equation 2.3
In principle, bromine-lithium exchange o f A-^-bromobenzyOpivalamide (60) 
could be achieved by use o f three mole equivalents o f /-BuLi. One mole would be to 
deprotonate the nitrogen, another to exchange the bromine and the third to eliminate 
the bromide ion from /-BuBr to produce isobutane and isobutene. However, Smith has 
found that bromine-lithium exchange o f A'-(2-bromoaryl)-J/V,A-dimethylureas was 
more successfully achieved by the sequential use o f MeLi (1.1 equivalents -  to 
remove the NH proton) and /-BuLi (2.2 equivalents) at -78 °C.90 Therefore, bromine- 
lithium exchange o f compound 60 was attempted with MeLi and then /-BuLi at 
-78 °C in THF.
Compound 60 was treated with MeLi (1.1 equivalents) at -78 °C for 10 min to 
give the lithiated species 61 as a result o f deprotonation at the nitrogen (Scheme 2.7). 
The mixture was then treated with /-BuLi (2.2 mole equivalents) and the colourless 
mixture was stirred for 2 h at -78 °C in an attempt to ensure complete formation o f 55. 
An electrophile (benzophenone, cyclohexanone, benzaldehyde, 4-anisaldehyde, or 
deuterium oxide) was added and the mixture was stirred for 2 h at -78 °C (Scheme
2.7). Following work-up, the crude products obtained were crystallized from EtOAc- 
Et20 (1:3) to give the corresponding /V-(2-substituted benzyl)pivalamides 57 and 62- 
66 (Scheme 2.7) in high yields (Table 2.2). The products were all characterized by 
standard spectroscopic methods (see Chapter 7; Section 7.5).
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OLi
1.1 MeLi, -78 °C,
10 min.
2.2 f-BuLi 
-78 °C, 2 h
i, Electrophile, 
-78 °C, 2 h
57, 62-66(85-91%)
Scheme 2.7
Table 2.2: Synthesis o f jV-(2-substituted benzyl)pivalamides 57 and 62-66
according to Scheme 2.7
Product Electrophile E Yield (% )a
57 Ph2CO Ph2C(OH) 90
62 (CH2)5C =0 (CH2)5C(OH) 90
63 PhCHO PhCH(OH) 86
64 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 87
65 Mel Me 85
66* D20 D 91
C1 Yield o f isolated product after crystallization.
* Deuteration was almost 100% as indicated by NMR spectra.
As can be seen from Table 2.2, the yields o f products were high in all cases. 
The !H NMR spectra o f compounds 63 and 64 showed diastereotopicity for the two 
hydrogens o f the CH2 group at position 1. The diastereotopicity arises from creation 
o f a stereogenic carbon centre, on reaction o f lithium intermediate 55 with aldehydes. 
Compounds 63 and 64 were o f course present as racemic mixtures.
With a method for generating the ring-lithiated species essentially 
quantitatively now available, the opportunity presented itself to obtain further 
evidence about the stability of the lithiated species 55 at 20 °C (compare Section 2.3). 
To understand the reason for the lower yield o f 57 obtained from lithiation and 
substitution of 49 at 20 °C even better two experiments were carried out. The first 
involved treatment of 60 with MeLi and then /-BuLi in THF at -78 °C for 30 min. The 
mixture was then warmed to 20 °C and stirred for 30 min before benzophenone was 
added. The reaction mixture was stirred for 2 h at 20 °C and then worked-up. Under
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such conditions the isolated yield obtained of 57 was 78%, while unbrominated 
starting material 49 was obtained in 15% yield along with some benzophenone. The 
second experiment involved treatment of 60 with MeLi and then /-BuLi in dry THF at 
-78 °C for 30 min. The mixture was warmed to 20 °C and stirred for 30 min and then 
cooled down to -78 °C before benzophenone was added. The reaction mixture was 
stirred for 2 h at -78 °C. The yields obtained o f 57 and 49 were 82 and 12%, 
respectively, along with some benzophenone. Again, these results clearly indicated 
that lithium reagent 55 is not very stable at 20 °C and could be protonated back to 49.
Attention was next turned to the synthesis o f a series of ^-(substituted 
benzyl)pivalamides and investigation of their lithiation reactions to see what effect the 
type and position o f the substituent could have on the lithiation site.
2.6 Synthesis of various N-benzylpivalamides
Various iV-benzylpivalamides, namely A-(4-methoxybenzyl)pivalamide (44), 
A-(2-methoxybenzyl)pivalamide (46), A-(4-methylbenzyl)pivalamide (68) and 
A-(2-methylbenzyl)pivalamide (65) were prepared according to Scheme 2.8. The 
solids obtained after work-up were purified by crystallization to give pure products as 
white crystals in high yields (Table 2.3).
NH2 f-BuCOCI/TEA
Rir RTrDCM, 1 h, 0 °C
44, 46, 65 and 68
(87-92%)
R = 4 -OMe, 4 -Me, 2-OMe, 2-Me
Scheme 2.8
Table 2.3: Synthesis of N -(substituted benzyl)pivalamides 44, 46, 65 and 68
according to Scheme 2.8
Product R Yield (%)fl
44 4-OMe 87
46 2-OMe 91
65 2-Me 89
68 4-Me 92
Yield of isolated product after crystallization.
27
Chapter Two: Investigation o f the influences o f substituents on the lithiation sites of
various N-benzylpivalamides
Our attention was next turned to investigate the directed lithiation of 
jV-(4-methoxybenzyl)pivalamide (44) with /-BuLi at -7 8  °C followed by reactions 
with a range of electrophiles.
2.7 Directed lithiation of yV-(4-methoxybenzyl)pivalamide (44)
Previous experience with A-benzylpivalamide (49) suggested that /-BuLi 
might provide higher yields that «-BuLi and sec-BuLi in reactions involving 
lithiation. Therefore, reactions similar to those of Schlosser85 (Scheme 2.1) were 
carried out with /-BuLi in THF at -7 8  °C. Directed lithiation o f N-(4- 
methoxybenzyl)pivalamide (44) took place smoothly with /-BuLi (2.2 mole 
equivalents) in THF at -78  °C. Initial addition of /-BuLi gave the monolithium 
reagent 69, as a yellow solution, then the solution turned brownish red as the 
remaining /-BuLi was added, presumably because o f formation of the dilithium 
reagent 70. The mixture was stirred for 4 h at -78  °C and then an electrophile (1.1 
mole equivalents) was added and the mixture was stirred for 2 h at -78 °C (Scheme 
2.9). Following work-up o f the reaction mixture the crude products were purified by 
column chromatography (silica gel; Et20-hexane, 1:3) to give the corresponding 
substituted products in high yields (Table 2.4). The products were all characterised by 
standard spectroscopic methods (see Chapter 7; Section 7.7). It was difficult from 
simple *H NMR spectra of products to determine whether lithiation had taken place 
ortho to the C ^N H C O 'B u  group or ortho to the methoxy group. However, the 13C 
NMR spectra o f compounds 71-76 showed two signals somewhat upfield in the 
region of 111-117 ppm, which could attributed to C-3 and C-5. Also, they showed a 
signal somewhat downfield in the 5 = 129-134 ppm region, which could be attributed 
to C-6. These patterns indicated that electrophiles were introduced ortho- to the 
pivaloylaminomethyl group and that the products were A-(2-substituted
4-methoxybenzyl)pivalamides 71-76 (Scheme 2.9). Moreover, lithiation next to the 
-CH^NHCO'Bu group was expected based on Schlosser’s findings using n-BuLi at 
0 °C.85
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f-BuLi, -78 °C
MeO MeO
6944
f-BuLi, -78 °C
OLi
i, Electrophile,
-78 °C, 2 h
ii, aq. NH4CI MeOMeO
71-76 (77-88%
Scheme 2.9
Table 2.4: Synthesis o f A^-(2-substituted 4-methoxybenzyl)pivalamides 71-76
according to Scheme 2.9
Product Electrophile Yield (%)a
71
72
73
74
75 
76c
Mel
Ph2CO
(CH2)5O 0
MeCOBu
4-MeOC6H4CHO
D20
Me 8 r
Ph2C(OH) 80
(CH2)5C(OH) 77
MeC(OH)Bu 78
4-MeOC6H4CH(OH) 82 
D 88
a Yield of isolated product after purification by column chromatography. 
b iV-(4-Methoxy-2-methylbenzyl)-Ar-methylpivalamide (77) was obtained in 5% yield 
as side-product due to methylation on the nitrogen. Compound 77 was obtained in 
87% yield when the reaction was repeated with 2.2 equivalents of Mel. 
c Deuteration % was ca. 95% as indicated by NMR spectra.
The 'H  NMR spectra o f compounds 74 and 75 showed diastereotopicity for 
the two hydrogens of the CH2 group at position 1 and also for the two hydrogens of 
the CH2 group next to the newly created stereogenic carbon at position 2 in compound 
74. Compounds 74 and 75 would, of course, be formed as racemic mixtures.
The results obtained clearly showed that reactions o f the lithium reagent with 
electrophiles is general and substitution had taken place next to the -C H 2NHCOBu' 
group, which is consistent with Schlosser’s findings with «-BuLi at 0 °C.85 By 
contrast, Fiihrer and Gschwend had reported that lithiation of
37iV-(4-methoxyphenyl)pivalamide, using «-BuLi at 25 °C, was not selective. In this 
case, reactions o f the lithium intermediates obtained with an electrophile produced 
three substitution products, ortho- to the -NHCOBu', ortho- to the methoxy group and
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ortho- to both groups. The results o f Fiihrer and Gschwend suggest that the 
pivaloylamino group is slightly superior to a methoxy group in terms of its ortho-
-> n
directing ability. However, our results and those o f Schlosser suggest that the 
pivaloylaminomethyl group is substantially superior to a methoxy group at directing 
lithiation ortho to itself.
Our attention was next turned to investigate the directed lithiation of 
/V-(2-methoxybenzyl)pivalamide (46).
2.8 Directed lithiation of Ar-(2-methoxybenzyl)pivalamide (46)
iV-(2-Methoxybenzyl)pivalamide (46) had been lithiated previously by
o r
Schlosser using «-BuLi at 0 °C (Scheme 2.2). However, the reaction was not 
selective. Therefore, we decided to investigate the directed lithiation o f 46 under the 
general conditions used to lithiate compound 44 (Section 2.7; Scheme 2.9).
Therefore, compound 46 was treated with /-BuLi (2.2 mole equivalents) at 
-78 °C in THF under nitrogen (Scheme 2.10). It was found that initial addition of 
/-BuLi provided the monolithium reagent 78 as a yellow solution then turned to the 
dilithium reagent 79 as a reddish brown solution (Scheme 2.10). The mixture was 
stirred for 4 h at -78  °C after which an electrophile (1.1 mole equivalents) was added 
and the mixture was stirred for 2 h at -78 °C (Scheme 2.10) and then allowed to warm 
to room temperature. Following work-up o f the reaction mixture the crude products 
were purified by column chromatography (silica gel; Et20-hexane, 1:3) or direct 
crystallization from ethyl acetate to give the corresponding yV-(3-substituted 
2-methoxybenzyl)pivalamides 80-85 (Scheme 2.10) in high yields (Table 2.5).
/-BuLi, -78 °C
OMe OMe
7846
f-BuLi, -78 °C 
OLi
i.Electrophile, 
-78 °C, 2 h
OMeOMe
80-84 (73-86%)
Scheme 2.10
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The products were all characterised by standard spectroscopic methods (see 
Chapter 7; Section 7.9) and clearly indicated that lithiation and substitution took place 
ortho- to the OMe group rather than ortho- to the pivaloylaminomethyl group. In 
some cases, a low yield (2-3%) of a side-product was formed due to side-chain 
lithiation at the CH2 to produce dilithium reagent 86 (Figure 2.1). The structures of 
compounds 80 and 84 were confirmed by X-ray crystallography, as represented in 
Figures 2.291 and 2.3,92 respectively.
Table 2.5: Synthesis of vV-(3-substituted 2-methoxybenzyl)pivalamides 80-84
according to Scheme 2.10
Product Electrophile E Yield (% )a
80 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 76*
81 PhCHO PhCH(OH) 75
82 Ph2CO Ph2C(OH) 73'
83d D 20  D 86
84 ' C 0 2 C 0 2H 8 O'
" Yield o f pure product after column chromatography unless otherwise indicated. 
b Compound 85 (Figure 2.1) was obtained as a side product in 2% yield due to
lithiation and substitution at the side-chain. Also, traces o f 46 (3%) were recovered.
c Compound 87 (Figure 2.1) was obtained in 3% yield as a side product due to
lithiation and substitution at the side-chain. 
d Deuteration % was ca. 95% as indicated by NMR spectra. 
e Compound 84 was purified by crystallization from ethyl acetate.
 ^ The 'id NMR spectrum of the mother liquor from crystallization showed the 
presence, in nearly equal proportions, o f 46, the expected product from side chain 
lithiation 48 (Scheme 2.2) and additional 84, which were not separated.
MeO
OMe
NHCOBu'
86
OMe
Bu'
Ph
OMe
NHCOBu
Figure 2.1
The !H NMR spectra o f 80 and 81 showed that the signals of the two 
hydrogens of their CH2 groups appeared separately, as two separated double doublets, 
verifying that they are diastereotopic. Compounds 80 and 81 would, of course, be
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formed as racemic mixtures. Indeed, the X-ray crystallography of compound 80 
(Figure 2.2) showed a single type of crystal containing both enantiomers in equal 
proportions, but the structure displayed (Figure 2.2) shows the structure as 
A^-((.S*)-3-(hydroxy(4-methoxyphenyl)methyl)-2-methoxybenzyl)pivalamide. The l3C 
NMR spectrum of 87 showed that signals of the two phenyl groups appeared 
separately, verifying that they are diastereotopic. The compound would, of course, be 
produced as a racemic mixture.
Figure 2.2 X-ray crystal structure of compound 80. 
Thermal ellipsoids are shown at the 50% probability level.
Figure 2.3 X-ray crystal structure of compound 84. 
Thermal ellipsoids are shown at the 50% probability level.
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Compound 85 could potentially be formed as a pair of racemic 
diastereoisomers. However, its NMR spectra showed what appeared to be single sets 
of signals, indicating that the isolated product was probably a single diastereoisomer. 
However, since this side-product was isolated in only 2% yield, it is possible that a 
small amount of the other diastereoisomer was formed but not isolated. The X-ray 
crystallography of compound 85 showed a single type of crystal containing both 
enantiomers in equal proportions, but the structure displayed (Figure 2.4)92 shows 
only one part of the repeating unit, indicating the structure as A-((lS*,2S*)-2- 
hydroxy-l-(2-methoxyphenyl)-2-(4-methoxyphenyl)ethyl)pivalamide.
  "
Figure 2.4 X-ray crystal structure of compound 85. 
Thermal ellipsoids are shown at the 50% probability level.
Some of the aims of the experiments -  obtaining a higher yield and better 
selectivity in the reaction -  had been realised, but the major product was different than 
would have been expected based on either of the products obtained by Schlosser
q  r
following lithiation of the same substrate (Scheme 2.2). In an attempt to use 
conditions closer to those used by Schlosser we attempted lithiation of compound 46 
at 0 °C. It was found that lithiation of 46 with /-BuLi (2.2 mole equiv.) at 0 °C 
followed by reaction with 4-anisaldehyde gave a mixture of 80 and 85, which were 
isolated in 41 and 39% yields, respectively. Both products could be kinetic, but 80 is 
formed quicker than 85 and at low temperature is the overwhelming product whereas 
at higher temperature the rates are more comparable. Although this produced two
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products in comparable proportions, as found by Schlosser, the ring-substituted
Q C
product was still not the one expected based on Schlosser’s work.
The results obtained from directed lithiation and substitution of 44 (Section
2.7) and 46 are interesting in that there is a big difference between the situation when 
the methoxy group is in the 4-position and when it is in the 2-position. When the 
methoxy group was at the 4-position lithiation took place at the 2-position which is
O f
consistent with the results obtained by Schlosser for this substrate. This indicates 
that the pivaloylaminomethyl group is intrinsically a better directing metallating 
group than methoxy. However, when the position of the substituent is changed 
(methoxy at the 2-position) the reaction selectivity is very different, and lithiation 
occurred selectively at the 3-position, next to the methoxy group rather than next to 
-CH2NHCOBU'. The reasons for the change are not known. However, in the case of 
the 2-methoxy derivative 46 the two groups capable o f coordinating the metallating 
agent (monolithiated -C ^N H C O B u ' and methoxy) are adjacent to each other and 
may possibly chelate the incoming metallating agent (structure 88; Figure 2.5). In this 
case the hydrogen at the 3-position may be closer to the basic alkyl group than that at 
the 6-position, making the hydrogen at the 3-position the site o f choice for lithiation.
Figure 2.5
Clearly, lithiation o f Ar-(2-methoxybenzyl)pivalamide (46) with r-BuLi in THF 
at -78 °C, followed by reactions with electrophiles, gave ring substitution, but next to 
the methoxy group rather than next to the pivaloylaminomethyl group, which was 
unexpected based on earlier results reported by Schlosser when «-BuLi was used at 
0 °C.85 In order to clarify the situation we decided to use carbon dioxide as an 
electrophile under various reaction conditions.
The lithiation procedure for compound 46 described in Scheme 2.10 was 
varied by use of different lithium reagents (/-BuLi, sec-BuLi and «-BuLi) and 
different reaction temperatures (-78 and 0 °C). Compound 46 was treated with RLi 
(2.2 mole equivalents) at -78 or 0 °C and the mixture was stirred for 2 h at 0 °C or 4 h
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at -78 °C. Solid carbon dioxide was added and the reaction mixture was stirred for 30 
minutes. The mixture was diluted with ethyl acetate and quenched with dilute HC1. 
The crude product was crystallized from ethyl acetate to give the pure product and the 
mother liquor from crystallization was analysed by ’H NMR spectroscopy. The results 
obtained are recorded in Table 2.6.
Table 2.6: Products from lithiation o f 46, with different alkyllithiums (RLi) at
different temperatures (T), followed by reaction with CO2
c o 2h
T
c o 2h
T
NHCOBu' n h c o b u ' r NHCOBu* NHCOBu'
I
OMe OMe OMe J  OMe
46 47 48 C 02H 84
Yields of isolated Composition of mother liquor
Entry RLi T (°C) compounds (% )a following crystallization (%)*
47 84 46 47c 48^ 84
1 /-BuLi -78 — 80" 2 — 7 7
2 /-BuLi 0 5 40 — 14 26 9
3 sec-BuLi -78 12 — 22 24 34 —
4 sec-BuLi 0 25 — 9 23 38 —
5 A?-BuLi -78 — — 97 — — —
6 «-BuLi 0 11' — 17 19 40 8
" Yield o f pure product following fractional crystallization o f the product mixture. 
b The approximate % yield o f each component in the mother liquor following 
crystallization, as calculated from !H NMR spectra and weight of residue. 
c The structure o f 47 was confirmed by X-ray crystallography (Figure 2.6).92 
d No attempt was made to isolate a pure sample o f 48. 
e Yield obtained under the general conditions.
f  8 S1 Yield obtained under Schlosser’s conditions.
09The ring-substituted product 47 (Figure 2.6), the one expected based on 
Schlosser’s work (Scheme 2.2),85 was obtained, but in only low yield as a minor 
product using /-BuLi at 0 °C. When sec-BuLi was used as the lithium reagent, 47 was 
isolated in 12-25% yield as white crystals. There was no evidence for the formation of 
84 under the conditions tried using sec-BuLi. Repeating the same reaction but under 
Schlosser’s conditions using «-BuLi at 0 °C gave compound 47 in 11% yield 
following fractional crystallization of the crude product. Also, the 'H NMR spectrum 
of the mother liquor from crystallization showed the presence of additional 47, 48 and
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46 in the ratio of 1:1:2 along with traces with 84. This result is very similar to the one 
produced by Schlosser and implies that difficulty in isolation of the products from the 
reaction mixture was the reason for the low yields reported rather than that lithiation
o r
was ineffective. ~ Also, it was found that no products were obtained when /?-BuLi was 
used at lower temperature (-78 °C), suggesting that lithiation with rc-BuLi is very slow 
at low temperature.
Figure 2.6 X-ray crystal structure of compound 47. 
Thermal ellipsoids are shown at the 50% probability level.
It is not clear why lithiation of 46 with /-BuLi in THF at -78 °C gives 
substitution ortho- to the methoxy group while a similar procedure with sec-BuLi, or 
use of «-BuLi at higher temperature, gives a mixture containing two different 
substitution products, one of which involves lithiation ortho- to the 
pivaloylaminomethyl group. It could have something to do with the way the lithium 
reagents aggregate, their ability to chelate the two substituents or the relative bulk of 
the alkyl groups, but without further information it is not easy to decide. However, 
whatever, the explanation, the procedure we introduced represents a simple, efficient 
and high yielding route for substitution of 46 and has practical significance.
Attention was next turned to investigate the directed lithiation of 
AL(4-methylbenzyl)pivalamide (68) with /-BuLi at -78 °C.
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2.9 Directed lithiation of A^-m ethylbenzyOpivalam ide (68)
It was found that directed lithiation of Ar-(4-methylbenzyl)pivalamide (68), 
under the general conditions used to lithiate yV-(4-methoxybenzyl)pivalamide (44; 
Section 2.7) and V-(2-methoxybenzyl)pivalamide (46; Section 2.8), using /-BuLi in 
THF at -78 °C was general and successful with a range of electrophiles (Scheme
2.11). Various V-(2-substituted 4-methylbenzyl)pivalamides 89-95 were obtained in 
high yields (Table 2.7).
N
Hi, 2.2 /-BuLi, - 7 8 ° C , 4 h >
ii, Electrophile, -78 °C, 2 h |^e-
iii, aq. NH4CI
Me'
89-95 (79-90%)68
Scheme 2.11
Table 2.7: Synthesis of V-(2-substituted 4-methylbenzyl)pivalamides 89-95
according to Scheme 2.11
Product Electrophile E Yield (%)fl
89 c 6h 5c h o C6H5CH(OH) 79
90 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 81
91 Ph2CO Ph2C(OH) 81
92 (CH2)5C =0 (CH2)5C(OH) 82
93b d 2o D 88
94 Mel Me 00 o n
95 EtI Et 81
" Yield of isolated product after purification by column chromatography
Deuteration % was at least 95% as indicated by NMR spectra.
c Ar-(2,4-Dimethylbenzyl)-V-methylpivalamide (96) was obtained as a side product in 
2% yield. Compound 96 was obtained in 88% yield when the reaction was repeated 
under identical conditions with excess Mel (2.2 equivalents).
The products were all characterised by standard spectroscopic methods (see 
Chapter 7; Section 7.15) and clearly indicated that substitution had taken place ortho 
to the -CH2NHCOBu' which is similar to the case where a methoxy group was present 
at position 4 (Compound 44; Section 2.7).
The 'i i  NMR spectra of 89 and 90 showed that the signals o f the two 
hydrogens o f the CH2 group appeared separately, as two separated double doublets, 
verifying that they are diastereotopic. Both compounds would have been formed as 
racemic mixtures. Indeed, the X-ray crystallography o f compound 89 showed a single
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type of crystal containing both enantiomers in equal proportions, but the structure 
portrayed (Figure 2.7)92 shows just one enantiomeric form, 
Ar-((/?*)-2-(hydroxy(phenyl)methyl)-4-methylbenzyl)pivalamide. There is significant 
disorder of the carbons of the /er/-butyl group.
Figure 2.7 X-ray crystal structure of compound 89. 
Thermal ellipsoids are shown at the 50% probability level.
Attention was next turned to investigate the lithiation of 
Af-(2-methylbenzyl)pivalamide under the general conditions used for other substrates.
2.10 Lithiation of yV-(2-methylbenzyl)pivalamide (65)
In the case of A-(2-methylbenzyl)pivalamide (65) another possibility for 
lithiation exists that is not available for the other compounds studied so far. This 
involves lithiation at the methyl group (lateral lithiation). Lithiation of benzylic alkyl 
groups that are ortho-to a directing metallating group is an important methodology in
Q
organic synthesis. ’ The organolithium intermediates from lateral lithiation usually 
have significantly greater thermodynamic stability than the corresponding ortho-
Q
lithiated species obtained by directed lithiation. Lateral lithiation of benzenoid 
aromatics requires a stabilising group capable of either delocalising negative charge or 
stabilising an organolithium by coordination. Nitrogen-based stabilising groups 
placed on the or/Zio-position have been used for a number of lateral lithiations.8,93’95
Lateral lithiation of Af-(2-methylbenzyl)pivalamide (65) was attempted with 
/-BuLi (2.2 mole equivalents) at -78 °C in THF under the general conditions used for
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other substrates. Addition o f the first mole o f /-BuLi provided the monolithium 
reagent 97 as a yellow solution and the second mole produced a dilithium reagent 
(presumed to be 98) as a reddish brown solution (Scheme 2.12). The dilithium reagent 
was allowed to react with a range of electrophiles under identical conditions (Scheme
2.12). Following work-up the crude products were purified, by column 
chromatography, to give the corresponding substituted derivatives 99-106 (Scheme
2.12) in high yields (Table 2.8). The products were all characterised by standard 
spectroscopic methods (Chapter 7; Section 7.17). The NMR spectra o f all compounds 
showed the presence o f two different CH2 groups and indicated that lateral lithiation 
to give 98 had indeed taken place.
OLi
f-BuLi
-78 °CMe Me
65
f-BuLi 
-78 °C
OLi
i, Electrophile 
-78 °C, 2 h
99-106 (76-89%)
Scheme 2.12
Table 2.8: Synthesis of jV-(2-(substituted methyl)benzyl)pivalamides 99-106
according to Scheme 2.12
Product Electrophile E Yield (%)fl
99 c 6h 5c h o C6H5CH(OH) 84
100 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 89
101 PhCOMe PhC(OH)Me 80
102 Ph2CO Ph2C(OH) 88
103 (CH2)5C =0 (CH2)5C(OH) 76
104 Mel Me 87
105 EtI Et 88
106'’ D20 D 85
" Yield of isolated product after purification by column chromatography. 
h Deuteration was almost complete as indicated by NMR spectra.
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As can be seen from Table 2.8, the yields of pure products were high in all 
cases and the process was general to produce various 2-substituted derivatives.
The 'H NMR spectra of compounds 99-101 showed diastereotopicity for the 
two hydrogens of the CH2 groups. They would of course be formed as racemic 
mixtures. However, the structure of 99 based on X-ray crystallography (Figure 2.8)92 
showed the structure of the specific crystal analysed to be /V-((S*)-2-(2-hydroxy-2- 
phenylethyl)benzyl)pivalamide.
Figure 2.8 X-ray crystal structure of compound 99. 
Thermal ellipsoids are shown at the 50% probability level.
The results obtained clearly indicated a big difference between the situation 
when the methyl group is in the 4-position and when it is in the 2-position. It is 
presumably because the acidity of the methyl group at the 2-position is higher than 
that of the ring hydrogens, but when it is in the 4-position the advantage gained from 
the coordination of the lithium to the directing group encourages lithiation at the ring. 
Also, when the methyl group is in a position close to the coordination site 
(i.e. position 2), the geometry and/or the acidity of the methyl group made it the site 
of choice for metallation. The differences in lithiation sites could also arise from the 
fact that the lithium intermediates obtained from lateral lithiation of 
jV-(2-methylbenzyl)pivalamide have greater thermodynamic stability than the 
corresponding ones produced from or/Zzo-lithiation of /V-(4-methylbenzyl)pivalamide.
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Similar observation has been made previously with Ar-(2-methylphenyl)pivalamide 
with /7-BuLi at 0 °C.37
2.11 Conclusion
A simple, efficient and high yielding lithiation procedure that allows 
electrophilic substitution of various A-benzylpivalamides has been demonstrated to 
provide various substituted derivatives. Lithiation o f unsubstituted 
N-benzylpivalamide with /-BuLi in THF at -78-20 °C followed by reactions with 
benzophenone as an electrophile gave a mixture of ring substitution at position 2 
(or//?o-substitution) and side-chain lithiation o f the CH2 group (a-substitution). 
However, the yield of or/Zio-substitution product obtained from lithiation carried out 
at 20 °C was lower than the corresponding reaction carried out at 0 °C, presumably 
because the lithium reagent is not very stable at 20 °C and could be protonated back to 
the starting material. Ring substitution could be achieved via bromine-lithium 
exchange of A-(2-bromobenzyl)pivalamide followed by reactions with electrophiles. 
Lithiation of A-(4-methoxybenzyl)pivalamide and Ar-(4-methylbenzyl)pivalamide, in 
which a methoxy or methyl substituent was at position 4, with /-BuLi in THF at 
-78 °C followed by reactions with a variety o f electrophiles, gave only substitution at 
position 2 ortho to the pivaloylaminomethyl group, which therefore acted as a 
directed metallation group (DMG). By contrast, lithiation o f 
7/-(2-methoxybenzyl)pivalamide, with a methoxy group at position 2, followed by 
reactions with electrophiles under similar reaction conditions, gave ring substitution, 
but next to the methoxy group rather than next to the pivaloylaminomethyl group, 
which was unexpected based on the earlier results reported by Schlosser. Also, 
lithiation o f the 2-methoxy derivative at 0 °C gave a mixture of ring substitution at 
position 3 (o -substitution) and side-chain lithiation o f the CH2 group (a-substitution), 
which again was not expected based on Schlosser’s findings under similar conditions 
using tf-BuLi. It was found that lithiation o f A-(2-methylbenzyl)pivalamide, where the 
methyl group was at position 2, at low temperature (-78 °C) followed by reactions 
with various electrophiles, gave products substituted in the methyl group.
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C H A P T E R  T H R EE  
IN V E ST IG A T IO N  OF TH E IN FL U E N C E S O F SU B ST IT U E N T S  
ON TH E L IT H IA T IO N  SITES O F V A R IO U S  
A -B E N Z Y L -A yV -D IM E T H Y L U R E A S
3.1 Introduction
Lithiation of aromatic compounds ortho to a directed metallation group has 
become an invaluable route for the synthesis of various substituted aromatics.4' 11 
Various substituents were used as ortho directing groups, however, relatively little 
attention has been paid to ureas. For example, Clayden has shown that A, A-diaryl 
ureas undergo o rth o -1 and lateral lithiations,13,95 Schlosser lithiated V-benzyl-V.V- 
dimethylureas at the 2-position,96 Seebach lithiated V-allylurea by deprotonation of 
the methylene group,97 Beak lithiated V-benzyl-VA'-dimethylureas at the benzylic 
position,98 Joule has shown that six-membered cyclic ureas have some ortho directing 
ability,99 Queguiner lithiated Vr/V-dimethyl-V-(quinolin-3-yl)urea at C-4100 and Smith 
lithiated V'-aryl-AV-dimethylureas.101 The reports of Smith and Schlosser are the 
most relevant ones to the work presented in this chapter.
Smith showed that lithiation o f V-aryl-AV-dimethylureas was highly 
dependent on the nature of substituents on the aryl ring. In favourable cases, the 
lithium intermediates were generated in high yield via directed lithiation.101 In other 
cases, lithiation took place on the iV-methyl groups of the urea moiety or elsewhere on 
the aryl ring.101 For example, lithiation o f V-(4-chlorophenyl)- and 
V-(4-trifluoromethylphenyl)-V,V-dimethylureas took place ortho to the urea 
containing group, using «-BuLi at 0 °C.101 However, «-BuLi failed to lithiate 
N 1,-(4-fluorophenyl)-A/,Ar-dimethylurea under similar conditions, but the use of f-BuLi 
did effect lithiation on the ring next to the urea unit.101 By contrast, 
/V-(4-methylphenyl)-V,V-dimethylurea was lithiated primarily on one o f the V-methyl 
groups under similar conditions, while Ar-(4-methoxyphenyl)-jV,V-dimethylurea was 
lithiated ortho- to the methoxy group.101
Schlosser has shown that V-benzyl-AV-dimethylurea (107) and 
V-(4-methoxybenzyl)-A(vV-dimethylurea (108) undergo selective lithiation ortho to 
the urea containing group when treated with sec-BuLi in THF at -5 0  °C to give the 
corresponding carboxylic acid derivatives 109 and 110, respectively, in high yields
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(Scheme 3 .1).96 However, the generality o f the process has never been tested, carbon 
dioxide having been the only electrophile used.
, 2 sec-BuLi, THF, -50 °C
, CO
109 X = H (82%)
110 X =  OMe (85%)
107 X = H
108 X =  OMe
Scheme 3.1
By contrast, directed lithiation o f Ar-(2-methoxybenzyl)-A^,7V-dimethylurea 
(111) under similar reaction conditions was not selective, giving concomitant o- and 
o -lithiation, and no pure products were separated from the reaction mixture after 
reaction of the lithium reagents formed with carbon dioxide (Scheme 3.2).96
i, 2 sec-BuLi, THF Concomitant o-, o'-lithiation 
(no products or yields reported)ii, CO
OMe
111
Scheme 3.2
In Chapter Two, a simple and convenient lithiation procedure for 
iV-benzylpivalamides, followed by reactions of the lithium reagents obtained in-situ 
with various electrophiles, has been developed to produce various substituted 
products. We therefore decided to investigate the directed lithiation and substitution 
of various ^-(substituted benzyl)-A^,Wdimethylureas, under conditions similar to 
those used for directed lithiation of substituted Wbenzylpivalamides (Chapter Two), 
in order to examine the products formed and the generality of the process. We have 
selected TV-benzylW.TV-dimethylurea, 7V-(4-methoxybenzyl)-J/V,Ar-dimethylurea, 
Ar-(2-methoxybenzyl)-Af,Ar-dimethylurea, iV-(4-methylbenzyl)-Ar,Wdimethylurea and 
N '-(2-methylbenzyl)W,Wdimethylurea as substrates for this study.
Therefore, the aim of the work represented in this chapter was to synthesise 
various Ar-benzyl--/V,iV-dimethylureas and investigate their lithiation reactions. In this 
chapter, the successful syntheses of various N-benzyl-A^TV-dimethylureas and their
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lithiation reactions, with /-BuLi (2.2 equivalents) in dry THF, followed by reactions of 
the lithium intermediates generated in situ with various electrophiles to produce the 
corresponding substituted products in high yields are reported. The results, which we 
now report in this chapter using /-BuLi at low temperature (-78 or -20 °C), show 
consistency with the earlier results reported by Schlosser when sec-BuLi was used as 
the lithium reagent at -50 °C.96 Also, we found that lithiation of A-(4-methylbenzyl)- 
ACV-dimethylurea using /-BuLi at -78 °C takes place on the ring ortho- to the urea 
unit, while, lithiation of A-(2-methylbenzyl)-A^V-dimethylurea /-BuLi at -20 °C takes 
place on the methyl group at the 2-position. Similar observations had been made on 
lithiation o f A-(4-methylbenzyl)pivalamide and Ar-(2-methylbenzyl)pivalamide 
(Chapter Two; Sections 2.9 and 2.10).
3.2 Syntheses of A-benzyl-AyV-dimethylureas from the reactions of
benzylamines with triphosgene followed by reactions with dimethylamine
^-(Substituted benzyl)-A,A-dimethylureas should be accessible by reactions 
of substituted benzyl isocyanates with dimethylamine. However, whilst this method 
can be quite efficient, it suffers from the poor availability and stability of 
appropriately substituted benzyl isocyanates. These shortcomings prompted us to 
investigate an approach in which benzyl isocyanates could be generated in situ from 
the corresponding substituted benzylamines, followed by reactions with
1 09dimethylamine. Triphosgene is an alternative to phosgene, with the advantages that 
it is solid, gives three equivalents o f phosgene per mole in situ , is easy to handle and 
is much more pleasant to use than phosgene. Triphosgene has been used previously in 
our group for the synthesis of A-aryl-A,A-dimethylureas from the corresponding 
substituted anilines, followed by reaction with dimethylamine in the presence of 
triethylamine.90,101 We decided to use a similar approach for synthesis of 
/V-(substituted benzyl)-A,A-dimethylureas directly from readily available substituted 
benzylamines in a ‘one pot’ reaction (Scheme 3.3).
Slow addition o f a solution of the appropriate benzylamine 67 in DCM to a 
stirred solution o f triphosgene in DCM at 0 °C produced the corresponding benzyl 
isocyanates 112 in situ (Scheme 3.3). A solution o f dimethylamine in THF was slowly 
added to 112 at 0 °C and the reaction mixture was stirred at 0 °C for an extra 1 h. The 
reaction mixture was worked-up and the products were separated by extraction using
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boiling EtOAc/Et20 (1:3), in which A-benzyl-A,A-dimethylureas 107, 108, 111, 113 
and 114 dissolved and were obtained in 74-82% yield after crystallizing nicely as 
colourless crystals from the Et0 Ac/Et20 solution. The corresponding dibenzylureas 
115 (Figure 3.1) were highly insoluble in hot EtOAc/Et20 and were collected by 
filtration as white solids in 2-4% yield (based on 67). The nature o f the products is 
illustrated in Table 3.1, which also gives the yields obtained. The products were 
characterized by standard spectroscopic methods (see Chapter 7; Section 7.18).
\
0
H '
1/3(CI3CO)2CO| (f 
TEA, DCM, 0 °C ^ y
^N C O  Me2NH^ 
DCM
67 112 o
o o 107, 108,111, 113,114
R = 4-OMe, 4-Me, 2-OMe, 2-Me ) (74-82%)
Scheme 3.3
Table 3.1: Synthesis of A-(substituted benzyl)-A,A-dimethylureas 107, 108, 111,
113 and 114 according to Scheme 3.3
Yield (%)
107, 108, 111, 113 and 114" 115aV
H 81 4
4-OMe 82 3
2-OMe 79 2
4-Me 80 3
2-Me 74 4
a Yield o f pure product. 
b Based on the amount o f benzylamine 67.
A,A-Bis(substituted benzyl)ureas 115a-e (Figure 3.1) were formed as by­
products, presumably as a result o f reactions o f benzylamines 67 with their 
corresponding benzyl isocyanates 112, which were generated in-situ. The formation 
o f 115 (2-4% yield) was not avoidable even when the addition o f benzylamine 67 to a 
solution o f triphosgene was very slow. Dibenzylurea 115a was obtained as the main 
product when the mode of addition was reversed, so that a solution o f triphosgene was 
added to 67.
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R-u
115a-e (2-4%)
Figure 3.1
As can be seen from Table 3.1, the yields of all compounds were good, 
proving that the procedure is general for a range of substituents, and this overcomes 
the poor availability and stability o f appropriately substituted benzyl isocyanates. 
Therefore, it represents a useful one pot procedure for the synthesis o f A-(substituted 
benzyl^AA-dimethylureas. However, the method always produced 
A,A'-bis(substituted benzyl)ureas 115 as side-products. Therefore, our attention was 
next turned to the syntheses o f A-(substituted benzyl)-A,/V-dimethylureas from 
reactions of substituted benzylamines 67 with dimethylcarbamoyl chloride in order to 
compare the product yields from such a method with the ones obtained using the 
triphosgene method.
3.3 Syntheses of /V-benzyWV,/V-dimethylureas from reactions of 
benzylamines with dimethylcarbamoyl chloride
A mixture of 67 and dimethylcarbamoyl chloride in DCM, in the presence of 
triethylamine as a base, was heated under reflux conditions for 1 h (Scheme 3.4). The 
reaction mixture was allowed to cool to room temperature and poured onto water. 
Following work-up the residue obtained was purified by crystallization from Et20 or 
EtOAc/Et20 mixture (1/3) to give the pure A-(substituted benzyl)-A,A-dimethylureas 
107, 108, 111, 113 and 114 as white crystals in high yields (Table 3.2). The products 
were found to be identical in all respects with the ones produced according to Scheme
3.3 using triphosgene.
■
k-Co VR- Me2NCOCI, DCM^ TEA, reflux, 1 h
67 107,108,111, 113, 114
R = 4-OMe, 4-Me, 2-OMe, 2-Me ) (84-90%)
Scheme 3.4
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As can be seen from Table 3.2, the yields were high. Therefore, either of the 
two methods can be used for synthesis o f such compounds. However, the method 
involving dimethylcarbamoyl chloride gave better yields with no side-products being 
obtained, but the hazards o f the reagents involved in both methods should also be 
taken into consideration.
Table 3.2: Synthesis of A-(substituted benzyl)-A,A-dimethylureas 107, 108, 111,
113 and 114 according to Scheme 3.4
Compound R Yield (%)fl
107 H 88
108 4-OMe 89
111 2-OMe 85
113 4-Me 90
114 2-Me 84
" Yield o f isolated product after crystallization.
Having successfully synthesized various ^-(substituted benzy^-A^A- 
dimethylureas, our attention was next turned to investigate their lithiation reactions, 
under the general conditions used for A-benzylpivalamides (Chapter Two) using 
/-BuLi at -78 °C, followed by reaction with a range of electrophiles to give the 
corresponding substituted derivatives.
3.4. Directed lithiation of yV'-benzyl-AyV-dimethylureas 107,108 and 113
Previous experience with A-benzylpivalamides (Chapter Two) suggested that 
/-BuLi might provide higher yields of lithiation products than sec- or «-BuLi. 
Therefore, double lithiation o f A'-benzyl-AfjV-dimethylurea (107), 
A-(4-methoxybenzyl)-A,Ar-dimethylurea (108), and A-(4-methylbenzyl)-Ar,A- 
dimethylurea (113) were attempted under identical conditions using /-BuLi (2.2 mole 
equivalents) at -78 °C in anhydrous THF under nitrogen (Scheme 3.5). Two mole 
equivalents o f /-BuLi were required, the first one to deprotonate the urea to form the 
monolithium reagents 116 as yellow solutions and the second to deprotonate at 
position 2 to give the dilithium reagents 117 as reddish orange solutions (Scheme 3.5). 
The mixtures were stirred for 4 h at -78 °C in an attempt to ensure complete formation 
of dilithium reagents 117. The general utility o f 117 was demonstrated by their further 
reactions with a range of electrophiles (benzaldehyde, 4-anisaldehyde, benzophenone,
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iodomethane, iodoethane, or deuterium oxide) for 2 h at -78  °C under identical 
conditions (Scheme 3.5). The mixtures were allowed to warm to room temperature 
and quenched by the addition o f aqueous NH4C1 solution. Following work-up, the 
crude products were purified by column chromatography (silica gel; Et20-hexane, 
1:3) to give the corresponding pure products identified as N'-(2-substituted benzyl)- 
/V,iV-dimethylureas 114 and 118-131 (Scheme 3.5) in high yields (Table 3.3). The 
products were all characterised by standard spectroscopic methods (see Chapter 7; 
Section 7.20).
OLi
f-BuLi, THF
-78 °C
116107 R = H
108 R = OMe 
113 R = Me f-BuLi, THF 
-78 °C
OLi
i, Electrophile, 
-78 °C, 2 h
114,118-131 (70-89%) 117
Scheme 3.5
The NMR spectra of all compounds showed the presence o f CH2 signals, 
indicating that lithiation took place on the ring. The !H NMR spectra o f compound 
118, 119, 122, 123, 127 and 128 showed that the signals o f the two hydrogens of the 
CH2 group appeared separately, as two separated double doublets, which converted to 
two doublets after addition o f D20 ,  verifying that they are diastereotopic and coupling 
to NH. Such compounds would, o f course, be formed as racemic mixtures. Indeed, the 
X-ray crystallography92 o f compounds 122 (Figure 3.2) and 127 (Figure 3.3) showed 
a single type of crystal containing both enantiomers in equal proportions in each case, 
but the structure displayed shows the structure as (5'*)-A^'-(2-(hydroxy(4- 
methoxyphenyl)methyl)-4-methoxybenzyl)-A^,A^-dimethylurea and (R *)-N’-(2- 
(hydroxy(4-methoxyphenyl)methyl)-4-methylbenzyl)-A^,Ar-dimethylurea, respectively.
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Table 3.3: Synthesis of N'-(2-substituted benzyl)-AyV-dimethylureas 114 and 118-
131 according to Scheme 3.5
Product R Electrophile E Yield (%)"
114 H Mel Me 80
118 H 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 86
119 H PhCHO PhCH(OH) 82
120 H Ph2CO Ph2C(OH) 84
1216 H D20 D 89
122 OMe 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 85
123 OMe PhCHO PhCH(OH) 89
124 OMe Ph2CO Ph2C(OH) 84
125* OMe D20 D 86
126 OMe EtI Et 88(
127 Me 4-MeOC6H4CHOH 4-MeOC6H4CH(OH) 76
128 Me PhCHO PhCH(OH) 70
129 Me Ph2CO Ph2C(OH) 72
130 Me EtI Et 80
131* Me D ,0 D 86
a Yield of isolated product after purification by column chromatography. 
h Deuteration was at least ca. 95% as indicated by NMR spectra. 
c 7V-Ethyl-A^-(2-ethyl-4-methoxybenzyl)-Arr/V-dimethylurea (132) was obtained as a 
side product in 3% yield due to substitution at nitrogen. Compound 132 was obtained 
in 90% yield after purification when the reaction was repeated with EtI (2.2 equiv.).
Figure 3.2 X-ray crystal structure of compound 122. 
Thermal ellipsoids are shown at the 50% probability level.
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Figure 3.3 X-ray crystal structure of compound 127. 
Thermal ellipsoids are shown at the 50% probability level.
From the results in Table 3.3 it is clear that ortho-lithiation of TV'-benzyl-A^N- 
dimethylureas 107, 108 and 113, ortho to urea containing group, is a general process 
that can be conducted using /-BuLi at -78  °C as well as 5ec-BuLi at -50  °C (as used 
by Schlosser96) and with a variety of different electrophiles. Similar observations had 
been previously made for directed lithiation of A^-(4-methoxybenzyl)- and 
Ar-(4-methylbenzyl)pivalamides under similar conditions (Chapter Two; Sections 2.7 
and 2.9, respectively), whereas lithiation of N-benzylpivalamide was not selective and 
gave ring and side chain substitution (Chapter Two; Section 2.3). By contrast to the 
situation here, Smith showed that double lithiation of N'-phenyl and 
N-(4-methylphenyl)-Af,jV-dimethylureas was achieved using /-BuLi at -20 °C and 
took place on one of the two methyl groups of the urea.101 On the other hand, 
lithiation of Ar-(4-methoxyphenyl)-7V,Ar-dimethylurea using /-BuLi at 0 or -20 °C took 
place partially on carbon at the 3-position but primarily on a methyl group of the urea, 
leading to a mixture of ring substitution, methyl substitution and disubstitution (on the 
ring and on the methyl) on reaction with an electrophile. The disubstituted derivatives 
were obtained in high yields when 3 equivalents of /-BuLi and excess of the 
electrophile were used.101
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Having successfully achieved directed lithiation and substitution o f 107, 108 
and 113, attention was next turned to the directed lithiation of A'-(2-methoxybenzyl)- 
A^iV-dimethylurea (111) with /-BuLi.
3.5 Directed lithiation of TV1-(2-methoxybenzyl)-Ar,./V-dimethylurea (111)
Schlosser has lithiated AA'-(2-methoxybenzyl)-AfA-dimethylurea (111) with 
sec-BuLi, at o- and o -positions, but no pure products were separated (Scheme 3.2).96
It was of interest to see if the reaction could be made selective and general. 
Therefore, compound 111 was treated with /-BuLi (2.2 mole equivalents) at -78  °C in 
anhydrous THF under nitrogen under identical conditions to those used for other 
substrates (Section 3.4). It was found that initial addition of /-BuLi provided a yellow 
solution, presumably because of formation o f the monolithium reagent 133 (Scheme 
3.6), until approximately one equivalent had been added, then a reddish orange 
solution was formed as the remaining /-BuLi was added, presumably because of 
formation of a dilithium reagents. The mixture was stirred for 2 h at -78  °C in an 
attempt to ensure complete formation o f the dilithium reagents. 4-Anisaldehyde was 
added and the mixture was stirred for 2 h at -7 8  °C. The mixture was worked-up and 
the product mixture was purified by column chromatography (silica gel; Et20-hexane, 
1:3) to give two products subsequently identified as A-(2-(hydroxy(4- 
methoxyphenyl)methyl)-6-methoxybenzyl)-iV,iV-dimethylurea (136; 29% yield) and 
/V'-(3-(hydroxy-(4-methoxyphenyl)methyl)-2-methoxybenzyl)-AyV-dimethylurea 
(137; 26%), along with the starting material 111 (39%) and 4-anisaldehyde.
Compound 136, having the hydroxy(4-methoxyphenyl)methyl group ortho- to 
the -CH2NHCONMe2 group, is the expected product from the reaction o f 
4-anisaldehyde with dilithium intermediate 134 (Scheme 3.6). Compound 137, having 
the hydroxy(4-methoxyphenyl)methyl group ortho- to the methoxy group, is the 
expected product from the reaction of dilithium intermediate 135 with 4-anisaldehyde 
(Scheme 3.6). The sites of lithiations were the ones expected based on Schlosser’s 
findings but in his case no pure products were separated from the reaction mixture.96
The !H NMR spectra of 136 and 137 showed signals for the two hydrogens o f 
a CH2 group appearing separately, as two separated double doublet, verifying that 
they were diastereotopic. Compounds 136 and 137 were of course present as racemic 
mixtures.
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OMe
111
0 to -78 °C OMe
133
f-BuLi 
0 to -78 °C
CHOi, MeO
0 to -78 °C 
ii, aq. NH4CIOMe OMe
134 135
MeO
OH
OMe
HO
OMe OMe
136 (29-50%) 137 (12-40%)
Scheme 3.6
It was of interest to see if the reaction would proceed in the same manner 
under different reaction conditions. Therefore, a more detailed lithiation study o f 111 
using /-BuLi as the lithium reagent was conducted in an attempt to find conditions 
under which only one product would be obtained or to improve the yields of 136 
and/or 137. In this study the reaction time and temperature were varied. The results 
obtained are recorded in Table 3.4. It was found that double lithiation of 111 with 
/-BuLi at -78  °C for 4 h followed by reaction with 4-anisaldehyde for 4 h, gave 136 
and 137 in slightly better yields (31 and 27%, respectively) along with residual 111 
(34%) after separation by column chromatography (Table 3.4; entry 2).
On lithiation of 111 at -50  °C for 2 h followed by reaction with 
4-anisaldehyde for 2 h it was found that yields of 136 and 137 were increased further 
to 35 and 33%, respectively (Table 3.4; entry 3), while the residual quantity of 111 
was less (13%). When the reaction time o f the lithium reagents with 4-anisaldehyde 
was increased to 4 h at -50  °C the yields o f 136 and 137 were slightly increased to 36 
and 34%, respectively (Table 3.4, entry 4).
It was clear from these results that the temperature had a greater effect on the 
yields of products than the reaction time. It was found that double lithiation of 111 at 
-20 °C for 2 h followed by reaction with 4-anisaldehyde for 2 h, gave 136 and 137 in
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49 and 40%, respectively, with no starting material 111 being recovered (Table 3.4, 
entry 5). This result clearly indicated that good overall yields can be achieved from 
such a reaction.
Table 3.4: Yields o f 136 and 137 under various reaction conditions according to
Scheme 3.6 under various reaction conditions
111
OMe
MeO
OH
136
OMe
HO
137
OMe
OMe
Entry T (°C )
Time (h) 
Lithiation
Yield (%)a
111 136 137
1 -78 2 39 29 26
2 -78 4 34 31 27
3 -50 2 13 35 33
4 -50 4 13 36 34
5 -20 2 — 49 40
6 0* 2 12 50 12
11 Yield of isolated products after purification.
Compound 138 (3%) and compound 139 (11%) were also obtained (Figure 3.4).
Double lithiation of 111 with /-BuLi for 2 h at 0 °C followed by reaction with 
4-anisaldehyde for 2 h at 0 °C was attempted. Following work-up, the mixture was 
subjected to TLC, which showed that both products 136 and 137 were present, along 
with a small quantity of 111. The TLC also showed the formation of two other minor 
products, subsequently shown to be 138 and 139 (Figure 3.4).
OMe
LiO
^ X ) M e  
139 (11%)
OH
138 (3%) 140
Figure 3.4
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All compounds were separated by column chromatography (Table 3.4; entry 
6). Compounds 136 and 137 were obtained in 50% and 12% yields, respectively, and 
111 was recovered in 12% yield after column chromatography, while 138 and 139 
were obtained in yields of 3% and 11%, respectively.
Compound 138 was formed due to cleavage of the ether bond by /-BuLi. The 
formation of 138 was avoided in subsequent experiments by very slow addition of 
/-BuLi. Compound 139 could potentially be formed as a pair of racemic 
diastereoisomers; however, its NMR spectra showed what appeared to be a single set 
of signals, indicating that the isolated product was a single racemic diastereoisomer. 
However, since this compound 139 was isolated in only 11% yield, it is possible that a 
small amount of the other diastereoisomer was formed but not isolated. The X-ray 
crystallography of compound 139 showed a single type of crystal containing both 
enantiomers in equal proportions, but the structure displayed (Figure 3.5)92 shows 
only one part of the repeating unit, indicating the structure as 3-(7? *)-3-((£*)- 
hydroxy(4-methoxyphenyl)methyl)-4-methoxyisoindolin-l-one. Compound 139 could 
arise from the reaction of the cyclic lithium intermediate 140 (Figure 3.4), generated 
in situ, with 4-anisaldehyde. Successful syntheses in higher yield of 139 and other 
related derivatives will be discussed in Chapter Six.
Figure 3.5 X-ray crystal structure of compound 139. 
Thermal ellipsoids are shown at the 50% probability level.
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Clearly, direct lithiation of 111 on the ring ortho to the urea containing group 
without lithiation ortho to the methoxy group was not a realistic hope. Both 
substitution sites were attacked competitively. It was nevertheless of interest to see if 
the reaction of the dilithium intermediates 134 and 135 with other electrophiles at 
-20 °C would be general to produce 7V'-(2-substituted b-methoxybenzyl)-^,^- 
dimethylureas and 7V-(3-substituted 2-methoxybenzyl)-J/V,A/r-dimethylureas. 
Consequently, reactions of the lithium reagents 134 and 135, prepared in-situ from 
compound 111, with a range o f electrophiles (benzaldehyde, benzophenone, 
iodomethane, or iodoethane) were carried out at -20 °C (Scheme 3.7). Each reaction 
was conducted under identical conditions and then worked-up. The products were 
separated by column chromatography (silica gel; Et20-hexane, 1:3), to give a mixture 
of the corresponding N'-(2-substituted 6-methoxybenzyl)-J/V,./V-dimethylureas 141,
143, 145 and 147 and ^ - ( 3 -substituted 2-methoxybenzyl)-7V, N-dimethylureas 142,
144, 146 and 148 (Scheme 3.7) in high overall yields (Table 3.5). The products were 
characterised by standard spectroscopic methods (see Chapter 7; Section 7.24).
'
i, 2.2 f-BuLi, h
m
> \ / s  / s  /-20 °C, 2 h - (I 4 M ¥ f i ^ r  t i v
L A  "  1 ii, Electrophile, 1 + L A  H 1OMe -20 °C, 2 h OMe OMe
iii, aq. NH4CI E
111 141, 143,145 and 147 142, 144,146 and 148
(47-51%) (30-40%)
Scheme 3.7
From the results recorded in Table 3.5 it was clear that lithiation of 
Ar-(2-methoxybenzyl-jV,A^-dimethylurea (111) followed by reaction with a variety of 
different electrophiles was a general process, producing a mixture of N ‘'-(2-substituted 
6-methoxybenzyl)-Ar,vV-dimethylureas and tV-(3-substituted 2-methoxybenzyl)-Ar,Ar- 
dimethylureas in high overall yields. The yields o f the two major products from all o f 
the reactions were remarkably consistent, suggesting that lithiation ortho to methoxy 
and ortho to the urea containing group took place under these conditions in a ratio of 
around 55:45.
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Table 3.5: Synthesis of iV'-(2-substituted 6-methoxybenzyl)-Ar,./V-dimethylureas
141, 143, 145 and 147 and -(3-substituted 2-methoxybenzyl)-jV,J/V- 
dimethylureas 142, 144, 146 and 148 according to Scheme 3.7
Yield (%)fl
Electrophile E ------- :-------------------------------------- :-------------------------
141, 143, 145 and 147 1 4 2 / 144, 146 and 148
PhCHO PhCH(OH) 51 38
Ph2COc Ph2C(OH) 47 30
MelJ Me 51 40
EtI Et 51 38
a Yield of isolated products after purification.
h The !H NMR spectra showed diastereotopicity for the two hydrogens o f the CH2 
groups.
r Starting material 111 (4%) was recovered.
d Compounds 149 and 150 (Figure 3.6) were obtained in 5% combined yield, but as a 
mixture which was difficult to separate. Formation of 149 and 150 clearly indicated 
that methylation had taken place at both the ring (o-/o'~) and the nitrogen.
OMe
149
OMe
150
Figure 3.6
The results obtained from directed lithiation and substitution of 108 (Section 
3.4) and 111 are consistent with the results obtained by Schlosser for both 
substrates.96 When the methoxy group was at the 4-position lithiation took place at the 
2-position. This indicates that the urea containing group is intrinsically a better 
directing metallating group than methoxy. However, when the methoxy was at the 
2-position lithiation occurred on the ring competitively at the 3-position, next to the 
methoxy group, and at the 6-position, next to -CH2NHCONMe2. The reasons for the 
change are not known. However, in the case o f the 2-methoxy derivative 111 the two 
groups capable of coordinating the metallating agent (monolithiated 
-CH2NHCONMe2 and methoxy) are adjacent to each other and may possibly chelate 
the incoming metallating agent.
Finally, attention was next turned to lateral lithiation of jV'-(2-methylbenzyl)- 
/V,7V-dimethylurea (114) using t-BuLi at -78 °C.
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3.6 Lateral lithiation of N lf-(2-methylbenzyl)-Ar,Ar-dimethylurea (114)
An activating group with the ability to coordinate and to acidify is important in 
benzylic lithiation as well as ortho-lithiation. However, the acidifying groups in 
ortho-lithiation operate by inductive effects, since the C-Li bond is in the same plane 
as the aromatic ring, while, for lateral lithiation involving formation of a benzylic 
C-Li bond, the acidifying group works best by conjugation.8 Lateral lithiation of 
various aromatics containing nitrogen-based stabilising groups on the ortho-position 
has been reported previously.8,13,93'95 Also, we have shown that lateral lithiation of 
A-(2-methylbenzyl)pivalamide took place smoothly on the methyl group with /-BuLi 
at -78 °C (Chapter Two; Section 2.10). Therefore, it was of interest to test the 
possibility of lateral lithiation o f Ar-(2-methylbenzyl)-A,A-dimethylurea (114) under 
similar conditions.
Indeed, treatment of 114 with /-BuLi (2.2 mole equivalents) at -78  °C in THF 
gave a yellow solution presumed to be the monolithium reagent 151 and then turned 
to a reddish orange solution presumed to be the dilithium reagent 152 (Scheme 3.8). 
The mixture was stirred for 4 h at -78 °C and then the dilithium reagent was allowed 
to react with a range o f electrophiles (benzaldehyde, 4-anisaldehyde, benzophenone, 
acetophenone, iodoethane, or deuterium oxide). Each reaction was conducted under 
identical conditions and then worked-up. The crude products were purified by column 
chromatography (silica gel; Et20-hexane, 1:3), to give the corresponding 
yV-(2-(substituted methyl)benzyl)-ACV-dimethylureas 153-158 (Scheme 3.8) in good 
yields (Table 3.6). The products were all characterised by standard spectroscopic 
methods (see Chapter 7; Section 7.25).
153-158 (74-83%)
114
Me
i, Electrophile, 
-78 °C, 2 h
ii, aq. NH4CI
-78 °C
f-BuLi
151
152
Me
f-BuLi 
-78 °C
Scheme 3.8
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Table 3.6: Synthesis of ^ -^ -(substitu ted  methyl)benzyl)-AGV-dimethylureas 153-
158 according to Scheme 3.8
Product Electrophile E Yield (%)a
153 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 79
154 PhCHO PhCH(OH) 77
155 PhCOMe PhCH(OH)Me 74
156 Ph2CO Ph2C(OH) 76
157 EtI Et 82
158* D20 D 83
" Yield of isolated product after purification by column chromatography. 
b Deuteration was over ca. 90% as indicated by NMR spectra.
The NMR spectra of all compounds showed the presence of two different CH2 
groups. The *H NMR spectra of compounds 153-155 showed that the signals of the 
two protons of the two CH2 groups, -CH2NHCONMe2 and the CH2 group at the 
2-position, appeared separately, verifying that they are diastereotopic. Such 
compounds were o f course present as racemic mixtures.
As can be seen from Table 3.6, it is clear that lateral lithiation o f 114 is a 
general process that can be conducted using /-BuLi and with a variety of different 
electrophiles. The difference in lithiation site in the case of A-(4-methylbenzyl)-A,A- 
dimethylurea and iV'-(2-methylbenzyl)-A/A-dimethylurea is presumably because the 
acidity o f the 2-methyl group is higher than that o f the ring hydrogens, but when it is 
in the 4-position the advantage gained from the coordination o f the lithium to the 
directing group encourages lithiation at the ring. Also, when the methyl group is in a 
position close to the coordination site (i.e. position 2), the geometry and/or the acidity 
of the methyl group made it the site o f choice for metallation.
3.7 Conclusion
Various substituted A'-benzyl-A/V-dimethylurea derivatives have been 
synthesized in high yield via simple and efficient lithiation procedures of V'-benzyl- 
A/V-dimethylureas followed by reactions with a range of electrophiles. Lithiation of 
unsubstituted A'-benzyl-A/A-dimethylurea, A-(4-methoxybenzyl)-A,A-dimethylurea 
and V-(4-methylbenzyl)-/V,/V-dimethylurea with /-BuLi at -78 °C in THF followed by 
reactions with various electrophiles gave ring substitution at position 2 ortho to the 
urea containing group, which therefore acted as a directed metallating group (DMG). 
By contrast, lithiation of Ar-(2-methoxybenzyl)-V.A-dimethylurea with /-BuLi at
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-20 °C in THF, with a methoxy group at position 2, followed by reactions with a 
range of electrophiles gave mixtures of ring substitution next to the methoxy group 
(o -substitution) and next to the urea containing group (o-substitution). The yields of 
the two products from all o f the reactions were remarkably consistent, suggesting that 
lithiation ortho to methoxy and ortho to the urea containing group took place under 
these conditions in a ratio of around 55:45. It was found that lithiation of 
/V-(2-methylbenzyl)-A^A^-dimethylurea, where the methyl group was at position 2, 
with /-BuLi at -78 °C in THF, followed by reactions with various electrophiles, gave 
products substituted in the methyl group, with no evidence for ring or side-chain 
substitution.
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Chapter Four: Synthesis o f substituted isoindolines
C H A PT E R  FO U R  
SY N T H E SIS O F SU B ST IT U T E D  ISO IN D O LIN E S
4.1 Introduction
Isoindoles show significant applications and useful properties since this ring
system can be found in a number o f valuable compounds including alkaloids and
drugs.103105 Isoindoles are commercially less important than indoles, at least partly
because of a lack o f good synthetic methods. Simple isoindoles can be prepared from
the cyclization o f 1,2-bis(bromomethyl)benzene, phthalaldehyde or 2-cyanobenzyl
chloride with amines or alkoxides or by condensation reactions of carbonyl
compounds with amines.106,107 However, these are particularly applicable to produce
isoindole compounds with no substituents on the benzenoid ring. Moreover, such
synthetic methods involve various steps and/or provide low yields. However, Clay den
has developed a very useful approach to dihydroisoindolones with particular
substitution patterns using dearomatising cyclization of lithiated /V-benzylbenzamides
108 112and demonstrated its utility for synthesis o f natural products such as kainic acid.
Other substitution patterns would be potentially available from reactions 
studied by Schlosser,85,96 but the reported reactions were not always highly 
regioselective and their generality has never been tested. Therefore, we became 
interested to develop a new approach for the synthesis of various dihydroisoindole 
derivatives, whereby highly selective processes for ortho-lithiation would allow 
production of specifically substituted isoindolines.
In Chapters 2 and 3, we have reported convenient procedures for the directed 
lithiation o f compounds of the general formula 159 (Figure 4.1) using f-BuLi in 
anhydrous THF at -78 °C followed by reactions with carbonyl compounds (aldehydes 
and ketones) to give the corresponding e>r//?e>-disubstituted products 160 (Figure 4.1) 
in high yields. The general utility o f compounds 160 would be demonstrated by their 
cyclization to the corresponding dihydroisoindoles (or isoindolines) 161 (Figure 4.1). 
Therefore, the aim of the work presented in this chapter was to investigate if 
cyclization of 160 could be achieved and would be general. In this chapter, the 
successful cyclizations o f 160 with trifluoroacetic anhydride (TFAA) in DCM at room 
temperature to give the corresponding isoindolines 161 in excellent yields are 
reported.
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NHCOR
OH
NHCOR
159 160 161
R = H, OMe, Me; R1 = fBu, NMe2; R2, R3 = H, Ar
Figure 4.1
4.2 Synthesis of l,l-diphenyl-2-pivaloylisoindoline (162)
It was hoped that cyclization o f jV-(2-(hydroxydiphenylmethyl)benzyl)- 
pivalamide (57) could be achieved via dehydration. Therefore, an initial reaction was 
carried out between compound 57 and few drops of TFAA at room temperature in 
DCM (Scheme 4.1). TLC was used to monitor the progress of the reaction, and 
indicated the formation of a new product, the formation of which was complete within 
5 minutes. The mixture was quenched by the addition of water and worked-up. The 
residue obtained was subjected to flash column chromatography (silica gel; Et20-  
hexane, 1:3) to give the pure product, identified as compound 162, in 85% yield.
>
9 f
"NHCOBif
.OH
> h
TFAA, RT 
DCM, 5 min
5’ 
X
O
 
CD
57 162 (85%)
Scheme 4.1
The chemical ionization (Cl) mass spectrum showed a very high intensity 
(100%) pseudo molecular ion (MH+) at m/z = 356. The accurate mass o f the pseudo 
molecular ion confirmed the formula as C25H26NO (MH+), indicating the loss of 18 
from the molecular weight o f the starting material 57. Moreover the microanalysis 
confirmed the formula of compound 162 as C25H25N2O. The IR spectrum of 
compound 162 showed no absorption band corresponding to the stretching vibrations 
of the NH or OH group. Also, in the !H NMR spectrum there were no exchangeable 
hydrogens. Clearly, cyclization of 57 via dehydration had taken place and the 
structure of 162 was further confirmed by X-ray crystallography (Figure 4.2).92
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Figure 4.2 X-ray crystal structure of compound 162. 
Thermal ellipsoids are shown at the 50% probability level.
The cyclization would be consistent with Baldwin’s rules as 5-exo-tet,113,114 
but it is far more likely that it occurs by an Sn 1 mechanism (Scheme 4.2).
HN Bu1 HN Bu1 HN- Bu1
TFAA
PH Ph- TFA
PhPh Ph
Bu1
PhPh Ph
162
Scheme 4.2
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4.3 Synthesis of substituted isoindolines 163-173
Having found that reaction of compound 57 with TFAA occurred smoothly 
and rapidly at room temperature in DCM, it was of interest to see if the cyclization 
reaction of other compounds o f the general formula 160 would be useful and general. 
Consequently, reactions of various 160 with TFAA were carried out at room 
temperature in DCM for 5 minutes (Scheme 4.3). Each reaction was conducted under 
identical conditions, examined by TLC and then quenched by the addition o f water. 
The reactions proceeded smoothly in all cases and the crude products were subjected 
to flash column chromatography (silica gel; Et20-hexane, 1:3), to give the 
corresponding isoindolines 163-173 (Scheme 4.3) in excellent yields (Table 4.1). The 
products were all characterised by standard spectroscopic methods (See Chapter 7; 
Section 7.27). The nature o f the products is illustrated in Table 4.1, which also gives 
the yields obtained.
NHCOR1 TFAA, RT 
OH DCM, 5 min
163-173 (87-98%)160
R = H, Me, OMe; R 1 = rBu, NMe2; R , R5 = H, Ar
Scheme 4.3
Table 4.1: Synthesis of substituted isoindolines 163-173 according to Scheme 4.3
Product R R1 R2 R3 Yield (%)fl
163 H 'Bu H 4-MeOC6H4 89
164 H 'Bu H Ph 87
165 OMe 'Bu H 4-MeOC6H4 90
166 OMe 'Bu Ph Ph 98
167 Me 'Bu H 4-MeOC6H4 88
168 H NMe2 H 4-MeOC6H4 89
169 H NMe2 Ph Ph 91
170 OMe NMe2 H 4-MeOC6H4 91
171 OMe NMe2 Ph Ph 88
172 Me NMe2 H 4-MeOC6H4 91
173 Me NMe2 Ph Ph 88
a Yield of isolated product after purification by column chromatography.
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The !H NMR spectra of compounds 163-165, 167, 168, 170 and 172 showed 
diastereotopicity for the two hydrogens of the CH2 group at position 3 of the 
isoindoline ring. Such compounds would have been formed as racemic mixtures. 
However, the X-ray crystallography of compound 165 (Figure 4.3)92 showed that the 
structure of the specific crystal looked at was (S*)-6-methoxy-l-(4-methoxyphenyl)- 
2-pivaloylisoindoline. By contrast, the X-ray crystallography of compound 170 
showed a single type of crystal containing both enantiomers in equal proportions, but 
the structure displayed (Figure 4.4)92 shows only one part of the repeating unit, 
indicating the structure as (^*)-2-dimethylaminocarbonyl-6-methoxy-l-(4- 
methoxyphenyl)isoindoline.
The two-dimensional NMR correlation spectroscopy (COSY) for compound 
170 showed that one of the hydrogens at the 3-position was also coupled to H-l. It 
also showed that there was no coupling between H-4 and either of the hydrogens at 
position 3 or between H-l and H-7.
Figure 4.3 X-ray crystal structure of compound 165. 
Thermal ellipsoids are shown at the 50% probability level.
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Figure 4.4 X-ray crystal structure of compound 170. 
Thermal ellipsoids are shown at the 50% probability level.
4.4 Synthesis of A-(2-cyclohexenylbenzyI)pivalamides 174 and 175
It was found that reactions o f A-(2-(l-hydroxycyclohexyl)benzyl)pivalamide 
(62) and A-(2-(l-hydroxycyclohexyl)-4-methoxybenzyl)pivalamide (73), where the 
substituent at position 2 was a hydroxycyclohexyl group, with TFAA in DCM at room 
temperature proceeded in a different manner (Scheme 4.4). Both reactions were 
conducted under conditions identical to those described in Schemes 4.1 and 4.3. The 
reaction mixtures were worked-up and the crude products were subjected to flash 
column chromatography (silica gel; Et20-hexane, 1:3), to give pure products, 
subsequently identified as 174 (82% yield) and 175 (83% yield), respectively 
(Scheme 4.4).
NHCOBu1NHCOBu1 TFAA. DCM 
RT, 5 min
HO
174 R = H (82%)
175 R = OMe (83%)
62 R = H 
73 R = OMe
Scheme 4.4
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The 'H NMR spectra of compounds 174 and 175 showed the presence of only
nine proton signals of the expected 10 for the cyclohexyl ring. One was a multiplet at
11relatively very low field suggestive of a vinylic hydrogen. Also, the C NMR spectra 
showed signals resonating at very low field suggestive of C-l and C-2 of a 
cyclohexenyl ring. The 13C NMR spectra of 174 and 175 also showed the presence of 
five different CH2 carbon signals. One CH2 signal was due the -C ^N H C O 'B u, while 
the other four CH2 signals should be due to the cyclohexenyl group. Clearly, these 
patterns indicated that dehydration from the side chain at position 2, from the OH and 
a hydrogen at position 2 of the cyclohexyl ring, had taken place. The reaction 
presumably proceeds via a cation similar to that shown in Scheme 4.2, but loss o f a 
proton from the adjacent position, impossible when the attached groups were 
aromatic, is easier, leading to an E l elimination process. The failure o f compounds 62 
and 73 to cyclise was presumably because the carbenium ions formed by loss o f water 
from the protonated species could easily eliminate a proton from the a-position o f the 
cyclohexyl group to produce 174 and 175, respectively, which is impossible in the 
case o f aryl substituents.
In an attempt to convert compounds 62 and 73 to the corresponding cyclic 
products, we have attempted reactions o f 62 and 73 with TFAA at room temperature 
but for longer reaction times up to 24 h. However, products 174 and 175 were 
obtained, respectively, in yields comparable to those obtained from reactions shown in 
Scheme 4.4. No further attempts were made to try to find conditions under which 
cyclization of 62 and 73 to the corresponding substituted isoindolines could be 
effective.
4.5. Attempted synthesis of 1-substituted isoindolines
In order to render the synthetic approach described in Sections 4.2 and 4.3 
even more valuable, it would be useful if  the pivaloyl or dimethylaminocarbonyl 
group in compounds of the general formula 161 (Figure 4.1) could be removed to 
reveal a free NH without the isoindole ring system itself being damaged. We therefore 
decided to attempt to remove such groups in compounds 161 to provide products of 
the general formula 176 (Figure 4.5) that would have even greater utility.
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NH
176
Figure 4.5
Using compounds 162 and 168 as models, these compounds were treated with 
a few drops of TFA at room temperature in DCM for 2 h. However, the quantitative 
recovery of starting materials indicated that no reactions took place under the 
conditions tried. Therefore, compounds 162 and 168 were treated with TFA, in the 
presence or absence of water, in DCM under reflux conditions for 20 minutes, at 
which time TLC indicated the presence o f a complex mixture of products. Purification 
of the product mixtures by column chromatography on silica gel proved to be difficult 
and no pure products were separated. We have also attempted removal of the pivaloyl 
or dimethylaminocarbonyl group by the use o f dilute hydrochloric acid but again there 
was no product obtained. No further attempts were made to try to find conditions 
under which removal of the pivaloyl group from 162 or the dimethylaminocarbonyl 
group from 168 could be effective.
4.6 Conclusion
Cyclization via dehydration o f A-(2-substituted benzyl)pivalamides and 
A-(2-substituted benzyl)-ACV-dimethylureas with trifluoroacetic anhydride as a 
catalyst in dichloromethane at room temperature takes place to give the corresponding 
isoindolines. The process is general, simple and convenient for compounds having 
aromatic groups attached to the carbinol carbon atom to produce various derivatives 
in excellent yields. However, when a hydroxycyclohexyl group is present at position 
2, cyclization is not successful and dehydration from the OH group and the hydrogen 
at position 2 of the cyclohexyl ring takes place to produce cyclohexenyl derivatives in 
high yield. Attempts to remove the pivaloyl or dimethylaminocarbonyl group from 
position 1 of the isoindoline ring using trifluoroacetic acid were not successful.
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C H A PT E R  FIV E  
SY N T H E SIS OF SU BSTITU TED  T E T R A H Y D R O ISO Q U IN O L IN E S
5.1 Introduction
Dihydroisoquinoline is an important and useful skeleton in organic 
synthesis.115 A number of approaches to the synthesis of dihydroisoquinolines has 
been developed.116118 However, most of the reported syntheses require multiple steps. 
Considerable effort has been directed toward the development of efficient syntheses 
of these compounds using a wide range of transition-metal catalysts. Recently, 
transition-metal-catalyzed cyclizations o f 2-(l-alkynyl)arylaldimines were used as 
tools for the syntheses of isoquinolines,119,120 and they were also successfully applied 
to the total synthesis of natural products.121 Unfortunately, some of the syntheses 
would create a number of environmental disadvantages, such as the production o f 
large quantities o f toxic or corrosive waste, if used on a large scale.
Two useful approaches to the synthesis of 1,2,3,4-tetrahydroisoquinolines,
12"> 123involving lithiation procedures, have been reported (Schemes 5.1 and 5.2). One 
method simply involves lithiation of A-(ter/-butoxycarbonyl)-2-methylbenzylamine 
(177) with sec-BuLi at -60 °C to give the lithium intermediate 178 which on reaction 
with veratraldehyde produces 179 in 66% yield. Treatment of 179 with TFA gives the 
corresponding tetrahydroisoquinoline 180 in 87% yield (Scheme 5.1).
NHBoc sec-BuLi
-60 °CMe
178 Li177
MeO CHO
MeO
NHBoc
OMe «, J F A  
DCM
OMe OMeHO 
179 (6 6 %)180 (87%) OMe
Scheme 5.1
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However, the cyclization appears to require the presence of the 4-methoxy 
group in the electrophile, presumably through stabilization o f the intermediate 
carbenium ion, as the corresponding unsubstituted phenyl compound (when 
benzaldehyde was used as the electrophile) failed to cyclise under similar, or more 
strongly acidic, conditions. Also, no cyclization took place when other carbonyl 
compounds were used, e.g. benzophenone and cyclohexanone.122
The other approach, reported by Schlosser, involved lithiation of
2-(3-methoxyphenyl)-A-pivaloylethylamine (181) at room temperature with BuLi at 
the aromatic position flanked by the two substituents (OMe and -C H 2CH2NHCO'Bu) 
and the lithium reagent thus formed was reacted with A,A-dimethylformamide (DMF) 
to produce the corresponding aldehyde 182 in 55% yield (Scheme 5.2).123 Acid 
catalysed cyclization o f 182 gave 8-methoxy-3,4-dihydroisoquinoline hydrochloride 
(183) in 79% yield, which on treatment with sodium hydroxide and sodium 
borohydride afforded 8-methoxy-l,2,3,4-tetrahydroisoquinoline (184) in 69% yield
123(Scheme 5.2). However, the generality of the reaction has never been tested. 
Therefore, we became interested in developing a new approach for the synthesis of 
tetrahydroisoquinoline derivatives, whereby regioselective lithiation would allow 
production of specifically substituted tetrahydroisoquinolines.
i, THF, BuLi, 2 h , 25 ° C
ii, Me2NCHO, 1 h, 25 °C
iii, aq. NH4CI
OMeO 
182 (55%)
DCM, HCI 
24 h, 25 °C
OMe
181
NaBH4/NaOH, MeOH
NH 30 min, 0 °C
OMe
184 (69%)
OMe
183 (79%)
Scheme 5.2
In Chapters 2 and 3, we have reported convenient procedures for the lateral 
lithiation of compounds of the general formula 185 (Figure 5.1) using /-BuLi in 
anhydrous THF at -78 °C followed by reactions with carbonyl compounds (aldehydes
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and ketones) to give the corresponding or/Zzo-disubstituted products 186 (Figure 5.1) 
in high yields. The general utility of 186 would be demonstrated by their cyclization 
to the corresponding 1,2,3,4-tetrahydroisoquinolines 187 (Figure 5.1). It was of 
interest to see if cyclization o f 186 could be achieved and would be general. 
Therefore, reactions o f 186 were carried out with trifluoroacetic anhydride (TFAA) in 
DCM at room temperature. In this chapter, we report on the attempts to cyclise 186 
under mild conditions to produce the corresponding tetrahydroisoquinolines 187.
NHCOR NHCOR
Me
OH185 187
186
Figure 5.1
5.2 Attempted cyclizations of A-(2-(2-hydroxy-2-arylalkyl)benzyl)pivalamides
It was hoped that cyclization of A-(2-(2-hydroxy-2-arylalkyl)benzyl)- 
pivalamides could be achieved via dehydration. Three compounds were tested, 
namely compounds 99-101 (Figure 5.2)
100 R1 = H, R2 = 4-MeOC6H
101 R1 = Me, R2 = Ph
»2 —
NHCOBu'
OH
Figure 5.2
The first reaction was carried out between A-(2-(2-hydroxy-2- 
phenylethyl)benzyl)pivalamide (99) and TFAA at room temperature in DCM (Scheme 
5.3). TLC indicated the formation of a new product, the formation o f which was
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complete within 5 minutes. The mixture was quenched by the addition of water and 
worked-up. The residue obtained was purified by flash column chromatography to 
give the pure product, identified as A-(2-(2-phenyl-2-trifluoroacetoxyethyl)benzyl)- 
pivalamide (188), obtained in 97% yield.
TFAA. RT , 
DCM, 5 min
Ph OH CFPh O 
188(97%)
Scheme 5.3
The 13C NMR spectrum of 188 showed that the carbonyl carbon atom of the 
CF3C = 0 group resonated as a quartet (.J  = 42 Hz) at 5 = 156.9 ppm, while the CF3 
carbon resonated as a quartet ( J =  284 Hz) at 5 = 114.8 ppm. Its !H NMR spectrum 
showed that the signals of the two protons of the two CH2 groups, the C ^N H C O 'B u 
and the CH2 at position 2 group, appeared separately, as two separated double 
doublets, indicating that they are diastereotopic. Compound 188 was of course present 
as a racemic mixture.
Compound 99 had evidently failed to cyclise and instead 188, which seemed 
to be stable, was produced. The stability of 188 could be due to the fact that the 
carbenium ion that could be formed if the trifluoroacetate anion was lost would not be 
highly stabilized.
Attempted cyclization of A-(2-(2-hydroxy-2-(4-methoxyphenyl)ethyl)benzyl)- 
pivalamide (100) under conditions similar to those used in Scheme 5.3 gave a new 
product, identified as compound 189 (Scheme 5.4), which was obtained in 97% yield 
after purification by flash column chromatography.
r
NHCOBu'
0H TFAA, DCMe f" ^ V ^ N H C O B u '
RT, 5 min ^
U OMe ^ ( D M e
1 0 0 189 (97%)
Scheme 5.4
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The ]H NMR spectrum of 189 showed the presence of two doublets at 7.06 
and 6.88 ppm with a high coupling constant (each with J =  16 Hz), indicating a trans- 
disubstituted double bond. The l3C NMR spectrum of 189 showed unsaturated carbon 
signals resonating downfield at 126.2 and 123.5 ppm. Clearly dehydration, from the 
OH and hydrogen of the CH2 group at position 2, had taken place. The structure of 
189 was confirmed further by X-ray crystallography (Figure 5.3)92 and was identified 
as (£)-Af-(2-(4-methoxystyryl)benzyl)pivalamide.
Figure 5.3 X-ray crystal structure of compound 189. 
Thermal ellipsoids are shown at the 50% probability level.
It is interesting that different types of products were produced when 
compounds 99 and 100 were treated with TFAA. It is clear that the 4-methoxy group, 
in the case of compound 100, would stabilize the carbenium ion produced in-situ due 
to elimination of trifluoroacetate anion from the ester initially formed from 100, 
compared to the corresponding compound lacking the methoxy group. Loss of a 
proton from the a-position of the carbenium ion would produce 189.
Similarly, treatment o f A-(2-(2-(hydroxy-2-phenylpropyl)benzyl)pivalamide 
(101) with TFAA at room temperature in DCM (Scheme 5.5) for 5 minutes gave 
compound 190 but in only 14% yield, along with 79% of starting material 101. We 
attempted to improve the yield of 190 under various reaction conditions and indeed, 
the yield was improved to 72% when the reaction time was 1 h.
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Me
Ph
101
NHCOBu'
OH
TFAA, DCM 
RT, 1 h
Me
190 (72%)
NHCOBu1
Scheme 5.5
Product 190 was characterised by standard spectroscopic methods (see 
Chapter 7; Section 7.31). The Nuclear Overhauser Effect (NOE) experiment clearly 
showed that when the methyl protons signal (5 = 2.05 ppm) was irradiated the signal 
corresponding to H-3 (8 = 7.46 ppm) was enhanced. Also, by analogy with the 
structure o f compound 189 (which was verified by X-ray crystal structure 
determination), it was expected that compound 190 would be present in the E-form, 
(£')-Ar-(2-(2-phenylprop-1 -enyl)benzyl)pivalamide.
In this case it seems likely that the formation of the trifluoroacetate is 
somewhat slower due to steric hindrance around the tertiary alcohol group in 101, but 
that once formed the additional methyl group tends to help elimination of 
trifluoroacetate anion due to stabilization o f the carbenium ion produced, which on 
loss o f a proton produces 190.
Clearly, cyclization reactions o f compounds 99-101, having a 
pivaloylaminomethyl group at position 1, with TFAA were not successful under the 
conditions tried. In such compounds the tert-butyl of the -C H 2NHCOIW  group only 
weakly donates electron density to the carbonyl group, while the carbonyl group pulls 
electron density from the NH and therefore leaves the NH less nucleophilic, which 
tends to make the cyclization process less likely. However, such compounds might 
still cyclise under more forcing conditions.
Esterification or dehydration was observed when compounds 99-101 were 
treated with TFAA to produce the corresponding trifluoroacetate ester 187 or alkenes 
189 and 190, respectively. Dehydration from compounds 100 and 101 probably 
occurs via the relatively stable cations 191 (Scheme 5.6). Such cations are secondary 
(R 1 = H, R2 = 4-MeOC6H4) or tertiary (R 1 = Me, R2 = Ph) and at least one of the 
groups is aromatic so the cations also receive benzylic stabilisation. Therefore, 
elimination (E l) to produce an alkene, as seen with compounds 189 and 190, is not
1
surprising. On the other hand, compound 188 (R = H, R = Ph), which will give a
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somewhat less stable cation, produces the trifluoroacetate ester rather than the alkene. 
In the light o f the results obtained the following general reaction mechanism is 
suggested (Scheme 5.6).
NHCOBu1 NHCOBu1 NHCOBu1
R OH
99-101
188 R1 = H,
NHCOBuNHCOBu
191 189 R1 = H, R2 = 4-MeOC6H
190 R1 = Me, R2 = Ph
Scheme 5.6
In principle it is quite likely that given more time for the reaction of 99 with 
TFAA that the trifluoroacetate group (CF3CO2 ) could be eliminated from 188 to give 
the corresponding cation 192 (Figure 5.4), which would either eliminate a hydrogen to 
form the corresponding alkene 193 or cyclise to produce the corresponding 
tetraisoquinoline 194.
iPY~"NHCOBu' fY ""'NHCOBu' .^COBu'N
192 > h 193
I
Ph 194
Ph
Figure 5.4
However, increasing the reaction time (up to 24 h) and the reaction 
temperature (reflux conditions) still gave mostly the trifluoroacetate ester 188 with 
little evidence for the formation o f the corresponding alkene 193 (via elimination o f a
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proton) or the cyclization product 194 (Figure 5.4). Also, when 188 was treated with 
TFA for 4 h under reflux conditions there was little evidence for formation of either 
193 or 194 and 91% of 188 was recovered.
In the cases when elimination occurred (i.e. production of 189 and 190 from 
reactions of TFAA with 100 and 101, respectively), it is possible that re-protonation 
by trifluoroacetic acid (TFA) produced in the reaction would have given cation 191 in 
equilibrium (Scheme 5.7), along with cation 195. In principle, cations 191 and 195 
could undergo cyclization to produce 196 and 197, respectively (Scheme 5.7).
NHCOBu1 NHCOBu1 NHCOBu1
191 195189 R1 = H, R2 = 4-MeOC6K
190 R1 = Me, R2 = Ph
cyclization cyclization
Bu]
BU
196 197
Scheme 5.7
However, treatment of compounds 189 and 190 with TFA under various 
reaction conditions (various reaction times and temperatures) gave no cyclised 
products. The quantitative recovery of 189 and 190 indicated that no reactions had 
taken place under the conditions tried.
No further attempts were made to try to find conditions under which 
cyclization could be effective. However, it was of interest to see if the cyclization 
reactions of related compounds, with a -C H 2NHCONMe2 group at position 1 instead 
of a pivaloylaminomethyl group, could be possible. Consequently, our attention was 
next turned to possible cyclization of A -(2-(2-hydroxy-2-arylalkyl)benzyl)-A,A- 
dimethylureas.
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5.3 Synthesis of 3-(4-methoxyphenyl)-2-dimethylaminocarbonyl-l,2,3,4-
tetrahydroisoquinoline (198)
Initially, a cyclization reaction o f A'-(2-(2-hydroxy-2-(4-methoxyphenyl)- 
ethyl)benzyl)-AyV-dimethylurea (153) was attempted under conditions similar to those 
described in Scheme 5.3. It was hoped that cyclization of 153 could be achieved via 
elimination of water, from the OH and NH hydrogen. Therefore, reaction between 
compound 153 and TFAA at room temperature in DCM for 5 minutes was carried out 
(Scheme 5.8). The mixture was quenched by the addition of water and worked-up. 
The residue obtained was purified by flash column chromatography (silica gel; E t20- 
hexane, 1:3) to give the pure product, subsequently identified as compound 198, 
obtained in 95% yield.
TFAA. RT , 
DCM, 5 min
HO
OMe OMe
198 (95%153
Scheme 5.8
The !H NMR spectrum of 198 showed that the signals of the two hydrogens of 
the CH2 groups, at positions 1 and 4 of the isoquinoline ring, appear separately, as two 
separated doublets, verifying that they are diastereotopic. Compound 198 would, of 
course, be formed as a racemic mixture. Indeed, the X-ray crystallography of 
compound 198 showed a single type o f crystal containing both enantiomers in equal 
proportions, but the structure displayed (Figure 5.5)92 shows the structure as 
(S*)-3-(4-methoxyphenyl)-2-dimethylaminocarbonyl-l,2,3,4-tetrahydroisoquinoline. 
Clearly, cyclization of 153 via dehydration, from OH and the NH hydrogen, had taken 
place.
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Figure 5.5 X-ray crystal structure of compound 198. 
Thermal ellipsoids are shown at the 50% probability level.
5.4 Synthesis of substituted tetrahydroisoquinolines 199 and 200
Having found that reaction of compound 153 with TFAA occurred smoothly 
and rapidly at room temperature in DCM, it was of interest to see if the cyclization 
reaction of other compounds related to 153 would be successful. Consequently, 
reactions of compounds 154 and 155 with TFAA were carried out at room 
temperature in DCM for 5 minutes (Scheme 5.9). The reactions proceeded smoothly 
in both cases and the crude products were subjected to flash column chromatography, 
to give the pure products, identified as 3-phenyl-2-dimethylaminocarbonyl-l,2,3,4- 
tetrahydroisoquinoline (199; 94% yield) and 3-methyl-3-phenyl-2-
dimethylaminocarbonyl-l,2,3,4-tetrahydroisoquinoline (200; 91% yield).
TFAA. RT , 
DCM, 5 min
HO Ph
Ph
199 R = H (94%)
200 R= Me (91%)
154 R = H
155 R- Me
Scheme 5.9
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The 'H  NMR spectra o f compounds 199 and 200 showed diastereotopicity for 
the two pairs of hydrogens at positions 1 and 4 of the isoquinoline rings. Both 
compounds would, o f course, be formed as racemic mixtures.
Having found that reaction of compounds 153-155 with TFAA occurred 
smoothly and rapidly, it was o f interest to see if the cyclization reactions of 
compounds containing bulky groups would be possible. Therefore, cyclization of 
/V-(2-(2-hydroxy-2,2-diphenylethyl)benzyl)-A,vV-dimethylurea (156) was attempted.
5.5 Synthesis of N l-(2-(2,2-diphenylvinyl)benzyl)-AyV-dimethylurea (201)
It was found that reaction of A-(2-(2-hydroxy-2,2-diphenylethyl)benzyl)-Ar,A- 
dimethylurea (156) with TFAA in DCM at room temperature proceeded in a different 
manner (Scheme 5.10). Following work-up, the crude product was purified by flash 
column chromatography to give pure product, subsequently identified as N'-(2-(2,2- 
diphenylvinyl)benzyl)-A,A-dimethylurea (201), which was obtained 95% yield.
TFAA, RT
DCM, 5 min
HO Ph
Ph PhPh
156 201 (95%)
Scheme 5.10
Product 201 was characterised by standard spectroscopic methods and X-ray 
crystallography (Figure 5.6).92 Clearly, dehydration from the OH and a hydrogen from 
the CH2 group had taken place.
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F igu re  5.6 X-ray crystal structure of compound 201. 
Thermal ellipsoids are shown at the 50% probability level.
Clearly, cyclization reactions of compounds having a -C H 2NHCONMe2 group 
at position 1 (compounds 153-155) with TFAA were successful to produce the 
corresponding tetrahydroisoquinolines 198-200, respectively. In the case of such 
compounds the dimethylamino part of the -C H 2NHCONMe2 group donates electron 
density to the carbonyl group. Therefore, the carbonyl group does not pull electron 
density to the same extent from the NH and leaves the NH more nucleophilic than in 
the pivaloylamino case, and therefore more likely to cyclise, as observed. However, in 
the case when the hydroxydiphenylethyl group is present at position 2 (compound 
156), cyclization is not successful and elimination of water takes place to produce the 
corresponding alkene 201.
Dehydration, either with cyclization or to form an alkene, probably goes via 
the relatively stable cations 202 (Scheme 5.11). Such cations are at least secondary 
and sometimes tertiary (if neither R 1 nor R2 is hydrogen) and in all cases at least one 
of the groups is aromatic so the cation also has benzylic stabilisation. Cyclization via 
substitution ( S n I )  is more likely to take place than in the pivaloylamino case because 
of the greater nucleophilicity of the N atom and is observed in the cases of products 
198-200. However, in the most stable case (R 1 = R2 = Ph; compound 156) the cation 
formed is tertiary, doubly benzylic and very hindered so that cyclization is not so 
likely to occur and elimination (E l) takes place to produce the corresponding alkene
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201. In the light o f these results the following general reaction mechanism is 
suggested (Scheme 5.11).
HN
i, TFAA substitution
OH
153-156 202
elimination
(E1)(a)
198 R1 = H, R2 = 4-MeOC6H
199 R1 = H, R2 = Ph
200 R1 = Me, R2 = Ph201 R1 = R2 = Ph
Scheme 5.11
5.6 Attempted synthesis of 2-unsubstituted 1,2,3,4-tetrahydroisoquinolines
In order to render the synthetic approach described in Sections 5.3 and 5.4 
even more valuable, it would be useful if  the dimethylamino group in compounds of 
the general formula 203 (Figure 5.7) could be removed to reveal a free NH without 
the isoquinoline ring system itself being damaged. We therefore decided to attempt to 
remove the dimethylamino group in compounds 203 to provide products of the 
general formula 204 (Figure 5.7).
C Y " * t x °
R2 R2
203 204
Figure 5.7
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Using compound 198 as the model, we attempted removal of the 
dimethylaminocarbonyl group at position 2 by treatment with a few drops of TFA in 
DCM at room temperature or under reflux conditions for 2 h. However, TLC and 
NMR indicated the presence of mainly starting material in the reaction mixture. We 
also attempted to use TFA under reflux conditions for 1 h with no DCM. The reaction 
mixture turned deep red but no pure products were separated from the reaction 
mixture by column chromatography on silica gel. Finally, reactions of 198 with dilute 
HC1 were attempted at room temperature and under reflux conditions for up to 24 h. 
However, the quantitative recovery o f 198 indicated that hydrolysis was not 
successful under the conditions tried. No further attempts were made to try to find 
conditions under which removal of the dimethylaminocarbonyl group from compound 
198 could be successful.
5.7 Conclusion
jV-(2-(2-Hydroxy-2-arylalkyl)benzyl)pivalamides are not cyclised on reaction 
with trifluoroacetic anhydride in DCM at room temperature. Instead, esterification of 
the hydroxyl group with TFA A or dehydration from the OH and a hydrogen from the 
CH2 at position 2, takes place to give the corresponding derivatives in high yields. In 
contrast, reactions o f TFAA with A-(2-substituted benzy^-A^-dimethylureas in 
DCM under identical conditions produced the corresponding tetrahydroisoquinolines 
in excellent yields (91-95%) for the derivatives tried. However, when a bulky group, 
such as hydroxy diphenyl ethyl, is present at position 2, cyclization is not successful 
and dehydration, from OH and a hydrogen from the CH2 group at position 2, takes 
place to produce an unsaturated derivative in high yield. Attempts to remove the 
dimethylaminocarbonyl group at position 1 o f the isoquinoline ring using 
trifluoroacetic acid or dilute HC1 were not successful.
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C H A PT E R  SIX  
SY N T H E SIS O F SU B ST IT U T E D  ISO IN D O LIN -1-O N E S
6.1 Introduction
Although the isoindolinone ( 2 ,3 - d ih y d r o - l / / - i s o in d o l - l - o n e )  skeleton was not 
commonly encountered in the past, in recent years there has been a great deal of 
interest in such compounds since they represent the core unit o f numerous naturally 
occurring substances.103' 105 Also, several members belonging to this family are new 
nonpeptidic low molecular weight broad-spectrum inhibitors o f Human Rhinovirus 
(HRV).124
Several traditional methods are available for the synthesis of
i  c  |  ' j / :
isoindolinones. ' However, such methods generally require multiple reaction 
steps, and are unsatisfactory, both in yield and generality. In recent years a number of 
new approaches have been developed for the synthesis of substituted isoindolines, of
P 7
which the most generally useful involve palladium-catalysed reactions “ and 
lithiation procedures.108"112128 ,30
In particular, among the methods involving lithiation two useful approaches to 
the synthesis o f 2,3-dihydroisoindolin-l-ones have been reported (Schemes 6.1 and 
6.2).108,128 One method simply involves lithiation o f a preformed 2,3-dihydroisoindol- 
1-one ring system, 205, at the 3-position using one equivalent of LDA at -78 °C, to 
produce the lithium intermediate 206, which on treatment with an electrophile gives 
the corresponding 207 (Scheme 6.1).128 Clearly, the general utility of this approach 
depends on the availability o f appropriately substituted analogues of the 
dihydroisoindolin-l-one ring system 205.
O 0 0
Li E
205 206 207 (39-98%)^ , 
R = Me, 4-MeOC6H4
E = Me, Bn, CH2=CH-CH2, MeS, PhCH(OH), PhCO, PhCH(NHMe), CQ2H
Scheme 6.1
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The other, potentially more useful, approach reported by Clayden involves 
generation of the isoindolin-1-one ring system during the lithiation step. For example, 
lithiation of TV-terr-butyl-A-benzylbenzamides 208 with LDA gives intermediates 209 
that cyclise to form a dearomatised species 210. Oxidation to re-aromatise the system 
gives the corresponding 2,3-dihydroisoindolin-l-ones 211 (Scheme 6.2; cyclization - 
rearomatisation).108 Treatment o f 211 (R = 5-OMe; Scheme 6.2) with trifluoroacetic 
acid (TFA) to remove the tert- butyl group gives the corresponding 
2,3-dihydroisoindolin-l-one 212 in 66% yield.108 However, this approach gives more 
modest yields, requires the additional step to remove the Bu' group, and also involves 
incorporating the eventual C-3 substituent into the starting material, which limits the 
generality.
OLi
LDAR“h R~r R -h0-20 °CPh Ph
Ph208 209 210
TFA, 3 hi. dry air. 12 h
ii, MsCI, Et3N
NH
Ph
211 (40-71%)
Ph
212 (R = 5-OMe; 66%)
MsCI = Methanesulfonyl chloride; R = 2-OMe, 4-OMe, 4-CN, 4-Br
Scheme 6.2
Clayden has improved the yield o f 2,3-dihydroisoindolin-l-ones such as 211 
using 2-methoxy amides 213 as the starting materials; in this case the methoxy group
1 OSacts as a leaving group, avoiding the need for an oxidation step. Thus, lithiation of 
213 with LDA gave lithium intermedaies 214 which cyclised to produce 211 in good
1 ORto excellent yields (Scheme 6.3; cyclization - substitution). However, this approach 
still requires an additional step to remove the Bu' group.
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O t U
LDAR -r
0-20 °COMe Ph
Ph
211 (66-85%)
213
R = 3-OMe, 6-OMe, 3,4-Benzo, 5,6-Benzo
Scheme 6.3
Therefore, with the aim of developing a methodology for the synthesis of
3-substituted isoindolin-1-ones, N ‘'-benzyl-N.iV-dimethylureas were subjected to 
lithiation reactions with /-BuLi, and subsequently with electrophiles. In this chapter, 
we describe a novel and efficient synthetic approach to 3-substituted isoindolin- 
1-ones that involves both cyclization to give the ring system and incorporation of a 
C-3 substituent in a single synthetic step via lithiation o f N'-benzyl-N.N-dimethylureas 
with /-BuLi in THF at 0 °C followed by reactions o f the cyclic dilithium intermediates 
thus formed with various electrophiles.
6.2 Synthesis of (/?*)-3-((S'*)-hydroxy(4-methoxyphenyl)methyl)-4-methoxy-
isoindolin-l-one (139)
In Chapter 3 (Section 3.5), we have shown that lithiation of 
7V-(2-methoxybenzyl)-A^,TV-dimethylurea (111) with two equivalents of /-BuLi at 
-20 °C followed by reaction with 4-anisaldehyde gave a mixture o f ring substitution 
products; o-substitution (next to the dimethylaminocarbonylaminomethyl group, 49% 
yield) and o -substitution (next to the methoxy group, 40% yield). The o-substitution 
product was obtained from reaction o f dilithium reagent 134, produced in-sitn from 
133 (Figure 6.1), with 4-anisaldehyde, while the o-substitution product was produced 
from reaction o f 135 (Figure 6.1) with 4-anisaldehyde.
133
OMe
134
OMe
135
OMe
Figure 6.1
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However, when the reaction was carried out at 0 °C rather than at -20 °C it 
produced o-substitution product (50% yield), o -substitution product (12% yield) and 
an isoindolin-1-one derivative (139; Figure 6.2, 11% yield). Also, some of the starting 
material 111 (12%) was recovered under the conditions tried. Compound 139 would 
arise by cyclization o f 134, produced in-situ from 133 (Figure 6.1), to give 215, 
followed by further lithiation to give 140 (Figure 6.2), which on reaction with 
4-anisaldehyde gives 139 (Figure 6.2). Therefore, it appeared likely that the yield of 
139 could be increased by use o f a larger quantity of /-BuLi (three equivalents).
.OMe
LiO, LiO,
NH -=N
OMeOMe OMe
140 215139
Figure 6.2
It was of interest to see if the production o f 139 in high yield could be 
achieved. Therefore, compound 111 was treated with /-BuLi (3.3 mole equivalents) at 
0 °C in anhydrous THF under nitrogen (Scheme 6.4). Initial addition of /-BuLi 
provided a yellow solution, presumably because o f formation of the monolithium 
reagent 133, until approximately one equivalent had been added, then a reddish 
orange solution was formed as the second /-BuLi was added, presumably because of 
formation of the dilithium reagent 134, which could cyclize to produce lithium 
intermediate 215. Reaction o f the third mole o f /-BuLi with 215 could produce the 
corresponding cyclic dilithium reagent 140. The mixture was stirred for 6 h at 0 °C in 
an attempt to ensure complete formation o f the 140. 4-Anisaldehyde (1.1 mole 
equivalents) was added (Scheme 6.4) and the mixture was stirred for 2 h at 0 °C. The 
mixture was allowed to warm to room temperature and quenched by the addition of 
aqueous NH4C1 solution. The solid obtained following work-up was washed with 
diethyl ether to give pure product identified as 139 which was isolated in 81% yield. 
Compound 139 was found to be identical in all respects with the one produced 
previously (Chapter 3; Section 3.5).
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OLiOLi
f-BuLi
0°C 0°C OMe‘OMe “OMe
111 133 134 ,OMe
LiO, LiO,
NH
i, 4-anisaldehyde, 
0°Cf-BuLi
0°COMe OMe OMe 
139 (81%)215 140
Scheme 6.4
Compound 139 could potentially be formed as a pair o f racemic 
diastereoisomers; however, its NMR spectra showed what appeared to be a single set 
of signals, indicating that the isolated product was a single diastereoisomer. However, 
although this compound was isolated in high yield (81%), it is possible that a small 
amount of the other diastereoisomer was formed but washed out during the 
purification process. The X-ray crystallography o f compound 139 confirmed the 
crystal structure as (^*)-3-((*S*)-hydroxy(4-methoxyphenyl)methyl)-4-methoxy-
Q9isoindolin-1-one (Figure 3.5: Chapter 3, Section 3.5).
Clearly, lithiation o f 111 with r-BuLi (3.3 mole equivalents) in anhydrous THF 
at 0 °C for 6 h, followed by treatment with 4-anisaldehyde (1.1 mole equivalents) 
gave 139 in high yield. While an increased yield of 139 was expected, the 
disappearance of o '-substitution product was a surprise. It would appear that at 0 °C, 
not only does 134 cyclise to give 215, but 135 (Figure 6.1) is also in equilibrium with 
134, allowing its eventual conversion into 215 and then 140 (Scheme 6.4).
6.3 Synthesis of 4-methoxyisoindolin-l-one (216)
It was of interest to prove that cyclic lithium reagent 215 was formed as an 
intermediate during the reaction described in Scheme 6.4. Therefore, compound 111 
was treated with t-BuLi (2.2 mole equivalents) at 0 °C in anhydrous THF under 
nitrogen for 6 h (Scheme 6.5). The mixture was allowed to warm to room temperature 
and quenched by the addition o f aqueous NH4CI solution. Following work-up, the 
solid obtained was washed with diethyl ether to give the pure product, identified as
4-methoxyisoindolin-l-one (216) and was obtained in 76% yield. Clearly, reaction of
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111 with /-BuLi (2.2 equivalents) produced the dilithium reagent 134 which could 
cyclize to produce lithium intermediate 215 and on protonation gave 216 (Scheme
6.5).
2.2 t-BuLi
0°COMe OMe
111 134
LiO,
NH
v  OMe 
216 (76%)
'OMe
215
Scheme 6.5
Compound 216 was characterised by standard spectroscopic methods and 
X-ray crystallography (Figure 6.3).92
Figure 6.3 X-ray crystal structure of compound 216. 
Thermal ellipsoids are shown at the 50% probability level.
6.4 Synthesis of various 3-substituted 4-methoxyisoindoIin-l-ones 216-224
It was of interest to see if the reaction of the cyclic dilithium intermediate 140 
with other electrophiles would be useful and general. Consequently, reactions of the
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cyclic dilithium intermediate 140, prepared in-situ from compound 111, with a range 
of electrophiles (H2O, iodomethane, iodoethane, bromobutane, cyclohexanone, 
benzophenone, acetophenone, 2-hexanone, or benzaldehyde) were carried out 
(Scheme 6.6). Each reaction was conducted under identical conditions and then 
quenched by the addition o f aq. NH4CI. Afterwards, the crude products were washed 
with diethyl ether to give the pure products that were identified as 3-substituted 
4-methoxyisoindolin-l-ones 216-224 (Scheme 6 .6) and were obtained in high yields 
(Table 6.1). The products were all characterised by standard spectroscopic methods 
(see Chapter 7; Section 7.37). The nature o f the products is illustrated in Table 6.1.
NH
Me ,3.3 f-BuLi, 0 °C, 6 h
Me i, Electrophile, 0 °C, 2 h
ii, aq. NH4CI
OMe v  OMe 
216-224(72-84%)111
Scheme 6.6
Table 6.1: Synthesis o f various 3-substituted 4-methoxyisoindolin-l-ones 216-
224 according to Scheme 6.6
Product Electrophile E Yield (%)a
216 h 2o H 82
217 Mel Me 79
218 EtI Et 84
219 BuBr Bu 72
220 (CH2)5CO (CH2)5C(OH) 78
221 Ph2CO Ph2C(OH) 81
222 PhCOMe PhC(OH)Me 81
223 BuCOMe BuC(OH)Me 78
224 PhCHO PhCH(OH) 80
a Yield o f isolated pure product.
The 'H  NMR spectra o f compounds 218, 219 and 223 showed 
diastereotopicity for the two hydrogens o f the CEE group attached to position 3 (218 
and 219) or to the C(OH)Me carbon attached to position 3 (223) of the isoindolone 
ring. In the l3C NMR spectrum of compound 220 the two sides o f the cyclohexane 
ring appeared as separated signals, and for compound 221 the two phenyl groups 
appeared as separated signals in the l3C NMR spectrum, verifying that they are
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diastereotopic. Compounds 217-221 would o f course be formed as racemic mixtures. 
Compounds 222-224 could potentially be formed as pair o f racemic diastereoisomers; 
however, their NMR spectra showed what appeared to be one set o f signals, indicating 
that the isolated product in each case was a single diastereoisomer. However, although 
these compounds were isolated in high yields (72-84%), it is possible that small 
amounts of the other diastereoisomers were formed but washed out during purification 
o f the crude products by washing with diethyl ether. We have not determined the 
stereochemistry o f compounds 222-224, however, by analogy with the structure of 
compound 139 (which was verified by x-ray crystal structure determination as (R*)-3- 
((iS'*)-hydroxy(4-methoxyphenyl)methyl)-4-methoxy-isoindolin-l-one; Figure 3.5, 
Chapter 3), it was expected that such compounds would be present as 
diastereoisomers.
From the results recorded in Table 6.1 it was clear that lithiation of 
Ar-(2-methoxybenzyl-A^,Wdimethylurea (111) with r-BuLi (3.3 mole equivalents) at 
0 °C followed by reaction with a variety o f different electrophiles was a general 
process, producing 3-substituted 4-methoxyisoindolin-l-ones 216-224 in high yields.
6.5 Synthesis of various substituted isoindolin-l-ones 225-245
The generality o f the process was tested further using other ring-substituted 
N-benzyl-A^iV-dimethylureas 107, 108 and 113. Each substrate was lithiated 
according to the standard procedure shown in Schemes 6.4 and 6.6, and then treated 
with various electrophiles. The crude products were washed with diethyl ether to give 
the pure products that were identified as substituted isoindolin-l-ones 225-245 
(Scheme 6.7) and were obtained in high yields (Table 6.2). The products were all 
characterised by standard spectroscopic methods (see Chapter 7; Section 7.38). The 
nature o f the products is illustrated in Table 6.2.
NH
i, 3.3 f-BuLi, 0°C, 6 h
ii, Electrophile, 0 °C, 2 h
iii, aq. NH4CI 225-245
(70-85%)
107 R = H
108 R = OMe 
113 R = Me
Scheme 6.7
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Table 6.2: Synthesis of various substituted isoindolin-l-ones 225-245 according
to Scheme 6.7
Product R Electrophile E Yield (%)fl
225 H H20 H 71
226 H Mel Me 75
111 H EtI Et 77
228 H BuBr Bu 76*
229 H Ph2CO Ph2C(OH) 74
230 H PhCHO PhCH(OH) 73
231 H 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 78
232 OMe h 2o H 70
233 OMe M el Me 76
234 OMe EtI Et 78
235 OMe BuBr Bu 77
236 OMe Ph2CO Ph2C(OH) 72
237 OMe PhCHO PhCH(OH) 75
238 Me H20 H 75
239 Me Mel Me 78
240 Me EtI Et 75
241 Me (CH2)5C = 0 (CH2)5C(OH) 72
242 Me Ph2CO Ph2C(OH) 85
243 Me MeCOBu MeC(OH)Bu 77
244 Me PhCHO PhCH(OH) 79
245 Me 4-MeOC6H4CHO 4-MeOC6H4CH(OH) 83
a Yield of isolated pure product.
* Compound 246 (Figure 6.4) was obtained in 5% yield.
The 'H  NMR spectra o f compounds 227, 228, 234, 235 and 240 showed 
diastereotopicity for the two hydrogens o f the CH2 group attached to position 3 of the 
isoindolinone ring, while the spectrum o f 243 showed it for the CH2 group next to the 
CH3C(OH) group, verifying that all are diastereotopic. For compounds 229, 236 and 
242 the two phenyl groups appeared as separated signals in their 13C NMR spectra, 
verifying that they are diastereotopic. The two sides of the cyclohexane ring in 
compound 241 should appear as separated signals; however, we were unable to record 
its l3C NMR spectrum due to its poor solubility. Compounds 226-229, 233-236 and 
239-242 would o f course be formed as racemic mixtures. Compounds 230, 231, 237, 
243-245 could potentially be formed as pairs o f racemic diastereoisomers. Indeed, the 
'H and 13C NMR spectra o f compound 231 showed the expected presence of two 
diastereoisomers in the ratio o f 6:1 according to the !H NMR spectrum. The isomers 
were not separated but based on the structure o f compound 139, it is believed that the 
major diastereoisomer would be present as (R*)-3-(S*)- and the minor one as (R*)-3-
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(/?*)-. However, the NMR spectra o f 230, 237, 243-245 showed what appeared to be 
one set o f signals, indicating that the isolated product in each case was probably a 
single diastereoisomer, and we have not determined which one. However, although 
these compounds were isolated in high yields (70-85%), it is possible that small 
amounts of the other diastereoisomers were formed but washed out during the 
purification process. Again, we have not determined the stereochemistry of such 
compounds, however, it seems likely that they would be present as (R*)-3-(S*)- 
diastereoisomers by analogy with the structure o f compound 139.
Compound 246 (Figure 6.4) was obtained as a side product in 5% yield when 
1-bromobutane was used as the electrophile. It was characterised by standard 
spectroscopic methods (see Chapter 7; Section 7.38). Compound 246 could be 
obtained due to further lithiation o f 247, produced in situ from 248, at position 3, to 
produce cyclic lithium intermediate 249 (Figure 6.4) followed by reaction with a 
further equivalent o f 1-bromobutane.
246
NH
Bu
247
OLi
Bu
248
OLi
249
Bu
Figure 6.4
From the results recorded in Table 6.2 it was clear that lithiation of A'-benzyl)- 
AfTV-dimethylureas 107, 108 and 113 with /-BuLi (3.3 mole equivalents) at 0 °C 
followed by cyclization and reactions with a variety of electrophiles was a general 
process, producing various substituted isoindolin-l-ones 225-245 in high yields (70- 
86%).
6.6 Attempted cyclization of TV-benzylpivalamide (49)
Having successfully synthesized various isoindolin-l-ones via lithiation and 
substitution of A'-benzyl-A^A-dimethylureas (Sections 6.2-6.5), attention was next 
turned to investigate whether the corresponding A'-benzylpivalamides could be 
cyclized in the same manner. Therefore, A'-benzylpivalamide (49; Figure 6.5) was 
treated with /-BuLi (2.2 mole equivalents) at 0 °C in anhydrous THF under nitrogen
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and the mixture was stirred for 6 h, in an attempt to produce compound 250 (Figure
6.5). The mixture was allowed to warm to room temperature and quenched by the 
addition o f aqueous NH4CI solution. The product mixture was examined by TLC and 
showed that no new product was formed; instead, only starting material was recovered 
(98%).
NHCOBu
250
Figure 6.5
We attempted to vary the length o f reaction time with /-BuLi (up to 24 h) but 
no cyclic product was formed indicating that no cyclization took place under the 
conditions tried. No further attempts were made to try to find conditions under which 
cyclization of TV-benzylpivalamide could be successful.
6.7 Attempted synthesis of l,2-dihydroisoquinolin-3(4//)-ones
Having successfully synthesized various isoindolin-l-ones from A-benzyl- 
/V,vV-dimethylureas (Sections 6.2-6.5), attention was next turned to investigate whether 
A-(2-methylbenzyl)-Ar,A-dimethylurea (114) could be lithiated and cyclised in the 
same manner under similar conditions to produce l,2-dihydroisoquinolin-3(4//)-one 
(251; Figure 6.6). Therefore, 114 was treated with /-BuLi (2.2 mole equivalents) at 
0 °C in anhydrous THF under nitrogen and the mixture was stirred for 6 h. The 
mixture was allowed to warm to room temperature and quenched by the addition of 
aqueous NH4C1 solution. The product mixture was examined by TLC and showed the 
presence of only starting material. Compound 114 was recovered quantitatively, 
which is an indication that no cyclization took place under these conditions. We 
attempted to vary the length of reaction time o f 114 with /-BuLi (up to 18 h) at 0 °C 
but no cyclic product was formed.
Figure 6.6
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Compound 65 was also treated with /-BuLi (2.2 mole equivalents) in THF at 
0 °C for 24 h. The product mixture was examined by TLC and showed the presence of 
only 65. The quantitative recovery o f starting material indicated that no cyclization 
took place under these conditions. This result was expected since N 1-benzylpivalamide 
(49; Figure 6.5) had also proved to be difficult to cyclize.
No further attempts were made to try to find conditions under which 
cyclization of 114 or 65 could be successful. It seems that the formation of six- 
membered rings is relatively difficult compared to the corresponding five-membered 
rings.
6.8 Conclusion
A lithiation procedure has been developed that allows the production of
3-substituted isoindolin-l-ones in high yields in only one step via lithiation of various 
substituted A'-benzyl-A^A-dimethylureas with /-BuLi (3.3 mole equivalents) in THF 
at 0 °C followed by reactions with various electrophiles. The procedure has been 
proven to be simple, efficient and general. However, A-(substituted 
benzyl)pivalamides on treatment with /-BuLi for a longer reaction time failed to 
produce the corresponding cyclic products. Also, lithiation of Ar-(2-methylbenzyl)- 
A,jV-dimethylurea and A-(2-methylbenzyl)pivalamide followed by reaction with an 
electrophile under similar conditions failed to produce the corresponding cyclized six- 
membered ring compounds and instead simple lithiation and substitution took place 
on the methyl group at position 2 .
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Chapter Seven: Experimental
C H A P T E R  SEV EN  
E X P E R IM E N T A L
7.1 General experimental
Melting point determinations were performed by the open capillary method 
using a Gallenkamp melting point apparatus and are reported uncorrected. 'H and 13C 
NMR spectra were recorded on a Bruker AV400 (Swansea University) or Bruker 
AV500 (Cardiff University) spectrometer operating at 400 or 500 MHz for *H and 
100 or 125 MHz for 13C measurements, respectively. Chemical shifts £are reported in 
parts per million (ppm) relative to TMS and coupling constants J  are in Hz and have 
been rounded to the nearest whole number. 13C multiplicities are based on DEPT 
signals and are reported s (C), d (CH), t (CH2) and q (CH3). Assignments o f signals 
are based on coupling patterns and expected chemical shift values and have not been 
rigorously confirmed. Signals with similar characteristics might be interchanged. 
Low-resolution mass spectra were recorded on a Quattro II spectrometer, electron 
impact (El) at 70 eV and chemical ionization (Cl) at 50 eV by the use o f NH3 as 
ionization gas. Accurate mass data were obtained on a MAT900 instrument. 
Electrospray (ES) analyses were performed on a ZQ4000 spectrometer in positive and 
negative ionisation modes. IR spectra were recorded on a Perkin Elmer Spectrum One 
FT-IR spectrometer. Microanalyses were performed by Warwick analytical service at 
the University of Warwick. X-ray analyses were obtained from the EPSRC National 
Crystallography Service, Department o f Chemistry, Southampton University, 
Southampton and the X-Ray Crystallography Service, School o f Chemistry, Cardiff 
University, Cardiff, UK. In all the figures, the thermal ellipsoids are displayed at 50% 
probability. Column chromatography was carried out using Fischer Scientific silica 
60A (35-70 micron). Alkyllithiums were obtained from Aldrich Chemical Company 
and were estimated prior to use by the method o f Watson and Eastham.22 Other 
chemicals were obtained from Aldrich Chemical Company and used without further 
purification. THF was distilled from sodium benzophenone ketyl. Other solvents were 
purified by standard procedures.131,132
7.2 Synthesis of A-benzylpivalamide (49)
To a cooled solution (0 °C) of benzylamine (52; 4.28 g, 40.0 mmol) and 
triethylamine (8.0 mL) in CH2CI2 (100 mL) pivaloyl chloride (5.3 g, 44.3 mmol) was
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slowly added in a drop-wise manner over 30 min. The reaction mixture was stirred at 
0 °C for an extra 1 h. The mixture was poured onto H2O (100 mL) and the organic 
layer was separated, washed with H20  (2 x 50 mL), and dried (M gS04) and the 
solvent was then removed under reduced pressure. The solid obtained was purified by 
crystallization from Et20-hexane (2:1) to give A-benzylpivalamide (49; 7.03 g, 36.8 
mmol; 92%) as white crystals.
NHCOBu1
Mp: 79-80 °C (lit.86 76-78 °C).
'H NMR (400 MHz, CDCI3): 5 = 7.27-7.16 (m, 5 H, Ph), 5.98 (br, exch., 1 H, NH), 
4.34 (d, J=  6 Hz, 2 H, CH2), 1.14 [s, 9 H, C(CH3)3].
13C NMR (100 MHz, CDC13): 5 = 178.7 (s, C =0), 139.1 (s, C -l), 129.1 (d, C-3/C-5),
128.0 (d, C-2/C-6), 127.8 (d, C-4), 43.9 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, C(CH3)3]. 
EI-M S: m/z (%) = 191 (M+, 7), 91 (PhCH2\  88), 77 (Ph+, 19), 57 ( W ,  100).
CI-M S: m/z (%) = 209 (M + NH4+, 27), 192 (MH+, 100).
HRMS: m/z calc, for C ,2H ,8NO (MH+), 192.1383; found, 192.1385.
FT-1R: vmax = 3303 (NH), 2961 (CH), 1636 (O O ) , 1544 (aromatic C=C), 1217, 1000 
cm*1.
7.3 Lithiation and substitution of TV-benzylpivalamide (49)
A solution of /-BuLi in pentane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
stirred solution o f 49 (0.38 g, 2.0 mmol) at the appropriate temperature (-78, 0 or 20 
°C) in anhydrous THF (20 mL) under N2. Formation of the monolithium reagent 53 
was observed as a yellow solution and the dilithium reagents were observed as 
brownish solution. The mixture was stirred at the appropriate temperature for 2-4  h 
and a solution o f benzophenone (0.40 g, 2.2 mmol) in anhydrous THF (8 mL) was 
added. The reaction mixture was stirred for 2 h at the appropriate temperature, and 
then allowed to warm to r.t. if the reaction was carried out at low temperature. It was 
then diluted with EtOAc (20 mL) and quenched with aq. sat. NH4CI (20 mL). The 
organic layer was separated, washed with H20  (2 x 20 mL), dried (M gS04), and 
evaporated under reduced pressure. The residue obtained was purified by column 
chromatography (silica gel; Et20-hexane, 1:3) to give the pure products 56 and 57.
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The yields obtained were in the range o f 6-42% for 56 and 10-34% for 57. A 
significant quantity of the starting material 49 (20-69%) was also recovered. The 
yields obtained under various reaction conditions are recorded in Table 2.1.
/V-(2-Hydroxy-l,2,2-triphenylethyl)pivalamide (56)
Ph OH
NHCOBu
Yield: 44 mg-0.31 g (0.12-0.83 mmol, 6-42% ); see Table 2.1.
Mp: 229-230 °C.
'H NMR (400 MHz, DMSO-d6): 5 = 7.58 (d, J =  9 Hz, exch., 1 H, NH), 7.55-7.02 
(m, 15 H, 3 Ph), 6.21 (br, exch., 1 H, OH), 5.88 (d, J =  9 Hz, 1 H, CH), 0.92 [s, 9 H, 
C(CH3)3].
,3C NMR (100 MHz, DMSO-d6): 5 = 177.0 (s, C =0), 147.5 (s, C-l of Ph), 145.9 (s, 
C-l of Ph), 140.6 (s, C -l), 129.9 (d, C-3/C-5), 128.6, 128.2 (2 d, C-3/C-5 of 2 Ph),
127.6 (d, C-2/C-6), 127.4 (d, C-4), 127.1, 126.7 (2 d, C-2/C-6 of 2 Ph), 127.0, 126.9 
(2 d, C-4 of 2 Ph), 80.7 (s, C-OH), 59.9 (d, CH), 38.8 [s, C(CH3)3], 27.9 [q, C(CH3)3]. 
EI-MS: m/z (%) = 355 (M+ - H20 , 8), 330 (35), 312 (18), 296 (M+ -  Ph, 11), 270 
(48), 256 (M+ -  NHCO'Bu -  OH, 32), 252 (100), 239 (81), 226 (34), 215 (35).
CI-MS: m/z (%) = 374 (MH+, 42), 356 (MH+ -  H20 , 100).
HRMS: m/z calc, for C25H28N 0 2 (MH+), 374.2115; found, 374.2114.
FT-IR: vmax = 3329 (NH and OH), 2922 (CH), 1614 (C=0), 1562 (aromatic C=C), 
1514, 1470, 1240 cm’1.
Anal. calc, for C25H27N 0 2: C, 80.40; H, 7.29; N, 3.75. Found: C, 80.41; H, 7.27; N, 
3.76.
^-^-(HydroxydiphenylmethyObenzyOpivalamide (57)
Ph
OHPh
NHCOBu1
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Yield: 74 mg-0.25 g (0.20-0.67 mmol, 10-34%); see Table 2.1.
Mp: 218-219 °C.
'H NMR (400 MHz, DMSO-r/6): 8 = 7.85 (t, J  = 6 Hz, exch., 1 H, NH), 7.35-7.32 (m, 
5 H, H-4 and H-3/H-5 o f 2 Ph), 7.28-7.23 (m, 7 H, H-6 and H-2/H-6/H-4 of 2 Ph), 
7.08-7.04 (m, 2 H, H-5 and OH), 6.53 (d, J  = 8 Hz, 1 H, H-3), 4.02 (d, J  = 6 Hz, 2 H, 
CH2), 1.08 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, DMSO-<f6): 5 = 178.5 (s, C =0), 148.5 (s, C-l o f 2 Ph), 145.3 (s, 
C -l), 140.2 (s, C-2), 129.7 (d, C-3), 129.4 (d, C-6), 128.6 (d, C-3/C-5 o f 2 Ph), 128.4 
(d, C-4), 128.3 (d, C-2/C-6 o f 2 Ph), 127.6 (d, C-4 o f 2 Ph), 126.4 (d, C-5), 82.3 (s, 
C-OH), 41.9 (t, CH2), 38.8 [s, C(CH3)3], 28.2 [q, C(CH3)3],
EI-MS: m/z (%) = 373 (M+, 31), 355 (M + -  H20 ,  47), 330 (11), 313 (25), 312 (100). 
CI-MS: m/z (%) = 374 (M H \ 4), 358 (M+ -  CH3, 71), 356 (MH+ -  H20 ,  100), 296 
(12), 243 (22), 200 (25), 192 (M+ -  Ph2CO, 48), 183 (Ph2COH+, 22), 119 (46), 102 
(35).
HRMS: m/z calc, for C25H27N 0 2 (M +), 373.2036; found, 373.2043.
FT-1R: vmax = 3359 (NH and OH), 2967 (CH), 1599 (C=0), 1526 (aromatic C=C), 
1364, 1210, 1027 cm '1.
7.4 Synthesis of ./V-(2-bromobenzyl)pivalamide (60)
The procedure was identical with that described for the synthesis of 
N-benzylpivalamide (49; Section 7.2) except that 2-bromobenzylamine hydrochloride 
(59; 8.86 g, 40.0 mmol) was used instead o f benzylamine (52). The reaction mixture 
was worked-up and the solid obtained was purified by crystallization from Et20 -  
hexane (2:1) to give 60 (9.47 g, 35.2 mmol, 88%) as white crystals.
NHCOBu1
Mp: 101-102 °C.
'H NMR (400 MHz, CDC13): 5 = 7.56 (dd, J  = 2, 8 Hz, 1 H, H-3), 7.33 (dd, J =  2, 8 
Hz, 1 H, H-6), 7.28 (app. dt, J =  2, 8 Hz, 1 H, H-4), 7.14 (app. dt, J =  2, 8 Hz, 1 H, 
H-5), 6.22 (br, exch., 1 H, NH), 4.47 (d, J =  6 Hz, 2 H, CH2), 1.22 [s, 9 H, C(CH3)3].
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l3C NMR (100 MHz, CDCI3): 8 = 178.7 (s, C =0), 138.0 (s, C -l), 133.2 (d, C-3),
130.7 (d, C-6), 129.5 (d, C-4), 128.1 (d, C-5), 124.1 (s, C-2), 44.3 (t, CH2), 39.2 [s, 
C(CH3)3], 28.0 [q, C(CH3)3].
El-M S: m/z (%) = 190 [M+ -  Br or PhCH2NHCO'Bu+, 73], 171 [M+ (8lBr) -  
NHCO'Bu, 70], 169 [M+ (79Br) -  NHCO'Bu, 71], 107 (50), 90 (79), 89 (85), 77 (72), 
57 ( 'B u \ 100).
CI-M S: m/z (%) = 289 [M (8lBr) + NH4+, 71], 287 [M (79Br) + NIL,7, 73], 272 [MH+ 
(8lBr), 100], 270 [MH+ (79Br), 99], 209 (68), 192 (48), 190 (18).
HRMS: m/z calc, for C l2H i7BrNO (MH* (79Br)), 270.0488; found, 270.0488.
FT-IR: vmax = 3334 (NH), 2935 (CH), 1635 (C =0), 1532 (aromatic C=C), 1228, 
1020, 701 c m 1.
7.5 Synthesis of A-^-substituted benzyl)pivalamides 57 and 62-66 via 
bromine-lithium exchange of Ar-(2-bromobenzyl)pivalamide (60)
To a cooled solution (-78 °C) o f A-(2-bromobenzyl)pivalamide (60; 0.54 g,
2.0 mmol) in anhydrous THF (20 mL) under a nitrogen atmosphere was added a 
solution of MeLi in Et20 (2.2 mL, 1.0 M, 2.2 mmol), in order to deprotonate the 
nitrogen to form the monolithium reagent 61. The mixture was stirred for 10 min at 
-78 °C. Bromine-lithium exchange was then effected by the addition of /-BuLi in 
heptane (2.6 mL, 1.7 M, 4.4 mmol). The mixture was stirred at -78 °C for 2 h, to 
ensure the complete formation o f the dilithium reagent 55, after which an electrophile 
(2.2 mmol), in anhydrous THF (8 mL) if  solid, otherwise neat, was added. The 
mixture was stirred for 2 h at -78 °C then the cooling bath was removed and the 
mixture allowed to warm to room temperature. The mixture was diluted with EtOAc 
(10 mL) and then quenched with aq. sat. NH4CI solution (15 mL). The organic layer 
was separated, dried (MgSCL), and evaporated under reduced pressure. The crude 
product obtained was purified by crystallization from EtOAc-Et20 (1:3) to give pure 
A-(2-substituted benzyl)pivalamides 57 and 62-66 as white crystals. The yields 
obtained are recorded in Table 2.2.
A-(2-(Hydroxydiphenylmethyl)benzyl)pivalamide (57)
Yield: 0.67 g (1.80 mmol, 90%).
Mp: 218-219 °C.
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Compound 57 was found to be identical in all respects with the one produced from 
ring lithiation o f 7V-benzylpivalamide (49) followed by reaction with benzophenone at 
low temperature (0 o r -7 8  °C; Section 7.3). See Section 7.3 for spectral data.
^-^-(l-H ydroxycyclohexyO benzytypivalam ide (62)
NHCOBu
HO
Yield: 0.52 g (1.80 mmol, 90%).
Mp: 127-128 °C.
'H NMR (400 MHz, CDC13): 8 = 7.38-7.35 (m, 2 H, H-3 and H-5), 7.28-7.19 (m, 
2 H, H-4 and H-6), 6.67 (br, exch., 1 H, NH), 4.73 (d, J  = 5 Hz, 2 H, CH2), 2.89 (s, 
exch., 1 H, OH), 2.00-1.68 [m, 10 H, (CH2)5], 1.16 [s, 9 H, C(CH3)3],
I3C NMR (100 MHz, CDC13): 8 = 178.5 (s, C = 0), 146.7 (s, C-2), 137.7 (s, C -l),
132.5 (d, C-6), 127.7 (d, C-3), 127.6 (d, C-4), 126.0 (d, C-5), 75.0 (s, C-l of 
cyclohexyl), 43.2 (t, CH2NH), 39.2 (t, C-2/C-6 o f cyclohexyl), 38.9 [s, C(CH3)3], 27.9 
[q, C(CH3)3], 25.7 (t, C-4 o f cyclohexyl), 22.4 (t, C-3/C-5 o f cyclohexyl).
EI-MS: m/z (%) = 289 (M +, 11), 246 (22), 204 (25), 170 (46), 145 (43), 129 (23), 115 
(20), 91 (21), 57 ( 'B u \ 100).
CI-M S: m/z (%) = 290 (M H+, 22), 272 (M H+ -  H20 ,  100), 192 (4).
HRMS: m/z calc, for C ,8H28N 0 2 (M H+), 290.2115; found, 290.2116.
FT-IR: vmax = 3329 (NH and OH), 2923 (CH), 1613 (C =0), 1520 (aromatic C=C), 
1239, 1023 c m 1.
,V-(2-( Hydroxy phenylmethyl)benzyl)pivalamide (63)
6 H.
"
. sH
5 [ j ^ k NHCOBu'
y>O H
5 2
Ph
Yield: 0.51 g (1.72 mmol, 86%). 
Mp: 138-139 °C.
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'H NMR (400 MHz, DMSO-oV): 5 = 7.90 (app. t, J =  6 Hz, exch., 1 H, NH), 7.45 (dd, 
J  = 2, 8 Hz, 1 H, H-6), 7.33-7.14 (m, 8 H, H-3, H-4, H-5 and Ph), 5.95 (d, J  = 5 Hz,
exch., 1 H, OH), 5.91 (d, J  = 5 Hz, 1 H, CH), 4.34 (dd, J  = 6, 16 Hz, 1 H, 1 H of
CHi), 4.17 (dd, J =  6, 16 Hz, 1 H, 1 H o f CH2), 1.13 [s, 9 H, C(CH3)3], 
l3C NMR (100 MHz, DMSO-cfe): 5 = 178.1 (s, C = 0), 145.2 (s, C -l o f Ph), 143.1 (s, 
C -l), 137.4 (s, C-2), 128.9 (d, C-3/C-5 o f Ph), 127.8 (d, C-2/C-6 o f Ph), 127.7 (d, C-4 
o f Ph), 127.6 (d, C-3), 127.5 (d, C-4), 127.4 (d, C-5), 127.3 (d, C-6), 71.7 (d, CH),
40.2 (t, CH2), 38.9 [s, C(CH3)3], 28.3 [q, C(CH3)3],
EI-MS: m/z (%) = 297 (M +, 8), 280 (M + + 1 -  H20 , 22), 279 (M+ - H20 ,  17), 236 
(12), 222 (M *  - H20  - 'Bu, 23), 197 (M + -  NHCO'Bu, 41), 196 (50), 195 (85), 180 
(52), 178 (82), 165 (79), 152 (55), 119 (62), 115 (81), 102 (79), 91 (PhCH2+, 80), 77 
(Ph+, 88), 65 (46), 57 ( 'B u \ 100).
CI-M S: m/z (%) = 315 (M + NH4+, 4), 298 (M H+, 26), 280 (MH+ -  H20 ,  100), 119 
(6).
HRMS: m/z calc. fo rC |9H24N 02 (M H+), 298.1802; found, 298.1805.
FT-IR: vmax = 3305 (NH and OH), 2956 (CH), 1628 (C =0), 1543 (aromatic C=C), 
1453, 1299, 1207, 1020 cm '1.
Ar-(2-(Hydroxy-(4-methoxyphenyl)methyl)benzyl)pivalamide (64)
NHCOBu1
OH
OMe
Yield: 0.57 g (1.74 mmol, 87%).
Mp: 164-166 °C.
'H NMR (400 MHz, DMSO-<4): 5 = 7.87 (app. t, J =  5 Hz, exch., 1 H, NH), 7.48 (dd, 
J  = 2, 8 Hz, 1 H, H-6), 7.27-7.20 (m, 4 H, H-4, H-5 and H-2/H-6 of 
4-methoxyphenyl), 7.13 (d, J  = 8 Hz, 1 H, H-3), 6.89 (d, J  = 9 Hz, 2 H, H-3/H-5 of 
4-methoxyphenyl), 5.88 (d, J  = 4 Hz, exch., 1 H, OH), 5.79 (d, J  = 4 Hz, 1 H, CH), 
4.33 (dd, J  = 5, 16 Hz, 1 H, 1 H o f CH2), 4.10 (dd, J  = 5, 16 Hz, 1 H, 1 H o f CH2), 
3.73 (s, 3 H, OCH3), 1.13 [s, 9 H, C(CH3)3].
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]3C NMR (100 MHz, DMSO-cfe): 5 = 177.6 (s, C=0), 158.5 (s, C-4 of 
4-methoxyphenyl), 142.8 (s, C -l), 142.7 (s, C-2), 136.7 (s, C-l of 4-methoxyphenyl),
128.6 (d, C-2/C-6 o f 4-methoxyphenyl), 127.0 (d, C-3), 126.9 (d, C-6), 126.8 (d, C-4),
126.7 (d, C-5), 114.1 (d, C-3/C-5 of 4-methoxyphenyl), 70.8 (d, CH), 55.4 (q, OCH3),
39.8 (t, CH2), 38.4 [s, C(CH3)3], 27.8 [q, C(CH3)3],
EI-MS: m/z (%) = 327 (M+, 7), 309 (M+ -  H20 ,  81), 294 (M+ -  H20  - Me, 13), 278 
(38), 252 (M+ -  H20  -  'Bu, 100), 240 (51).
Cl-M S: m/z (%) = 328 (MH+, 6), 326 (M+ -1 , 18), 311 (MH* -  H20 , 45), 310 (M+ -  
H20 , 100), 220 (14), 192 (20), 119 (46), 102 (34).
HRMS: m/z calc, for C20H25NO3 (MH+), 328.1907; found, 328.1908.
FT-IR: vmax = 3316 (NH and OH), 2932 (CH), 1636 (C=0), 1531 (aromatic C=C), 
1462, 1226, 1020 c m 1.
Anal. calc, for C20H25NO3: C, 73.37; H, 7.71; N, 4.22. Found: C, 73.37; H, 7.70; N, 
4.28.
A^l-Methylbenzytypivalamide (65)
NHCOBu1
Me
Yield: 0.35 g (1.70 mmol, 85%).
Mp: 108-109 °C.
'H NMR (400 MHz, CDC13): 5 = 7.07-7.02 (m, 4 H, H-3, H-4, H-5 and H-6), 5.65 
(br, exch., 1 H, NH), 4.29 (d, J  = 5 Hz, 2 H, CH2), 2.17 (s, 3 H, CH3), 1.09 [s, 9 H, 
C(CH3)3].
I3C NMR (100 MHz, CDC13): 5 = 178.5 (s, C =0), 136.9 (s, C -l), 136.6 (s, C-2),
130.9 (d, C-3), 128.8 (d, C-6), 128.1 (d, C-4), 126.6 (d, C-5), 42.3 (t, CH2), 39.2 [s, 
C(CH3)3], 28.0 [q, C(CH3)3], 19.3 (q, CH3).
EI-MS: m/z (%) = 205 (M+, 17), 105 (M+ -  NHCO'Bu, 78), 91 (PhCH2+, 23), 77 (30), 
57 ( 'B u \ 100).
CI-MS: m/z (%) = 411 (2 M+ + 1, 16), 223 (M + NH4\  24), 206 (MH+, 100).
HRMS: m/z calc, for C 13H20NO (MH+), 206.1539; found, 206.1542.
FT-IR: vmax = 3316 (NH), 2959 (CH), 1637 (C=0), 1538 (aromatic C=C), 1221, 1005
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7V-(2-Deuteriobenzyl)pivalamaide (66)
NHCOBu1
Yield: 0.35 g (1.82 mmol, 91%).
Mp: 79-80 °C (Mp o f undeuteriated analogue 76-78 °C86).
'H NMR (400 MHz, CDCI3): S = 7.27-7.23 (m, 2 H, H-3 and H-5), 7.21-7.17 (m, 
2 H, H-4 and H-6), 5.92 (br, exch., 1 H, NH), 4.35 (d, J =  4 Hz, 2 H, CH2), 1.15 [s, 9 
H, C(CH3)j].
I3C NMR (100 MHz, CDClj): 8 = 178.6 (s, C =0), 139.0 (s, C -l), 129.1 (d, C-4),
129.0 (d, C-6), 128.0 (d, C-3), 127.8 (d, C-5), 127.5 (seen as three lines, 1:1:1, 
because of coupling to D, C-2), 43.8 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, C(CH3)3]. 
EI-MS: m/z (%) = 192 (M+, 19), 92 (M+ -  NHCO'Bu, 96), 57 ('Bu+, 100).
CI-MS: m/z (%) = 210 (M + NH4+, 32), 193 (MH+, 100).
HRMS: m/z calc, for C i2H ,7DNO (MH+), 193.1446; found, 193.1445.
FT-IR: vmax = 3305 (NH), 2967 (CH), 1620 (C =0), 1525 (aromatic C=C), 1439, 1225 
cm '1.
7.6 Synthesis of ^ -(substituted benzyl)pivalamides
The procedure was identical with that described for the synthesis of 
yV-benzylpivalamide (49; Section 7.2) except that the appropriate substituted 
benzylamine (67; 40.0 mmol) was used. The reaction mixture was worked-up and the 
solid obtained was purified by crystallization from Et20-hexane (2:1) to give the pure 
^-(substituted benzyl)pivalamides 44, 46, 65 and 68 as white crystals. The yields 
obtained are reported in Table 2.3.
7V-(4-Methoxybenzyl)pivalamide (44)
NHCOBu1
M eO  4
Yield: 7.69 g (34.8 mmol, 87%). 
Mp: 90-91 °C (lit.1” ’134 88-90 °C).
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'H NMR (400 MHz, CDCI3): 8 = 7.19 (d, J =  8 Hz, 2 H, H-3 and H-5), 6.86 ( d ,J =  8 
Hz, 2 H, H-2 and H-6), 5.97 (br, exch., 1 H, NH), 4.36 (d, J  = 6 Hz, 2 H, CH2), 3.79 
(s, 3 H, OCH3), 1.21 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDC13): 8 = 178.6 (s, C =0), 159.3 (s, C-4), 131.2 (s, C -l),
129.4 (d, C-2/C-6), 114.5 (d, C-3/C-5), 55.7 (q, OCH3), 43.4 (t, CH2), 39.1 [s, 
C(CH3)3], 28.0 [q, C(CH3)3].
EI-MS: m/z (%) = 221 (M+, 47), 136 (M+ -  CO'Bu, 28), 121 (MeOC6H4CH2+, 100), 
91 (PhCH2+, 35), 77 (65), 57 ('Bu+, 96).
Cl-M S: m/z (%) = 239 (M + NH4+, 8), 222 (MH+, 100), 121 (11).
HRMS: m/z calc. fo rC |3H20NO2 (MH+), 222.1489; found, 222.1487.
FT-IR: vmilx = 3332 (NH), 2965 (CH), 1635 (C =0), 1539 (aromatic C=C), 1517, 
1254, 1218, 1031 c m 1.
iY-(2-Methoxybenzyl)pivalamide (46)
NHCOBu
OMe
Yield: 8.04 g (36.4 mmol, 91%).
Mp: 103-104 °C.
'H NMR (400 MHz, CDC13): 8 = 7.29-7.24 (m, 2 H, H-3 and H-5), 6.94-6.88 (m, 
2 H, H-4 and H-6), 6.25 (br, exch., 1 H, NH), 4.42 (d, J =  6 Hz, 2 H, CH2), 3.86 (s, 3 
H, OCHj), 1.20 [s, 9 H, C(CH3)3],
l3C NMR (100 MHz, CDC13): 8 = 178.4 (s, C =0), 158.0 (s, C-2), 130.0 (d, C-6),
129.1 (d, C-4), 126.9 (s, C -l), 121.1 (d, C-5), 110.7 (d, C-3), 55.7 (q, OCH3), 40.0 (t, 
CH2), 39.1 [s, C(CH3)3], 28.0 [q, C(CH3)3].
El-MS: m/z (%) = 221 (M+, 19), 136 (M + -  CO'Bu, 43), 121 (MeOC6H4CH2+, 78), 91 
(PhCH2\  70), 77 (21), 57 ('Bu+, 100), 41 (80).
CI-MS: m/z (%) = 222 (MH+, 100), 119 (9).
HRMS: m/z calc, for C ,3H20NO2 (MH*), 222.1489; found, 222.1490.
FT-IR: v max = 3338 (NH), 2964 (CH), 1637 (C =0), 1532 (aromatic C=C), 1517, 
1242, 1113, 1026 cm '1.
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/V-(2-Methylbenzyl)pivalamide (65)
Yield: 7.30 g (35.6 mmol, 89%).
Mp: 108-109 °C.
Compound 65 was found to be identical in all respects with the one produced via 
bromine-lithium exchange o f A^ -(2-bromobenzyl)pivalamide (60) followed by reaction 
with iodomethane as an electrophile (Section 7.5). See Section 7.5 for spectral data.
/V-(4-Methylbenzyl)pivalamide (68)
M e 4
Yield: 7.54 g (36.8 mmol, 92%).
Mp: 96-97 °C (lit.134 94-96 °C).
'H NMR (400 MHz, CDC13): 5 = 7.16 (br, 4 H, H-2, H-3, H-5 and H-6), 6.00 (br, 
exch., 1 H, NH), 4.40 (d, J  = 6 Hz, 2 H, CH2), 2.35 (s, 3 H, CH3), 1.23 [s, 9 H, 
C(CH3)3].
13C NMR (100 MHz, CDC13): 5 = 178.6 (s, C =0), 137.5 (s, C -l), 136.1 (s, C-4),
129.8 (d, C-3/C-5), 128.1 (d, C-2/C-6), 43.7 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, 
C(CH3)3], 21.5 (q, CH3).
EI-MS: m/z (%) = 205 (M+, 15), 105 (M + -  NHCO'Bu, 95), 91 (PhCH2+, 46), 77 (49), 
57('B u+, 100).
CI-MS: m/z (%) = 223 (M + NH4+, 12), 206 (MH+, 100), 122 (5).
HRMS: m/z calc, for C ,3H20NO (MH+), 206.1539; found, 206.1541.
FT-IR: vmax = 3318 (NH), 2958 (CH), 1637 (C O ) , 1537 (aromatic C=C), 1220, 1005 
cm '1.
7.7 Synthesis of 7V-(2-substituted 4-methoxybenzyl)pivalamides 71-76 via
directed lithiation of Ar-(4-methoxybenzyl)pivalamide (44)
A solution o f /-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (-78 °C), stirred solution of jV-(4-methoxybenzyl)pivalamide (44; 0.44 g, 2.0 
mmol) in anhydrous THF (20 mL) under N2. Formation of the monolithium reagent 
69 was observed as a yellow solution and the dilithium reagent 70 was observed as a 
brownish solution. The mixture was stirred at -78  °C for 4 h, to ensure the complete
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formation of the dilithium reagent 70, after which an electrophile (2.2 mmol), in 
anhydrous THF (8 mL) if solid, otherwise neat, was added. The mixture was stirred 
for 2 h at -78 °C then the cooling bath was removed and the mixture allowed to warm 
to room temperature. It was then diluted with Et20 (10 mL) and quenched with aq. 
sat. NH4C1 (10 mL). The organic layer was separated, washed with H20  (2 x 1 0  mL), 
dried (MgSCL), and evaporated under reduced pressure. The residue obtained was 
purified by column chromatography (silica gel; Et20-hexane, 1:3) to give pure 
products. The yields obtained are reported in Table 2.4.
/V-(4-Methoxy-2-methylbenzyl)pivalamide (71)
NHCOBu1
M eO  4 Me
Yield: 0.38 g (1.62 mmol, 81%).
Mp: 93-94 °C.
1H NMR (400 MHz, CDCI3): 8 = 7.04 (d, J  = 8 Hz, 1 H, H-6), 6.66 (d, J  = 2 Hz, 1 H, 
H-3), 6.62 (dd, J =  2, 8 Hz, 1 H, H-5), 5.64 (br, exch., 1 H, NH), 4.27 (d, / =  5 Hz, 
2 H, CH2), 3.70 (s, 3 H, OCH3), 2.20 (s, 3 H, CH3), 1.12 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDCI3): 8 = 178.4 (s, C =0), 159.5 (s, C-4), 138.5 (s, C-2),
130.4 (d, C-6), 128.7 (s, C -l), 116.7 (d, C-3), 115.5 (d, C-5), 55.6 (q, OCH3), 41.9 (t, 
CH2), 39.1 (s, C(CH3)3], 28.0 [q, CfCHjM , 19.6 (q, CH3).
El-MS: m/z (%) = 235 (M+, 8), 135 (M+ -  NHCO'Bu, 67), 134 (52), 91 (PhCH2+, 33), 
77(12), 57 ('Bu+, 100).
CI-MS: m/z (%) = 253 (M + NH4+, 3), 236 (MH+, 100), 135 (M+ -  NHCO'Bu, 21), 
119(12), 102(15), 52(47).
HRMS: m/z calc, for C ,4H22N 0 2 (MH+), 236.1645; found, 236.1646.
FT-IR: vmax = 3306 (NH), 2959 (CH), 1627 (C =0), 1532 (aromatic C=C), 1493, 
1244, 1024 cm '1.
/V-(2-(Hydroxydiphenylmethyl)-4-methoxybenzyl)pivalamide (72)
r <
'"NHCOBu'
/O H
MeO 4 ^  >
Ph ^Ph
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Yield: 0.64 g (1.60 mmol, 80%).
Mp: 205-207 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.35-7.25 (m, 11 H, H-6 and 2 Ph), 6.79 (dd, J  = 2, 
8 Hz, 1 H, H-5), 6.41 (t, J =  6 Hz, exch., 1 H, NH), 6.26 (d, J =  2 Hz, 1 H, H-3), 5.22 
(s, exch., 1 H, OH), 4.08 (d, J =  6 Hz, 2 H, CH2), 3.63 (s, 3 H, OCH3), 1.05 [s, 9 H, 
C(CH3)3].
13C NMR (100 MHz, CDCb): 6 = 178.8 (s, 0 = 0 ), 158.1 (s, C-4), 147.7 (s, C-l o f 
2 Ph), 146.7 (s, C-2), 132.8 (d, C-6), 131.1 (s, C -l), 128.4 (d, C-3/C-5 o f 2 Ph), 128.2 
(d, C-2/C-6 of 2 Ph), 127.6 (d, C-4 o f 2 Ph), 117.1 (d, C-3), 112.8 (d, C-5), 82.9 (s, 
C-OH), 55.4 (q, OCH3), 41.9 (t, CH2), 38.8 [s, C(CH3)3], 27.8 [q, C(CH3)3].
El-MS: m/z (%) = 385 (M+ -  H20 ,  43), 328 (M+ -  H20  -  'Bu, 33), 300 (M+ -  H20  -  
CO'Bu, 100).
CI-MS: m/z (%) = 402 (M+ - 1, 2), 388 (M+ -  CH3, 46), 386 (MH+ -  H20 , 42), 273 
(12), 222 (84), 200 (27), 183 (Ph2COH+, 40), 119 (63), 102 (100).
ES+-M S: m/z (%) = 426 (M + Na+, 25), 386 (MH+ -  H20 , 62), 285 (100).
E S -M S : m/z (%) = 403 (M , 10), 402 (M -  1, 24), 220 (100).
HRMS: m/z calc, for C26H29N 0 3Na (M + Na+), 426.2040; found, 426.2041.
FT-IR: vma* = 3323 (NH and OH), 2964 (CH), 1623 (C=0), 1531 (aromatic C=C), 
1493, 1242, 1034 c m 1.
/V-(2-(l-Hydroxycyclohexyl)-4-methoxybenzyl)pivalamide (73)
NHCOBu1
M eO  4
HO
Yield: 0.49 g (1.54 mmol, 77%).
Mp: 109-110 °C.
'H NMR (400 MHz, CDC13): 5 = 7.21 (d, J =  8 Hz, 1 H, H-6), 6.83 (d, J  = 2 Hz, 1 H, 
H-3), 6.64 (dd, 7 = 2 ,  8 Hz, 1 H, H-5), 6.56 (br t, exch., 1 H, NH), 4.55 (d, J =  6 Hz, 
2 H, CH2), 3.70 (s, 3 H, OCH3), 2.72 (s, exch., 1 H, OH), 1.89-1.61 [m, 10 H, 
(CH2)5], 1.06 [s, 9 H, C(CH3)3].
13C NMR (100 MHz, CDC13): 5 = 178.4 (s, C O ) ,  158.9 (s, C-4), 148.4 (s, C-2),
133.8 (d, C-6), 129.8 (s, C -l), 113.1 (d, C-3), 111.5 (d, C-5), 74.9 (s, C-l of
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cyclohexyl), 55.6 (q, OCH3), 42.7 (t, CH2NH), 39.1 (t, C-2/C-6 of cyclohexyl), 38.9 
[s, C(CH3)3], 27.9 [q, C(CH3)3], 25.7 (t, C-4 o f cyclohexyl), 22.4 (t, C-3/C-5 of 
cyclohexyl).
EI-MS: m/z (%) = 319 (M+, 13), 301 (M+ -  H20 , 18), 276 (10), 234 (30), 216 (100). 
CI-MS: m/z (%) = 320 (MH+, 17), 302 (MH+ -  H20 , 53), 222 (52), 201 (22), 189 
(19), 116(68), 102(100), 52 (74).
HRMS: m/z calc, for C i9H30NO3 (MH+), 320.2220; found, 320.2225.
FT-IR: vmax = 3330 (NH and OH), 2924 (CH), 1612 (C=0), 1530 (aromatic C=C), 
1238, 1025 c m 1.
/V-(2-(2-Hydroxyhexan-2-yl)-4-methoxybenzyl)pivalamide (74)
f  ..... -
H<
NHCOBuf
MeO 4 Y;
^ M e
3 \ OH
M e ^ ^ T ,#H
H
Yield: 0.50 g (1.56 mmol, 78%).
Mp: 102-103 °C.
'H NMR (400 MHz, CDC13): 5 = 7.20 (d, 8 Hz, 1 H, H-6), 6.72 (d, J  = 2 Hz, 1 H,
H-3), 6.68 (br, exch., 1 H, NH), 6.64 (dd, J =  2, 8 Hz, 1 H, H-5), 4.54 (dd, J =  6, 14 
Hz, 1 H, 1 H of C //2NH). 4.50 (dd, J =  5, 14 Hz, 1 H, 1 H of C //2NH), 3.71 (s, 3 H, 
OCH3), 2.83 (s, exch., 1 H, OH), 1.85 (m, 1 H, 1 H o f CH2COH), 1.74 (m, 1 H, 1 H of 
C //2COH), 1.55 (s, 3 H, C //iCOH), 1.25-1.11 (m, 4 H, CH2CH2CH3), 1.05 [s, 9 H, 
C(CH3)3], 0.78 (t, J =  7 Hz, 3 H, CH2CH3).
13C NMR (100 MHz, CDC13): 5 = 178.3 (s, C =0), 158.7 (s, C-4), 146.9 (s, C-2),
134.1 (d, C-6), 129.5 (s, C -l), 114.1 (d, C-3), 111.3 (d, C-5), 77.0 (s, C-OH), 55.6 (q, 
OCH3), 44.7 (t, CH2CH2CH2CH3), 42.9 (t, CH2NH), 38.9 [s, C(CH3)3], 31.5 (q, 
CH3COH), 27.9 [q, C(CH3)3], 26.9 (t, CH2CH2CH3), 23.5 (t, CH2CH3), 14.4 (q, 
CH2CH3).
EI-MS: m/z (%) = 321 (M+, 6), 303 (M+ -  H20 ,  41), 264 (M+ -  'Bu, 100), 246 (M+ -  
H20  -  'Bu, 36).
CI-MS: m/z (%) = 322 (MH+, 53), 304 (MH+ -  H20 , 100), 264 (M+ -  'Bu, 9), 222 
(12), 219 (33), 119(36), 102 (23).
HRMS: m/z calc, for C i9H32N 0 3 (MH+), 322.2377; found, 322.2379.
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FT-IR: vmax = 3315 (NH and OH), 2933 (CH), 1635 (C =0), 1531 (aromatic C=C), 
1462, 1352, 1227, 1020, 1000 c m 1.
Ar-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methoxybenzyl)pivalamide (75)
NHCOBu
OH
MeO
OMe
Yield: 0.58 g (1.64 mmol, 82%).
Mp: 130-132 °C.
'H NMR (400 MHz, DMSO-<4): 8 = 7.76 (app. t, J =  6 Hz, exch., 1 H, NH), 7.22 (d, J  
= 9 Hz, 2 H, H-2/H-6 o f 4-methoxyphenyl), 7.08 (d, J  = 2 Hz, 1 H, H-3), 7.07 (d, J  = 
8 Hz, 1 H, H-6), 6.88 (d, J =  9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 6.80 (dd, J  — 
2, 8 Hz, 1 H, H-5), 5.86 (s, 1 H, CH), 5.81 (s, exch., 1 H, OH), 4.26 (d d ,J  = 6, 15 Hz, 
1 H, 1 H of CH2), 3.98 (dd, 7  = 6, 15 Hz, 1 H, 1 H o f CH2), 3.74 (s, 3 H, OCH3), 3.73 
(s, 3 H, OCH3), 1.11 [s , 9 H, C(CH3)3].
I3C NMR (100 MHz, DMSO-r4): 6 = 177.5 (s, C =0), 158.5 (s, C-4), 158.4 (s, C-4 o f 
4-methoxyphenyl), 144.3 (s, C-2), 136.6 (s, C -l o f 4-methoxyphenyl), 136.5 (s, C -l),
128.7 (d, C-6), 128.6 (d, C-2/C-6 o f 4-methoxyphenyl), 113.8 (d, C-3/C-5 of 
4-methoxyphenyl), 112.8 (d, C-3), 111.9 (d, C-5), 70.8 (d, CH), 55.4 (q, OCH3), 55.3 
(q, OCH3), 39.2 [s, C(CH3)3], 39.4 (t, CH2), 27.8 [q, C(CH3)3],
EI-MS: m/z (%) = 357 (M +, 17), 339 (M + -  H20 ,  100), 324 (15), 308 (12), 296 (13). 
CI-M S: m/z (%) = 358 (MH+, 1), 356 (M + -  1, 9), 340 (MH+ -  H20 , 100), 250 (12), 
222 (28), 154 (11), 137 (8), 119 (15), 102 (23).
ES+-M S: m/z (%) = 380 (M + Na+, 25), 340 (MH* -  H20 ,  67), 239 (MH+ -  CO'Bu -  
H20  -  Me, 100).
ES -M S: m/z (%) = 357 (M”, 9), 356 (M~ -  1, 39), 220 (100).
HRMS: m/z calc, for C2,H27N 0 4Na (M + N a '), 380.1832; found, 380.1832.
FT-IR: vmax = 3313 (NH and OH), 2933 (CH), 1635 (C =0), 1531 (aromatic C=C), 
1462, 1352, 1227, 1020 c m 1.
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Anal. calc, for C21H27NO4: C, 70.56; H, 7.61; N, 3.92. Found: C, 70.63; H, 7.64; N, 
3.89%.
/V-(2-Deuterio-4-methoxybenzyl)pivalaniide (76)
NHCOBu
MeO 4
Yield: 0.39 g (1.76 mmol, 88%).
Mp: 90-91 °C (Mp o f undeuteriated analogue 88-90 ° c 133,134).
1H NMR (400 MHz, CDCIj): 8 = 7.18 (d, J  = 8 Hz, 1 H, H-6), 6.88-6.76 (m, 2 H, H-3 
and H-5), 5.96 (br t, exch., 1 H, NH), 4.34 (d, J  = 6 Hz, 2 H, CH2), 3.79 (s, 3 H, 
OCH3), 1.21 [s, 9 H, C(CH3)3],
I3C NMR (100 MHz, CDC13): 5 = 178.6 (s, C = 0), 159.3 (s, C-4), 131.1 (s, C -l),
129.4 (d, C-6), 129.1 (seen as three lines, 1:1:1, because o f coupling to D, C-2), 114.5 
(d, C-3), 114.4 (d, C-5), 55.7 (q, OCH3), 43.4 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, 
C(CH3)3].
EI-MS: m/z (%) = 222 (M +, 11), 122 (M + -  NHCO'Bu, 100), 79 (21), 57 ('Bu+, 88). 
CI-MS: m/z (%) = 240 (M + NH4\  7), 223 (MH+, 100), 122 (M+ -  NHCO'Bu, 12), 
102 (10), 52 (6).
HRMS: m/z calc, for C i3H i9D N 0 2 (MH+), 223.1551; found, 223.1553.
FT-IR: vmax = 3332 (NH), 2932 (CH), 1633 (C =0), 1531 (aromatic C=C), 1494, 
1238, 1033 c m 1.
Ar-(4-Methoxy-2-methylbenzyl)-Ar-m ethylpivalamide (77)
COBU
Me
MeMeO 4
Yield: 25 mg (0.10 mmol, 5%).
Colourless oil.
'H NMR (400 MHz, CDCI3): 8 = 6.87 (d, J  = 8 Hz, 1 H, H-6), 6.61-6.59 (m, 2 H, H-3 
and H-5), 4.47 (s, 2 H, CH2), 3.66 (s, 3 H, OCH3), 2.85 (s, 3 H, NCH3), 2.14 (s, 3 H, 
CH3), 1.21 [s, 9 H, C(CH3)3],
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l3C NMR (100 MHz, CDCI3): 5 = 178.9 (s, C = 0), 159.0 (s, C-4), 137.8 (s, C-2),
128.8 (s, C -l), 127.6 (d, C-6), 116.6 (d, C-3), 111.4 (d, C-5), 55.6 (q, OCH3), 50.7 (t, 
CH2), 39.5 [s, C(CH3)3], 36.4 (q, NCH3), 28.8 [q, C(CH3)3], 19.6 (q, CH3).
EI-MS: m/z (%) = 249 (M+, 4), 135 (M+ -  NMeCO'Bu, 100), 91 (PhCH2+, 34), 77 
(12), 57('B u+, 90).
CI-M S: m/z (%) = 250 (MH+, 100), 135 (M+ -  NHCO'Bu, 27), 116 (22).
HRMS: m/z calc, for C i5H24N 0 2 (M H+), 250.1802; found, 250.1804.
FT-IR: vmax = 2956 (CH), 1633 (C =0), 1536 (aromatic C=C), 1490, 1240, 1011cm 1.
7.8 Synthesis of /V-(4-methoxy-2-methylbenzyl)-7V-methylpivalainide (77) via 
directed lithiation of 7V-(4-methoxybenzyl)pivalamide (44)
The procedure was identical with that described in Section 7.7 except that 
excess iodomethane (0.63 g, 4.4 mmol) was used. The reaction mixture was worked- 
up and purified by column chromatography (silica gel; Et20-hexane, 1:3) to give 77 
(0.43 g, 1.74 mmol, 87%) as a colourless oil. Compound 77 was found to be identical 
in all respects with the one produced as a side product from reaction o f dilithium 
reagent o f compound 44 with 1.1 equivalents o f iodomethane (Section 7.7).
7.9 Synthesis of 7V-(3-substituted 2-methoxybenzyl)pivalamides 80-84 via 
directed lithiation of yV-(2-methoxybenzyl)pivalamide (46)
A solution o f /-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (-78 °C), stirred solution o f A-(2-methoxybenzyl)pivalamide (46; 0.44 g, 2.0 
mmol) in anhydrous THF (20 mL) under N2. Formation o f the monolithium reagent 
78 was observed as a yellow solution and the dilithium reagent 79 was observed as a 
brownish solution. The mixture was stirred at -7 8  °C for 4 h, to ensure the complete 
formation o f the dilithium reagent, after which an electrophile (2.2 mmol), in 
anhydrous THF (8 mL) if  solid, otherwise neat, was added. The mixture was stirred 
for 2 h at -78  °C then the cooling bath was removed and the mixture allowed to warm 
to room temperature. It was then diluted with Et20  (10 mL) and quenched with aq. 
sat. NH4CI (10 mL). The organic layer was separated, washed with H20  (2 x 10 mL), 
dried (M gS04), and evaporated under reduced pressure. The residue obtained was 
purified by column chromatography (silica gel; Et20-hexane, 1:3) to give pure 
products 80-84. In the case o f carbon dioxide as electrophile the cooling bath was
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removed before solid carbon dioxide was added and the mixture was stirred for 30 
minutes while the temperature rose, and then quenched with HC1 (2 M; 5 mL). The 
crude product was crystallised from ethyl acetate to give pure 84. The yields obtained 
are recorded in Table 2.5.
7V-(3-(Hydroxy-(4-methoxyphenyl)methyl)-2-methoxybenzyl)pivalamide (80)
NHCOBu
2 OMe
HO
OMe
Yield: 0.54 g (1.52 mmol; 76%).
Mp: 144-145 °C.
'H NMR (400 MHz, DMSO-c/6): 5 = 8.04 (app. t, 6 Hz, exch., 1 H, NH), 7.39 (dd, 
J  = 2, 8 Hz, 1 H, H-4), 7.28 (d, J =  9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl), 7.13 
(app. t, J  = 8 Hz, 1 H, H-5), 7.08 (dd, J  = 2, 8 Hz, 1 H, H-6), 6.89 (d, 9 Hz, 2 H,
H-3/H-5 of 4-methoxyphenyl), 5.98 (d, J  = 4 Hz, exch., 1 H, OH), 5.72 (d, = 4 Hz, 
1 H, CH), 4.40 (d d ,J =  6, 16 Hz, 1 H, 1 H o f CH2), 4.28 (d d ,7 =  6, 16 Hz, 1 H, 1 H of 
CH2), 3.75 (s, 3 H, OCHj), 3.72 (s, 3 H, OCH3), 1.19 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, DMSO-*/6): 5 = 178.4 (s, C =0), 158.9 (s, C-2), 154.9 (s, C-4 of
4-methoxyphenyl), 139.4 (s, C-l o f 4-methoxyphenyl), 138.3 (s, C -l), 133.5 (s, C-3),
128.5 (d, C-2/C-6 o f 4-methoxyphenyl), 127.0 (d, C-4), 126.8 (d, C-6), 124.7 (d, C-5)
114.1 (d, C-3/C-5 o f 4-methoxyphenyl), 68.7 (d, CH), 61.9 (q, OCH3), 55.9 (q, 
OCH3), 38.9 [s, C(CH3)3], 37.5 (t, CH2), 28.3 [q, C(CH3)3],
EI-MS: m/z(% )  = 357 (M+, 2), 339 (M+ -  H20 ,  29), 324 (M+ -  H20  -  Me, 38), 254 
(M+ -  H20 , -  CO'Bu, 51), 240 (M+ -  NHCO'Bu -  OH, 63), 238 (M+ -  MeOC6H4C+, 
100), 225 (30), 211 (MeOC6H4CH(OH)Ph+, 25), 195 (30), 181 (29), 165 (56), 152 
(62), 146 (82).
CI-MS: m/z(% )  = 375 (M + N H /, 11), 358 (MH+, 14), 340 (MH+ -  H20 , 100), 222
(57), 154 (30), 119 (72), 102 (37).
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HRMS: m/z calc, for C21H28NO4 (M H+), 358.2013; found, 358.2014.
FT-IR: vmax = 3329 (NH and OH), 2923 (CH), 1614 (C =0), 1562 (aromatic C=C), 
1469, 1241, 1037, 1001 cm '1.
Anal. calc, for C21H27NO4: C, 70.56; H, 7.61; N, 3.92. Found: C, 70.56; H, 7.64; N, 
4.09%.
Selected crystallographic data: C21H27NO4, FW  = 357.44, T = 150(2) K, Z = 0.71073 
A, Monoclinic, P2,/a, a = 12.6540(3) A, b = 10.5000(2) A, c = 14.5990(4) A, a  = 90°, 
p = 92.0180(10)°, y = 90°, V = 1938.52(8) A3, Z = 4, pcaic. = 1.225 Mg/m3, crystal size 
= 0.40 x 0.40 x 0.10 mm3, m = 0.084 m m 1, reflections collected = 7167, independent 
reflections = 4407, Rjnt = 0.07314, parameters = 239, final R\ = 0.0530, wR2 = 0.1239 
for I>2g(I) and Ri = 0.0759, WR2 = 0.1364 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 736587, and 
can be obtained free o f charge via http://www.ccdc.ac.uk/data_request/cif.
Ar-(3-(Hydroxyphenylmethyl)-2-methoxybenzyl)pivalamide (81)
NHCOBu1
2 OMe
OHPh
Yield: 0.49 g (1.50 mmol, 75%).
Mp: 133-135 °C.
'H NMR (400 MHz, CDClj): 8 = 7.41 (d, J  = 7 Hz, 2 H, H-3/H-5 o f Ph), 7.36-7.32 
(m, 3 H, H-2/H-4/H-6 o f Ph), 7.27 (dd, J  = 2, 8 Hz, 1 H, H-4), 7.19 (dd, J  = 2, 8 Hz, 
1 H, H-6), 7.13 (app. t, J =  8 Hz, 1 H, H-5), 6.12 (br t, exch., 1 H, NH), 6.10 (s, 1 H, 
CH), 4.51 (dd, J =  6, 15 Hz, 1 H, 1 H o f CH2), 4.44 (dd, 7 =  5, 15 Hz, 1 H, 1 H o f 
CH2), 3.59 (s, 3 H, OCH3), 2.97 (br, exch., 1 H, OH), 1.21 [s, 9 H, C(CH3)3], 
l3C NMR (100 MHz, CDC13): 5 =  178.9 (s, C = 0), 156.1 (s, C-2), 144.1 (s, C -l ofPh),
137.8 (s, C -l), 132.0 (s, C-3), 129.2 (s, C-4), 128.8 (d, C-3/C-5 o f Ph), 128.1 (d, C-4 
of Ph), 127.8 (d, C-6), 126.9 (d, C-2/C-6 o f  Ph), 125.2 (d, C-5), 71.8 (d, CH), 62.1 (q, 
OCH3), 39.1 (t, CH2), 39.0 [s, C(CH3)3], 28.0 [q, C(CH3)3].
E S -M S : m/z (%) = 357 (M + N a \  100), 328 (M H+, 16), 311 (MH* -  OH, 15). 310 
(MH+- H 20 ,  68), 281 (12).
ES -M S: m/z (%) = 327 (M~, 8), 326 ( \T  -  1, 22), 220 (100), 188 (13), 131 (30).
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HRMS: m/z calc, for C2oH26N 0 3 (M H+), 328.1907; found, 328.1905.
FT-IR: vmax = 3319 (NH and OH), 2929 (CH), 1639 (C =0), 1528 (aromatic C=C), 
1492, 1344, 1234, 1006 cm '1.
Anal. calc, for C20H25NO3: C, 73.37; H, 7.70; N, 4.28. Found: C, 73.39; H, 7.72; N, 
4.26%.
yV-(3-(HydroxydiphenylmethyI)-2-methoxybenzyl)pivalamide (82)
NHCOBu1
OMe
Ph Ph
OH
Yield: 0.59 g (1.46 mmol, 73%).
Mp: 173-174 °C.
'H NMR (400 MHz, DMSO-c4): 8 = 7.80 (t, J =  6 Hz, exch., 1 H, NH), 7.10-7.01 (m, 
10 H, 2 Ph), 6.90 (d, J  = 8 Hz, 1 H, H-4), 6.76 (app. t, J  = 8 Hz, 1 H, H-5), 6.48 (dd, J  
= 2, 8 Hz, 1 H, H-6), 5.74 (s, exch., 1 H, OH), 4.04 (d, J =  6 Hz, 2 H, CH2), 3.12 (s, 3 
H, OCH3), 0.92 [s, 9 H, C(CH3)3],
l3C NMR (100 MHz, DMSO-<f6): 5 = 178.5 (s, C = 0), 156.4 (s, C-2), 147.9 (s, C-l o f 
2 Ph), 141.2 (s, C -l), 134.5 (s, C-3), 128.4 (d, C-2/C-6 and C-3/C-5 o f 2 Ph), 128.4 
(d, C-4), 128.3 (d, C-6), 127.7 (d, C-4 o f 2 Ph), 123.7 (d, C-5), 81.5 (s, C-OH), 61.2 
(q, OCH3), 40.0 [s, C(CH3)3], 37.8 (t, CH2), 28.3 [q, C(CH3)3],
EI-M S: m/z (%) = 385 (M + -  H20 ,  100), 370 (M + -  H20  -  Me, 35).
CI-M S: m/z (%) = 421 (M + NH4+, 5), 405 (M H+ + 1 ,12), 404 (M H+, 3), 388 (M+ -  
CH3, 48), 386 (M H+ -  H20 ,  100), 343 (11), 273 (13), 222 (34), 200 (24), 183 
(Ph2C O H \ 14), 119 (100), 102 (45).
ES -M S: m!z (%) = 426 (M + N a \  38), 421 (M + NH4\  100), 404 (MH+, 13), 386 
(MH* -  H20 ,  88).
ES -M S: m/z (%) = 403 (M , 32), 402 (M- -  1, 100), 388 (M -  CH3, 40), 241 (18), 
206 (22).
HRMS: m/z calc, for C26H30NO3 (M H+), 404.2220; found, 404.2219.
FT-IR: vmax = 3334 (NH and OH), 2938 (CH), 1635 (C =0), 1533 (aromatic C=C), 
1462, 1238, 1019 c m 1.
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yV-(3-Deuterio-2-methoxybenzyl)pivalamide (83)
cn ^ N H C O B i /
2 O M e
D
Yield: 0.38 g (1.72 mmol, 86%).
Mp: 103-104 °C (Mp of undeuteriated analogue 103-104 °C; 46, Section 7.6).
'H NMR (400 MHz, CDClj): 8 = 7.21-7.15 (m, 2 H, H-5 and H-6), 6.83 (m, 1 H, 
H-4), 6.14 (br, exch., 1 H, NH), 4.36 (d, J  6 Hz, 2 H, CH2), 3.78 (s, 3 H, OCH3), 
1.11 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDC13): 8 = 178.4 (s, C=0), 158.0 (s, C-2), 130.1 (d, C-6),
129.1 (d, C-4), 129.0 (s, C -l), 121.1 (d, C-5), 110.5 (seen as three lines, 1:1:1, 
because of coupling to D, C-3), 55.7 (q, OCH3), 40.0 (t, CH2), 39.1 [s, C(CH3)3], 28.0 
[q, C(CH3)3],
EI-MS: m/z(%) = 222 (M+, 12), 137 (M+ -  CO'Bu, 28), 122 (M+ -  NHCO'Bu, 71), 92
(C6H40 +, 91), 79 (22), 77 (17), 57 ('Bu+, 100).
CI-MS: m/z(%) = 223 (MH+, 100), 137 (M+ -  CO'Bu, 4), 119 (5), 102 (3).
HRMS: m/z calc, for C 13Hi9D N 02 (MH+), 223.1551; found, 223.1550.
FT-IR: vmax = 3340 (NH), 2969 (CH), 1626 (C=0), 1538 (aromatic C=C), 1481,
1418, 1224 c m 1.
2-Methoxy-3-(pivalamidomethyl)benzoic acid (84)
2 O M e
Yield: 0.42 g (1.58 mmol, 80%). 
Mp: 156-157 °C.
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‘H NMR (500 MHz, DMSO-</6): 5 = 8.03 (t, J = 6 Hz, exch., 1 H, NH), 7.57 (dd, J  = 
2, 8 Hz, 1 H, H-6), 7.32 (dd, J  = 2, 8 Hz, 1 H, H-4), 7.16 (app. t, J  = 8 Hz, 1 H, H-5),
4.32 (d, J=  6 Hz, 2 H, CH2), 3.79 (s, 3 H, OCH3), 1.15 [s, 9 H, C(CH3)3].
13C NMR (125 MHz, DMSO-J6): 5 = 178.1 (s, C=0), 167.8 (s, C 0 2H), 157.1 (s, C-2),
134.6 (s, C-3), 131.5 (d, C-4), 129.6 (d, C-6), 126.1 (s, C-l), 123.9 (d, C-5), 62.1 (q, 
OCH3), 38.6 [s, C(CH3)3], 37.3 (t, CH2), 27.9 [q, C(CH3)3].
ES+-M S: m/z (%) = 569 (2 M + K+, 12), 553 (2 M + Na+, 100), 548 (2 M + NH4+, 32), 
329 (M + MeCNNa+, 25), 304 (M + K +, 27), 288 (M + Na+, 70), 266 (MH+, 71). 
HRMS: m/z calc, for C,4H2oN04 (MH+), 266.1392; found, 266.1386.
FT-IR: vmax = 3377 (NH and OH), 2972 (CH), 1698 (C 02), 1610 (C=0), 1540 
(aromatic C=C), 1427, 1368, 1247 cm '1.
Selected crystallographic data: Ci4H ,9N 0 4, FW = 265.30, T = 150(2) K, A. = 0.71073 
A, Monoclinic, P2i/c, a = 13.9970(5) A, b = 13.9230(5) (2) A, c = 15.0940(8) A, a  = 
90°, p = 106.480(2)°, y = 90°, V = 2820.7(2) A3, Z = 8, pcaic. = 1.249 Mg/m3, crystal 
size = 0.40 x 0.30 x 0.06 mm3, m = 0.091 mm'1, reflections collected = 10912, 
independent reflections = 6430, R jnt = 0.0712, parameters = 353, final R\ = 0.0750, 
w R 2 = 0.1406 for I>2a(I) and Ri = 0.1497, wR2 = 0.1673 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 736584, and can be obtained free o f charge via 
http://www.ccdc.ac.uk/data_request/cif.
/V-((lS*,2S*)-2-hydroxy-l-(2-methoxyphenyl)-2-(4-methoxyphenyI)ethyl)- 
pivalamide (85)
MeO
OMe
Yield: 14 mg (0.04 mmol, 2%).
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Mp: 203-205 °C.
'H NMR (400 MHz, DMSO-rf6): 8 = 7.25 (d, . 7 = 9  Hz, 2 H, H-2/H-6 of 
4-methoxyphenyl), 7.23-7.19 (m, 3 H, NH, H-4 and H-6), 6.96 (d, J  = 8 Hz, 1 H, 
H-3), 6.91 (app. t, J  = 8 Hz, 1 H, H-5), 6.86 (d, J  = 9 Hz, 2 H, H-3/H-5 of 
4-methoxyphenyl), 5.52 (d, J  = 4 Hz, exch., 1 H, OH), 5.24 (dd, J  = 3, 6 Hz, 1 H, 
CH), 4.78 (dd, J  = 4, 3 Hz, 1 H, C //O H ), 3.83 (s, 3 H, OCH3), 3.72 (s, 3 H, OCH3),
1.05 [s, 9 H, C(CH j)3],
l3C NMR (100 MHz, DMSO-<4): 8 = 176.5 (s, C =0), 158.4 (s, C-4 of 
4-methoxyphenyl), 156.5 (s, C-2), 136.2 (s, C -l o f 4-methoxyphenyl), 130.3 (s, C -l),
128.1 (d, C-6), 127.6 (d, C-4), 127.2 (d, C-2/C-6 o f 4-methoxyphenyl), 120.3 (d, C-5),
113.3 (d, C-3/C-5 o f 4-methoxyphenyl), 110.9 (d, C-3), 73.1 (d, CHOH), 55.8 (q, 
OCH3), 55.3 (q, OCH3), 53.8 (d, CH), 38.5 [s, C(CH3)3], 27.6 [q, C(CH3)3].
EI-MS: m/z (%) = 339 (M+ -  H20 ,  3), 254 (M+ -  H20  -  CO'Bu, 4), 222 (M+ -  
MeOC6H4CO, 10), 221 [M+ -  M eOC6H4CHO or MeOC6H4CH(OH)Ph+, 81], 220 [M+ 
-  MeOC6H4CHOH or MeOC6H4C(OH)Ph+, 22], 203 (8), 137 (29), 136 (72), 121 (48), 
109 (18), 94 (28), 91 (22), 77 (47), 57 ('Bu+, 100).
CI-MS: m/z (%) = 358 (MH+, 8), 340 (MH+ -  H20 ,  56), 222 (M+ -  MeOCefCCO, 
100), 154 (61), 137 (63), 119 (75), 102 (90), 86 (15).
HRMS: m/z calc, for C2]H28N 0 4 (M H+), 358.2013; found, 358.20124.
FT-IR: Vmax = 3451 (NH and OH), 3258 (CH), 1635 (C =0), 1560 (aromatic C=C), 
1513, 1252, 1027 c m 1.
Selected crystallographic data: C2iH2yN04, FW  = 357.44, T = 150(2) K, X = 0.71073 
A, Triclinic, P I, a = 7.403(2) A, b = 16.774(3) A, c = 18.372(4) A, a  = 62.537(7)°, p 
= 77.658(10)°, y = 76.021(15)°, V = 1950.4(8) A3, Z = 4, pcaic. = 1.214 Mg/m3, crystal 
size = 0.25 x 0.06 x 0.06 mm3, m = 0.084 mm"1, reflections collected = 5162, 
independent reflections = 3239, Rjnt = 0.1707, parameters = 270, final Rj = 0.2028, 
w R 2 = 0.4072 for I>2a(I) and Ri = 0.2559, wR2 = 0.4390 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 736588, and can be obtained free of charge via 
http ://www. cede. ac. uk/data_request/c if.
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/V-(2-Hydroxy-l-(2-methoxyphenyl)-2,2-diphenylethyl)pivalamide (87)
NHCOBu1
OMe
Yield: 24 mg (0.06 mmol, 3%).
Mp: 203-204 °C.
'H NMR (400 MHz, DM SO-J6): 5 = 7.54-6.99 (m, 13 H, 2 Ph, H-4, H-6 and NH), 
6.86 (app. t, J =  8 Hz, 1 H, H-5), 6.54 (d, J =  8 Hz, 1 H, H-3), 6.34 (d, J =  9 Hz, 1 H, 
CH), 6.15 (s, exch., 1 H, OH), 3.14 (s, 3 H, OCH3), 0.91 [s, 9 H, C(CH3)3].
13C NMR (100 MHz, DM SO-40: S = 176.6 (s, C=0 ), 157.0 (s, C-2), 147.5, 145.3 
(2 s, C-l o f Ph), 130.8 (d, C-6), 128.9 (s, C -l), 128.52, 128.49 (2 d, C-3/C-5 of 2 Ph), 
127.51, 127.41 (2 d, C-2/C-6 o f 2 Ph), 127.4, 127.1 (2 d, C-4 of 2 Ph), 126.6 (d, C-4),
120.1 (d, C-5), 110.4 (d, C-3), 80.9 (s, C-OH), 55.4 (q, OCH3), 52.1 (d, CH), 38.7 [s, 
C(CH3)3], 27.9 [q, C(CH3)3].
EI-MS: m/z (%) = 386 (MH+ -  H20 , 10), 360 (13), 300 (24), 286 (34), 270 (90), 252
(41), 241 (62), 239(100).
CI-MS: m/z (%) = 405 (MH+ + 1,4), 404 (MH+, 8), 386 (MH+ -  H20 , 10), 222 (100), 
220 (M+ -  Ph2COH, 41), 183 (Ph2COH+, 43), 136(27), 119(22), 102(11).
HRMS: m/z calc, for C26H30NO3 (MH+), 404.2220; found, 404.2221.
FT-IR: vmax = 3338 (NH and OH), 2932 (CH), 1631 (C=0), 1528 (aromatic C=C), 
1242, 1172, 1022 cm '1.
7.10 Lithiation of 46 with f-BuLi at 0 °C followed by reaction with 
4-anisaldehyde
The procedure was identical with that described in Section 7.9 except that the 
reaction was carried out at 0 °C and 4-anisaldehyde was the electrophile. The reaction 
mixture was worked-up and purified by column chromatography (silica gel; Et20 -  
hexane, 1:3) to give 80 (0.28 g, 0.78 mmol, 39%) and 85 (0.29 g, 0.81 mmol, 41%). 
Compounds 80 and 85 were identical in all respects with the ones produced from 
reaction o f the dilithium reagents o f compound 46 with 4-anisaldehyde (Section 7.9).
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7.11 Lithiation of 46 with /-BuLi at 0 °C followed by reaction with CO2
The procedure was identical with that described in Section 7.9 except that the 
reaction was carried out at 0 °C and solid carbon dioxide was the electrophile. The 
reaction mixture was worked-up and the product mixture was purified by fractional 
crystallization using ethyl acetate to give 47 (26 mg, 0.098 mmol, 5%) and 84 (0.21 g, 
0.79 mmol, 40%) as white crystals. No attempts were made to isolate 48.
3-M ethoxy-2-(pivalamidomethyl)benzoic acid (47)
NHCOBu16
5
3 OMe
Mp: 170-171 °C (lit.85 168-169 °C).
'H NMR (500 MHz, DMSO-<4): 5 = 7.43 (t, 6 Hz, exch., 1 H, NH), 7.34 (app. t,
= 8 Hz, 1 H, H-5), 7.27 (dd, J =  2, 8 Hz, 1 H, H-6), 7.19 (dd, = 2, 8 Hz, 1 H, H-4), 
4.47 (d, J=  6 Hz, 2 H, CH2), 3.82 (s, 3 H, OCH,), 1.05 [s, 9 H, C(CH3)3],
I3C NMR (125 MHz, DMSO-c/6): 5 = 177.5 (s, C =0), 169.7 (s, C 0 2H), 158.4 (s, C-3),
134.3 (s, C-2), 128.7 (d, C-5), 126.7 (s, C -l), 121.6 (d, C-6), 114.6 (d, C-4), 56.5 (q, 
OCH3), 38.4 [s, C(CH3)3], 35.7 (t, CH2), 27.8 [q, C(CH3)3],
ES+-M S: m/z (%) = 553 (2 M + Na+, 34), 531 (2 M + H+, 42), 329 (M + MeCNNa+, 
32), 304 (M + K \  3), 266 (MH+, 100).
HRMS: m/z calc, for C l4H20NO4 (MH+), 266.1392; found, 266.1392.
FT-IR: Vmax = 3401 (NH and OH), 2965 (CH), 1698 (C 02), 1611 (C=0), 1539 
(aromatic C=C), 1467, 1385, 1219 c m 1.
Selected crystallographic data: C 14H 19NO4, FW = 265.30, T = 150(2) K, 0.71073 
A, Triclinic, PI, a = 7.6270(4) A, b = 8.3440(5) A, c = 11.1510(6) A, a  = 98.759(3)°, 
P = 95.311(4)°, y = 92.118(2)°, V = 697.42(7) A3, Z = 2, pCaic. = 1.263 Mg/m3, crystal
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size -  0.40 x 0.16 x 0.11 mm3, m = 0.092 m m '1, reflections collected = 4551, 
independent reflections = 3160, Rint = 0.0347, parameters = 177, final Ri = 0.0534, 
w R 2 = 0.1177 for I>2ct(I) and R, = 0.0797, wR2 = 0.1316 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 736585, and can be obtained free o f charge via 
http://www.ccdc.ac.uk/data_request/cif.
2-Methoxy-3-(pivalamidomethyl)benzoic acid (84)
Mp: 156-157 °C.
Compound 84 was found to be identical in all respects with the one produced in 
Section 7.9. See Section 7.9 for spectral data.
7.12 Lithiation of 46 with sec-BuLi at -78 °C followed by reaction with C 0 2
The procedure was identical with that described in Section 7.9 except that 
sec-BuLi in cyclohexane (3.2 mL, 1.4 M, 4.4 mmol) was used instead of /-BuLi and 
solid carbon dioxide was the electrophile. The residue obtained was treated with 
diethyl ether and on standing overnight gave 47 (63 mg, 0.24 mmol, 12%) as white 
crystals. No attempt was made to isolate 48.
7.13 Lithiation of 46 with sec-BuLi at 0 °C followed by reaction with C 0 2
The procedure was identical with that described in Section 7.9 except that 
sec-BuLi in cyclohexane (3.2 mL, 1.4 M, 4.4 mmol) was used instead o f /-BuLi and 
the reaction was carried out at 0 °C instead o f -78 °C in which solid carbon dioxide 
was the electrophile. The residue obtained was treated with diethyl ether and on 
standing overnight gave 47 (0.13 g, 0.49 mmol, 25%) as white crystals. No attempt 
was made to isolate 48.
7.14 Lithiation of 46 with «-BuLi at 0 °C followed by reaction with C 0 2
The procedure was identical with that described in Section 7.9 except that 
tf-BuLi in hexanes (2.8 mL, 1.6 M, 4.5 mmol) was used instead of /-BuLi and the 
reaction was carried out at 0 °C instead o f -78 °C in which solid carbon dioxide was 
the electrophile. The residue obtained was treated with diethyl ether to give 47 
(58 mg, 0.22 mmol, 11%) as white crystals. No attempts were made to isolate 48 or 
84.
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7.15 Synthesis of 7V-(2-substituted 4-methylbenzyl)pivalamides 89-95 via
directed lithiation of 7V-(4-methylbenzyl)pivalamide (68)
A solution of t-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (-78 °C), stirred solution of 68 (0.41 g, 2.0 mmol) in anhydrous THF (20 mL) 
under N2. The mixture was stirred at -78  °C for 4 h, after which an electrophile (2.2 
mmol), in anhydrous THF (8 mL) if solid, otherwise neat, was added. The mixture 
was stirred for 2 h at -78  °C and then worked-up as usual. The crude product obtained 
was purified by column chromatography (silica gel; Et20-hexane, 1:3) to give pure 
products as white solids. The yields obtained are recorded in Table 2.7.
yV-(2-(Hydroxyphenymethyl)-4-methylbenzyl)pivaIamide (89)
NHCOBu
OH
Me 4
Ph
Yield: 0.49 g (1.58 mmol, 79%).
Mp: 150-151 °C.
'H NMR (400 MHz, CDClj): 6 = 7.28-7.06 (m, 7 H, Ph, H-3 and H-6), 7.00 (dd,
2, 8 Hz, 1 H, H-5), 5.99 (b rt, exch., 1 H, NH), 5.92 (br, 1 H, CH), 4.29 (dd, J =  5, 14 
Hz, 1 H, 1 H o f CH2), 4.16 (dd, J  = 5, 14 Hz, 1 H, 1 H of CH2), 3.40 (br, exch., 1 H, 
OH), 2.23 (s, 3 H, CH3), 0.97 [s, 9 H, C(CH3)3].
l3C NMR (100 MHz, CDC13): 8 = 178.7 (s, C=0), 143.9 (s, C-l of Ph), 141.8 (s, C-2),
137.9 (s, C -l), 133.7 (s, C-4), 130.7 (d, C-3), 129.4 (d, C-6), 129.3 (d, C-5), 128.9 (d, 
C-3/C-5 of Ph), 127.8 (d, C-4 of Ph), 127.1 (d, C-2/C-6 of Ph), 74.1 (d, CH), 41.1 (t, 
CH2), 38.9 [s, C(CH3)3], 27.8 [q, C(CH3)3], 21.6 (q, CHj).
ES+-M S: m/z(%) = 334 (M + Na+, 89), 312 (MH+, 8), 295 (MH+ -  OH, 21), 294 
(MH+ -  H20 , 100), 208 (12), 193 (78), 102 (27), 57 ( W ,  81).
ES"-MS: m/z(%) = 311 (M~, 2), 310 (M~ -  1, 23), 204 [M -  C6H4CH(OH), 100],
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HRMS: m/z calc, for C20H26NO2 (MH*), 312.1958; found, 312.1960.
FT-IR: vmax = 3339 (NH and OH), 2906 (CH), 1630 (C=0), 1549 (aromatic C=C), 
1495, 1356, 1235, 1020 cm '1.
Anal. calc, for C20H25NO2: C, 77.14; H, 8.09; N, 4.50. Found: C, 77.23; H, 8.14; N, 
4.45%.
Selected crystallographic data: C20H25NO2, FW = 311.410, T = 296(2) K, X = 0.71073 
A, Monoclinic, P2,/c, a = 10.7160(7) A, b = 15.0800(7) A, c = 11.2900(11) A, a  = 
90°, p = 94.234(3)°, y = 90°, V = 1819.5(2) A3, Z  = 4, pca,c. = 1.137 Mg/m3, crystal 
size = 0.32 x 0.32 x 0.12 mm3, m = 0.073 m m '1, reflections collected = 9766, 
independent reflections = 3353, Rjnt = 0.0728, parameters = 214, final Rj = 0.0751, 
WR2 = 0.1741 for I>2a(I) and Ri = 0.1621, WR2 = 0.2090 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 736920, and can be obtained free of charge via 
http://www.ccdc.ac.uk/data_request/cif.
yV-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methylbenzyl)pivalamide (90)
N H C O B u
OH
M e 4
O M e
Yield: 0.55 g (1.61 mmol, 81%).
Mp: 184-186 °C.
'H NMR (400 MHz, DMSO-A): 8 = 7.55 (app. t, J =  6 Hz, exch., 1 H, NH), 7.05 (s, 
1 H, H-3), 6.96 (d, J  = 9 Hz, 2 H, H-2/H-6 o f 4-methoxyphenyl), 6.78 (br, 2 H, H-5 
and H-6), 6.62 (d, J  = 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 5.60 (d, J  = 4 Hz, 
1 H, CH), 5.51 (d, J  = 4 Hz, exch., 1 H, OH), 4.02 (dd, J =  6, 15 Hz, 1 H, 1 H of 
CH2), 3.79 (dd, J  = 6, 15 Hz, 1 H, 1 H o f CH2), 3.48 (s, 3 H, OCH3), 2.03 (s, 3 H, 
CH3), 0.86 [s, 9 H, C(CH3)3].
13C NMR (100 MHz, DMSCM,): 8 = 178.0 (s, C =0), 158.9 (s, C-4 of 
4-methoxyphenyl), 143.2 (s, C-2), 137.3 (s, C -l), 136.1 (s, C-4), 134.2 (s, C-l of 
4-methoxyphenyl), 129.0 (d, C-2/C-6 o f 4-methoxyphenyl), 128.1 (d, C-3), 128.0 (d,
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C-6), 127.7 (d, C-5), 114.2 (d, C-3/C-5 o f 4-methoxyphenyl), 71.3 (d, CH), 55.9 (q, 
OCH3), 40.0 (t, CH2), 38.9 [s, C(CH3)3], 28.3 [q, C(CH3)3], 21.8 (q, CH3).
EI-MS: m/z (%) = 323 (M + -  H20 ,  17), 266 (M+ -  H20  -  'Bu, 62), 238 (M+ -  H20  -  
CO'Bu, 33), 209 (M + -  HzO -  CH2NHCO'Bu, 50), 165 (55), 130 (44), 92 (46), 77 
(100).
CI-MS: m/z (%) = 341 (M+, 6), 340 (M+ -  1, 17), 326 (M+ -  Me, 48), 324 (MH+ -  
H:0 , 100), 206 (66), 154 (22), 137 [MeOC6H4CH(OH)+, 17], 119 (MeC6H3CH2NH+, 
37), 102 ['BuCOH(NH2)+, 22],
ES'-M S: m/z (%) = 364 (M + Na+, 82), 325 (MH+ -  H20 ,  22), 324 (M+ -  H20 , 79), 
223 (M+ -  H20  -  NHCO'Bu, 100).
ES -M S: m/z (%) = 341 (M , 12), 340 (M- -  1, 52), 204 [M -  MeOC6H4CH(OH), 
100],
HRMS: m/z calc, for C2,H26N 0 3 (M~ -  1), 340.1918; found, 340.1908.
FT-IR: vmas = 3328 (NH and OH), 2923 (CH), 1613 (C=0), 1563 (aromatic C=C), 
1469, 1242, 1026 c m 1.
iV -^K H ydroxydiphenylm ethyl^-m ethylbenzytypivalam ide (91)
-
^ N H C O B u '
M e >
^ P h
3 /  
Ph O H
Yield: 0.63 g (1.63 mmol, 81%).
Mp: 244-246 °C.
‘H NMR (400 MHz, DMSO-t/6): 8 = 7.81 (br t, exch., 1 H, NH), 7.34-7.24 (m, 10 H, 
2 Ph), 7.17 (d, J  = 8 Hz, 1 H, H-6), 7.08 (d, J  = 8 Hz, 1 H, H-5), 7.05 (s, 1 H, H-3), 
6.36 (s, exch., 1 H, OH), 3.93 (d, J  = 5 Hz, 2 H, CH2), 2.08 (s, 3 H, CH3), 1.07 [s, 9 H, 
C(CH3)3],
l3C NMR (100 MHz, DMSO-c/6): 5 = 178.4 (s, C =0), 148.6 (s, C-l o f 2 Ph), 145.3 (s, 
C-2), 137.1 (s, C -l), 135.2 (s, C-4), 130.4 (d, C-3), 129.7 (d, C-6), 129.0 (d, C-5),
128.6 (d, C-3/C-5 o f 2 Ph), 128.3 (d, C-2/C-6 o f 2 Ph), 127.5 (d, C-4 o f 2 Ph), 82.2 (s, 
C-OH), 41.7 (t, CH2), 38.7 [s, C(CH3)3], 28.2 [q , C(CH3)3], 21.8 (q , CH3).
EI-MS: m/z (%) = 370 (MH+ -  H20 ,  8), 369 (M+ -  H20 ,  28), 368 (M+ -  H20  -  H, 9), 
312 (M+ -  H20  -  'Bu, 51), 310 (48), 285 (MH* -  H20  -  CO'Bu, 83), 284 (M+ -  H20  -  
CO'Bu, 100).
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CI-MS: m/z (%) = 388 (MH+, 21), 370 (MH+ -  H20 ,  40), 206 (72), 200 (M+ -  2 Ph -  
H20  -  Me, 22), 183 (Ph2COH+, 35), 119 (MeC6H3CH2NH+, 81), 102
['BuCOH(NH2)+, 100],
ES+-M S: m/z (%) = 410 (M + Na+, 22), 370 (MH+ -  H20 ,  100), 270 (MH+ -  H20  -  
NHCO'Bu, 7), 269 (M+ -  H20  -  NHCO'Bu, 37).
ES -M S: m/z (%) = 432 (100), 387 (M_, 20), 386 (M -  1, 72).
HRMS: m/z calc, for C26H30NO2 (MH+), 388.2271; found, 388.2266.
FT-IR: vmax = 3334 (NH and OH), 2941 (CH), 1635 (C=0), 1532 (aromatic C=C), 
1461, 13377, 1237, 1020 cm '1.
yV-(2-(l-Hydroxycyclohexyl)-4-methylbenzyl)pivalamide (92)
NHCOBu1
Me'
HO
Yield: 0.50 g (1.65 mmol, 82%).
Mp: 127-129 °C.
1H NMR (400 MHz, CDC13): 8 = 7.15 (d, J  = 8 Hz, 1 H, H-6), 7.08 (s, 1 H, H-3), 6.93 
(d, J=  8 Hz, 1 H, H-5), 6.57 (br t, exch., 1 H, NH), 4.59 (d, J  = 5 Hz, 2 H, CH2), 2.85 
(br s, exch., 1 H, OH), 2.24 (s, 3 H, CH3), 1.89-1.59 [m, 10 H, (CH2)5], 1.06 [s, 9 H, 
C(CH3)3],
l5C NMR (100 MHz, CDC13): 8 = 178.4 (s, C =0), 146.6 (s, C-2), 137.1 (s, C -l),
134.6 (s, C-4), 132.6 (d, C-3), 128.3 (d, C-6), 126.8 (d, C-5), 75.0 (s, C-l o f 
cyclohexyl), 43.0 (t, CH2NH), 39.2 (t, C-2/C-6 o f cyclohexyl), 38.9 [s, C(CH3)3], 27.9 
[q, C(CH3)3], 25.8 (t, C-4 o f cyclohexyl), 22.4 (t, C-3/C-5 o f cyclohexyl), 21.7 (q, 
CH3).
EI-MS: m/z (%) = 303 (M+, 3), 184 (8), 159 (10), 105 (12), 91 (13), 57 ('Bu+, 100). 
CI-MS: m/z (%) = 304 (MH+, 18), 286 (MH+ -  H20 ,  100), 206 (9).
HRMS: m/z calc, for C |9H30NO2 (MH+), 304.2271; found, 304.2275.
FT-IR: vmax = 3329 (NH and OH), 2925 (CH), 1611 (C=0), 1564 (aromatic C=C), 
1514, 1241, 1028 c m 1.
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/V-(2-Deuterio-4-methylbenzyl)pivalamide (93)
NHCOBu
Me'
Yield: 0.39 g (1.76 mmol, 88%).
Mp: 96-97 °C (Mp o f undeuteriated analogue 94—96 ° c 133 134).
'H NMR (400 MHz, CDC13): 5 = 7.18-7.05 (m, 3 H, H-3, H-5 and H-6), 5.84 (br, 
exch., 1 H, NH), 4.03 (d, J  = 5 Hz, 2 H, CH2), 2.26 (s, 3 H, CH3), 1.14 [s, 9 H, 
C(CH3)3].
13C NMR (100 MHz, CDC13): 5 = 178.6 (s, C =0), 137.5 (s, C -l), 135.9 (s, C-4),
129.8 (d, C-3), 129.7 (d, C-5), 128.1 (d, C-6), 127.8 (seen as three lines, 1:1:1, 
because of coupling to D, C-2), 43.7 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, C(CH3)3],
21.5 (q, CH3).
EI-MS: m/z (%) = 206 (M+, 17), 106 (M+ -  NHCO'Bu, 100), 92 (M+ -  
CH2NHCO'Bu, 18), 78 (19), 77 (17), 57 ( W ,  92).
CI-MS: m/z (%) = 224 (M + NH4+, 12), 207 (MH+, 100).
HRMS: m/z calc, for C]3H ,9DNO (MH+), 207.1602; found, 207.1598.
FT-IR: vmax = 3332 (NH), 2970 (CH), 1625 (C =0), 1538 (aromatic C=C), 1482, 
1417, 1219 cm '1.
iV-^^-DimethylbenzyOpivalamide (94)
NHCOBu
MeMe'
Yield: 0.35 g (1.60 mmol, 80%).
Mp: 95-97 °C.
'H NMR (400 MHz, CDC13): 5 = 7.01 (d, J =  8 Hz, 1 H, H-6), 6.93 (s, 1 H, H-3), 6.90 
(d, J  = 8 Hz, 1 H, H-5), 5.63 (br, exch., 1 H, NH), 4.30 (d, J  = 5 Hz, 2 H, CH2), 2.23 
(s, 3 H, CH3), 2.19 (s, 3 H, CH3), 1.13 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDC13): 5 = 178.4 (s, C =0), 137.8 (s, C -l), 136.9 (s, C-2),
133.5 (s, C-4), 131.8 (d, C-3), 129.1 (d, C-6), 127.2 (d, C-5), 42.2 (t, CH2), 39.1 [s, 
C(CH3)3], 28.1 [q, C(CH3)3], 21.4 (q, CH3), 19.3 (q, CH3).
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CI-MS: m/z (%) = 237 (M + NH4+, 12), 220 (MH+, 100), 119 (10), 102 (5).
HRMS: m/z calc, for C 14H22NO (MH+), 220.1696; found, 220.1693.
FT-IR: vmax = 3329 (NH), 2969 (CH), 1638 (C =0), 1533 (aromatic C=C), 1362, 
1302, 1220, 1006 cm '1.
^-(l-EthyM-methylbenzyOpivalamide (95)
NHCOBu
Me'
Yield: 0.38 g (1.63 mmol, 81%).
Mp: 88-89 °C.
'H NMR (400 MHz, CDC13): 6 = 7.03 (d, J =  8 Hz, 1 H, H-6), 6.97 (s, 1 H, H-3), 6.92 
(d, J  = 8 Hz, 1 H, H-5), 5.60 (br, exch., 1 H, NH), 4.33 (d, J  = 5 Hz, 2 H, C //2NH),
2.54 (q, J =  7 Hz, 2 H, C //2CH3), 2.26 (s, 3 H, CH3), 1.13 [s, 9 H, C(CH3)3], 1.11 (t, J  
= 7 Hz, 3 H, CH2C//j).
I3C NMR (100 MHz, CDCI3): 8 = 178.4 (s, C =0), 143.0 (s, C -l), 138.1 (s, C-2),
132.8 (s, C-4), 130.1 (d, C-3), 129.5 (d, C-6), 126.8 (d, C-5), 41.6 (t, CH2NH), 39.1 
[s, C(CH3)3], 28.0 [q, C(CH3)3], 25.7 (t, CH2CH3), 21.5 (q, CH3), 16.0 (q, CH2CH3). 
CI-MS: m/z (%) = 251 (M + NH4+, 8), 234 (MH+, 100), 218 (6), 206 (12), 132 (9), 
119(10), 116(11), 52 (40).
HRMS: m/z calc, for C i5H34NO (MH+), 234.1852; found, 234.1854.
FT-IR: vmax = 3326 (NH), 2963 (CH), 1635 (C =0), 1534 (aromatic C=C), 1266, 
1220, 1009 c m 1.
.Y-(2.4-I)imethylbenzyl)-.Y-methylpivalamide (96)
Me
Me' Me
Yield: 9.5 mg (0.04 mmol, 2%).
Colourless oil.
'H NMR (400 MHz, CDCI3): 6 = 7.04-6.85 (m, 3 H, H-3, H-5 and H-6), 4.49 (s, 2 H, 
CH3), 2.86 (s, 3 H, NCH3), 2.18 (s, 3 H, CH3), 2.12 (s, 3 H, CH3), 1.21 [s, 9 H, 
C(CH3)3].
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l3C NMR (100 MHz, CDCI3): 5 = 178.0 (s, C =0), 137.0 (s, C-2), 136.2 (s, C-4),
133.5 (s, C -l), 131.6 (d, C-3), 129.7 (d, C-6), 127.1 (d, C-5), 51.1 (t, CH2), 39.4 (q, 
NCHj), 36.6 [s, C(CH3)3], 28.8 [q, C(CH3)3], 21.3 (q, CH3), 19.3 (q, CH3).
EI-MS: m/z (%) = 233 (M+, 9), 119 (M+ -  NMeCO'Bu or MeC6H3CH2NH+, 93), 105 
(M+ -  CH2N(Me)CO'Bu, 15), 91 (MeC6H4\  33), 77 (21), 57 ('Bu+, 100).
CI-MS: m/z (%) = 234 (MH+, 100), 220 (MH+ -  CH2, 17).
HRMS: m/z calc, for C |5H24NO (MH+), 234.1852; found, 234.1853.
FT-IR: vmax = 2970 (CH), 1626 (C =0), 1504 (aromatic C=C), 1479, 1401, 1364, 
1188, 1023 c m 1.
7.16 Synthesis of -/V-(2,4-dimethylbenzyl)-7V-methylpivalamide (96) via directed
lithiation of A^-m ethylbenzyO pivalam ide (68)
The procedure was identical with that described in Section 7.15 except that 
excess iodomethane (0.63 g, 4.4 mmol) was used. The reaction mixture was worked- 
up and purified by column chromatography (silica gel; Et20-hexane, 1:3) to give 96 
(0.41 g, 1.76 mmol, 88%) as a colourless oil. Compound 96 was identical in all 
respects with the one produced as a side product from reaction of the dilithium 
reagent of compound 68 with 1.1 equivalents o f iodomethane (Section 7.15).
7.17 Synthesis of 7V-(2-substituted methyl)benzylpivalamides 99-106 via lateral
lithiation of Ar-(2-methylbenzyl)pivalamide (65)
A solution o f /-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (-78 °C), stirred solution o f A-(2-methylbenzyl)pivalamide (65; 0.41 g, 2.0 
mmol) in anhydrous THF (20 mL) under N2. Formation o f the monolithium reagent 
97 was observed as a yellow solution and the dilithium reagent 98 was observed as a 
brownish solution. The mixture was stirred at -7 8  °C for 4 h, to ensure the complete 
formation of the dilithium reagent 98, after which an electrophile (2.2 mmol), in 
anhydrous THF (8 mL) if solid, otherwise neat, was added. The mixture was stirred 
for 2 h at -78  °C then the cooling bath was removed and the mixture allowed to warm 
to room temperature. The reaction mixture was worked-up as usual and purified by 
column chromatography (silica gel; Et20-hexane, 1:3) to give the pure products as 
white solids. The yields obtained are recorded in Table 2.8.
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yV-(2-(2-Hydroxy-2-phenyethyl)benzyl)pivalamide (99)
t
1
NHCOBu
F H
HO^ Ph
Yield: 0.52 g (1.67 mmol, 84%).
Mp: 133-134 °C.
'H NMR (400 MHz, CDC13): 8 = 7.42-7.21 (m, 9 H, Ph, H-3, H-4, H-5 and H-6), 
6.69 (br t, exch., 1 H, NH), 4.94 (dd, 1 H, 9, 4 Hz, CH), 4.53 (dd, = 6, 14 Hz, 
1 H, 1 H of C //2NH), 4.33 (dd, J =  2, 14 Hz, 1 H, 1 H of C ftN H ), 3.10 (d d ,J=  9, 14 
Hz, 1 H, 1 H of CH2), 3.01 (dd, J  = 4, 14 Hz, 1 H, 1 H of CH2), 2.78 (br, exch., 1 H, 
OH), 1.19 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDC13): 5 = 178.7 (s, C =0), 144.6 (s, C -l), 137.7 (s, C-l of Ph),
137.6 (s, C-2), 130.8 (d, C-3), 130.3 (d, C-6), 128.9 (d, C-3/C-5 of Ph), 128.3 (d, C-4 
o f Ph), 128.1 (d, C-4), 127.4 (d, C-5), 126.2 (d, C-2/C-6 of Ph), 76.2 (d, CH), 42.5 (t, 
CH2), 41.8 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, C(CH3)3],
EI-MS: m/z (%) = 311 (M+, 6), 295 (MH+ -  OH, 31), 294 (M+ -  OH, 100), 278 (M+ -  
OH -  Me, 8).
CI-MS: m/z (%) = 329 (M + N H /, 9), 313 (MH+ + 1, 13), 312 (MH+, 78), 294 (MH+ 
-  H20  or M+ - OH, 100), 234 (M+ -  Ph, 8), 206 [M+ -  PhCH(OH), 12], 205 (M+ - 
PhCHO, 17), 192 (7), 119 (10), 102 (9).
HRMS: m/z calc, for C20H26NO2 (MH+), 312.1958; found, 312.1955.
FT-IR: vmax = 3314 (NH and OH), 2971 (CH), 1627 (C=0), 1542 (aromatic C=C), 
1367,1216, 1055 cm '1.
Anal. calc, for C20H25NO2: C, 77.14; H, 8.09; N, 4.50. Found: C, 77.21; H, 8.14; N, 
4.54%.
Selected crystallographic data: C20H25NO2, FW = 311.41, T = 150(2) K, X = 0.71073
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A, Orthorhombic, Pca2i, a = 10.4480(3) A, b = 11.3910(3) A, c = 29.4400(9) A, a  = 
90°, p = 90°, y = 90°, V = 3503.75(17) A3, Z = 8, pcaic. = 1.181 Mg/m3, crystal size = 
0.50 x 0.08 x 0.06 mm3, m = 0.075 m m '1, reflections collected = 20758, independent 
reflections = 7296, Rjnt = 0.1196, parameters = 423, final Ri = 0.0598, WR2 = 0.1025 
for I>2ct(I) and Rj = 0.1544, WR2 = 0.1288 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 737412, and 
can be obtained free o f charge via http://www.ccdc.ac.uk/data_request/cif.
/V-(2-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)benzyl)pivalamide (100)
HO
OMe
Yield: 0.61 g (1.79 mmol, 89%).
Mp: 124-126 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.29 (d, J  = 9 Hz, 2 H, H-2/H-6 of 
4-methoxyphenyl), 7.28-7.20 (m, 4 H, H-3, H-4, H-5 and H-6), 6.88 (d, J  = 9 Hz, 
2 H, H-3/H-5 o f 4-methoxyphenyl), 6.83 (br, exch., 1 H, NH), 4.87 (dd, J  = 4, 9 Hz, 
1 H, CH), 4.49 (dd, J  = 6, 14 Hz, 1 H, 1 H o f C tf2NH), 4.30 (dd, /  = 4, 14 Hz, 1 H, 
1 H o f C ftN H ), 3.80 (s, 3 H, OCH3), 3.22 (br, exch., 1 H, OH), 3.07 (dd, J =  9, 14 
Hz, 1 H, 1 H o f CH2), 2.94 (dd, J  = 4, 14 Hz, 1 H, 1 H o f CH2), 1.17 [s, 9 H, 
C(CH3)3].
I3C NMR (100 MHz, CDCI3): 8 = 178.8 (s, C =0), 159.4 (s, C-4 o f 4-methoxyphenyl),
137.9 (s, C -l), 137.5 (s, C-2), 137.0 (s, C -l o f 4-methoxyphenyl), 130.8 (d, C-3),
130.2 (d, C-6), 128.2 (d, C-4), 127.6 (d, C-2/C-6 o f 4-methoxyphenyl), 127.3 (d, C-5),
114.2 (d, C-3/C-5 o f 4-methoxyphenyl), 75.7 (d, CH), 55.7 (q, OCH3), 42.5 (t, CH2),
41.9 (t, CH2), 39.01 [s, C(CH3)3], 28.0 [q, C(CH3)j].
El-MS: m/z (%) = 341 (M+, 5), 324 (M+ -  OH, 63), 323 (M+ -  H20 , 79), 308 (5), 266 
(M + -  H20  -  'Bu, 21), 254 (13), 238 (M+ -  H20  -  CO'Bu, 100).
CI-MS: m/z (%) = 357 (M + NH4\  4), 342 (MH+, 8), 341 (M*, 20), 325 (MH+ -  OH, 
24), 324 (MH+ -  H20 ,  100), 251 (4), 234 (6), 205 (7), 154 (8), 119 (15), 102 (7), 52 
( 10).
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ES*-MS: m/z (%) = 364 (M + Na+, 19), 324 (M+ -  H20 ,  33), 223 (M+ -  H20  -  
NHCO'Bu, 100).
E S -M S : m/z (%) = 340 (M -  1, 12), 205 (NT -  MeOC6H4CHO, 12), 204 [M -  
MeOC6H4CH(OH), 100], 100 (28).
HRMS: m/z calc, for C2,H28N 0 3 (M H+), 342.2064; found, 342.2065.
FT-IR: vmax = 3321 (NH and OH), 2954 (CH), 1629 (C =0), 1555 (aromatic C=C), 
1463, 1370, 1220, 1035 c m 1.
jV-(2-(2-Hydroxy-2-phenylpropyl)benzyl)pivalamide (101)
NHCOBh
HO Ph
Me
Yield: 0.52 g (1.60 mmol, 80%).
Mp: 135-137 °C.
1H NMR (400 MHz, CDC13): 5 = 7.43 (d, J  = 8 Hz, 2 H, H-2/H-6 o f Ph), 7.35 (t, J  = 8 
Hz, 2 H, H-3/H-5 o f Ph), 7.30-7.26 (m, 2 H, H-4 o f Ph and H-6), 7.20 (app. dt, J =  2, 
8 Hz, 1 H, H-4), 7.12 (app. dt, J  = 2, 8 Hz, 1 H, H-5), 6.87 (dd, J =  2, 8 Hz, 1 H, H-3),
6.55 (br app. t, exch., 1 H, NH), 4.44 (dd, J =  5, 14 Hz, 1 H, 1 H o f C7CNH), 4.37 
(dd, J  = 5, 14 Hz, 1 H, 1 H o f C ftN H ), 3.17 (d, J =  14 Hz, 1 H, 1 H o f CH,), 3.12 (d, 
J  = 14 Hz, 1 H, 1 H o f CH2), 2.42 (s, exch., 1 H, OH), 1.68 (s, 3 H, CH3), 1.21 [s, 9 H, 
C(CH3)3],
l3C NMR (100 MHz, CDC13): 6 = 178.6 (s, C = 0), 149.2 (s, C -l o f Ph), 138.7 (s, C -l),
135.8 (s, C-2), 132.4 (d, C-3), 130.0 (d, C-6), 128.5 (d, C-3/C-5 o f Ph), 127.5 (d, 
C-4), 127.3 (d, C-4 o f Ph), 127.2 (d, C-2/C-6 o f Ph), 125.4 (d, C-5), 75.5 (s, C-OH),
46.6 (t, CH2), 41.7 (t, CH,), 39.1 [s, C(CH3)3], 30.3 (q, CH3), 29.5 [q, C(CH3)3], 
EI-MS: m/z (%) = 325 (M +, 1), 308 (M + -  OH, 77), 307 (M + -  H ,0 , 34), 292 (12), 
282 (23), 264 (31), 248 (19), 229 (60), 222 (M + -  H20  -  CO'Bu, 100).
Cl-M S: m/z (%) = 343 (M + NH4+, 2), 326 (MH+, 34), 309 (MH+ -  H20  or M+ -  OH, 
36), 308 (MH* -  H20 ,  100), 248 (5), 306 (M H ‘ -  PhCOMe, 17), 205 (MH+ -  
PhC(OH)Me, 22), 138 (7), 119 (9), 102 (9), 52 (7).
HRMS: m/z calc, for C2|H 28NO, (MH*), 326.2115; found, 326.2115.
FT-IR: vmax = 3324 (NH and OH), 2964 (CH), 1623 (C =0), 1493 (aromatic C=C), 
1242, 1025 c m 1.
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/V-(2-(2-Hydroxy-2,2-diphenylethyl)benzyl)pivalamide (102)
NHCOBu1
Ph Ph
OH
Yield: 0.68 g (1.76 mmol, 88%).
Mp: 94-95 °C.
'H NMR (400 MHz, CDClj): 8 = 7.42-7.23 (m, 11 H, 2 Ph and H-6), 7.17 (app. dt, J  
= 2 ,8  Hz, 1 H, H-4), 6.97 (app. dt, J  = 2, 8 Hz, 1 H, H-5), 6.56 (dd, J  = 2, 8 Hz, 1 H, 
H-3), 6.38 (br t, exch., 1 H, NH), 4.36 (d, J =  5 Hz, 2 H, C7/2NH), 3.75 (s, 2 H, CH2), 
2.72 (s, exch., 1 H, OH), 1.18 [s, 9 H, C(CH3)3],
l3C NMR (100 MHz, CDC13): 5 = 178.6 (s, C =0), 147.1 (s, C-l of 2 Ph), 139.0 (s, 
C -l), 134.8 (s, C-2), 132.3 (d, C-3), 129.7 (d, C-6), 128.5 (d, C-4), 128.3 (d, C-3/C-5 
of 2 Ph), 127.6 (d, C-4 o f 2 Ph), 127.2 (d, C-5), 126.8 (d, C-2/C-6 o f 2 Ph), 79.0 (s, 
C-OH), 43.8 (t, CH2), 42.3 (t, CH2), 39.1 [s, C(CH3)3], 29.5 [q, C(CH3)3],
El-MS: m/z (%) = 370 (M+ -  H20 , 7), 284 (M+ -  H20  -  CO'Bu, 12), 269 (M+ -  H20  
-  NHCO'Bu, 39), 268 (M + -  H20  -  H2NCO'Bu, 100), 252 (13).
CI-MS: m/z (%) = 405 (M + N H /, 5), 388 (M H+, 18), 387 (M+, 33), 370 (MH+ -  H20  
or M+ -  OH, 100), 310 (M+ -  Ph, 11), 285 (5), 257 (7), 223 (12), 206 (MH+ -  Ph2CO, 
41), 200 (M+ -  2 Ph -  H20  -  Me, 52), 183 (Ph2CHO+, 17), 119 (PhCH2CO+, 29), 102 
['BuCOH(NH2)+, 12], 52 (16).
ES+-M S: m/z (%) = 410 (M + N a \  23), 370 (MH+ -  H20 , 72), 270 (M+ -  OH -  
NHCO'Bu, 22), 269 (M+ -  H20  -  NHCO'Bu, 100), 191 (47), 102 (49), 91 (47).
ES -M S: miz (%) = 388 (MH , 3), 387 (M , 21), 386 (M~ -  1, 100).
HRMS: m/z calc, for C26H33N20 2 (M + N R t+), 405.2537; found, 405.2534.
FT-IR: vmax = 3310 (NH and OH), 2933 (CH), 1635 (C=0), 1531 (aromatic C=C), 
1449, 1227, 1020 cm '1.
Ar-(2-(( l-Hydroxycyclohexyl)methyl)benzyl)pivalamide (103)
NHCOBU
OH
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Yield: 0.46 g (1.52 mmol, 76%).
Mp: 93-96 °C.
'H NMR (400 MHz, CDCI3): 8 = 7.23-7.09 (m, 4 H, H-3, H-4, H-5 and H-6), 6.77 (br 
t, exch., 1 H, NH), 4.41 (br d, 2 H, C/CNH), 2.75 (s, 2 H, CH2), 1.86 (br s, exch., 1 H, 
OH), 1.51-1.43 [m, 10 H, (CH2)5], 1.10 [s, 9 H, C(CH3)3],
I3C NMR (100 MHz, CDC13): 5 = 178.7 (s, 0 = 0 ), 138.6 (s, C -l), 136.3 (s, C-2),
132.3 (d, C-3), 130.3 (d, C-6), 127.4 (d, C-4), 127.3 (d, C-5), 72.2 (s, C-l o f 
cyclohexyl), 45.0 (t, CH2NH), 42.2 (t, CH2NH), 39.1 [s, C(CH3)3], 38.3 (t, C-2/C-6 of 
cyclohexyl), 28.0 [q, C(CH3)3], 26.1 (t, C-4 o f cyclohexyl), 22.4 (t, C-3/C-5 of 
cyclohexyl).
EI-MS: m/z (%) = 303 (M+, 7), 286 (M+ -  OH, 39), 285 (M+ -  H20 , 87), 270 (M+ -  
H20  -  Me, 12), 260 (M+-  Me -  C2H4, 100), 242 (40), 228 (M+ -  H20  -  'Bu, 77), 218 
(M+ -  CO'Bu, 71).
CI-MS: m/z (%) = 321 (M + NH4+, 3), 304 (MH+, 100), 286 (MH+ -  H20 , 58), 205 
(9), 119(5), 52(11).
HRMS: m/z calc, for C i9H30NO2 (MH+), 304.2271; found, 304.2272.
FT-IR: vmax = 3341 (NH and OH), 2929 (CH), 1634 (C O ) , 1529 (aromatic C=C), 
1449, 1208 c m 1.
/V-(2-Ethylbenzyl)pivalamide (104)
NHCOBu1
Yield: 0.38 g (1.74 mmol, 87%).
Mp: 64-65 °C.
'H NMR (400 MHz, CDC13): 5 = 7.18-7.08 (m, 4 H, H-3, H-4, H-5 and H-6), 5.69 (b r 
t, exch., 1 H, NH), 4.37 (d, J  = 5 Hz, 2 H, C //2NH), 2.58 (q, J  = 7 Hz, 2 H, C tf2CH3), 
1.14 (t, J  = 7 Hz, 3 H, CH2C //3), 1.13 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDC13): 8 = 178.5 (s, C =0), 143.0 (s, C -l), 135.9 (s, C-2),
129.3 (d, C-3), 129.2 (d, C-6), 128.4 (d, C-4), 126.6 (d, C-5), 41.8 (t, CH2NH), 39.1 
(s, C(CH3)3], 28.0 [q, C(CH3)3], 25.7 (t, CH2CH3), 15.8 (q, CH2CH3).
ES+-M S: m/z (%) = 237 (M + NH4+, 15), 220 (MH+, 100).
HRMS: m/z calc, for C |4H22NO (MH+), 220.1696; found, 220.1694.
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FT-IR: vmax = 3331 (NH), 2963 (CH), 1632 (C=0), 1531 (aromatic C=C), 1217, 1008 
cm '1.
yV-^-PropylbenzyOpivalamide (105)
N H C O B u 1
Yield: 0.41 g (1.76 mmol, 88%).
Mp: 66-67 °C.
'H NMR (400 MHz, CDClj): 5 = 7.18-7.08 (m, 4 H, H-3, H-4, H-5 and H-6), 5.68 (br 
t, exch., 1 H, NH), 4.37 (d, J  = 5 Hz, 2 H, C //2NH), 2.52 (t, J  = 7 Hz, 2 H, 
C /f2CH2CH3), 153 (app. sextet, J =  1 Hz, 2 H, C tf2CH3), 1.14 [s, 9 H, C(CH3)3], 0.98 
( t ,J = 7  Hz, 3H , CH3).
I3C NMR (100 MHz, CDC13): 5 = 178.4 (s, O O ) ,  141.5 (s, C -l), 136.1 (s, C-2),
130.1 (d, C-3), 129.2 (d, C-6), 128.1 (d, C-4), 126.6 (d, C-5), 41.8 (t, CH2NH), 39.1 
[s, C(CH3)3], 34.9 (t, CH2CH2CH3), 28.0 [q, C(CH3)3], 24.8 (t, CH2CH3), 15.8 (q, 
CH3).
EI-MS: m/z (%) = 233 (M+, 9), 204 (M+ -  Et, 5), 190 (M+ -  Pr, 4), 133 (M+ -  Pr -  
'Bu, 14), 132 (M+-  Pr -  'BuH, 97), 117 (M+-  NHCO'Bu -  CH4, 100), 105 (PhCH2N+, 
81), 91 (PhCH2\  24), 57 ('Bu, 49).
CI-MS: m/z (%) = 251 (M + NH4+, 45), 334 (MH+, 100), 206 (18), 132 (M+-  CO'Bu -  
CH4, 20), 119(8), 102 (6).
ES+-M S: mlz (%) = 251 (M + NH4+, 7), 234 (MH+, 42), 133 (17), 114 (18), 106 
(PhCH2NH+, 32), 105 (PhCH2N +, 100), 104 (PhCHN+, 95).
HRMS: m/z calc, for C ,5H24NO (MH+), 234.1852; found, 234.1852.
FT-IR: vmax = 3331 (NH), 2963 (CH), 1633 (C =0), 1530 (aromatic C=C), 1363, 
1218, 1008 c m 1.
/V-(2-(Deuteriomethyl)benzyl)pivalamide (106)
N H C O B u 1
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Yield: 0.35 g (1.70 mmol, 85%).
Mp: 108-109 °C (Mp o f undeuteriated analogue 108-109 °C; 65, Section 7.5).
'H NMR (400 MHz, CDC13): 5 = 7.13-7.09 (m, 4 H, H-3, H-4, H-5 and H-6), 5.70 (br 
t, exch., 1 H, NH), 4.34 (d, J  = 5 Hz, 2 H, CH2NH), 2.21 [(1:1:1) t, J =  2 Hz, 2 H, 
CH2D], 1.14 [s , 9 H, C(CH3)3],
l3C NMR (100 MHz, CDCI3): 8 = 178.5 (s, C = 0), 136.9 (s, C -l), 136.5 (s, C-2),
131.0 (d, C-3), 128.8 (d, C-6), 128.1 (d, C-4), 126.6 (d, C-5), 42.3 (t, CH2NH), 39.2 
[s, C(CH3)3], 28.1 [q, C(CH3)3], 19.1 (seen as three lines, 1:1:1, because of coupling 
to D, CH2D).
EI-MS: m/z (%) = 207 (M+ + 1, 4), 206 (M+, 13), 109 (M+ -  CH2D, 2), 107 
(PhCH2NH2+, 20), 106 (PhCH2NH+, 60), 105 (PhCH2N+, 37), 92 (10), 78 (12), 57 
('Bu+, 92).
CI-MS: m/z (%) = 224 (M + NH4+, 12), 208 (MH+ + 1, 32), 207 (MH+, 100).
HRMS: m/z calc, for C 13H 19DNO (MH+), 207.1602; found, 207.1602.
FT-IR: vmax = 3328 (NH), 2924 (CH), 1612 (C =0), 1532 (aromatic C=C), 1238, 1024 
c m 1.
7.18 Synthesis of A^-benzyl-AyV-dimethylureas from reactions of benzylamines 
with triphosgene followed by reactions with dimethylamine
To a cooled (0 °C) stirred solution o f triphosgene (4.72 g, 16.0 mmol) in 
CH2C12 (60 mL) a solution o f the appropriate substituted benzylamine (67, 40.0 
mmol) and triethylamine (8.88 g, 88.0 mmol) in CH2C12 (60 mL) was slowly added in 
a drop-wise manner over 30 min. The reaction mixture was stirred at 0 °C for 2 h, 
after which a solution o f dimethylamine in THF (24.0 mL, 2.0 M, 48.0 mmol) was 
added. The reaction mixture was stirred at 0 °C for an extra 1 h. The mixture was 
poured onto H20  (50 mL) and the organic layer was separated, washed with H20  (2 x 
25 mL), and dried (M gS04) and the solvent was then removed under reduced 
pressure. The products were separated by extraction using boiling EtOAc/Et20  (1:3), 
from which (V-benzyl-ACV-dimethylureas crystallized nicely as white crystals on 
cooling. The white solids that were highly insoluble in hot EtOAc/Et20  were collected 
by filtration and identified as ACV-dibenzylureas 115. The yields obtained are 
reported in Table 3.1.
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/V1-Benzyl-AyV-dimethylurea (107)
N H C O N M e
Yield: 5.77 g (32.4 mmol, 81%).
Mp: 76-77 °C (lit.135 77 °C).
NMR (400 MHz, CDC13): 5 = 7.27-7.15 (m, 5 H, Ph), 4.75 (br, exch., 1 H, NH),
4.33 (d, J =  6 Hz, 2 H, CH2), 2.83 [s, 6 H, N(CH3)2].
,3C NMR (100 MHz, CDC13): 5 = 158.8 (s, O O ) , 140.2 (s, C -l), 129.0 (d, C-3/C-5),
128.1 (d, C-2/C-6), 127.6 (d, C-4), 45.4 (t, CH2), 36.7 [q, N(CH3)2].
EI-MS: m/z (%) = 178 (M+, 22), 106 (PhCH2NH+, 21), 91 (PhCH2+, 78), 77 (Ph+, 51), 
72 (Me2NCO+, 75), 65 (31), 56 (19), 51 (26), 44 (Me2N+, 93), 42 (CON+, 100). 
CI-MS: m/z (%) = 196 (M + N H /,  6), 179 (MH+, 100), 106 (PhCH2NH+, 8), 46 (29), 
44(18).
HRMS: m/z calc, for C 10H 15N 2O (MH+), 179.1179; found, 179.1181.
FT-IR: vmax = 3319 (NH), 2924 (CH), 1621 (C =0), 1538 (aromatic C=C), 1343, 1216 
cm '1.
/V-(4-Methoxybenzyl)-AyV-dimethyIurea (108)
M e O  4
Yield: 6.82 g (32.8 mmol, 82%).
Mp: 81-82 °C.
1H NMR (400 MHz, CDCI3): 5 = 7.09 (d, J  = 8 Hz, 2 H, H-2/H-6), 6.71 (d, J  = 8 Hz, 
2 H, H-3/H-5), 4.54 (br, exch., 1 H, NH), 4.19 (br, 2 H, CH2), 3.64 (s, 3 H, OCH3), 
2.76 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 5 = 159.2 (s, C =0), 158.7 (s, C-4), 132.2 (s, C -l), 
129.5 (d, C-2/C-6), 114.4 (d, C-3/C-5), 55.7 (q, OCH3), 44.9 (t, CH2), 36.6 [q, 
N(CH3)2],
El-MS: m/z (%) = 208 (M +, 23), 136 (MeOC6H4CH2NH+, 25), 121 (MeOC6H4CH2+, 
87), 109 (9), 78 (34), 77 (37), 72 (Me2NCO+, 100), 65 (17), 51 (21), 46 (44), 44 (69), 
42 (52).
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CI-MS: m/z (%) = 226 (M + N H /, 3), 209 (MH+, 100), 136 (MeOC6H4CH2NH4, 4), 
121 (MeOC6H4CH2+, 5).
HRMS: m/z calc, for C n H i7N20 2 (MH4), 209.1285; found, 209.1283.
FT-IR: vmax = 3318 (NH), 2927 (CH), 1622 (C =0), 1537 (aromatic C=C), 1378, 
1351, 1229, 1027 cm"'.
yV-^-Methoxybenzyty-AVV-dimethyliirea (111)
N H C O N M e
2  O M e
Yield: 6.57 g (31.6 mmol, 79%).
Mp: 97-98 °C.
'H NMR (400 MHz, DMSO-cf6): 5 = 7.20 (dt, J  = 2, 8 Hz, 1 H, H-4), 7.14 (d, J =  8 
Hz, 1 H, H-6), 6.94 (d, J =  8 Hz, 1 H, H-3), 6.90 (t, J =  8 Hz, 1 H, H-5), 6.60 (t, J  = 6 
Hz, exch., 1 H, NH), 4.21 (d, J  = 6 Hz, 2 H, CH2), 3.80 (s, 3 H, OCH3), 2.84 [s, 6 H, 
N(CH3)2],
l3C NMR (100 MHz, DMSO-r/6): 5 = 159.1 (s, C =0), 157.1 (s, C-2), 129.4 (s, C -l),
128.2 (d, C-6), 127.7 (d, C-4), 120.8 (d, C-5), 111.0 (d, C-3), 56.0 (q, OCH3), 39.2 (t, 
CH: ), 36.8 [q, N(CH3)2],
El-MS: m/z (%) = 208 (M \ 43), 136 (MeOC6H4CH2NH+, 84), 121 (MeOC6H4CH24, 
56), 91 (PhCH2+, 90), 109 (12), 107 (12), 78 (30), 77 (36), 72 (Me2N C 04, 100), 65 
(35), 51 (24), 46 (48), 44 (77), 42 (46).
CI-MS: m/z (%) = 209 (M H4, 100), 52 (7).
HRMS: m/z calc, for C, |H I7N20 2 (MH4), 209.1285; found, 209.1284.
FT-IR: vmax = 3327 (NH), 2924 (CH), 1622 (C =0), 1534 (aromatic C=C), 1376, 
1241,1228,10267 c m 1.
/V'-(4-Methylbenzyl)-AyV-dimethylurea (113)
M e  4
Yield: 6.14 g (32.0 mmol, 80%). 
Mp: 94-95 °C (lit.136 93 °C).
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'H NMR (400 MHz, DMSO-d6): 5 = 7.14 (d, J =  8 Hz, 2 H, H-3/H-5), 7.09 (d, J =  8 
Hz, 2 H, H-2/H-6), 6.82 (t, J =  6 Hz, exch., 1 H, NH), 4.18 (d, J  = 6 Hz, 2 H, CH2), 
2.81 [s, 6 H, N(CH3)2], 2.27 (s, 3 H, CH3).
13C NMR (100 MHz, DM SO-J6): 5 = 159.1 (s, O O ) , 139.1 (s, C -l), 136.1 (s, C-4),
129.4 (d, C-3/C-5), 127.8 (d, C-2/C-6), 44.1 (t, CH2), 36.8 [q, N(CH3)2], 21.5 (q, 
CH3).
EI-MS: m/z (%) = 192 (M+, 36), 120 (MeC6H4CH2NH+, 38), 105 (MeC6H4CH2+, 68), 
91 (MeC6H4+, 68), 77 (40), 72 (Me2NCO+, 100), 65 (23), 51 (17), 46 (33), 44 (88), 42 
(55).
CI-MS: m/z (%) = 385 (2 M+ + 1, 3), 210 (M + NH4\  5), 193 (MH+, 100).
HRMS: m/z calc. fo rC i,H i7N20  (MH+), 193.1335; found, 193.1338.
FT-IR: vmax = 3318 (NH), 2923 (CH), 1618 (C O ) , 1534 (aromatic C=C), 1372, 
1227, 1025 cm '1.
A-(2-Methylbenzyl)-AyV-dimethy lurea (114)
N H C O N M e
2  M e
Yield: 5.68 g (29.6 mmol, 74%).
Mp: 82-83 °C.
'H NMR (400 MHz, CDC13): 5 = 7.19-7.01 (m, 4 H, Ar), 4.48 (br, exch., 1 H, NH), 
4.31 (br, 2 H, CH2), 2.82 [s, 6 H, N(CH3)2], 2.26 (s, 3 H, CH3).
,3C NMR (100 MHz, CDC13): 5 = 158.7 (s, C =0), 137.5 (s, C -l), 136.8 (s, C-2),
130.8 (s, C-3), 128.8 (d, C-6), 127.9 (d, C-4), 126.5 (d, C-5), 43.6 (t, CH2), 36.7 [q, 
N(CH3)2], 19.45 (q, CH3).
EI-MS: m/z (%) = 192 (M+, 35), 177 (M+ -  Me, 5), 148 (7), 120 (MeC6H4CH2NH+, 
49), 105 (MeC6H4CH2+, 88), 104 (MeC6H4CH2+, 94) 91 (MeC6H4+, 40), 77 (40), 72 
(Me2N C O \ 100), 65 (17), 46 (16), 44 (46), 42 (16).
CI-MS: m/z (%) = 210 (M + NH4+, 4), 193 (MH+, 100), 122 (14), 120 
(MeC6H4CH2NH+, 20), 103 (15), 89 (12), 52 (27), 46 (39), 44 (16).
HRMS: m/z calc, for C n H 17N20  (MH+), 193.1335; found, 193.1335.
FT-IR: Vmax = 3317 (NH), 2925 (CH), 1635 (C=0), 1533 (aromatic C=C), 1353, 1231 
cm '1.
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AyV1-D ibenzylurea (115a)
Yield: 0.38 g (1.58 mmol, 4%).
Mp: 175-176 °C (lit.137 175-176 °C).
'H NMR (400 MHz, DMSO-(/6): 5 = 7.34-7.23 (m, 10 H, 2 Ph), 6.47 (t, J  = 6 Hz,
exch., 2 H, 2 NH), 4.25 (d, J =  6 Hz, 4 H, 2 CH2).
I3C NMR (100 MHz, DMSO-rf6): 5 = 159.0 (s, C =0), 141.8 (s, C -l), 129.1 (d,
C-3/C-5), 127.9 (d, C-2/C-6), 127.4 (d, C-4), 43.9 (t, CH2).
EI-MS: m/z (%) = 240 (M+, 16), 149 (M+ -  PhCH2, 20), 106 (PhCH2NH+, 53), 91 
(PhCH2+, 100), 77 (Ph+, 34), 65 (32), 51 (27).
CI-MS: m/z (%) = 258 (M + NH4\  2), 241 (MH*, 36), 108 (PhCH2NH3+, 82), 106 
(PhCH2N H \ 100), 78 (13), 52 (47).
HRMS: m/z calc, for C i5H ,7N20  (MH+), 241.1335; found, 241.1340.
FT-IR: vmax = 3330 (NH), 2922 (CH), 1614 (C =0), 1563 (aromatic C=C), 1514, 
1470, 1240 c m 1.
AVV1-Bis(4-m ethoxybenzyl)urea (115b)
4  O M eM e O  4
Yield: 0.36 g (1.2 mmol, 3%).
Mp: 173-174 °C (lit.138 171-173 °C).
1H NMR (400 MHz, DMSO-t/f,): 8 = 7.17 (d, J  = 8 Hz, 4 H, H-2/H-6), 6.87 (d, /  = 8 
Hz, 4 H, H-3/H-5), 6.32 (t, J  = 6 Hz, exch., 2 H, 2 NH), 4.15 (d, J  = 6 Hz, 4 H, 2 
CH2), 3.73 (s, 6 H, 2 OCH3).
I3C NMR (100 MHz, DMSO-c/6): 8 = 159.9 (s, C =0), 158.9 (s, C-4), 133.7 (s, C -l),
129.2 (d, C-2/C-6), 114.5 (d, C-3/C-5), 55.9 (q, OCH3), 43.3 (t, CH2).
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EI-MS: m/z (%) = 300 (M+, 10), 179 (M+ -  MeOC6H4CH2, 27), 136 
(MeOC6H4CH2NH+, 86), 121 (MeOC6H4CH2+, 100), 109 (26), 91 (PhCH2+, 18), 77
(42), 65 (17), 51 (14).
CI-MS: m/z (%) = 318 (M + NHV, 4), 301 (MH*, 100), 198(11), 181 (17), 179 (M+-  
MeOC6H4CH2, 7), 138 (MeOC6H4CH2NH3\  22), 136 (MeOC6H4CH2NH+, 56), 121 
(MeOC6H4CH2+, 50), 52 (23).
HRMS: m/z calc, for C |7H21N 20 3 (MH*), 301.1547; found, 301.1547.
FT-IR: vmax = 3327 (NH), 2922 (CH), 1624 (C =0), 1562 (aromatic C=C), 1509, 
1236, 1029 cm '1.
AyV1-Bis(2-methoxybenzyl)urea (115c)
6
5 f ^
o
-
4 L . 1  H H 1 J 4
3
2  O M e  M e O  2
3
Yield: 0.24 g (0.8 mmol, 2%).
Mp: 202-204 °C.
‘H NMR (400 MHz, DMSO-c4): 5 = 7.22 (t, J  = 8 Hz, 2 H, H-4), 7.19 ( d ,J = 8  Hz, 
2 H, H-6), 6.95 (d, J =  8 Hz, 2 H, H-3), 6.89 (t, J =  8 Hz, 2 H, H-5), 6.30 (t, J =  6 Hz, 
exch., 2 H, 2 NH), 4.18 (d, J  = 6 Hz, 4 H, 2 CH2), 3.78 (s, 6 H, 2 OCH3).
I3C NMR (100 MHz, DMSO-<4): 5 = 158.4 (s, C =0), 157.1 (s, C-4), 128.6 (s, C -l),
128.3 (d, C-6), 128.1 (d, C-4), 120.4 (d, C-5), 110.7 (d, C-3), 55.6 (q, OCH3), 38.6 (t, 
CH2).
EI-MS: m/z (%) = 300 (M+, 11), 179 (M+ -  MeOC6H4CH2, 21), 163 (28), 136 
(MeOC6H4CH2NH*, 100), 121 (MeOC6H4CH2\  52), 104 (20), 91 (PhCH2+, 76), 77 
(32), 65 (31), 51 (17).
CI-MS: m/z (%) = 301 (MH*, 42), 151 (4), 138 (MeOC6H4CH2NH3+, 41), 136 
(MeOC6H4CH2NH*, 23), 122 (36), 121 (MeOC6H4CH2+, 18), 108 (MeOC6H5+, 100) 
106 (35), 94(28).
HRMS: m/z calc, for C I7H2,N20 3 (MH*), 301.1547; found, 301.1546.
FT-IR: vmax = 3318 (NH), 2922 (CH), 1617 (C =0), 1584 (aromatic C=C), 1464, 
1235, 1021 cm '1.
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AyV-Bis(4-methylbenzyl)urea (j 15^)
Yield: 0.32 g (1.2 mmol, 3%).
Mp: 226-227 °C.
'H NMR (400 MHz, DMSO-d),): 5 = 7.15-7.01 (m, 8 H, 2 Ar), 6.37 (t, J  = 6 Hz, 
exch., 2 H, 2 NH), 4.18 (d, J  = 6 Hz, 4 H, 2 CH2), 2.28 (s, 6 H, 2 CH3).
I3C NMR (100 MHz, DMSO-r/6): 5 = 158.9 (s, C =0), 138.7 (s, C -l), 136.4 (s, C-4),
130.0 (d, C-3/C-5), 127.9 (d, C-2/C-6), 43.6 (t, CH2), 21.5 (q, CH3).
EI-MS: m/z (%) = 268 (M+, 14), 163 (M + -  MeC6H4CH2, 12), 120 (MeC6H4CH2NH+, 
63), 105 (MeC6H4CH2+, 100), 91 (PhCH2+, 61), 77 (52), 65 (22), 51 (13).
CI-MS: m/z (%) = 286 (M + NH4\  4), 269 (MH+, 57), 179 (13), 165 (17), 139 (16), 
122 (MeC6H4CH,NH3+, 95), 120 (MeC6H4CH,NH+, 100), 105 (MeC6H4CH2+, 15), 78
(14), 52 (79).
HRMS: m/z calc, for C i7H2,N 20  (MH3), 269.1648; found, 269.1650.
FT-IR: = 3326 (NH), 2921 (CH), 1611 (C =0), 1558 (aromatic C=C), 1512,
1468, 1237, 1066 c m 1.
AVV-Bis(2-methylbenzyl)urea (115e)
Yield: 0.43 g (1.6 mmol, 4%).
Mp: 223-225 °C.
'H NMR (MHz, DMSO-t/6): 5 = 7.25-7.12 (m, 8 H, 2 Ar), 6.32 (t, J  = 6 Hz, exch., 
2 H, 2 NH), 4.23 (d, J =  6 Hz, 4 H, 2 CH,), 2.22 (s, 6 H, 2 CH3). 
n C NMR (100 MHz, DMSO-<4): 6 = 158.8 (s, C =0), 139.3 (s, C -l), 136.2 (s, C-2),
130.7 (d, C-3), 128.1 (d, C-6), 127.5 (d, C-4), 126.6 (d, C-5), 42.0 (t, CH2), 19.4 (q, 
CH3).
EI-MS: m/z (%) = 268 (M+, 26), 163 (M+ -  M eC6H4CH2, 33), 120 (MeC6H4CH2NH+, 
77), 105 (MeC6H4CH2\  100), 91 (P h C H ,\ 78), 77 (84), 65 (38), 51 (14).
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CI-MS: m/z (%) = 286 (M + NH4+, 7), 269 (MH+, 100), 182 (12), 179 (33), 165 (21), 
122 (MeC6H4CH2NH3+, 47), 120 (MeC6H4CH2NH+, 43), 52 (53).
HRMS: m/z calc, for C ,7H2,N20  (MH+), 269.1648; found, 269.1647.
FT-IR: vmax = 3316 (NH), 2933 (CH), 1635 (C =0), 1531 (aromatic O C ) , 1462, 
1227, 1020 cm '1.
7.19 Synthesis o f Af-benzyWV^V-dimethylureas from reactions of substituted
benzylamines with dimethylcarbamoyl chloride
A stirred mixture o f 67 (40.0 mmol), dimethylcarbamoyl chloride (4.83 g, 45 
mmol) and triethylamine (5.05 g, 55.0 mmol) in CH2C12 (60 mL) was heated under 
reflux for 1 h. The mixture was poured onto H20  (50 mL) and the organic layer was 
separated, washed with H20  (2 x 25 mL), and dried (M gS04) and the solvent was then 
removed under reduced pressure. The solid obtained was purified by crystallization 
from EtOAc/Et20  (1/3) to give pure N ‘'-(substituted benzyl)-vV,A/-dimethylureas as 
white crystalline solids. The yields obtained are reported in Table 3.2. The products 
were found to be consistent in all respects with the ones produced using triphosgene 
method (Sections 7.18). See Section 7.18 for spectral data.
7.20 Synthesis of /V-(2-substituted benzyl)-AyV-dimethylureas 114 and 118-131
via directed lithiation of TV1-benzyk/V,yV-dimethylureas 107,108 and 113
A solution of /‘-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (-78 °C), stirred solution o f the appropriate N'-benzyl-A^V-dimethylurea (107, 
108 or 113; 2.0 mmol) in anhydrous THF (20 mL) under N2. Formation of the 
monolithium reagent 116 was observed as a yellow solution and the dilithium reagent 
117 was observed as a brownish solution. The mixture was stirred at -78  °C for 4 h, 
to ensure the complete formation o f the dilithium reagent 117, after which an 
electrophile (2.2 mmol), in anhydrous THF (8 mL) if solid, otherwise neat, was 
added. The mixture was stirred for 2 h at -7 8  °C then the cooling bath was removed 
and the mixture allowed to warm to room temperature. It was then diluted with Et20  
(10 mL) and quenched with aq. sat. NH4C1 (10 mL). The organic layer was separated, 
washed with H20  (2 x 10 mL), dried (M gS04), and evaporated under reduced 
pressure. The residue obtained was purified by column chromatography (silica gel; 
Et20-hexane, 1:3) to give the corresponding A-(2-substituted benzy\)-NJV- 
dimethylureas 114 and 118-131. The yields obtained are recorded in Table 3.3.
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TV-(2-Methylbenzyl)-AyV-dimethylurea (114)
Yield: 0.31 g (1.61 mmol, 80%).
Mp: 82-83 °C.
Compound 114 was found to be identical in all respects with the one produced either 
from reaction o f 2-methylbenzylamine (67e) with triphosgene followed by reaction 
with dimethylamine (Section 7.18) or with dimethylcarbamoyl chloride in the 
presence of triethylamine as a base (Section 7.19). See Section 7.18 for spectral data.
A^-(2-(Hydroxy-(4-methoxyphenyl)methyl)benzyl)-A',Ar-dimethylurea (118)
5 fi
xH
S'NHCONMe2
3 2 J
j.OH
|1
1)
OMe
Yield: 0.54 g (1.72 mmol, 86%).
Mp: 185-186 °C.
'H NMR (400 MHz, DMSCM„): 8 = 7.44 (app. dt, J =  2, 8 Hz, 1 H, H-4), 7.27-7.21 
(m, 5 H, H-3, H-5, H-6 and H-2/H-6 o f 4-methoxyphenyl), 6.87 (d, J  = 9 Hz, 2 H, 
H-3/H-5 of 4-methoxyphenyl), 6.66 (t, J  = 6 Hz, exch., 1 H, NH), 5.92 (d, J  = 4 Hz, 
1 H, CH), 5.80 (d, J  = 4 Hz, exch., 1 H, OH), 4.30 (dd, J  = 6, 16 Hz, 1 H, 1 H of 
CH2), 4.09 (dd, 7 = 6 ,  16 Hz, 1 H, 1 H o f CH2), 3.73 (s, 3 H, OCH3), 2.79 [s, 6 H, 
N(CH3)2].
I3C NMR (100 MHz, DMSO-</6): 5 = 159.0 (s, C =0), 158.9 (s, C-4 of 
4-methoxyphenyl), 143.3 (s, C -l), 138.3 (s, C-2), 137.4 (s, C -l o f 4-methoxyphenyl),
129.0 (d, C-2/C-6 o f 4-methoxyphenyl), 128.1 (d, C-3), 127.4 (d, C-6), 127.3 (d, C-4),
127.1 (d, C-5) 114.2 (d, C-3/C-5 o f 4-methoxyphenyl), 71.2 (d, CH), 55.9 (q, OCH,),
44.4 (t, CH2), 36.7 [q, N(CH3)2],
ES*-MS: m/z (%) = 337 (M + Na+, 62), 315 (MH*, 7), 297 (MH* -  H20 ,  58), 209 (M+ 
-  H20  -  NHCONMe2, 100), 89 (84), 72 (78).
HRMS: m/z calc, for C i8H23N20 3 (MH*), 315.1703; found, 315.1700.
FT-IR: vmax = 3331 (NH and OH), 2924 (CH), 1616 (C =0), 1563 (aromatic C=C), 
1510, 1238, 1023 cm '1.
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Anal. calc, for C I8H22N 20 3: C, 68.77; H, 7.05; N, 8.91. Found: C, 68.55; H, 7.14; N, 
8.84%.
N' '-(2-(Hydroxyphenylm ethyl)benzyl)-AyV-diinethyliirea (119)
Ph
Yield: 0.47 g (1.65 mmol, 82%).
Mp: 138-140 °C.
'H NMR (400 MHz, CDCI3): 8 = 7.37-7.23 (m, 9 H, ArH), 6.05 (d, J  = 4 Hz, 1 H, 
CH), 5.00 (t, J  = 6 Hz, exch., 1 H, NH), 4.71 (d, J  = 4 Hz, exch., 1 H, OH), 4.38 (dd, J  
= 6, 14 Hz, 1 H, 1 H o f CH2), 4.27 (dd, J  = 6, 14 Hz, 1 H, 1 H o f CH2), 2.71 [s, 6 H, 
N(CH3)2],
l3C NMR (100 MHz, CDCI3): 8 = 158.7 (s, C = 0), 144.1 (s, C-l ofPh), 142.2 (s, C -l),
137.8 (s, C-2), 130.6 (d, C-3), 128.9 (d, C-6), 128.7 (d, C-3/C-5 of Ph), 128.4 (d, 
C-4), 128.0 (d, C-5), 127.6 (d, C-4 o f Ph), 127.1 (d, C-2/C-6 o f Ph), 73.8 (d, CH),
42.6 (t, CH2), 36.4 [q, N(CH3)2].
ES*-MS: mtz (%) = 285 (MH*, 44), 268 (MH* -  OH, 18), 267 (MH* -  H20 , 100), 
179 (4), 60 (8).
HRMS: m/z calc, for C |7H2,N20 2 (MH*), 285.1598; found, 285.1600.
FT-IR: vmax = 3289 (NH and OH), 2925 (CH), 1645 (C=0), 1545 (aromatic C=C), 
1352, 1231, 1019 c m 1.
,V'-(2-( H\dro\ydiphenylniethyl)benzy I )-.\.\-(li methyl urea (120)
^NHCONMe2
4 /O H
3 /  
Ph "> h
Yield: 0.61 g (1.69 mmol, 84%). 
Mp: 235-236 °C.
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'H  NMR (400 MHz, D M SO -^): 5 = 7.43-7.23 (m, 13 H, 2 Ph, H-4, H-6 and OH),
7.04 (dt, 7  = 2, 8 Hz, 1 H, H-5), 6.80 (t, J  = 6 Hz, exch., 1 H, NH), 6.49 (dd, J =  2, 8 
Hz, 1 H, H-3), 3.86 (d, J = 6 Hz, 2 H, CH2), 2.76 [s, 6 H, N(CH3)2].
13C NMR (100 MHz, DMSO-<4): 5 = 159.3 (s, C =0), 149.0 (s, C-l of 2 Ph), 145.3 (s, 
C -l), 141.2 (s, C-2), 130.5 (d, C-3), 129.5 (d, C-6), 128.9 (d, C-3/C-5 of 2 Ph), 128.6 
(d, C-5), 128.4 (d, C-2/C-6 o f 2 Ph), 127.4 (d, C-4 of 2 Ph), 126.3 (d, C-4), 82.0 (s, 
C-OH), 43.0 (t, CH2), 36.7 [q, N(CH3)2J.
ES+-M S: m/z (%) = 383 (M + Na+, 48), 343 (MH+ -  H20 , 27), 255 (100), 89 (84).
ES -M S: m/z (%) = 360 (NT, 5), 359 (NT -  1, 41), 177 [M- -  Ph2C(OH), 100], 132 
(20), 104 (40).
HRMS: m/z calc, for C23H24N20 2Na (M + Na+), 383.1730; found, 383.1731.
FT-IR: vmax = 3329 (NH and OH), 2928 (CH), 1621 (C=0), 1530 (aromatic C=C), 
1264, 1029 c m 1.
.Y'-(2-I)euteriobcnzyl)-,Y,.Y-diinethylurea (121)
NHCONMe
Yield: 0.32 g (1.79 mmol, 89%).
Mp: 76-77 °C (Mp o f undeuteriated analogue lit.135 77 °C).
'H NMR (400 MHz, CDC13): 8 = 7.35-7.24 (m, 4 H, H-3, H-4, H-5 and H-6), 4.84 
(br, exch., 1 H, NH), 4.41 (br, 2 H, CH2), 2.91 [s, 6 H, N(CH,b].
I3C NMR (100 MHz, CDCI3): 5 = 158.8 (s, O O ) ,  140.2 (s, C -l), 128.9 (d, C-3),
128.8 (seen as three lines, 1:1:1, because o f coupling to D, C-2), 128.1 (d, C-5), 127.8 
(d, C-6), 127.6 (d, C-4), 45.4 (t, CH2), 36.6 [q, N(CH3)2].
EI-MS: m/z (%) = 179 (M+, 25), 106 (36), 92 (C6H40 +, 48), 91 (C6H30 +, 57), 77 (41), 
72 (92), 44 (100).
CI-M S: m/z (%) = 197 (M + NH4+, 23), 180 (MH+, 100), 179 (M+, 88), 106 
(PhCH2N H \ 25), 52 (30), 46 (31).
HRMS: m/z calc, for C i0H |4DN2O (MH+), 180.1242; found, 180.1243.
FT-IR: vmax = 3320 (NH), 2925 (CH), 1622 (C =0), 1533 (aromatic C=C), 1512, 
1375, 1232, 1035 cm’1.
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N '-(2-(Hydroxy-(4-methoxyphenyl)methyl)-4-methoxybenzyl)-AyV-dimethylurea 
(122)
N H C O N M e
O H
M eO
O M e
Yield: 0.59 g (1.71 mmol; 85%).
Mp: 137-138 °C.
'H NMR (400 MHz, DMSO-</6): 5 = 7.21 (d, J  = 9 Hz, 2 H, H-2/H-6 of 
4-methoxyphenyl), 7.14 (d, J =  8 Hz, 1 H, H-6), 7.03 (d, J =  2 Hz, 1 H, H-3), 6.86 (d, 
J =  9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 6.78 (dd, J  = 2, 8 Hz, 1 H, H-5), 6.53 
(app. t, J =  6 Hz, exch., 1 H, NH), 5.88 (d, J  = 5 Hz, 1 H, CH), 5.81 (d, J  = 5 Hz, 
exch., 1 H, OH), 4.21 (dd, J = 6, 14 Hz, 1 H, 1 H o f CH2), 3.96 (dd, J  = 6, 14 Hz, 1 H, 
1 H of CH2), 3.73 (s, 6 H, 2 OCH3), 2.77 [s, 6 H, N(CH3)2].
13C NMR (100 MHz, DMSO-d6): 5 = 159.0 (s, C =0), 158.9 (s, C-4), 158.8 (s, C-4 of 
4-methoxyphenyl), 144.8 (s, C-2), 137.3 (s, C -l o f 4-methoxyphenyl), 130.3 (s, C -l),
129.9 (d, C-6), 129.0 (d, C-2/C-6 o f 4-methoxyphenyl), 114.2 (d, C-3/C-5 of 
4-methoxyphenyl), 113.2 (d, C-3), 112.4 (d, C-5), 71.2 (d, CH), 55.9 (q, OCH3), 55.8 
(q, OCH3), 41.2 (t, CH2), 36.7 [q, N(CH3)2].
EI-MS: m/z (%) = 344 (M+, 7), 326 (M+ -  H20 , 11), 282 (M+ -  H20  -  NMe2, 21), 254 
(M+ -  H20  -  CONMe?, 66), 243 (96), 239 (75), 225 (92), 210 (12), 195 (13), 181
(10), 165 (20), 152 (31), 135 (100), 121 (82), 102 (80), 89 (78).
CI-MS: m/z (%) = 345 (MH+, 1), 343 (M+ -  1, 6), 327 (MH+ -  H20 , 51), 260 (8), 246
(11), 209 (22), 154 (31), 137 (22), 121 (25), 106 (65), 103 (98), 91 (51), 89 (100), 74
(24), 63 (87).
ES+-M S: m/z (%) = 367 (M + Na+, 71), 345 (MH+, 6), 327 (MH+ -  H20 , 66), 239 
(100), 89 (22), 72 (27).
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ES’-M S: m/z (%) = 344 (M , 15), 343 (M“ -  1, 70), 298 (31), 207 [NT -
MeOC6H4CH(OH), 100], 190(12), 162 (15), 120(20).
HRMS: m/z calc, for C ,9H25N 204 (MH+), 345.1809; found, 345.1811.
FT-IR: vmax = 3328 (NH and OH), 2923 (CH), 1633 (C=0), 1563 (aromatic C=C), 
1511, 1239, 1023 cm’1.
Anal. calc, for C |9H24N204 : C, 66.26; H, 7.02; N, 8.13. Found: C, 66.23; H, 7.04; N, 
8.05%.
Selected crystallographic data: C|9H24N 20 4, FW = 344.40, T = 150(2) K, /, = 0.71073 
A, Monoclinic, P2,/c, a = 10.9920(4) A, b = 15.3230(5) A, c = 11.1540(5) A, a  = 90°, 
p  = 108.7900(10)°, y = 90°, V = 1778.55(12) A3, Z = 4, pca,c. = 1.286 Mg/m3, crystal 
size = 0.38 x 0.30 x 0.06 mm3, m = 0.091 mm’1, reflections collected = 7298, 
independent reflections = 4046, R]nt = 0.0483, parameters = 231, final R\ = 0.0599, 
wR2 = 0.1267 for I>2ct(I) and R] = 0.1008, wR2 = 0. 0.1444 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC,
reference number 736581, and can be obtained free of charge via
http://www.ccdc.ac.uk/data_request/cif.
/V-(2-(Hydroxyphenylmethyl)-4-methoxybenzyl)-AyV-diinethylurea (123)
M e O ‘
P h
Yield: 0.56 g (1.78 mmol, 89%).
Colourless oil.
'H NMR (400 MHz, CDCI3): 8 = 7.27-7.12 (m, 6 H, Ph and H-6), 6.81 (d, J =  2 Hz, 
1 H, H-3), 6.66 (dd, J  = 2, 8 Hz, 1 H, H-5), 5.89 (d, J  = 4 Hz, 1 H, CH), 4.80 (app. t, J  
= 6 Hz, exch., 1 H, NH), 4.68 (d, J  = 4 Hz, exch., 1 H, OH), 4.21 (dd, J  = 6, 14 Hz, 
1 H, 1 H o f CH2), 4.08 (dd, J =  6, 14 Hz, 1 H, 1 H o f CH2), 3.64 (s, 3 H, OCH3), 2.58 
[s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 8 = 159.3 (s, C =0), 158.7 (s, C-4), 144.0 (s, C-l o f Ph),
143.8 (s, C-2), 132.1 (d, C-6), 129.8 (s, C -l), 128.7 (d, C-3/C-5 o f Ph), 127.6 (d, C-4 
of Ph), 127.2 (d, C-2/C-6 o f Ph), 114.6 (d, C-5), 113.3 (d, C-3), 73.7 (d, CH), 55.6 (q, 
OCHj), 42.1 (t, CH2), 36.4 [q, N(CH3)2].
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EI-MS: m/z (%) = 314 (M+, 5), 297 (MH+ -  H20 ,  12), 252 (M* -  H20  -  NMe2, 11), 
225 (71), 224 (M+ -  H20  -  CONMe2, 82), 208 [MH+ -  PhCH(OH), 100], 180 (22), 
165 (36), 148 (24), 121 (40), 102 (77), 89 (67), 77 (Ph*, 85), 72 (Me2NCO+, 92), 44
(70).
CI-MS: m/z (%) = 315 (MH*, 13), 299 (100), 297 (MH* -  H20 ,  82), 241 (23), 226 
(31).
HRMS: m/z calc, for C |8H23N20 3 (MH*), 315.3869; found, 315.3866.
FT-IR: vmax = 3321 (NH and OH), 2836 (CH), 1627 (C=0), 1525 (aromatic C=C), 
1494, 1229, 1033 cm '1.
yV-(2-(Hydroxydiphenylmethyl)-4-methoxybenzyl)-AyV-dimethylurea (124)
f ........
V'NHCONMe2
MeO >  
Ph
^OH
^Ph
Yield: 0.66 g (1.69 mmol, 84%).
M p : 2 2 3 - 2 2 4  °C .
'H NMR (400 MHz, DMSO-4,): 6 = 7.48 (s, exch., 1 H, OH), 7.36-7.18 (m, 11 H, 
H-6 and 2 Ph), 6.78 (dd, J  = 2, 8 Hz, 1 H, H-5), 6.64 (t, J  = 6 Hz, exch., 1 H, NH),
6.01 (d, J =  3 Hz, 1 H, H-3), 3.75 (d, J  = 6 Hz, 2 H, CH2), 3.54 (s, 3 H, OCH3), 2.76 
[s, 6 H, N(CH3)2],
l3C NMR (100 MHz, DMSO-cfe): 5 = 159.3 (s, C =0), 157.6 (s, C-4), 148.9 (s, C-l of 
2 Ph), 146.9 (s, C-2), 132.8 (s, C -l), 132.4 (d, C-6), 128.3 (d, C-3/C-5 o f 2 Ph), 128.1 
(d, C-2/C-6 o f 2 Ph), 127.2 (d, C-4 o f 2 Ph), 116.8 (d, C-3), 112.3 (d, C-5), 81.8 (s, 
C-OH), 55.4 (q, OCH3), 42.5 (t, CH2), 36.6 [q, N(CH3)2],
ES*-MS: m/z (%) = 413 (M + Na+, 12), 391 (MH*, 8), 372 (M* -  H20 , 100), 285 
(22), 209(10), 101 (11), 89(12).
ES~-MS: m/z (%) = 390 (M“, 14), 389 (M~ -  1, 61), 157 (13), 115 (15), 101 (13), 62 
( 100).
HRMS: m/z calc, for C24H26N20 3Na (M + Na*), 413.1836; found, 413.1837.
FT-IR: vmM = 3322 (NH and OH), 2964 (CH), 1622 (C =0), 1531 (aromatic C=C), 
1446, 1243, 1025 cm '1.
146
Chapter Seven: Experimental
Ar-(2-Deuterio-4-methoxybenzyl)-Ar^ V-dimethylurea (125)
NHCONMe-
MeO 4
Yield: 0.36 g (1.72 mmol, 86%).
Mp: 81-82 °C (Mp o f undeuteriated analogue 81-82 °C; 108, Section 7.18).
'H NMR (400 MHz, CDCI3): 8 = 7.18 (d, J  = 8 Hz, 1 H, H-6), 6.80-6.77 (m, 2 H, H-3 
and H-5), 4.30 (br t, exch., 1 H, NH), 4.28 (d, J  = 6 Hz, 2 H, CH2), 3.72 (s, 3 H, 
OCH3), 2.83 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 8 = 159.3 (s, C =0), 158.7 (s, C-4), 132.0 (s, C -l), 29.5 
(d, C-6), 129.2 (seen as three lines, 1:1:1, because o f coupling to D, C-2), 114.4 (d, 
C-3), 114.3 (d, C-5), 55.7 (q, OCH3), 44.9 (t, CH2), 36.7 [s, N(CH3)2].
EI-MS: m/z (%) = 209 (M+, 23), 163 (M+ -  OMe -  Me, 6), 137 (M+ -  CONMe2, 32), 
122 (M+ -  NHCONMe2, 100), 110 (9), 92 (12), 72 (Me2NCO+, 96), 52 (28), 44 (100). 
CI-MS: m/z (%) = 227 (M + NH„+, 6), 210 (MH+, 100), 122 (M+ -  NHCONMe2, 2), 
52 (6).
HRMS: m/z calc. fo rC n H |6DN20 2 (MH+), 210.1347; found, 210.1349.
F T - IR :  v max =  3 3 1 7  (N H ) , 2 9 2 6  (C H ) , 1 6 1 8  ( C = 0 ) ,  153 2  (aromatic C = C ), 1495 , 
1 3 7 7 , 1226 , 1031 c m 1.
Y'-(2-Ethyl-4-niethoxybeiizyl)-.Y,.Y-diniethylurea (126)
MeO 4
Yield: 0.42 g (1.78 mmol, 89%).
M p : 9 0 -9 1  °C .
1H NMR (400 MHz, CDCI3): 8 = 7.21 (d, J  = 8 Hz, 1 H, H-6), 6.78 (d, J  = 2 Hz, 1 H, 
H-3), 6.73 (dd, J  = 2, 8 Hz, 1 H, H-5), 4.38 (br, 3 H, CH2N and NH), 3.81 (s, 3 H, 
OCH3), 2.91 [s, 6 H, N(CH3)2], 2.68 (q, J =  7 Hz, 2 H, C7/2CH3), 1.24 (t, J =  7 Hz, 3 
H, CH2CH3).
I3C NMR (100 MHz, CDCI3): 8 = 159.6 (s, C =0), 158.6 (s, C-4), 144.7 (s, C-2),
130.9 (d, C-6), 129.0 (s, C -l), 115.0 (d, C-3), 111.3 (d, C-5), 55.6 (q, OCH3), 42.7 (t, 
NCH2), 36.6 [q, N(CH3)2], 26.0 (t, CH2CH3), 15.8 (q, CH2CH3).
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EI-MS: m/z (%) = 236 (M+, 6), 164 (M+ -  CONMe2, 8), 162 (10), 149 (M+ -  
HNCONMe2, 32), 148 (M+ -  H2NCONMe2, 21), 134 (12), 117 (21), 101 (16), 90 
(30), 72 (Me2NCO+, 74), 44 (18).
CI-MS: m/z (%) = 237 (MH+, 66), 179 (8), 149 (M+ -  HNCONMe2, 21), 89 (51), 46 
(100), 44(10).
HRMS: m/z calc, for C]3H2,N20 2 (MH+), 237.1598; found, 237.1599.
FT-IR: vmax = 3320 (NH), 2932 (CH), 1627 (C=0), 1533 (aromatic C=C), 1502, 
1371,1240,1193, 1029 c m 1.
yV'-(2-(Hydroxy-(4-methoxyphenyl)inethyl)-4-methylbenzyl)-AyV-dimethylurea
(127)
NHCONMe
OH
Me'
OMe
Yield: 0.50 g (1.52 mmol, 76%).
Mp: 174-175 °C.
'H NMR (400 MHz, DMSO-<4): 8 = 7.26 (s, 1 H, H-3), 7.21 (d, = 9 Hz, 2 H,
H-2/H-6 of 4-methoxyphenyl), 7.11 (d, J  = 8 Hz, 1 H, H-6), 7.01 (d, = 8 Hz, 1 H,
H-5), 6.86 (d, J  = 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 6.58 (t, = 6 Hz, exch.,
1 H, NH), 5.89 (d, J  = 5 Hz, 1 H, CH), 5-78 (d, = 5 Hz, exch., 1 H, OH), 4.25 (dd,
= 6, 16 Hz, 1 H, 1 H o f CH2), 4.03 (dd, J  = 6, 16 Hz, 1 H, 1 H of CH2), 3.72 (s, 3 H,
OCHj), 2.78 [s, 6 H, N(CH3)2], 2.58 (s, 3 H, CH3).
13C NMR (100 MHz, DMSO-<4): 5 = 159.0 (s, C=0), 158.9 (s, C-4 of 
4-methoxyphenyl), 143.2 (s, C-2), 137.5 (s, C -l), 136.0 (s, C-4), 135.3 (s, C-l of 
4-methoxyphenyl), 128.9 (d, C-2/C-6 o f 4-methoxyphenyl), 128.5 (d, C-3), 128.0 (d, 
C-6), 127.8 (d, C-5) 114.2 (d, C-3/C-5 of 4-methoxyphenyl), 71.2 (d, CH), 55.9 (q, 
OCH3), 41.4 (t, CH2), 36.7 [q, N(CH3)2], 21.8 (q, CH3).
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EI-MS: m/z (%) = 328 (M+, 1), 310 (M+ -  H20 ,  14), 266 (M+ -  H20  -N M e 2, 57), 239 
(M+ -  H20  -  CONMe2, 49), 227 (47), 209 (M+ -  H20  -C H 2NHCONMe2, 79), 178
(22), 165 (58), 152 (35), 130 (28), 109 (48), 92 (CH3C6H5+, 100), 90 (85).
CI-MS: m/z (%) = 329 (MH+, 3), 328 (M+, 6), 327 (M+ -  1, 16), 311 (MH+ -  H20 , 
100), 240 (MH+ -  H20  -  CONMe2, 22), 203 (14), 193 (MH+ -  MeOC6H4CO, 47), 154 
(18), 137 (10), 118 (11), 106 (30), 89 (33), 72 (5), 63 (22).
E S -M S : m/z (%) = 351 (M + Na+, 30), 329 (MH+, 12), 312 (MH+ -  OH, 17), 311 
(MH+- H 20 , 100).
ES -M S: m/z (%) = 328 (M“, 19), 327 (NT -  1, 100).
HRMS: m/z calc, for C i9H25N20 3 (MH+), 329.1860; found, 329.1852.
FT-IR: Vmax = 3318 (NH and OH), 2962 (CH), 1627 (C=0), 1606 (aromatic O C ) , 
1533, 1239, 1171, 1010 cm '1.
Anal. calc, for Ci9H24N20 3: C, 69.49; H, 7.37; N, 8.53. Found: C, 69.44; H, 7.40; N, 
8.58%.
Selected crystallographic data: C 19H24N 20 3, FW = 328.40, T = 150(2) K, X = 0.71073 
A, Monoclinic, P2j/n, a = 10.3320(5) A, b = 14.8650(7) A, c = 12.1720(7) A, a  = 90°, 
P = 112.812(2)°, y = 90°, V = 1723.21(15) A3, Z = 4, pcak, = 1.266 Mg/m3, crystal size 
= 0.22 x 0.20 x 0.08 mm3, m = 0.086 m m '1, reflections collected = 7279, independent 
reflections = 3943, Rjm = 0.0795, parameters = 222, final Ri = 0.0698, wR2 = 0.1335 
for I>2cr(I) and Ri = 0.1574, wR2 = 0.1653 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 736583, and 
can be obtained free o f charge via http://www.ccdc.ac.uk/data_request/cif.
A-(2-(Hydroxyphenylmethyl)-4-methylbenzyl)-AyV-dimethylurea (128)
Me'
Ph
Yield: 0.41 g (1.39 mmol, 70%).
M p: 135-136 °C .
'H NMR (400 MHz, CDCb): 6 = 7.29-7.13 (m, 10 H, ArH, NH and OH), 5.97 (br s, 
1 H, CH), 4.27 (d ,y =  14 Hz, 1 H, 1 H o f CH2), 4.17 (d, J =  14 Hz, 1 H, 1 H ofC H 2), 
2.64 [s, 6 H, N(CH3)2], 2.21 (s, 3 H, CH3).
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l3C NMR (100 MHz, C'DCIj): S = 158.7 (s, C =0), 144.2 (s, C -l o f Ph), 142.2 (s, C-2),
138.5 (s, C -l), 134.7 (s, C-4), 130.8 (d, C-3), 129.6 (d, C-6), 129.l(d, C-5), 128.9 (d, 
C-3/C-5 o f Ph), 127.7 (d, C-4 o f Ph), 127.1 (d, C-2/C-6 o f Ph), 73.9 (d, CH), 42.4 (t, 
CH2), 36.5 [q, N(CH3)2], 21.6 (q, CH3).
EI-MS: m/z (%) = 298 (M*, 11), 281 (M* -  OH or MH+ -  H20 , 42), 280 (M+ -  H20 , 
32), 236 (M+ -  H20  -  NMe2, 100), 235 (M + -  OH -  NMe2, 83), 220 (48).
CI-M S: m/z (%) = 299 (MH*, 24), 282 (MH* -  OH, 43), 281 (MH* -  H20 , 100), 221 
(M* -  Ph, 7), 210(10), 193 (14), 106 (11), 89 (27), 52 (75), 46 (40).
HRMS: m/z calc, for C |8H23N20 2 (MH*), 299.1754; found, 299.1753.
FT-IR: vmax = 3218 (NH and OH), 2934 (CH), 1630 (C=0), 1606 (aromatic C=C), 
1533, 1234, 1171, 1010 cm '1.
7V-(2-(Hydroxydiphenylmethyl)-4-methylbenzyl)-AyV-dimethylurea (129)
NHCONMe
OH
M e 4
Ph Ph
Yield: 0.54 g (1.44 mmol, 72%).
M p : 2 2 5 - 2 2 7  °C .
‘H NMR (400 MHz, DMSO-d6): 5 = 7.40 (s, exch., 1 H, OH), 7.34-7.22 (m, 11 H, 
2 Ph and H-6), 7.09 (dd, J  = 1, 8 Hz, 1 H, H-5), 6.76 (t, J =  6 Hz, exch., 1 H, NH), 
6.31 (d, J=  1 Hz, 1 H, H-3), 3.79 (d, J = 6 Hz, 2 H, CH2), 2.75 [s, 6 H, N(CH3)2], 2.08 
(s, 3 H, CH3).
13C NMR (100 MHz, DMSO-^6): 5 = 159.3 (s, O O ) , 149.1 (s, C-l of 2 Ph), 145.3 (s, 
C-2), 138.2 (s, C -l), 135.1 (s, C-4), 130.7 (d, C-3), 130.2 (d, C-6), 129.4 (d, C-5),
128.9 (d, C-3/C-5 o f 2 Ph), 128.5 (d, C-2/C-6 o f 2 Ph), 127.4 (d, C-4 o f 2 Ph), 81.9 (s, 
C-OH), 42.8 (t, CH2), 36.7 [q, N(CH3)2], 21.8 (q, CH3).
EI-MS: m/z (%) = 374 (M+, 6), 357 (M+ -  OH, 12), 356 (M+ -  H20 , 46), 312 (M+ -  
H20  -  NMe2, 13), 311 (M+ -  H20  -N H M e2, 22), 297 (33), 285 (MH+ -  H20  -  
CONMe2, 73), 284 (M+ -  H20  -  CONMe2, 100).
CI-MS: m/z (%) = 374 (M+, 1), 373 (M+ -  1, 6), 359 (24), 357 (MH+ -  H20 , 100), 
286 (MH+ -  OH -  CONMe2, 46), 284 (M+ -  H20  -  CONMe2, 22), 257 (MH+ -  H20  -  
CHNHCONMe2, 20).
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ES+-M S: m/z (%) = 397 (M + Na+, 12), 375 (MH+, 8), 358 (MH+ -  OH, 32), 357 
(MH+ -  H20 , 100), 169 (20), 193 (12), 89 (23).
ES'-M S: m/z (%) = 374 (M~, 27), 373 (M" -  1, 100).
HRMS: m/z calc, for C24H27N2O2 (MH+), 375.2067; found, 375.2072.
FT-IR: Vmax = 3323 (NH and OH), 2959 (CH), 1636 (C=0), 1530 (aromatic C C ) ,  
1243, 1024 cm"'.
^-(Z-EthyM-methylbenzyO-AyV-dimethylurea (130)
NHCONMe
Me 4
Yield: 0.35 g (1.59 mmol, 80%).
Mp: 60-62 °C.
'H NMR (400 MHz, CDC13): 8 = 7.08 ( d ,J  = 8 Hz, 1 H, H-6), 6.95 (s, 1 H, H-3), 6.91 
(d, J  = 8 Hz, 1 H, H-5), 4.38 (br, exch., 1 H, NH), 4.31 (br, 2 H, C ftN H ), 2.58 (q, J  = 
7 Hz, 2 H, C tf2CH3), 2.25 [s, 6 H, N(CH3)2], 2.25 (s, 3 H, CH3), 1.14 (t, 7 =  7 Hz, 3 
H, CH2C //3).
13C NMR (100 MHz, CDC13): 8 = 158.6 (s, C =0), 142.9 (s, C -l), 137.8 (s, C-2),
133.7 (s, C-4), 130.0 (d, C-3), 129.5 (d, C-6), 127.2 (d, C-5), 42.9 (t, CH2NH), 36.6 
[q, N(CH3)2], 25.8 (t, CH2CH3), 21.5 (q, CH3), 16.0 (q, CH2CH3).
EI-MS: m/z (%) = 220 (M +, 7), 191 (M+ -  Et, 5), 133 (M+ -  NHCONMe2, 12), 132 
(M+ -  H2NCONMe2, 33), 117 (M+ -  Me -  H2NCONMe2, 25), 91 (MeC6H4+, 22), 77 
(13), 72 (Me2NCO+, 100), 65 (8), 46 (16), 44 (62), 42 (34).
CI-MS: m/z (%) = 238 (M + NH„+, 8), 221 (MH+, 100).
HRMS: m/z calc, for C ,3H2lN20  (MH+), 221.1648; found, 221.1649.
FT-IR: vmax = 3317 (NH), 2964 (CH), 1634 (C =0), 1606 (aromatic C=C), 1532, 
1239, 1010 cm '.
N ’-(2-Deuterio-4-methylbenzyl)-iV^V-dimethylurea (131)
NHCONMe
Me 4
Yield: 0.33 g (1.71 mmol, 86%).
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Mp: 94-95 °C (Mp o f undeuteriated analogue lit.136 93 °C).
'H NMR (400 MHz, CDC13): 5 = 7.23-7.14 (m, 3 H, H-3, H-5 and H-6), 4.73 (br, 
exch., 1 H, NH), 4.38 (br, 2 H, CH2), 2.92 [s, 6 H, N(CH3)2], 2.35 (s, 3 H, CH3).
I3C NMR (100 MHz, CDC13): 6 = 158.8 (s, C =0), 137.3 (s, C -l), 137.0 (s, C-4),
129.6 (d, C-3), 129.5 (d, C-5), 128.2 (d, C-6), 127.9 (seen as three lines, 1:1:1, 
because of coupling to D, C-2), 45.2 (t, CH2), 36.7 [q, N(CH3)2], 21.5 (q, CH3). 
EI-MS: m/z (%) = 193 (M+, 63), 192 (M+ -  1, 33), 121 (M+ -  CONMe2, 36), 120 (M+ 
-  H -  CONMe2, 28), 106 (M+ -  NHCONMe2, 50), 105 (M+ -  H2NCONMe2, 37), 92 
(MeC6H5\  18), 91 (MeC6H4+, 16), 77 (25), 72 (Me2NCO+, 100), 46 (46), 44 (91), 42
(23).
CI-MS: m/z (%) = 211 (M + NH4+, 21), 194 (MH+, 100), 179 (M+, 61).
HRMS: m/z calc, for C ,,H 16DN20  (MH+), 194.1398; found, 194.1398.
FT-IR: vmax = 3331 (NH), 2952 (CH), 1612 (C =0), 1563 (aromatic C=C), 1510, 
1239, 1024 c m 1.
7.21 Synthesis of N {-ethyl-./V-(2-ethyl-4-methoxybenzyl)-./V,ALdimethylurea 
(132) via directed lithiation of 108
A solution of /-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a cold 
(-78 °C), stirred solution o f A-(4-methoxybenzyl)-A/,7V-dimethylurea (108; 0.42 g, 2.0 
mmol) in anhydrous THF (20 mL) under N2. The mixture was stirred at -78  °C for 4 
h, after which iodoethane (0.69 g, 4.4 mmol) was added. The mixture was stirred for 2 
h at -78 °C then the cooling bath was removed and the mixture allowed to warm to 
room temperature. The reaction mixture was worked-up as described in Section 
3.10.5. The product was purified by column chromatography (silica gel; Et20-hexane, 
1:3) to give 132 (0.48 g, 1.81 mmol, 90%) as a colourless oil.
'
6
.CONMeoN|
Et
MeO Et
'H NMR (400 MHz, CDCI3): 5 = 7.10 (d, J =  8 Hz, 1 H, H-6), 6.68 (d, J  = 2 Hz, 1 H, 
H-3), 6.63 (dd, J  = 2, 8 Hz, 1 H, H-5), 4.24 (s, 2 H, CH2N), 3.71 (s, 3 H, OCH3), 3.04 
(q, J  = 7 Hz, 2 H, N Ctf2CH3), 2.74 [s, 6 H, N(CH3)2], 2.52 (q, J  = 1 Hz, 2 H, 
C7/2CH3), 1.31 (t, 7  = 7 Hz, 3 H, NCH2C/75), 1.02 (t, J  = 1 Hz, 3 H, CH2C//j).
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l3C NMR (100 MHz, CDCI3): 8 = 165.8 (s, C =0), 159.2 (s, C-4), 144.0 (s, C-2),
129.4 (d, C-6), 127.9 (s, C -l), 114.9 (d, C-3), 110.9 (d, C-5), 55.6 (q, OCH3), 48.6 (t, 
CH2N), 42.8 (t, NCH2CH3), 39.1 [q, N(CH3)2], 25.7 (t, CH2CH3), 15.0 (q, CH2CH3),
13.0 (q, CH2CH3).
EI-MS: m/z (%) = 264 (M+, 8), 235 (M+ -  Et, 7), 190 (20), 162 (39), 149 [M+ -  
N(Et)CONMe2, 100], 148 [M+ -  NH(Et)CONMe2, 54], 129 (33), 121 (20), 91 (35), 72
(71).
CI-MS: m/z (%) = 265 (MH+, 100), 149 [M+ -  N(Et)CONMe2, 50], 129 (34), 117 
(68), 72 (Me2NCO+, 25), 46 (47), 44 (40).
HRMS: m/z calc, for C i5H25N20 2 (M H+), 265.3713; found, 265.3713.
FT-1R: vmax = 2964 (CH), 1639 (C =0), 1578 (aromatic C=C), 1492, 1394, 1238, 
1121, 1029 cm '1.
7.22 Synthesis of N 1-(2-(hydroxy(4-methoxyphenyl)methyl)-6-methoxybenzyl)- 
AyV-dimethylurea (136) and N 1-(3-(hydroxy(4-methoxyphenyl)methyl)-2- 
methoxybenzyl)-AyV-dimethylurea (137) via lithiation of N 1-(2-methoxy- 
benzyty-AyV-dimethylurea (111) at -20 °C
A solution o f r-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (-20 °C), stirred solution o f A-(2-methoxybenzyl)-A,A-dimethylurea (111; 0.42 
g, 2.0 mmol) in anhydrous THF (20 mL) under N2. Formation of the monolithium 
reagent 133 was observed as a yellow solution and the dilithium reagents 134 and 135 
were observed as a reddish orange solution. The mixture was stirred at -2 0  °C for 2 h, 
to ensure the complete formation o f the dilithium reagents, after which 4-anisaldehyde 
(0.30 g, 2.2 mmol) was added. The mixture was stirred for 2 h at -20 °C then the 
cooling bath was removed and the mixture allowed to warm to room temperature. It 
was then diluted with Et20  (10 mL) and quenched with aq. sat. NH4C1 (10 mL). The 
organic layer was separated, washed with H20  (2 x 10 mL), dried (M gS04), and 
evaporated under reduced pressure. The product mixture was separated by column 
chromatography (silica gel; Et20-hexane, 1:3) to give 136 (0.34 g, 0.99 mmol, 49%) 
and 137 (0.28 g, 0.81 mmol, 40%) as white solids.
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yV-(2-(Hydroxy-(4-methoxyphenyl)methyl)-6-methoxybenzyl)-AyV-dimethylurea
(136)
Yield: 0.34 g (0.99 mmol, 49%).
Mp: 139-140 °C.
'H NMR (400 MHz, CDCIi): 8 = 7.23 (d, /  = 9 Hz, 2 H, H-2/H-6 of 
4-methoxyphenyl), 7.10 (app. t, J =  8 Hz, 1 H, H-4), 6.78-6.72 (m, 4 H, H-3, H-5 and 
H-3/H-5 of 4-methoxyphenyl), 6.12 (d, J  = 6 Hz, exch., 1 H, OH), 6.02 (d, J =  6 Hz, 
1 H, CH), 5.23 (app. t, J =  6 Hz, exch., 1 H, NH), 4.30 (dd, J  = 6, 16 Hz, 1 H, 1 H of 
CH2), 4.22 (dd, J  = 6, 16 Hz, 1 H, 1 H o f CH2), 3.78 (s, 3 H, OCH3), 3.70 (s, 3 H, 
OCH3), 2.72 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 8 = 159.2 (s, C =0), 158.9 (s, C-6), 158.7 (s, C-4 o f 
4-methoxyphenyl), 144.6 (s, C-2), 137.1 (s, C -l o f 4-methoxyphenyl), 128.8 (d, C-4),
127.8 (d, C-2/C-6 o f 4-methoxyphenyl), 126.1 (s, C -l), 122.4 (d, C-3), 113.8 (d, 
C-3/C-5 of 4-methoxyphenyl), 110.2 (d, C-5), 73.3 (d, CH), 56.0 (q, OCH3), 55.6 (q, 
OCH3), 37.2 (t, CH2), 36.5 [q, N(CH3)2].
ES+-M S: m/z (%) = 689 (2 M+ + 1, 12), 345 (MH+, 47), 327 (MH+ -  H20 ,  100), 239 
(6), 219 (5).
HRMS: m/z calc, for C i9H25N20 4 (MH+), 345.1809; found, 345.1807.
FT-1R: vmax = 3308 (NH and OH), 2934 (CH), 1630 (C=0), 1611 (aromatic C=C), 
1509, 1242, 1029 c m 1.
JV-(3-(Hydroxy-(4-methoxyphenyl)methyl)-2-methoxybenzyl)-7V,/V-dimethyliirea
(137)
NHCONMe
NHCONMe-
Yield: 0.28 g (0.81 mmol, 40%).
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Mp: 140-141 °C.
‘H NMR (400 MHz, CDCh): 8 = 7.24 (dd, J =  2, 8 Hz, 1 H, H-4), 7.19 (d, 7 =  9 Hz, 
2 H, H-2/H-6 o f 4-methoxyphenyl), 7.16 (br d, J  = 8 Hz, 1 H, H-6), 7.01 (app. t, J  = 
8 Hz, 1 H, H-5), 6.75 (d, J  = 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 5.96 (s, 1 H, 
CH), 5.44 (s, exch., 1 H, OH), 4.81 (app. t, J  = 6 Hz, exch., 1 H, NH), 4.36 (dd, J =  6, 
16 Hz, 1 H, 1 H o f CH2), 4.32 (dd, J  = 6, 16 Hz, 1 H, 1 H o f CH2), 3.69 (s, 3 H, 
OCH3), 3.49 (s, 3 H, OCH3), 2.78 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDC13): 8 = 159.3 (s, C = 0), 158.9 (s, C-2), 156.0 (s, C-4 of 
4-methoxyphenyl), 137.8 (s, C -l o f 4-methoxyphenyl), 136.4 (s, C -l), 133.0 (s, C-3),
129.3 (d, C-4), 128.3 (d, C-2/C-6 o f 4-methoxyphenyl), 127.6 (d, C-6), 125.0 (d, C-5),
114.1 (d, C-3/C-5 o f 4-methoxyphenyl), 71.2 (d, CH), 62.1 (q, OCH3), 55.6 (q, 
OCH3), 40.3 (t, CH2), 36.6 [q, N(CH3)2].
CI-MS: m/z (%) = 345 (MH+, 6), 344 (M+, 2), 343 (M+ -  1, 5), 329 (M+ -  Me, 82), 
327 (MH+ -  H20 ,  56), 301 (MH+ -  NM e2, 12), 282 (M+ -  H20  -N M e2, 16), 256 (8), 
237 (7), 209 (10), 137 (53), 121 (16), 101 (11), 89 (58), 72 (Me2NCO+, 25), 46 (100). 
HRMS: m/z calc, for C 19H25N204 (MH+), 345.1809; found, 345.1813.
FT-IR: vmax = 3344 (NH and OH), 2935 (CH), 1625 (C=0), 1611 (aromatic C=C), 
1509, 1461, 1242, 1170, 1031 c m 1.
7.23 Lithiation of N '-(2-methoxybenzyl)-AyV-dimethylurea (111) at 0 °C 
followed by reaction with 4-anisaldehyde
The procedure was identical to that described in Section 7.22 except that the 
reaction was carried out at 0 °C for 2 h followed by reaction with 4-anisaldehye at 
0 °C for 2 h. The reaction mixture was worked-up and the product mixture was 
examined by TLC to show a mixture o f four products, 136,137,138,139, and starting 
material 111. A white solid was obtained from treatment of the product mixture with 
diethyl ether (20 mL) which was filtered and washed with diethyl ether (2 x 1 5  mL) to 
give 139 (66 mg, 0.22 mmol, 11%). The filtrate was concentrated and subjected to 
column chromatography (silica gel; Et20-hexane, 1:3) to give 136 (0.35 g, 1.02 
mmol, 50%), 137 (0.08 g, 0.24 mmol, 12%), 138 (12 mg, 0.06 mmol, 3%) and 111 
(50 mg, 0.24 mmol, 12%). Compounds 136 and 137 were found to be identical in all 
respects with the ones produced from similar reactions carried out at low temperatures 
(-78 to -2 0  °C).
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TV-^-HydroxybenzyO-AyV-dimethylurea (138)
OH
Yield: 12 mg (0.06 mmol, 3%).
Mp: 152-153 °C.
‘H NMR (400 MHz, CDC13): 5 = 10.44 (s, exch., 1 H, OH), 7.23 (dt, J =  2, 8 Hz, 1 H, 
H-4), 7.06 (dd, J =  2, 8 Hz, 1 H, H-6), 6.94 (dd, J=  2, 8 Hz, 1 H, H-3), 6.80 (app. dt, J  
= 2, 8 Hz, 1 H, H-5), 5.29 (br, exch., 1 H, NH), 4.34 (d, J =  6 Hz, 2 H, CH2), 2.91 [s, 
6 H, N(CH3)2].
,3C NMR (100 MHz, CDC13): 6 = 160.3 (s, C=0), 156.7 (s, C-2), 131.1 (d, C-6),
130.2 (d, C-4), 126.2 (s, C -l), 119.8 (d, C-5), 118.2 (d, C-3), 42.1 (t, CH2), 36.7 [q, 
N(CH3)2].
EI-MS: m/z (%) = 194 (M+, 22), 149 (8), 122 (M+ -  Me2NCO, 20), 107 (M+ -  
Me2NCONH, 24), 106 (M+ -  Me2NCO NH2, 31), 78 (30), 77 (32), 72 (Me2NCO+, 
100), 46 (24), 44 (47).
CI-MS: m/z (%) = 195 (MH+, 22), 106 (M+ -  Me2NCO NH2, 33), 89 (Me2NCONH3+, 
100).
HRMS: m/z calc, for C 10H 15N2O2 (MH+), 195.1128; found, 195.1127.
FT-IR: vmax = 3393 (NH and OH), 2763 (CH), 1682 (C=0), 1583 (aromatic C=C), 
1534, 1387, 1226 cm '1.
(/?*)-3-((S*)-Hydroxy(4-methoxyphenyl)methyl)-4-methoxyisoindolin-l-one (139)
■OMe
\3a - 
I  OH 
4 OMe
5
Yield: 66 mg (0.22 mmol, 11%).
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Mp: 199-201 °C.
'h  NMR (400 MHz, DMSO-cfe): 5 = 8.77 (s, exch., 1 H, NH), 7.31 (app. t, J =  8 Hz,
1 H, H-6), 7.16 ( d , J =  8 Hz, 1 H, H-5), 6.93 ( d ,J = 8 H z ,  1 H, H-7), 6.89 (d, J =  9 Hz,
2 H, H-2/H-6 o f 4-methoxyphenyl group), 6.58 (d, J  = 9 Hz, 2 H, H-3/H-5 of 
4-methoxyphenyl group), 5.73 (d, J  = 3 Hz, exch., 1 H, OH), 5.39 (app. t, J =  3 Hz, 
1 H, H-3), 4.89 (d, J =  3 Hz, 1 H, C//OH), 3.97 (s, 3 H, OCH3), 3.60 (s, 3 H, OCH3). 
n C NMR (100 MHz, DMSCWs): 8 = 169.7 (s, C -l), 158.4 (s, C-4 of 
4-methoxyphenyl), 155.0 (s, C-4), 134.9 (s, C-l of 4-methoxyphenyl), 131.6 (s, 
C-7a), 131.5 (s, C-3a), 130.1 (d, C-6), 128.3 (d, C-2/C-6 of 4-methoxyphenyl), 114.9 
(d, C-7), 113.6 (d, C-5), 112.5 (d, C-3/C-5 o f 4-methoxyphenyl), 71.6 (d, CHOH),
61.5 (d, C-3), 56.0 (q, OCH3), 55.1 (q, OCH3).
EI-MS: m/z (%) = 163 (46), 136 (M+ -  MeOC6H4CH(OH)CHN, 54), 135 (M+ -  
MeOC6H4CH(OH)CHNH, 100), 119 (8), 107 (10), 92 (11), 77 (15).
CI-MS: m/z (%) = 300 (MH+, 100), 284 (M+ -  NH2, 8), 237 (24).
HRMS: m/z calc, for C i7H 18N 0 4 (MH+), 300.1230; found, 300.1231.
FT-IR: vmax = 3304 (NH and OH), 2872 (CH), 1677 (C=0), 1604 (aromatic C=C), 
1512, 1273, 1048 c m 1.
Selected crystallographic data: C ,7H ]7N 0 4, FW = 299.32, T = 293(2) K, Z = 0.71073 
A, Triclinic, PI, a = 7.5240(3) A, b = 9.4100(3) A, c = 11.9960(5) A, a  = 83.877(2)°, 
P = 77.311(2)°, y = 68.559(2)°, V = 770.92(5) A3, Z = 2, pcaic. = 1.289 Mg/m3, crystal 
size = 0.20 x 0.15 x 0.15 mm3, m = 0.092 mm’1, reflections collected = 5071, 
independent reflections = 3513, Rjnt = 0.0334, parameters = 202, final Ri = 0.0570, 
wR2 = 0.1277 for I>2a(I) and Ri = 0.0855, wR2 = 0.1433 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 737415, and can be obtained free of charge via 
http://www.ccdc.ac.uk/data_request/cif.
7.24 Synthesis of -(2-(substituted-6-methoxybenzyi)-A r^ V-dimethyIureas 141, 
143, 145 and 147 and /V-(3-(substituted-2-methoxybenzyl)-/V,/V-
dim ethylureas 142, 144, 146 and 148 via lithiation of /V-(2-methoxy- 
benzyl)-AyV-dimethylurea (111) a t -2 0  °C
The procedure was identical to that described for the synthesis of 136 and 137 
(Section 7.22) except that an electrophile (2.2 mmol), in anhydrous THF (8 mL) if
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solid, otherwise neat, was used instead o f 4-anisaldehyde. The reaction mixture was 
worked-up and the product mixture was separated by column chromatography (silica 
gel; Et20-hexane, 1:3) to give pure products. The yields of products 141-148 are 
recorded in Table 3.5.
yV-(2-(Hydroxyphenylmethyl)-6-methoxybenzyl)-AyV-dimethyhirea (141)
NHCONMe
6 OMe
Yield: 0.32 g (1.02 mmol, 51%).
Mp: 126-127 °C.
'H NMR (400 MHz, CDCh): 8 = 7.45 (d, J =  8 Hz, 2 H, H-2/H-6 o f Ph), 7.34 (app. t, 
J  = 8 Hz, 2 H, H-3/H-5 o f Ph), 132-1 .2d  (m, 2 H, H-4 and H-4 o f Ph), 6.86 (dd, J  = 
1, 8 Hz, 1 H, H-3), 6.82 (dd, J =  1, 8 Hz, 1 H, H-5), 6.41 (d, .1 = 6  Hz, exch., 1 H, 
OH), 6.18 (d, J =  6 Hz, 1 H, CH), 5.36 (app. t, J =  6 Hz, exch., 1 H, NH), 4.41 (dd, 
J=  6, 16 Hz, 1 H, 1 H o f CH2), 4.32 (dd, / =  6, 16 Hz, 1 H, 1 H o f CH2), 3.90 (s, 3 H, 
OCH,), 2.85 [s, 6 H, N(CH3)2],
13C NMR (100 MHz, CDC13): 8 = 159.2 (s, C =0), 159.0 (s, C-6), 144.9 (s, C-l o f Ph),
144.5 (s, C-2), 128.8 (d, C-4), 128.4 (d, C-3/C-5 o f Ph), 126.9 (d, C-4 of Ph), 126.7 
(d, C-2/C-6 o f Ph), 126.3 (s, C -l), 122.8 (d, C-3), 110.3 (d, C-5), 73.7 (d, CH), 56.0 
(q, OCH3), 37.3 (t, CH2), 36.5 [q, N(CH3)2].
EI-MS: m/z (%) = 314 (M+, 2), 296 (M+ -  H20 ,  61), 252 (M+ -  H20  -  NMe2, 5), 224 
(M+ -  H20  -  CONMe2, 33), 209 (M+ -  H20  -  NHCONMe2, 13), 208 (M+ -  H20  -  
H2NCONMe2, 23), 180 (9), 165 (12), 148 (19), 89 (17), 77 (Ph+, 24), 72 (Me2N C O \ 
100), 44 (33).
CI-MS: m/z (%) = 315 (MH+, 42), 299 (M+ -  Me, 22), 297 (MH* -  H20 , 100), 226
(12), 225 (MH* -  H20  -  CONMe2, 11), 224 (M+ -  H20  -  CONMe2, 10), 209 (M+ -  
H20  -  NHCONMe2, 82), 197 (12), 103 (15), 89 (85), 72 (Me2NCO+, 38), 46 (45), 44 
(26).
HRMS: m/z calc, for C |8H23N203 (MH+), 315.1703; found, 315.1702.
FT-IR: vmax = 3311 (NH and OH), 2851 (CH), 1622 (C=0), 1550 (aromatic C=C), 
1460, 1381, 1235,1041 cm '1.
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/V'-(3-Hydroxyphenylmethyl)-2-methoxybenzyl)-AyV-dimethylurea (142)
NHCONMe-
OMe
HO Ph
Yield: 0.24 g (0.76 mmol, 38%).
M p: 1 4 6 -1 4 7  °C .
'H NMR (400 MHz, CDCh): 8 = 7.32 (d, 7  = 8 Hz, 2 H, H-2/H-6 o f Ph), 7.26 (app. t, 
7 = 8  Hz, 2 H, H-3/H-5 o fP h), 7.21-7.15 (m ,4 H , H-4, H-5, H-6 and OH), 7.01 (t, 7  = 
8 Hz, 1 H, H-4 o f Ph), 6.00 (s, 1 H, CH), 4.75 (app. t, 7  = 6 Hz, exch., 1 H, NH), 4.37 
(dd, 7  = 6, 16 Hz, 1 H, 1 H ofC’H:), 4.34 (d d ,7 =  6, 16 Hz, 1 H, 1 H of CH2), 3.51 (s, 
3 H, OCH3), 2.80 [s, 6 H, N(CH,)2].
n C N M R (100 MHz, CDCh): 8 = 158.8 (s, C =0), 156.1 (s,C -2), 144.2 (s ,C -l ofPh),
137.6 (s, C -l), 133.1 (s, C-3), 129.5 (d, C-4), 128.7 (d, C-3/C-5 o f Ph), 127.9 (d, C-4 
of Ph), 127.8 (d, C-6), 127.0 (d, C-2/C-6 o f Ph), 125.1 (d, C-5), 71.8 (d, CH), 62.2 (q, 
OCH3), 40.4 (t, CH2), 36.6 [q, N(CH3)2],
EI-MS: m/z (%) = 314 (M+, 1), 297 (M H+ -  H20 ,  4), 296 (M+ -  H20 ,  8), 252 (M+ -  
H20  -  NMe2, 6), 236 (8), 226 (12), 209 (M+ -  H20  -  NHCONMe2, 14), 208 (M+ -  
H20  -  H2NCONMe2, 32), 181 (8), 165 (18), 152 (13), 133 (16), 105 (PhCH2N+, 29), 
91 (PhCH2+, 62), 77 (Ph+, 60), 72 (Me2NCO+, 100), 44 (69).
CI-M S: m/z (%) = 315 (MH+, 6), 299 (M + -  Me, 23), 297 (MH+ -  H20 ,  7), 237 (12), 
209 (M+ -  H20  -  NHCONMe2, 82), 197 (8), 103 (15), 89 (85), 72 (Me2NCO+, 23), 46 
(100), 44(43).
HRMS: m/z calc, for C ,8H23N20 3 (MH+), 315.1703; found, 315.1700.
FT-1R: vmax = 3303 (NH and OH), 2835 (CH), 1607 (C=0), 1552 (aromatic C=C), 
1461, 1378, 1233, 1023 cm'1.
Anal. calc, for C ,8H22N20 3: C, 68.77; H, 7.05; N, 8.91. Found: C, 68.74; H, 7.06; N, 
8.90%.
159
Chapter Seven: Experimental
yV-(2-(Hydroxydiphenylmethyl)-6-methoxybenzyl)-AyV-dimethyliirea (143)
Ph
OHPh
NHCONMe
OMe
Yield: 0.37 g (0.95 mmol, 47%).
Mp: 218-219 °C.
'H NMR (400 MHz, DMSO-</6): 5 = 7.98 (s, exch., 1 H, OH), 7.64 (d, J =  8 Hz, 4 H, 
H-2/H-6 of 2 Ph), 7.31 (t, J =  8 Hz, 4 H, H-3/H-5 o f 2 Ph), 7.21 (t, J =  8 Hz, 2 H, H-4 
of 2 Ph), 7.07 (app. t, J =  8 Hz, 1 H, H-4), 6.88 (br d, J =  8 Hz, 1 H, H-3), 6.31 (dd, J  
= 3, 8 Hz, 1 H, H-5), 5.48 (br t, exch., 1 H, NH), 4.04 (d, J =  6 Hz, 2 H, CH2), 3.91 (s, 
3 H, OCH3), 2.85 [s, 6 H, N(CH3)2].
,3C NMR (100 MHz, DMSO-</6): 5 = 159.8 (s, C =0), 159.4 (s, C-6), 149.2 (s, C-l of 
2 Ph), 147.9 (s, C-2), 128.2 (d, C-3/C-5 o f 2 Ph), 128.0 (d, C-2/C-6 of 2 Ph), 127.7 (d, 
C-4), 126.9 (s, C -l), 126.8 (d, C-4 o f 2 Ph), 123.5 (d, C-3), 110.6 (d, C-5), 81.4 (s, 
C-OH), 56.1 (q, OCH3), 39.5 (t, CH2), 36.5 [q, N(CH3)2].
EI-MS: m/z (%) = 390 (M+, 4), 372 (MH+ -  H20 , 9), 313 (M+ -  Ph, 8), 284 (18), 224 
(15), 178 (12), 161 (16), 105 (45), 91 (PhCH2+, 25), 77 (Ph+, 46), 72 (Me2NCO+, 
100), 44 (22).
CI-MS: m/z (%) = 391 (MH+, 7), 373 (MH+ -  H20 , 100), 306 (22), 292 (30), 273 
(42), 235 (15).
HRMS: m/z calc, for C24H29N20 3 (MH+), 391.2016; found, 391.2013.
FT-IR: vmax = 3399 (NH and OH), 3025 (CH), 1630 (C=0), 1569 (aromatic C=C), 
1500, 1443, 1243, 1025 c m 1.
N'-(3-(Hydroxydiphenylmethyl)-2-methoxybenzyl)-AyV-diniethyliirea (144)
NHCONMe.
OMe
PhHO
Ph
Yield: 0.24 g (0.61 mmol, 30%). 
Mp: 207-209 °C.
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'H NMR (400 MHz, CDCI3): 5 = 7.27-6.81 (m, 13 H, 2 Ph, OH, H-4 and H-5), 6.42 
(dd, J =  2, 8 Hz, 1 H, H-6), 4.88 (br, exch., 1 H, NH), 4.40 (d, 7  = 6 Hz, 2 H, CH2), 
3.79 (s, 3 H, OCH3), 2.86 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 8 = 158.8 (s, C =0), 158.0 (s, C-2), 147.0 (s, C-l of 
2 Ph), 133.5 (s, C -l), 128.7 (s, C-3), 128.4 (d, C-3/C-5 o f 2 Ph), 128.3 (d, C-2/C-6 of 
2 Ph), 128.2 (d, C-4), 128.1 (d, C-4 o f 2 Ph), 127.7 (d, C-6), 124.0 (d, C-5), 82.6 (s, 
C-OH), 61.6 (q, OCHj), 40.4 (t, CH2), 36.7 [q, N(CH3)2].
Cl-MS: m/z (%) = 391 (MH+, 100), 373 (MH+ -  H20 , 47), 292 (46), 72 (Me2NCO+, 
76), 44 (46).
HRMS: m/z calc, for C24H29N2O3 (MH+), 391.2016; found, 391.2015.
FT-IR: vmax = 3368 (NH and OH), 2998 (CH), 1632 (C=0), 1559 (aromatic C=C), 
14980, 1445, 1246, 1029 c m 1.
N-^-M ethoxy^-methylbenzyty-AyV-dimethylurea (145)
NHCONMe2
OMe
Yield: 0.23 g (1.03 mmol, 51%).
Colourless oil.
'H NMR (400 MHz, CDC13): 8 = 7.07 (app. t, J =  8 Hz, 1 H, H-4), 6.72 (d, J  = 8 Hz,
1 H, H-5), 6.66 (d, J  = 8 Hz, 1 H, H-3), 4.81 (br, exch., 1 H, NH), 4.38 (d, J =  6 Hz,
2 H, CH2), 3.77 (s, 3 H, OCH3), 2.78 [s, 6 H, N(CH3)2], 2.37 (s, 3 H, CH3).
I3C NMR (100 MHz, CDC13): 8 = 158.8 (s, C =0), 158.7 (s, C-2), 138.9 (s, C-6),
128.4 (d, C-4), 126.4 (s, C -l), 124.8 (d, C-5), 108.5 (d, C-3), 55.9 (q, OCH3), 37.3 (t, 
CH2), 36.6 [q, N(CHj)2], 20.2 (q, CH3).
EI-MS: m/z (%) = 222 (M+, 12), 207 (M + -  Me, 3), 150 (M+ -  Me2NCO, 40), 135 (M+ 
-  Me2NCONH, 35), 105 (21), 91 (PhCH2+, 20), 77 (12), 72 (Me2NCO+, 100), 44 (72). 
Cl-M S: m/z (%) = 445 (2 M+ + 1, 2), 223 (MH+, 100), 222 (M+, 13), 150 (M+ -  
Me2NCO, 12), 135 (M+ -  Me2NCONH, 11), 72 (Me2NCO+, 12), 46 (9).
HRMS: m/z calc, for C ,2Hi9N20 2 (M H ), 223.1441; found, 223.1441.
FT-IR: vmax = 3341 (NH), 2932 (CH), 1635 (C =0), 1540 (aromatic C=C), 1471, 
1264, 1090 cm '1.
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iV-^-Methoxy-S-methylbenzyty-AyV-dimethylurea (146)
OMe
Me
Yield: 0.18 g (0.81 mmol, 40%).
Colourless oil.
'H NMR (400 MHz, CDCI3): 6 = 7.09 (dd, J  = 1, 8 Hz, 1 H, H-4), 7.02 (br d, J  = 
8 Hz, 1 H, H-6), 6.91 (app. t, J  = 8 Hz, 1 H, H-5), 4.84 (br, exch., 1 H, NH), 4.37 (d, 
J  = 6 Hz, 2 H, CH2), 3.69 (s, 3 H, OCH3), 2.82 [s, 6 H, N(CH3)2], 2.22 (s, 3 H, CH3). 
I3C NMR (100 MHz, CDCI3): 6 = 158.8 (s, C =0), 157.2 (s, C-2), 132.7 (s, C -l),
131.5 (s, C-3), 131.0 (d, C-4), 127.8 (d, C-6), 124.7 (d, C-5), 60.8 (q, OCH3), 40.9 (t, 
CH,), 36.6 [q, N(CH3)2], 16.4 (q, CH3).
EI-MS: m/z (%) = 222 (M*, 12), 191 (6), 150 (M+ -  Me2NCO, 31), 135 (M+ -  
Me,NCONH, 16), 105 (12), 91 (PhCH2+, 18), 77 (11), 72 (Me2NCO+, 100), 44 (54). 
Cl-M S: m/z (%) = 223 (MH*, 100), 209 (8), 150 (M* -  Me,NCO, 6), 72 (Me2NCO+, 
7), 46 (9).
HRMS: m/z calc, for C 12H 19N2O2 (MH*), 223.1441; found, 223.1443.
FT-IR: vmax = 3341 (NH), 2928 (CH), 1633 (C =0), 1528 (aromatic C=C), 1469, 
1372, 1206, 1007 c m 1.
yV-(2-Ethyl-6-methoxybenzyl)-AV/V-dimethyliirea (147)
NHCONMe2
OMe
Yield: 0.24 g (1.02 mmol, 51 %).
Colourless oil.
'H NMR (400 MHz, CDCI3): 8 = 7.19-7.14 (m, 2 H, H-4 and NH), 6.86 (d, 7 = 8  Hz, 
1 H, H-3), 6.68 (d, J =  8 Hz, 1 H, H-5), 4.30 (br, 2 H, CH2NH), 3.74 (s, 3 H, OCH3),
3.07 (q, J  = 7 Hz, 2 H, C //:CH3), 2.72 [s, 6 H, N(CH3)2], 1.06 (t, J = 1 Hz, 3 H, CH3). 
' ’C NMR (100 MHz, CDCI3): 8 = 164.5 (s, C =0), 156.3 (s, C-6), 126.9 (d, C-4),
126.8 (s, C-2), 125.4 (s, C -l), 119.4 (d, C-3), 109.0 (d, C-5), 54.2 (q, OCH3), 45.4 (t, 
CH2NH), 41.5 (t, CH2CH3), 37.7 [q, N(CH3)2], 11.8 (q, CH2CH3).
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EI-MS: m/z (%) = 236 (M+, 13), 207 (M+ -  Et, 7), 164 (M+ -  Me2NCO, 52), 134 (M+ 
-  Me2NCONH -  Me, 51), 121 (M+ -  Me2NCO -  Et, 87), 115 (17), 91 (PhCH2+, 51), 
72 (Me2NCO+, 100), 44 (30).
HRMS: m/z calc, for C n H2|N20 2 (MH+), 237.1598; found, 237.1598.
FT-IR: Vmax = 3340 (NH), 2937 (CH), 1632 (C =0), 1490 (aromatic C=C), 1397, 
1239, 1028 cm '1.
/V'-^-Ethyl^-methoxybenzyty-AyV-dimethylurea (148)
NHCONMe2
OMe
Yield: 0.18 g (0.76 mmol, 38%).
Colourless oil.
'H NM R (400 MHz, CDCh): 6 = 7.11 (app. t, J = 8 H z ,  1 H, H-5), 6.75 (d, J  = 8 Hz,
1 H, H-6), 6.67 (d, J  = 8 Hz, 1 H, H-4), 4.84 (br, exch., 1 H, NH), 3.89 (d, J =  6 Hz,
2 H, CH2NH), 3.78 (s, 3 H, OCH3), 2.77 [s, 6 H, N(CH3)2], 2.73 (q, J  = 7 Hz, 2 H, 
C //2CH3), 1.12 (t, .1=1  Hz. 3 H, C'H2C7/j).
I3C NMR (100 MHz, CDC13): 5 = 158.8 (s, C =0), 158.7 (s, C-2), 130.7 (s, C -l),
130.7 (d, C-4), 127.7 (s, C-3), 124.7 (d, C-6), 121.9 (d, C-5), 55.9 (q, OCH3), 36.9 (t, 
CH2NH), 36.6 [q, N(CH3)2], 26.6 (t, CH2CH3), 16.5 (q, CH2CH3).
EI-MS: m/z (%) = 236 (M +, 12), 207 (M+ -  Et, 9), 164 (M+ -  Me2NCO, 32), 149 (M' 
-  Me2NCO -  Me, 51), 148 (M + -  Me2NCONH2, 95), 135 (15), 117 (34), 101 (24), 91 
(PhCH2+, 56), 77 (25), 72 (Me2NCO+, 100), 44 (67).
Cl-M S: m/z (%) = 237 (MH+, 100), 164 (M+ -  Me2NCO, 5), 148 (M+ -  
Me2NCONH2, 11), 89 (13), 72 (Me2NCO+, 10), 46 (19), 44 (12).
HRMS: m/z calc, for C |3H2,N20 2 (MH+), 237.1598; found, 237.1599.
F T - I R :  v max = 3 3 2 9  (N H ) , 2 9 6 5  (C H ) , 1 6 3 6  ( C = 0 ) ,  152 0  (aromatic C = C ), 1 4 7 0 , 
1 2 7 0 , 1095 cm '1.
7.25 Synthesis of yV-(2-substituted methylbenzyl)-AyV-dimethyIureas 153-158 
via directed lithiation of 7V-(2-inethylbenzyl)-AyV-dimethyIurea (114)
The procedure was identical with that described in Section 7.20 except that 
Af-(2-methylbenzyl)-N,iV-dirnethylurea (114) was used instead of compound 107, 108
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or 113. The reaction mixture was worked-up and purified by column chromatography 
(silica gel; Et20-hexane, 1:3) to give pure products as white solids. The yields 
obtained are recorded in Table 3.6.
A^-(2-(2-(Hydroxy-2-(4-methoxyphenyl)ethyl)benzyl)-7V^V-dimethylurea (153)
NHCONMe
HO
OMe
Yield: 0.52 g (1.58 mmol, 79%).
Mp: 108-109 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.31 (d, /  = 9 Hz, 2 H, H-2/H-6 o f 
4-methoxyphenyl), 7.29-7.22 (m, 5 H, H-3, H-4, H-5, H-6 and NH), 6.89 (d, J  = 
9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 5.32 (s, exch., 1 H, OH), 4.88 (dd, J  = 4, 
9 Hz, 1 H, CH), 4.44 (d , J =  14 Hz, 1 H, 1 H o f C //2NH), 4.35 (d, J =  14 Hz, 1 H, 1 H 
of C //2NH), 3.81 (s, 3 H, OCH3), 3.12 (dd, J =  9, 14 Hz, 1 H, 1 H of CH2), 2.94 (dd, 
J  = 4, 14 Hz, 1 H, 1 H o f CH2), 2.85 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 8 = 159.4 (s, C =0), 158.9 (s, C-4 o f 4-methoxyphenyl),
138.4 (s, C -l), 137.8 (s, C-2), 137.0 (s, C -l o f 4-methoxyphenyl), 130.7 (d, C-3),
130.4 (d, C-6), 128.1 (d, C-4), 127.4 (d, C-2/C-6 o f 4-methoxyphenyl), 127.3 (d, C-5),
114.2 (d, C-3/C-5 o f 4-methoxyphenyl), 75.7 (d, CH), 55.7 (q, OCH3), 43.3 (t, CH2),
42.5 (t, CH2), 36.6 [q, N(CH3)2],
EI-MS: m/z (%) = 328 (M+, 2), 311 (M+ -  OH, 100), 310 (M+ -  H20 , 51), 308 (20), 
265 (63).
Cl-M S: m/z (%) = 328 (M+, 3), 327 (M+ -  1, 3), 312 (MH+ -  OH, 17), 311 (MH+ -  
H20 , 100), 240 (MH+ -  H20  -  CONMe2, 11), 193 (28), 179 (14), 154 (28), 137 (22), 
135 (17), 106 (58), 89 (81), 63 (20).
ES+-M S: miz (%) = 351 (M + Na+, 58), 329 (MH3, 2), 312 (MH+ -  OH, 22), 311 
(MH+- H 20 , 100).
E S -M S : m/z (%) = 328 (M‘, 14), 327 (M“ -  1, 100).
HRMS: m/z calc, for C |,H 25N20 3 (MH+), 329.1860; found, 329.1864.
FT-IR: vmax = 3314 (NH and OH), 2933 (CH), 1632 (C=0), 1530 (aromatic C=C), 
1510, 1243, 1024 c m 1.
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yV-(2-(2-Hydroxy-2-phenylethyl)benzyl)-AyV-dimethylurea (154)
fi H»A O  
5 1 1 1
nH
NHCONMe2
xH
3 r H
HO Ph
Yield: 0.46 g (1.54 mmol, 77%).
Mp: 116-117 °C.
'H NMR (400 MHz, CDC13): 8 = 7.27-7.12 (m, 10 H, Ph, H-3, H-4, H-5, H-6 and 
NH), 5.44 (br s, exch., 1 H, OH), 4.82 (dd, 7  = 4, 9 Hz, 1 H, CH), 4.33 (d, 7  = 14 Hz, 
1 H, 1 H o f C //2NH), 4.25 (d, 7  = 14 Hz, 1 H, 1 H o f C //2NH), 3.02 (dd, 7 =  9, 14 Hz, 
1 H, 1 H of CH2), 2.88 (dd, 7 =  4, 14 Hz, 1 H, 1 H o f CH2), 2.75 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDC13) :5  = 158.9 (s, C =0), 144.8 (s, C -l), 138.5 (s, C-l ofPh),
137.7 (s, C-2), 130.7 (d, C-3), 130.4 (d, C-6), 128.9 (d, C-3/C-5 o f Ph), 128.1 (d, 
C-4), 128.0 (d, C-5), 127.3 (d, C-4 o f Ph), 126.2 (d, C-2/C-6 of Ph), 76.1 (d, CH),
43.3 (t, CH,), 42.5 (t, CH2), 36.6 [q, N(CH3)2],
EI-MS: m/z (%) = 299 (M + + 1, 6), 298 (M+, 1), 281 (M ' -  OH or MH+ -  H20 ,  51), 
280 (M+ -  H20 ,  14), 209 (33), 208 (100).
Cl-MS: m/z (%) = 316 (M + NH4+, 3), 299 (MH+, 100), 282 (MH+ -  OH, 26), 281 
(MH+- H 20 ,  100), 193(44), 179(12), 106(41), 89 (64), 52 (68), 46 (78).
HRMS: m/z calc, for C l8H23N20 2 (M H 1), 299.1754; found, 299.1755.
FT-IR: vmax = 3230 (NH and OH), 2938 (CH), 16310 (C=0), 1586 (aromatic C=C), 
1530, 1212, 1018 c m 1.
Anal. calc, for Ci8H22N 20 2: C, 72.46; H, 7.43; N, 9.39. Found: C, 72.50; H, 7.47; N, 
9.40%.
V-(2-(2-Hydroxy-2-pheiiylpropYl)benzyl)-.V..Y-diincthyIurea (155)
NHCONMe
HO Ph
Me
Yield: 0.45 g (1.47 mmol, 74%).
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Mp: 82-83 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.33 (d, J  = 8 Hz, 2 H, H-2/H-6 o f Ph), 7.26-7.22 
(m, 3 H, H-3, H-4 and H-5 o f Ph), 7.17 (d, J =  8 Hz, 1 H, H-3), 7.14 (br, exch., 1 H, 
NH), 7.08 (app. t, J =  8 Hz, 1 H, H-5), 6.99 (app. t, J =  8 Hz, 1 H, H-4), 6.74 (d, J  = 
8 Hz, 1 H, H-6), 5.35 (s, exch., 1 H, OH), 4.31 (d, J =  14 Hz, 1 H, 1 H o f C ftN H ),
4.23 (d, J  = 14 Hz, 1 H, 1 H o f C //2NH), 3.09 (d, J =  14 Hz, 1 H, 1 H o f CH2), 3.04 
(d, J  = 14 Hz, 1 H, 1 H o f CH2), 2.78 [s, 6 H, N(CH3)2], 1.6 (s, 3 H, CH3). 
n C NMR (100 MHz, CDCI3): 6 = 158.9 (s, 0 = 0 ) , 148.5 (s, C-l ofPh), 139.6 (s, C -l),
135.8 (s, C-2), 132.3 (d, C-3), 130.2 (d, C-6), 128.5 (d, C-3/C-5 o f Ph), 127.4 (d, C-4 
o f Ph), 127.1 (d, C-5), 126.5 (d, C-4), 125.4 (d, C-2/C-6 o f Ph), 75.4 (s, C-OH), 46.6 
(t, CH2), 43.2 (t, CH2), 36.7 [q, N(CH,)2], 30.3 (q, CHj).
EI-MS: m/z (%) = 312 (M +, 1), 295 (M + -  OH, 12), 294 (M+ -  H20 ,  10), 222 (M* -  
H20  -  CONMe2, 25), 207 (M + -  H20  -  NHCONMe2, 32), 206 (MH+ -  H20  -  
NCONMe2, 100).
Cl-M S: m/z (%) = 313 (MH*, 33), 297 (24), 296 (MH* -  OH, 20), 295 (MH+ -  H20 , 
100), 235 (M+ -  Ph, 13), 193 (78), 179 (9), 138 (39), 106 (PhCHO+, 42), 89 (78), 52 
(58), 46 (67), 44 (24).
HRMS: m/z calc, for C i9H25N 20 2 (MH*), 313.1911; found, 313.1912.
FT-IR: vmax = 3329 (NH and OH), 2928 (CH), 1611 (C=0), 1531 (aromatic C=C), 
1246, 1026 cm*1.
N-(2-(2-Hydroxy-2,2-diphenylethyl)benzyl)-AyV-dimethylurea (156)
NHCONMe-
HO Ph
Ph
Yield: 0.57 g (1.52 mmol, 76%).
Mp: 119-120 °C.
'H NMR (400 MHz, D M SO -d6): 5 = 7.41 (d, J =  8 Hz, 4 H, H-2/H-6 of 2 Ph), 7.27 
(app. t, J  = 8 Hz, 4 H, H-3/H-5 o f 2 Ph), 7.19-6.86 (m, 6 H, H-3, H-4, H-5, H-6 and 
H-4 o f 2 Ph), 6.66 (t, 7 = 6  Hz, exch., 1 H, NH), 5.83 (s, exch., 1 H, OH), 3.99 (d, J  = 
6 Hz, 2 H, CH2NH), 3.68 (s, 2 H, CH2), 2.79 [s, 6 H, N(CH3)2].
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13C NMR (100 MHz, DMSO-<4): 8 = 158.5 (s, C =0), 148.5 (s, C -l of 2 Ph), 140.9 (s, 
C -l), 135.4 (s, C-2), 131.8 (d, C-3), 128.0 (d, C-6), 127.9 (d, C-3/C-5 o f 2 Ph), 126.8 
(d, C-2/C-6 o f 2 Ph), 126.6 (d, C-4 o f 2 Ph), 126.0 (d, C-4), 125.4 (d, C-5), 77.8 (s, 
C-OH), 42.9 (t, CH2), 41.3 (t, CH2), 36.3 [q, N(CH3)2],
EI-MS: m/z (%) = 374 (M+, 2), 357 (M+ -  OH, 11), 268 (MH+ -  OH -  CONMe2, 
100), 252 (16), 239 (12), 206 (25).
Cl-M S: m/z (%) = 375 (MH*, 12), 374 (M*, 6), 373 (M* -  1, 5), 359 (33), 357 (MH* 
-  H20 ,  89), 286 (MH* -  OH -  CONMe2, 10), 257 (MH* -  H20  -  CHNHCONMe2, 
12), 200 (81), 193 (100), 183 (Ph2COH+, 71), 179 (17), 118 (24), 106 (55), 89 (87), 63
(15).
ES*-MS: m/z (%) = 397 (M + Na*, 100), 375 (MH*, 4), 358 (MH* -  OH, 13), 357 
(MH* -  H20 , 69), 270 (MH* -  H20  -  NHCONMe2, 14), 269 (M* -  H20  -  
NHCONMe-., 52), 191(34), 89 (78).
E S -M S : m/z (%) = 374 (NT, 2), 373 (NT -  1, 8), 191 (100), 146 (9), 118 (21), 87
(25).
HRMS: m/z calc, for C24H3oN30 2 (M + NH4*), 392.2333; found, 392.2330.
FT-IR: vmax = 3331 (NH and OH), 2927 (CH), 1621 (C=0), 1531 (aromatic C=C), 
1246, 1026 c m 1.
yV-(2-Propylbenzyl)-AyV-dimethylurea (157)
Yield: 0.36 g (1.64 mmol, 82%).
Mp: 59-61 °C.
'H NMR (400 MHz, CDC13): 8 = 7.20-7.05 (m, 4 H, H-3, H-4, H-5 and H-6), 4.58 
(br, exch., 1 H, NH), 4.33 (br, 2 H, Cff-NFI), 2.80 [s, 6 H, N(CH3)2], 2.54 ( t ,7 =  7 Hz, 
2 H, C //2CH2CH3), 1.53 (app. sextet, 7 = 7  Hz, 2 H, C//.CTI3), 0.89 (t, 7  = 7 Hz, 3 H, 
CH3).
I3C NMR (100 MHz, CDC13): 8 = 158.6 (s, C =0), 141.3 (s, C -l), 137.1 (s, C-2),
129.9 (d, C-3), 129.1 (d, C-6), 127.8 (d, C-4), 126.5 (d, C-5), 42.9 (t, CH2NH), 36.6 
[q, N(CH3)2], 34.9 (t, CH2CH2CH3), 24.8 (t, CH2CH3), 14.5 (q, CH3).
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EI-MS: m/z (%) = 220 (M+, 31), 177 (M+ -  Pr, 13), 148 (M* -  CONMe2, 10), 132 
(M* -  H2NCONMe2, 47), 117 (M* -  Me -  H2NCONMe2, 82), 105 (M+ -  CONMe2 -  
Pr, 53), 91 (MeC6H4+, 22), 89 (34), 77 (24), 72 (Me2NCO+, 100), 65 (15), 46 (23), 44 
(69), 42 (33).
Cl-M S: m/z (%) = 441 (2 M* + 1, 12), 238 (M + NH4+, 13), 221 (MH+, 100).
HRMS: m/z calc, for C l3H2,N20  (MH+), 221.1648; found, 221.1648.
FT-IR: vmax = 3325 (NH), 2957 (CH), 1631 (C=0), 1529 (aromatic C=C), 1375, 1227 
cm .
/V-(2-Deuteriomethylbenzyl)-AyV-dimethylurea (158)
NHCONMe
Yield: 0.32 g (1.66 mmol, 83%).
Mp: 73-75 °C (Mp o f undeuteriated analogue 73-75 °C; 114, Section 7.18).
‘H NMR (400 MHz, CDCh): 6 = 7.26-7.12 (m, 4 H, H-3, H-4, H-5 and H-6), 4.61 
(br, exch., 1 H, NH), 4.42 (br, 2 H, C //2NH), 2.91 [s, 6 H, N(CH3)2], 2.31 [(1:1:1) t, 
J  =2  Hz, 2 H, CH2D],
l3C NMR (100 MHz, CDCh): 5 = 158.7 (s, C =0), 137.5 (s, C -l), 136.8 (s, C-2),
130.8 (d, C-6), 128.7 (d, C-3), 127.8 (d, C-5), 126.5 (d, C-4), 43.6 (t, CH2NH), 36.6 
[q, N(CH3)2], 19.4 (seen as three lines, 1:1:1, because o f coupling to D, CH2D). 
EI-MS: m/z (%) = 194 (M+ + 1, 15), 193 (M+, 43), 149 (M* -  NMe2, 11), 121 (M+ -  
CONMe2, 37), 106 (M+ -  NHCONMe2, 71), 105 (M* -  H2NCONMe2, 66), 92 
(MeC6H5+, 21), 78 (24), 77 (Ph*, 21), 72 (Me2NCO+, 100), 46 (32), 44 (79), 42 (27). 
Cl-M S: m/z (%) = 211 (M + NH4+, 17), 195 (23), 194 (MH*, 100), 52 (20).
HRMS: m/z calc, for C n H ,6DN20  (MH*), 194.1398; found, 194.1398.
FT-IR: vmax = 3315 (NH), 2926 (CH), 1622 (C=0), 1537 (aromatic C=C), 1512, 
1376,12.35,1027 cm '1.
7.26 Synthesis of l,l-diphenyI-2-pivaIoylisoindoIine (162) via cyclization of 
7V-(2-(hydroxydiphenyImethyl)benzyl)pivalamide (57)
Trifluoroacetic anhydride (0.5 mL) was added to a stirred solution of 
yV-(2-(hydroxydiphenylmethyl)benzyl)pivalamide (57; 0.50 g, 1.34 mmol) in DCM
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(10 mL) at room temperature. The mixture was stirred for 5 min at room temperature, 
after which TLC showed the formation o f a single product. The reaction mixture was 
quenched with H20  (10 mL). The organic layer was separated, washed with aq. sat. 
NaHCC>3 (10 mL), FLO (2 x 10 mL), dried (MgSCL), and evaporated under reduced 
pressure. The residue obtained was subjected to flash column chromatography (silica 
gel; Et2 0 -hexane, 1:3) to give pure 162 (0.40 g, 1.14 mmol, 85%) as a white solid.
Mp: 149-150 °C.
'H NMR (400 MHz, CDC13): 8  = 7.41-7.23 (m, 13 H, 2 Ph, H-4, H-5 and H-6 ), 7.04 
(d, J= 8  Hz, 1 H, H-7), 5.30 (s, 2 H, H-3), 1.35 [s, 9 H, C(CH3)3], 
l3C NMR (100 MHz, CDC13): 5 = 174.8 (s, C =0), 146.5 (s, C-7a), 143.1 (s, C-l o f  2 
Ph), 135.7 (s, C-3a), 128.8 (d, C-2/C-6 o f  2 Ph), 128.5 (d, C-4), 128.0 (d, 127.9
(d, C-3/C-5 o f 2 Ph), 127.0 (d, C-4 o f  2 Ph), 125.1 (d, C-6 ), 122.2 (d, C-5), 80.9 (s, 
C -l), 53.9 (t, C-3), 40.1 [s, C(CH3)3], 28.0 [q, C(CH3)3],
EI-MS: m/z(%) = 355 (M+, 22), 298 (M+ -  'Bu, 55), 278 (M+ -  Ph, 20), 255 (M+ -  
'BuCONH, 42), 239 (21), 220 (19), 206 (12), 194 (40), 178 (28), 165 (32), 116 (11), 
105 (PhCHjK", 23), 91 (PhCH2+, 9), 77 (Ph+, 20), 57 ('Bu+, 1 0 0 ), 41 (27).
Cl-MS: m/z (%) = 356 (MH*, 100).
HRMS: m/z calc, for C2 5H26NO (MH+), 356.2009; found, 356.2010.
FT-IR: v max = 2957 (CH), 1618 (C =0), 1510 (aromatic C=C), 1371, 1348, 1242, 
1173, 1030 cm'1.
Anal. calc, for C2 5 H2 5NO: C, 84.47; H, 7.09; N, 3.94. Found: C, 84.35; H, 7.03; N, 
3.83%.
Selected crystallographic data: C2sH2 5NO, FW = 355.46, T = 150(2) K, =  0.71073
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A, Orthorhombic, Pna2h a = 19.5940(2) A, b = 10.8450(2) A, c = 9.2270(5) A, a  = 
90°, p = 90°, y = 90°, V = 1960.71(11) A3, Z = 4, pcaic. = 1.204 Mg/m3, crystal size = 
0.40 x 0.34 x 0.30 mmJ, m = 0.072 ram '1, reflections collected = 4301, independent 
reflections = 3656, R;nt = 0.0300, parameters = 247, final Ri = 0.0481, WR2 = 0.1016 
for I>2g(I) and Ri = 0.0616, WR2 = 0.1085 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 737413, and 
can be obtained free of charge via http://www.ccdc.ac.uk/data_request/cif.
7.27 Synthesis of substituted isoindolines 163-173
The procedure was identical to that described in Section 7.26 except that 
compounds of the general formula 160 (0.50 g) were used as starting materials instead 
of 57. The reaction mixtures were worked-up as described in Section 7.26 and the 
residues obtained subjected to flash column chromatography (silica gel; Et20-hexane, 
1:3) to give the pure products 163-173 as white solids.
1 -(4-Methoxyphenyl)-2-pivaloylisoindoline (163)
Bu
7a
OMe
Yield: 0.42 g (1.36 mmol, 89%).
Mp: 112-114 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.32 (app. t, J  = 8 Hz, 1 H, H-6), 7.29 (d, J =  8 Hz, 
1 H, H-4), 7.25 (app. t, J  = 8 Hz, 1 H, H-5), 7.19 (d, J  = 9 Hz, 2 H, H-2/H-6 of 
4-methoxyphenyl), 7.09 (d, J  = 8 Hz, 1 H, H-7), 6.83 (d, J  = 9 Hz, 2 H, H-3/H-5 of 
4-methoxyphenyl), 6.32 (s, 1 H, H -l), 5.26-5.16 (m, 2 H, H-3), 3.78 (s, 3 H, OCH3),
1.24 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDCI3): 8 = 176.8 (s, C=0), 159.0 (s, C-4 of 4-methoxyphenyl),
141.4 (s, C-7a), 136.3 (s, C-3a), 128.3 (d, C-4 and C -l), 128.1 (s, C-l of 
4-methoxyphenyl), 128.0 (d, C-2/C-6 of 4-methoxyphenyl), 123.9 (d, C-6), 122.7 (d, 
C-5), 114.3 (d, C-3/C-5 of 4-methoxyphenyl), 69.0 (d, C -l), 55.6 (q, OCH3), 54.0 (t, 
C-3), 39.7 [s, C(CH3)3], 28.0 [q, C(CH3)3].
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EI-MS: m/z (%) = 309 (M*, 12), 294 (M+ -  Me, 3), 278 (M* -  OMe, 7), 252 (M+ -  
'Bu, 15), 224 (M+ -  'BuCO, 12), 209 (M+ -  'BuCO -  Me, 23), 194 (8), 165 (9), 135 
(7), 116 (6), 57 ('Bu*, 100), 41 (73).
Cl-M S: m/z (%) = 310 (MH*, 100).
HRMS: m/z calc, for C20H24NO2 (MH*), 310.1802; found, 310.1802.
FT-IR: vmax = 2958 (CH), 1616 (C =0), 1510 (aromatic C=C), 1371, 1357, 1242, 
1117 c m 1.
Anal. calc, for C20H23NO2: C, 77.64; H, 7.49; N, 4.53. Found: C, 77.65; H, 7.54; N, 
4.52%.
1 -Phenyl-2-pivaloylisoindoline (164)
7 a
P h
Yield: 0.41 g (1.47 mmol, 87%).
Mp: 110-111 °C.
'H NMR (400 MHz, CDCI3): 6 = 7.23-7.11 (m, 8 H, Ph, H-4, H-5 and H-6), 7.00 (d, 
7 = 8  Hz, 1 H, H-7), 6.24 (s, 1 H, H -l), 5.17-5.07 (m, 2 H, H-3), 1.24 [s, 9 H, 
C(CH3)3].
n C NMR (100 MHz, CDCI3): 8 = 175.2 (s, C =0), 143.9 (s, C-l o f Ph), 141.0 (s, 
C-7a), 136.2 (s, C-3a), 129.0 (d, C-3/C-5 o f Ph), 128.4 (d, C-4), 128.1 (d, C-2/C-6 of 
Ph), 127.6 (d, C-4 o f Ph), 126.7 (d, C -l), 123.9 (d, C-6), 122.7 (d, C-5), 69.7 (d, C -l),
54.2 (t, C-3), 39.8 [s, C(CH3)3], 28.0 [q, C(CH3)3].
EI-MS: m/z (%) = 279 (M*, 11), 222 (M* -  'Bu, 10), 194 (M* -  'BuCO, 11), 179 (M* 
-  'BuCONH, 32), 178 (M* -  'BuCONH2, 29), 165 (M* -  'BuCONHCH2, 16), 116
(12), 105 (PhCH2N*, 6), 91 (PhCH2+, 9), 89 (15), 77 (Ph*, 18), 57 ('Bu*, 100), 41 (95). 
Cl-M S: m/z (%) = 297 (M + NH4*, 2), 280 (MH*, 100).
HRMS: m/z calc, for Q 9H22NO (MH*), 280.1696; found, 280.1694.
FT-IR: vmax = 2962 (CH), 1616 (C =0), 1510 (aromatic C=C), 1410, 1369, 1357, 
1209, 1093 cm '1.
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6-M ethoxy-l-(4-methoxyphenyl)-2-pivaloylisoindoline (165)
MeO 7a
OMe
Yield: 0.43 g (1.26 mmol, 90%).
Mp: 133-134 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.21 (d, J  8 Hz, 1 H, H-4), 7.18 (d, 9 Hz, 2 H, 
H-2/H-6 of 4-methoxyphenyl), 6.85 (dd, J  2, 8 Hz, 1 H, H-5), 6.83 (d, 9 Hz, 2 
H, H-3/H-5 of 4-methoxyphenyl), 6.58 (d, 2 Hz, 1 H, H-7), 6.25 (s, 1 H, H -l),
5.20-5.09 (m, 2 H, H-3), 3.78 (s, 3 H, OCH3), 3.74 (s, 3 H, OCH3), 1.32 [s, 9 H, 
C(CH3)j].
I3C NMR (100 MHz, CDCI3): 6 = 176.7 (s, C=0), 160.2 (s, C-6), 159.0 (s, C-4 of 
4-methoxyphenyl), 142.8 (s, C-7a), 136.2 (s, C -l of 4-methoxyphenyl and C-3a),
128.2 (d, C-4), 123.5 (d, C -l), 114.9 (d, C-5), 114.3 (d, C-2/C-6 of 4-methoxyphenyl),
108.5 (d, C-3/C-5 o f 4-methoxyphenyl), 69.1 (d, C -l), 55.9 (q, OCH3), 55.6 (q, 
OCH3), 53.5 (t, C-3), 39.7 [s, C(CH3)3], 28.0 [q, C(CH3)3].
EI-MS: m/z(%) = 339 (M+, 8), 282 (M+ -  'Bu, 41), 254 (M+ -  'BuCO, 12), 239 (M+ -
'BuCONH, 16), 238 (M+ -  'BuCONH2, 20), 224 (7), 208 (6), 195 (5), 165 (8), 152 (8), 
139 (7), 104 (8), 92 (5), 77 (14), 57 ('Bu+, 100), 41 (73).
Cl-MS: m/z(%) = 340 (MH+, 100).
HRMS: m/z calc, for C2iH26N 0 3 (MH+), 340.1907; found, 340.1913.
FT-IR: vmax = 2959 (CH), 1615 (C =0), 1511 (aromatic C=C), 1477, 1400, 1358, 
1243, 1171, 1023 c m 1.
Anal. calc, for C2iH25N0 3: C, 74.31; H, 7.42; N, 4.13. Found: C, 74.42; H, 7.46; N, 
4.08%.
Selected crystallographic data: C2iH2sN 03, FW = 339.42, T = 150(2) K, 0.71073
172
Chapter Seven: Experimental
A, Orthorhombic, P2 i2 j2 i, a = 5.85700(10) A, b = 16.4960(4) A, c = 18.6450(6) A, a  
= 90°, p = 90°, y = 90°, V = 1801.43(8) A3, Z = 4, pcaic. = 1.251 Mg/m3, crystal size = 
0.25 x 0.25 x 0.20 mm3, m = 0.083 mm’1, reflections collected = 4120, independent 
reflections = 3365, Rint = 0.0606, parameters = 231, final R\ = 0.0504, WR2 = 0.1003 
for I>2ct(I) and Ri = 0.0699, WR2 = 0.1090 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 737410, and 
can be obtained free o f charge via http://www.ccdc.ac.uk/data_request/cif.
6-M ethoxy-l,l-diphenyl-2-pivaloylisoindoline (166)
3a 3 Bu1
MeO 7a / 
Ph
Yield: 0.47 g (1.22 mmol, 98%).
Mp: 119-121 °C.
*H NMR (400 MHz, CDC13): 5 = 7.26-7.10 (m, 11 H, 2 Ph and H-4), 6.73 (dd, J =  2, 
8 Hz, 1 H, H-5), 6.37 (d, J  = 2 Hz, 1 H, H-7), 5.11 (s, 2 H, H-3), 3.56 (s, 3 H, OCH3), 
1.20 [s, 9 H, C(CH3)3].
,3C NMR (100 MHz, CDC13): 5 = 175.2 (s, C =0), 160.2 (s, C-6), 147.6 (s, C-7a),
142.7 (s, C -l o f 2 Ph), 128.7 (d, C-3/C-5 o f 2 Ph), 128.4 (s, C-3a), 127.9 (d, C-2/C-6 
of 2 Ph), 127.15 (d, C-4 o f 2 Ph), 123.0 (d, C-4), 114.8 (d, C-7), 110.0 (d, C-5), 81.2 
(s, C -l), 55.8 (q, OCH3), 53.5 (t, C-3), 40.2 [s, C(CH3)3], 27.88 [q, C(CH3)3].
EI-MS: m/z (%) = 386 (M+ + 1, 22), 385 (M+, 81), 328 (M+ -  'Bu, 100), 308 (42), 300 
(M+ -  'BuCO, 38), 292 (21), 220 (16).
Cl-M S: m/z (%) = 386 (MH+, 100), 328 (M+ -  'Bu, 3), 303 (19), 284 (5).
HRMS: m/z calc, for C26H28NO2 (M H+), 386.2115; found, 386.2113.
FT-IR: vmax = 2957 (CH), 1638 (C =0), 1599 (aromatic C=C), 1490, 1444, 1351, 
1210, 1172 c m 1.
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1 -(4-M ethoxyphenyl)-6-methyl-2-pivaloylisoindoline (167)
3a oo Bu
Me 7a
OMe
Yield: 0.42 g (1.29 mmol, 88%).
Mp: 148-149 °C.
'H NMR (400 MHz, CDClj): 8 = 7.22 (d, J  = 8 Hz, 1 H, H-4), 7.18 d, J = 9  Hz, 2 H, 
H-2/H-6 o f 4-methoxyphenyl), 7.10 (d, J  = 8 Hz, 1 H, H-5), 6.90 (s, 1 H, H-7), 6.84 
(d, J  = 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 6.26 (s, 1 H, H -l), 5.21-5.11 (m, 
2 H, H-3), 3.78 (s, 3 H, OCH3), 2.30 (s, 3 H, CH3), 1.33 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, C D C I 3 ): 5 = 176.7 (s, C = 0), 159.0 (s, C-4 o f 4-methoxyphenyl),
141.5 (s, C-7a), 138.1 (s, C -l o f 4-methoxyphenyl), 136.5 (s, C-6), 133.4 (s, C-3a),
128.9 (d, C-2/C-6 o f 4-methoxyphenyl), 128.1 (d, C-7), 124.3 (d, C-4), 122.4 (d, C-5),
114.3 (d, C-3/C-5 o f 4-methoxyphenyl), 70.0 (d, C -l), 55.6 (q, O C H 3 ) , 53.8 (t, C-3),
39.7 [s, C (C H 3)3], 28.0 [q, C ( C H 3) 3], 21.7 (q, C H 3).
EI-MS: m/z (%) = 323 (M +, 4), 266 (M + -  'Bu, 3), 238 (M+ -  'BuCO, 8), 223 (M+ -  
'BuCONH, 13), 208 (9), 194 (6), 165 (8), 130 (7), 77 (14), 57 ('Bu+, 100), 41 (77). 
Cl-M S: m/z (%) = 324 (M H+, 100), 266 (3), 216 (5).
HRMS: m/z calc, for C2|H 26N 02 (M H+), 324.1958; found, 324.1953.
FT-IR: v^x = 2958 (CH), 1637 (C = 0), 1535 (aromatic C=C), 1357, 1231 c m 1.
Anal. calc, for C2]H25N 0 2: C, 77.98; H, 7.79; N, 4.33. Found: C, 77.84; H, 7.83; N, 
4.41%.
l-(4-M ethoxyphenyl)-2-dimethylaminocarbonylisoindoline (168)
3a
OMe
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Yield: 0.42 g (1.42 mmol, 89%).
M p : 1 1 1 - 1 1 2  °C .
'H NMR (400 MHz, CDC13): 5 = 7.28-7.21 (m, 5 H, H-4, H-5, H-6 and H-2/H-6 of 
4-methoxyphenyl), 7.03 (d, J  = 8 Hz, 1 H, H-7), 6.83 (d, J  = 9 Hz, 2 H, H-3/H-5 of 
4-methoxyphenyl), 6.37 (d, J  = 3 Hz, 1 H, H -l), 5.10 (dd, J  = 3, 14 Hz, 1 H, 1 H of 
H-3), 4.66 (d, J  = 14 Hz, 1 H, 1 H o f H-3), 3.78 (s, 3 H, OMe), 2.90 [s, 6 H, N(CH3)2], 
l3C NMR (100 MHz, CDC13): 8 = 163.4 (s, C =0), 159.2 (s, C-4 o f 4-methoxyphenyl),
142.2 (s, C-7a), 136.6 (s, C-3a), 136.3 (s, C -l o f 4-methoxyphenyl), 128.8 (d, C-2/C-6 
of 4-methoxyphenyl), 128.0 (d, C-4), 127.8 (d, C-7), 123.9 (d, C-6), 122.4 (d, C-5),
114.3 (d, C-3/C-5 o f 4-methoxyphenyl), 67.8 (d, C -l), 55.6 (q, OMe), 55.5 (t, C-3),
38.7 [q, N(CH3)2].
EI-MS: m/z (%) = 296 (M+, 7), 252 (M+ -  Me2N, 11), 224 (M+ -  Me2NCO, 23), 208
(13), 194 (4), 180 (5), 165 (7), 135 (5), 116 (8), 87 (Me2NCONH+, 12), 72 
(Me2NCO+, 100), 44 (22).
Cl-M S: m/z (%) = 297 (M H+, 100), 91 (14).
HRMS: m/z calc, for C ,8H21N20 2 (MH+), 297.1598; found, 297.1598.
F T - I R :  v max =  2 9 5 9  (C H ) , 1 6 1 3  ( C = 0 ) ,  1 5 1 0  (aromatic C = C ) , 1 3 7 1 , 1 3 5 7 , 1243 , 
1028  cm '1.
Anal. calc, for C ,8H20N2O2: C, 72.95; H, 6.80; N, 9.45. Found: C, 72.80; H, 6.78; N, 
9.30%.
2-Dim ethylam inocarbonyl-l,l-diphenylisoindoline (169)
Ph
Yield: 0.43 g (1.26 mmol, 91%).
Mp: 161-163 °C.
'H NMR (400 MHz, CDCI3): 5 = 7.29-7.09 (m, 13 H, 2 Ph, H-4, H-5 and H-6), 6.90 
(d, J=  8 Hz, 1 H, H-7), 4.90 (s, 2 H, H-3), 2.61 [s, 6 H, N(CH3)2].
13C NMR (100 MHz, CDC13): 5 = 160.7 (s, C =0), 146.1 (s, C-7a), 142.3 (s, C-l of 
2 Ph), 134.7 (s, C-3a), 127.6 (d, C-2/C-6 o f 2 Ph), 126.7 (d, C-4), 126.5 (d, C-3/C-5 of 
2 Ph), 126.3 (d, C-7), 125.7 (d, C-4 o f 2 Ph), 123.4 (d, C-6), 120.9 (d, C-5), 80.0 (s, 
C -l), 52.5 (t, C-3), 38.0 [q, N(CH3)2].
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EI-MS: m/z(%) = 342 (M+, 10), 265 (M+ -  Ph, 22), 254 (M+ -  Me2NCONH2, 24), 
239 (9), 193 (M+ -  Ph -  Me2NCO, 7), 178 (M+ -  Ph -  Me2NCONH, 15), 165 (M+ -  
Ph -  Me2NCONCH2, 20), 72 (Me2NCO+, 100), 42 (10).
Cl-MS: m/z(%) = 343 (MH4, 100), 272 (10), 106 (12), 89 (16), 63 (17), 52 (89), 46 
(Me2NH2+, 47).
HRMS: m/z calc, for C23H23N20  (MH4), 343.1805; found, 343.1809.
FT-IR: vmax = 2957 (CH), 1617 (C =0), 1510 (aromatic C=C), 1371, 1358, 1242, 
1173, 1037 cm '1.
2-Dimethylaminocarbonyl-6-methoxy-l-(4-m ethoxyphenyl)isoindoline (170)
MeO
OMe
Yield: 0.43 g (1.32 mmol, 91%).
Mp: 98-100°C.
'H NMR (400 MHz, CDC13): 5 = 7.12 (d, Hz, 2 H, H-2/H-6 of
4-methoxyphenyl), 7.05 (d, J  = 8 Hz, 1 H, H-4), 6.74-6.71 (m, 3 H, H-5 and H-3/H-5 
of 4-methoxyphenyl), 6.42 (d, J  = 2 Hz, 1 H, H-7), 6.23 (d, J =  3 Hz, 1 H, H -l), 4.90 
(dd, 7 =  3, 13 Hz, 1 H, 1 H of H-3), 4.46 (d, = 13Hz, 1 H, 1 H of H-3), 3.67 (s, 3 H, 
OCHj), 3.61 (s, 3 H, OCH3), 2.77 [s, 6 H, N(CH3)2],
l3C NMR (100 MHz, CDC13): S = 163.4 (s, C =0), 160.0 (s, C-6), 159.3 (s, C-4 of 
4-methoxyphenyl), 143.6 (s, C-7a), 136.2 (s, C-l o f 4-methoxyphenyl), 129.7 (d, 
C-2/C-6 o f 4-methoxyphenyl), 129.1 (s, C-3a), 123.5 (d, C-4), 115.0 (d, C-7), 114.7 
(d, C-3/C-5 of 4-methoxyphenyl), 108.9 (d, C-5), 67.9 (d, C -l), 55.8 (q, OCH3), 55.7 
(q, OCH3), 55.0 (t, C-3), 38.7 [q, N(CH3)2].
EI-MS: m/z(%) = 326 (M+, 3), 282 (M4 -  Me2N, 5), 254 (M4 -  Me2NCO, 10), 238 
(M4 -  Me2NCONH2, 16), 218 (5), 146 (4), 72 (Me2NCO+, 100), 44 (10).
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CI-M S: m/z (%) = 327 (MH+, 100), 105 (5), 91 (6), 52 (8), 46 (Me2NH2\  13).
HRMS: m/z calc, for C 19H23N2O3 (MH+), 327.1703; found, 327.1702.
FT-IR: vmax = 2931 (CH), 1616 (C =0), 1511 (aromatic C=C), 1400, 1370, 1251, 
1023 cm '1.
Anal. calc, for C 19H22N2O3: C, 69.92; H, 6.79; N, 8.58. Found: C, 69.97; H, 6.73; N, 
5.42%.
Selected crystallography data: C i 9 H 2 2 N 2 0 3 , FW = 326.39, T = 150(2) K, X  = 0.71073 
A, Monoclinic, P2 ,/c, a = 13.9310(5) A, b = 6.0890(2) A, c = 20.0590(8) A, a  = 90°, 
P = 91.349(2)°, y = 90°, V = 1701.05(11) A3, Z = 4, pcalc. = 1.274 Mg/m3, crystal size 
= 0.40 x 0.20 x 0.10 mm3, m = 0.087 m m 1, reflections collected = 6476, independent 
reflections = 3877, Rint = 0.0534, parameters = 222, final R\ = 0.0571, wR.2 = 0.1237 
for I>2a(I) and Ri = 0.1098, WR2 = 0.1460 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 737418, and 
can be obtained free o f charge via http://www.ccdc.ac.uk/data_request/cif.
2-Dimethylammocarbonyl-l,l-diphenyl-6-methoxyisoindoline (171)
MeO'
Ph
Yield: 0.42 g (1.13 mmol, 88%).
Mp: 157-158 °C.
'H NMR (400 MHz, CDC13): 5 = 7.29-7.11 (m, 10 H, 2 Ph), 7.08 (d, J =  8 Hz, 1 H, 
H-4), 6.70 (dd, J =  2, 8 Hz, 1 H, H-5), 6.42 (d, J  = 2 Hz, 1 H, H-7), 4.85 (s, 2 H, H-3), 
3.58 (s, OCH3), 2.61 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCI3): 8 = 162.0 (s, C =0), 159.9 (s, C-6), 148.9 (s, C-7a), 
143.6 (s, C-l o f 2 Ph), 129.3 (d, C-3/C-5 o f 2 Ph), 128.2 (s, C-3a), 128.0 (d, C-2/C-6 
of 2 Ph), 127.2 (d, C-4 o f 2 Ph), 123.1 (d, C-4), 114.3 (d, C-5), 109.9 (d, C -l), 79.5 (s, 
C -l), 55.8 (q, OCH3), 53.6 (t, C-3), 39.5 [q, N(CH3)2].
EI-MS: m/z (%) = 372 (M +, 20), 295 (M+ -  Ph, 6), 284 (M+ -  Me2NCONH2, 41), 165 
(7), 91 (8), 88 (19), 72 (Me2NCO+, 100), 42 (22).
Cl-M S: m/z (%) = 373 (MH+, 100).
HRMS: m/z calc, for C24H25N202 (MH+), 373.1911; found, 373.1911.
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FT-IR: vmax = 2997 (CH), 1617 (C =0), 1510 (aromatic C=C), 1371, 1242, 1172, 
1029 cm '1.
Anal. calc, for C24H24N 2O2: C, 77.39; H, 6.49; N, 7.52. Found: C, 77.37; H, 6.51; N, 
7.47%.
2-Dimethylaminocarbonyl-l-(4-methoxyphenyl)-6-methylisoindoline (172)
o NMe
Me' 7a
OMe
Yield: 0.43 g (1.39 mmol, 91%).
Mp: 125-126 °C.
‘H NMR (400 MHz, CDC13): 5 = 7.13 (d, J  = 9 Hz, 2 H, H-2/H-6 of 
4-methoxyphenyl), 7.05 (d, J  = 8 Hz, 1 H, H-4), 6.97 (d, J  = 8 Hz, 1 H, H-5), 6 .75- 
6.73 (m, 3 H, H-7 and H-3/H-5 o f 4-methoxyphenyl), 6.22 (d, J  = 2 Hz, 1 H, H -l), 
4.94 (dd, J =  2, 14 Hz, 1 H, 1 H o f H-3), 4.50 (d, J =  14 Hz, 1 H, 1 H o f H-3), 3.68 (s, 
3 H, OCH3), 2.78 [s, 6 H, N(CH3)2], 2.18 (s, 3 H, CH3).
I3C NMR (100 MHz, CDC13): 6 = 163.4 (s, C =0), 159.2 (s, C-4 o f 4-methoxyphenyl),
142.3 (s, C-7a), 137.7 (s, C-6), 136.4 (s, C -l o f 4-methoxyphenyl), 133.6 (s, C-3a),
128.5 (d, C-2/C-6 o f 4-methoxyphenyl), 128.2 (d, C -l), 124.3 (d, C-4), 122.2 (d, C-5),
114.3 (d, C-3/C-5 o f 4-methoxyphenyl), 67.8 (d, C -l), 55.6 (q, OCH3), 55.3 (t, C-3),
38.7 [q,N (C H 3)2], 15.7 (q, CH3).
EI-MS: m/z (%) = 310 (M +, 5), 266 (M + -  M e2N, 14), 238 (M+ -  Me2NCO, 22), 222 
(M+ -  Me2NCONH2, 19), 165 (13), 130(12), 72 (Me2NCO+, 100), 44 (15), 42 (23). 
CI-MS: m/z (%) = 311 (MH+, 100), 52 (22).
HRMS: m/z calc, for C ,9H23N 20 2 (M H+), 311.1754; found, 311.1749.
FT-IR: v,nax = 2958 (CH), 1616 (C =0), 1511 (aromatic C=C), 1371, 1358, 1243, 
1029 c m 1.
Anal. calc, for C ,9H22N20 2: C, 73.52; H, 7.14; N, 9.03. Found: C, 73.50; H, 7.15; N, 
9.01%.
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2-Dim ethylaminocarbonyl-l,l-diphenyl-6-m ethylisoindoline (173)
3a NMe-
Me'
Ph
Yield: 0.42 g (1.18 mmol, 88%).
Mp: 158-160 °C.
'H NMR (400 MHz, CDC13): 5 = 7.27-7.13 (m, 10 H, 2 Ph), 7.07 (d, J  = 8 Hz, 1 H, 
H-4), 6.95 (d, J  = 8 Hz, 1 H, H-5), 6.72 (s, 1 H, H-7), 3.25 (s, 2 H, H-3), 2.61 [s, 6 H, 
N(CH3)2] ,2 .1 5 ( s ,3 H , CHj).
I3C NMR (100 MHz, CDCI3): 5 = 161.9 (s, C =0), 147.6 (s, C-7a), 143.8 (s, C-l of 
2 Ph), 137.9 (s, C-6), 133.1 (s, C-3a), 129.0 (d, C-3/C-5 o f 2 Ph), 128.8 (d, C-7),
127.9 (d, C-2/C-6 o f 2 Ph), 127.1 (d, C-4 o f 2 Ph), 125.2 (d, C-4), 122.1 (d, C-5), 79.4 
(s, C -l), 53.8 (t, C-3), 39.5 [q, N(CH3)2], 21.9 (q, CH3).
EI-MS: m/z (%) = 356 (M +, 7), 279 (M+ -  Ph, 13), 268 (M+ -  Me2NCONH2, 31), 253 
(M+ -  Me2NCONHCH2, 7), 165 (13), 72 (Me2NCO+, 100), 42 (15).
CI-MS: m/z (%) = 357 (MH+, 100), 193 (12), 106 (14), 89 (16), 46 (CONH2+, 30). 
HRMS: m/z calc, for C24H25N20  (MH+), 357.1961; found, 357.1960.
FT-IR: vmax = 2852 (CH), 1619 (C =0), 1520 (aromatic C=C), 1363, 1340, 1218 cm '1.
7.28 Synthesis o f 7V-(2-(cyclohexenyl)pivalamides 174 and 175
The procedure was identical with that described in Section 7.26 except that 
compounds 62 and 73 (0.50 g) were used as starting materials instead of 57. The 
reaction mixtures were worked-up and the residues obtained were subjected to flash 
column chromatography (silica gel; Et20 -hexane, 1:3) to give the pure products 174 
and 175 as white solids.
/V-(2-Cyclohexen-l-ylbenzyl)pivalam ide (174)
NHCOBu
Yield: 0.38 g (1.42 mmol, 82%). 
Mp: 118-119 °C.
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'H NMR (400 MHz, CDC13): 5 = 7.19-7.03 (m, 4 H, H-3, H-4, H-5 and H-6), 5.78 
(br, exch., 1 H, NH), 5.52 (m, 1 H, H-2 o f cyclohexenyl), 4.34 (d, ./ = 5 Hz, 2 H, 
CH2), 2.15-2.07 (m, 4 H, H-3 and H-6 o f cyclohexenyl), 1.71-1.58 (m, 4 H, H-4 and 
H-5 o f cyclohexenyl), 1.13 [s, 9 H, C(CH3)3].
I3C NMR (100 MHz, CDC13): 5 = 178.4 (s, C =0), 144.8 (s, C-l of cyclohexenyl),
138.4 (s, C -l), 135.5 (s, C-2), 129.3 (d, C-5), 128.9 (d, C-6), 127.7 (d, C-3), 127.4 (d, 
C-4), 127.2 (d, C-2 o f cyclohexenyl), 42.2 (t, CH2NH), 39.1 [s, C(CH3)3], 31.0 (t, C-6 
of cyclohexenyl), 28.0 [q, C(CH3)3], 25.8 (t, C-3 o f cyclohexenyl), 23.4 (t, C-5 of 
cyclohexenyl), 22.4 (t, C-4 o f cyclohexenyl).
EI-M S: m/z (%) = 271 (M+, 4), 186 (M+ -  'BuCO, 8), 171 (M+ -  rBuCONH, 17), 170 
(Mf -  /BuCONH2, 56), 157 (M+ -  'BuCONHCH2, 11), 142 (50), 128 (32), 115 (26), 
102 (12), 91 (PhCH2+, 11), 77 (5), 57 ('Bu+, 100), 41 (71).
CI-MS: m/z (%) = 543 (2 M+ + 1, 4), 289 (M + NH4+, 6), 272 (MH+, 100), 170 (15), 
119(17), 102 (9), 52 (24).
HRMS: m/z calc, for C i8H26NO (MH+), 272.2009; found, 272.2012.
FT-IR: vmax = 3328 (NH), 2921 (CH), 1638 (C =0), 1512 (aromatic C=C), 1540, 
1368, 1210, 1003 c m 1.
Anal. calc, for C 18H25NO: C, 79.66; H, 9.28; N, 5.16. Found: C, 79.73; H, 9.33; N, 
5.09%.
A-(2-Cyclohexen-l-yl-4-m ethoxybenzyl)pivalam ide (175)
NHCOBu
MeO
Yield: 0.39 g (1.30 mmol, 83%).
Mp: 99-100 °C.
‘H NMR (400 MHz, CDC13): 8 = 7.09 (d, J =  8 Hz, 1 H, H-6), 6.68 (dd, J =  2, 8 Hz, 
1 H, H-5), 6.58 (d, J =  2 Hz, 1 H, H-3), 5.70 (br, exch., 1 H, NH), 5.52 (m, 1 H, H-2 
of cyclohexenyl), 4.26 (d, J  = 5 Hz, 2 H, CH2), 3.71 (s, 3 H, OCH3), 2.15—2.06 (m, 
4 H, H-3 and H-6 o f cyclohexenyl), 1.71-1.58 (m, 4 H, H-4 and H-5 o f 
cyclohexenyl), 1.11 [s, 9 H, C(CH3)3].
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l3C NMR (100 MHz, C'DCl,): 8 = 178.2 (s, C = 0), 159.1 (s, C-4), 146.2 (s, C-l o f 
cyclohexenyl), 138.5 (s, C-2), 130.5 (d, C-6), 127.7 (s, C -l), 127.1 (d, C-2 o f 
cyclohexenyl), 114.7 (d, C-5), 112.7 (d, C-3), 55.7 (q, OCH3), 41.8 (t, CH2NH), 39.0 
[s, C(CH3)3], 30.9 (t, C-6 o f cyclohexenyl), 28.0 [q, C(CH3)3], 25.7 (t, C-3 of 
cyclohexenyl), 23.4 (t, C-5 o f cyclohexenyl), 21.9 (t, C-4 o f cyclohexenyl).
EI-MS: m/z (%) = 301 (M +, 2), 200 (22), 172 (13), 159 (9), 128 (6), 115 (8), 77 (5), 
57 ('Bu+, 100), 41 (93).
CI-M S: m/z (%) = 319 (M + NH4\  3), 302 (MH+, 100), 200 (11), 119 (17), 102 (12), 
52(15).
HRMS: m/z calc, for C 19H28N O 2 (M H+), 302.2115; found, 302.2115.
FT-IR: vmax = 3347 (NH), 2940 (CH), 1647 (C =0), 1505 (aromatic C=C), 1492, 
1330, 1207, 1029 c m 1.
7.29 Synthesis of AL(2-(2-phenyl-2-trifluoroacetoxyethyl)benzyl)pivalamide 
(188)
Trifluoroacetic anhydride (0.5 mL) was added to a stirred solution of N-(2-(2- 
hydroxy-2-phenylethyl)benzyl)pivalamide (99; 0.50 g, 1.61 mmol) in DCM (10 mL) 
at room temperature. The mixture was stirred for 5 min at room temperature, at which 
time TLC showed the formation o f a pure product. The reaction mixture was 
quenched with FLO (10 mL). The organic layer was separated, washed with aq. sat. 
N aH C 03 (10 mL) and H20  (2 x 10 mL), dried (M gS04), and evaporated under 
reduced pressure. The residue obtained was subjected to flash column 
chromatography (silica gel; Et20 -h ex an e , 1:3) to give pure 188 (0.63 g, 1.55 mmol, 
97%) as a white solid.
NHCOBu1
CF
Ph'
Mp: 127-128 °C.
'H NMR (400 MHz, CDC13): 5 = 7.32-7.07 (m, 9 H, H-3, H-4, H-5, H-6 and Ph),
6.01 (dd, J =  6 , 8 Hz, 1 H, CH), 5.80 (br app. t, exch., 1 H, NH), 4.38 (dd, J =  6, 15 
Hz, 1 H, 1 H o f C //2NH), 4.29 (dd, J  = 6, 15 Hz, 1 H, 1 H of C i/2NH), 3.24 (dd, J=  8,
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15 Hz, 1 H, 1 H o f CH2CH), 3.19 (dd, 7  = 6 , 15 Hz, 1 H, 1 H o f C //2 CH), 1.13 [s, 9 H, 
C(CH3)3].
13C NMR (100 MHz, CDCI3): 6  = 178.7 (s, C =0), 156.9 (q, 42 Hz, CF3 C =0),
137. 8  (s, C -l), 137.1 (s, C -l o f  Ph), 134.5 (s, C-2), 131.6 (d, C-3), 129.9 (d, C-4),
129.5 (d, C-5), 129.4 (d, C-6 ), 129.3 (d, C-3/C-5 o f Ph), 128.3 (d, C-4 o f Ph), 126.7 
(d, C-2/C-6 o f  Ph), 114.8 (q, J  =284 Hz, CF3), 80.9 (d, CH), 41.5 (t, CH2NH), 39.9 (t, 
CH2CH), 39.1 [s, C(CH3)3], 27.9 [q, C(CH3)3],
EI-MS: m/z(%) = 407 (M4, 4), 310 (M 4  -  CF3CO, 4), 294 (M+ -  CF3C 0 2, 85), 293
(M4 -  CF3 C 0 2 H, 100), 278 (3).
CI-MS: m/z(%) = 425 (M + NH4\  6 ), 408 (MH4, 5), 329 (11), 312 (42), 294 (M+ -
CF3C 0 2> 100), 192 (10), 119 (19), 52 (16).
HRMS: m/z calc, for C2 2 H2 5 F3N 0 3 (MH4), 408.1781; found, 408.1789.
FT-IR: Vmax = 3313 (NH), 2933 (CH), 1635 (C =0), 1531 (aromatic C=C), 1462, 
1227, 1030, 1020, 1000 cm'1.
7.30 Synthesis of (£)-A^-(2-(4-methoxystyryl)benzyl)pivalamide (189)
The procedure was identical with that described in Section 7.29 except that 
7V-(2-(2-hydroxy-2-(4-methoxyphenyl)ethyl)benzyl)pivalamide (100; 0.50 g, 1.47 
mmol) was used as starting material instead o f 99. The reaction mixture was worked- 
up and the residue obtained subjected to flash column chromatography (silica gel; 
Et2 0 -hexane, 1:3) to give the pure product 100 (0.46 g, 1.35 mmol, 97%) as a white 
solid.
NHCOBu1
O M e
Mp: 113-115 °C.
!H NMR (400 MHz, CDC13): 5 = 7.57 (d, J=  8  Hz, 1 H, H-3), 7.37 (d, J=  9 Hz, 2 H, 
H-2/H-6 o f 4-methoxyphenyl), 7.24 (app. dt, J  = 2, 8  Hz, 1 H, H-4), 7.18-7.12 (m,
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2 H, H-5 and H-6), 7.06 (d, J =  16 Hz, 1 H, CH), 6.88 (d, J =  16 Hz, 1 H, CH), 6.80 
(d, J  = 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 5.67 (br t, exch., 1 H, NH), 4.50 (d, 
J=  5 Hz, 2 H, CH2), 3.74 (s, 3 H, OCH3), 1.05 [s, 9 H, C(CH3)3].
13C NMR (100 MHz, CDC13): 6 = 178.1 (s, C =0), 159.9 (s, C-4 of 4-methoxyphenyl),
137.4 (s, C -l), 135.6 (s, C-2), 130.9 (d, C-5), 130.4 (s, C-l o f 4-methoxyphenyl),
130.2 (d, C-6), 128.7 (d, C-4), 128.4 (d, C-2/C-6 o f 4-methoxyphenyl), 127.7 (d, C-3),
126.2 (d, CH), 123.5 (d, CH), 114.5 (d, C-3/C-5 o f 4-methoxyphenyl), 55.7 (q, 
OCH3), 42.7 (t, CH2), 39.1 [s, C(CH3)3], 27.9 [q, C(CH3)3].
EI-MS: m/z (%) = 323 (M+, 10), 222 (M+ -  'BuCONH2, 88), 207 (M+ -  'BuCONH2 -  
Me, 21), 191 (M+ -  'BuCONH2 -  OMe, 22), 165 (15), 115 (13), 57 ('Bu+, 100).
CI-MS: m/z (%) = 341 (M + NH4+, 12), 324 (MH+, 100), 222 (M+ -  'BuCONH2, 7), 
119(18), 52(17).
HRMS: m/z calc, for C2,H29N 20 2 (M + NH4+), 341.2224; found, 341.2225.
FT-IR: vmax = 2961 (CH), 1628 (C =0), 1512 (aromatic C=C), 1453, 1225, 1037 cm '1. 
Anal. calc, for C2iH25N 0 2: C, 77.98; H, 7.79; N, 4.33. Found: C, 77.89; H, 7.81; N, 
4.30%.
Selected crystallographic data: C2iH2sN 0 2, FW  = 323.42, T = 150(2) K, X = 0.71073 
A, Triclinic, P I, a = 5.4050(5) A, b = 10.0960(9) A, c = 16.5930(18) A, a  = 
91.891(4)°, p = 98.280(4)°, y = 95.537(5)°, V = 890.83(15) A3, Z = 2, pcak, = 1.206 
Mg/m3, crystal size = 0.36 x 0.20 x 0.20 mm3, m = 0.077 m m '1, reflections collected 
= 5471, independent reflections = 3957, Rjnt = 0.0471, parameters = 221, final Ri = 
0.0847, wR2 = 0.1573 for I>2cr(I) and Ri = 0.1734, wR2 = 0.1886 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 737414, and can be obtained free of charge via 
http ://www .cede. ac.uk/data_request/cif.
7.31 Synthesis of (£)-/V-(2-(2-phenylprop-l-enyl)benzyl)pivalamide (190)
Trifluoroacetic anhydride (0.5 mL) was added to a stirred solution of 
iV-(2-(2-(hydroxy-2-phenylpropyl)benzyl)pivalamide (101; 0.50 g, 1.54 mmol) in 
DCM (10 mL) at room temperature. The mixture was stirred for 1 h before being 
worked-up and the residue obtained was then purified by column chromatography 
(silica gel; Et20-hexane, 1:3) to give the pure product 190 (0.34 g, 1.11 mmol, 72%) 
as a white solid.
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M e ' Ph
Mp: 85-86 °C.
'H NMR (400 MHz, CDCI3): S = 7.46 (d, J  = 8 Hz, 1 H, H-3), 7.31-7.18 (m, 8 H, 
H-4, H-5, H-6 and Ph), 6.79 (s, 1 H, CH), 5.76 (br t, exch., 1 H, NH), 4.38 (d, J =  6 
Hz, 2 H, CH2), 2.05 (s, 3 H, CH3), 1.06 [s, 9 H, C(CH3)3],
I3C NMR (100 MHz, CDC13): 5 = 178.4 (s, C = 0), 143.2 (s, C -l), 139.0 (s, C-2),
137.7 (s, C-l o f Ph), 136.9 (s, C-CH3), 130.5 (d, C-5), 129.0 (d, C-6), 128.8 (d, 
C-3/C-5 o f Ph), 128.5 (d, C-4), 128.3 (d, C-3), 128.2 (d, C-4 o f Ph), 127.4 (d, C-2/C-6 
of Ph), 126.3 (d, CH), 42.5 (t, CH2), 39.1 [s, C(CH3)3], 28.0 [q, C(CH3)3], 17.6 (q, 
CH3).
EI-MS: m/z (%) = 307 (M +, 7), 222 (M+ -  'BuCO, 4), 206 (M + -  'BuCONH2, 38), 191 
(M+ -  'BuCONH, -  Me, 18), 178 (8), 165 (6), 128 (15), 115 (8), 91 (22), 77 (Ph+, 8), 
57 ('Bu+, 100), 41 (58).
CI-M S: m/z (%) = 325 (M + NH4+, 23), 308 (MH*, 100), 206 (6), 119 (32), 102 (22), 
52 (60).
HRMS: m/z calc, for C2iH26NO (MH*), 308.2009; found, 308.2006.
FT-IR: vmax = 3329 (NH), 2921 (CH), 1638 (C=Q), 1539 (aromatic C=C), 1357, 1210
7.32 Synthesis of 3-(4-m ethoxyphenyl)-2-d im ethylam m ocarbonyl-l,2,3,4- 
tetrahydro isoquino line (198) via cyclization N '-(2-(2-hydroxy-2-(4- 
m ethoxyphenyl)ethyl)benzyl)-i\yV -diiiiethylurea (153)
Trifluoroacetic anhydride (0.5 mL) was added to a stirred solution o f 
jV'-(2-(2-hydroxy-2-(4-methoxyphenyl)ethyl)benzyl)-AyV-dimethylurea (153; 0.50 g,
1.52 mmol) in DCM (10 mL) at room temperature. The mixture was stirred for 5 min 
at room temperature, by which time TLC showed the formation of a pure product. The 
reaction mixture was quenched with H20  (10 mL). The organic layer was separated, 
washed with aq. sat. NaHCCb (10 mL) and H20  (2 x 10 mL), dried (MgSCL), and 
evaporated under reduced pressure. The residue obtained was subjected to flash
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column chromatography (silica gel; Et20-hexane, 1:3) to give pure 198 (0.45 g, 1.45 
mmol, 95%) as a white solid.
5
OMe
Mp: 102-103 °C.
'H NMR (400 MHz, C’DCh): 5 = 7.18-7.07 (m, 3 H, H-6, H-7 and H-8), 7.04 (d, 7  = 
9 Hz, 2 H, H-2/H-6 o f 4-methoxyphenyl), 6.90 (d, 7  = 8 Hz, 1 H, H-5), 6.69 (d, 7  
9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 5.18 (dd, 7  = 3, 6 Hz, 1 H, H-3), 4.34 (d, 
7 =  16 Hz, 1 H, 1 H o f H -l), 4.00 (d, 7 = 1 6  Hz, 1 H, 1 H o f H -l), 3.65 (s, 3 H, 
OCH3), 3.36 (dd, 7 =  6, 16 Hz, 1 H, 1 H o f H-4), 3.13 (dd, 7 =  3, 16 Hz, 1 H, 1 H of 
H-4), 2.80 [s, 6 H, N(CH3)2].
,3C NMR (100 MHz, CDC13): S = 165.2 (s, C =0), 158.9 (s, C-4 o f 4-methoxyphenyl),
134.3 (s, C-4a), 133.1 (s, C-8a), 129.1 (s, C -l o f 4-methoxyphenyl), 128.7 (d, C-8),
128.4 (d, C-2/C-6 o f  4-methoxyphenyl), 127.2 (d, C-5), 126.4 (d, C-6), 126.2 (d, C-7),
114.1 (d, C-3/C-5 o f 4-methoxyphenyl), 55.6 (q, OCH3), 54.0 (d, C-3), 46.3 (t, C -l),
39.0 [q,N(CH3)2], 32.2 (t, C-4).
EI-MS: m/z(%) = 310 (M+, 12), 266 (M+ -  M e2N, 9), 238 (M* -  Me2NCO, 32), 222 
(M+ -  Me2NCONH2, 62), 202 (15), 189 (23), 178 (11), 165 (13), 121 (31), 104 
(C6H4CH2N+, 100), 91 (PhCH2+, 17), 72 (Me2NCO+, 93), 44 (17).
CI-MS: m/z(%) = 311 (MH*, 100), 89 (17), 52 (33), 46 (28).
HRMS: m/z calc, for C i9H23N 20 2 (MH*), 311.1754; found, 311.1751.
FT-IR: vmax = 2958 (CH), 1618 (C =0), 1510 (aromatic C=C), 1399, 1370, 1348, 
1242, 1173, 1033 cm '.
Selected crystallographic data: Ci9H22N 20 2, FW = 310.39, T = 150(2) K, 3. = 0.71073 
A, Monoclinic, P2,/n, a = 13.0240(9) A, b = 8.9900(7) A, c = 15.2990(13) A, a  = 90 
°, (3 = 112.974(3)°, y = 90°, V = 1649.2(2) A3, Z = 4, pcaic. = 1.250 Mg/m3, crystal size
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= 0.40 x 0.20 x 0.16 mm3, m = 0.082 mm"1, reflections collected = 6302, independent 
reflections = 3737, Rjnt = 0.0516, parameters = 211, final Ri = 0.0658, wR2 = 0.1379 
for I>2ct(I) and R\ = 0.1237, wR2 = 0.1613 for all data. Full crystallographic data for 
this compound have been deposited with the CCDC, reference number 737417, and 
can be obtained free o f charge via http://www.ccdc.ac.uk/data_request/cif.
7.33 Synthesis of substitu ted  te trahydroisoquinolines 199 and 200
The procedure was identical with that described in Section 7.32 except that 
compounds 154 and 155 were used as starting materials instead of 153. The reaction 
mixtures were worked-up and the residues obtained subjected to flash column 
chromatography (silica gel; Et20-hexane, 1:3) to give the pure products 199 and 200 
as white solids.
3-Phenyl-2-dim ethylam inocarbonyl-l,2 ,3 ,4-tetrahydroisoquinoline (199)
Yield: 0.44 g (1.57 mmol, 94%).
Mp: 96-98 °C.
'H NMR (400 MHz, CDC13): 8 = 7.27-7.08 (m, 9 H, H-5, H-6, H-7, H-8 and Ph), 
4.78 (dd, J =  4, 9 Hz, 1 H, H-3), 4.31 (d, J  = 14 Hz, 1 H, 1 H o f H -l), 4.21 (d, J  = 
14 Hz, 1 H, 1 H o f H -l), 2.96 (dd, J  = 9, 14 Hz, 1 H, 1 H o f H-4), 2.83 (dd, J  = 4, 
14 Hz, 1 H, 1 H o f H-4), 2.72 [s, 6 H, N(CH3)2].
I3C NMR (100 MHz, CDCb): 5 = 158.8 (s, C =0), 144.5 (s, C-4a), 137.9 (s, C-8a),
137.2 (s, C -l o f Ph), 130.0 (d, C-8), 129.6 (d, C-4 o f Ph), 129.3 (d, C-3/C-5 o f Ph),
128.9 (d, C-5), 128.2 (d, C-6), 127.5 (d, C-7), 126.9 (d, C-2/C-6 o f Ph), 76.3 (d, C-3),
43.5 (t, C -l), 42.6 (t, C-4), 38.1 [q, N(CH3)2].
EI-MS: m/z (%) = 280 (M+, 2), 208 (M + -  M e2NCO, 4), 192 (44), 177 (6), 148 (7), 
120 (18), 104 (PhCHN+, 100), 91 (PhCH2+, 25), 77 (Ph+, 61), 72 (Me2NCO+, 66), 44
(26).
CI-M S: m/z (%) = 299 (M + NH4+, 62), 281 (M H4, 72), 271 (9), 193 (22), 179 (15), 
118 (16), 106 (32), 89 (36), 72 (Me2N C O \ 7), 63 (12), 46 (100).
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HRMS: m/z calc, for C ,8H2|N20  (MH+), 281.1648; found, 281.1647.
FT-IR: vmax = 2935 (CH), 1636 (C =0), 1523 (aromatic C=C), 1512, 1455, 1203, 
1174, 1037 cm '1.
3-M ethyl-3-phenyl-2-dim ethylam inocarbonyl-l,2,3,4-tetrahydroisoquinoline
(200)
Yield: 0.43 g (1.46 mmol, 91%).
Mp: 122-124 °C.
'H NMR (400 MHz, CDCI3): 8 = 7.30-7.04 (m, 8 H, H-6, H-7, H-8 and Ph), 6.89 (d, 
7 = 8  Hz, 1 H, H -5),4.28 (d ,7 =  16 Hz, 1 H, 1 H o fH -1 ), 4 .1 4 (d ,7 =  16 Hz, 1 H, 1 H 
o f H-l), 3.42 (d , J  = 16 Hz, 1 H, 1 H o f H-4), 3.23 (d, J =  16 Hz, 1 H, 1 H ofH -4), 
2.82 [s, 6 H, N(CH3)2], 1.59 (s, CH3).
I3C NMR (100 MHz, CDC13): 5 = 164.6 (s, C =0), 147.7 (s, C-l o f Ph), 135.6 (s, 
C-4a), 134.1 (s, C-8a), 129.4 (d, C-5), 128.8 (d, C-3/C-5 o f Ph), 127.9 (d, C-6), 127.1 
(d, C-7), 126.5 (d, C-4 o f Ph), 125.6 (d, C-8), 125.5 (d, C-2/C-6 of Ph), 59.4 (s, C-3),
49.8 (t, C-4), 43.6 (t, C -l), 39.8 [q, N(CH3)2], 28.1 (q, CH3).
El-MS: m/z (%) = 294 (M+, 22), 279 (M* -  Me, 24), 222 (M+ -  Me2NCO, 52), 206 
(M* -  Me2NCONH2, 100).
CI-MS: m/z (%) = 295 (MH*, 100), 222 (M+ -  Me2NCO, 7), 193 (8), 89 (12), 52 (28), 
46 (52).
HRMS: m/z calc, for C |9H23N20  (MH+), 295.1805; found, 295.1807.
FT-IR: vmax = 2973 (CH), 1645 (C =0), 1522 (aromatic C=C), 1492, 1381, 1361, 
1174,1107 cm '1.
7.34 Synthesis of .Y'-(2-(2.2-diphenylviny])benzyl)-.Y,.Y-dimethylurea (201)
The procedure was identical with that described in Section 7.32 except that 
compound 156 was used as starting material instead of 153. The reaction mixture was 
worked-up and the residue obtained subjected to flash column chromatography (silica
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gel; Et20-hexane, 1:3) to give the pure product 201 (0.45 g, 1.26 mmol, 95%) as a 
white solid.
NHCONMe-
Ph Ph
Mp: 106-108 °C.
'H NMR (400 MHz, CDC13): 5 = 7.39-7.05 (m, 13 H, H-5, H-6, CH and 2 Ph), 6.87 
(app. t, J =  8 Hz, 1 H, H-4), 6.83 (t, J = 6 Hz, exch., 1 H, NH), 6.71 (d, J=  8 Hz, 1 H, 
H-3), 4.31 (d, J = 6 Hz, 2 H, CH2), 2.77 [s, 6 H, N(CH3)2].
,3C NMR (100 MHz, CDC13): 6 = 158.4 (s, C=0), 143.0 (s, C-l of 2 Ph), 142.9 (s, 
C-CH), 140.0 (s, C -l), 136.0 (s, C-2), 130.7 (d, C-3/C-5 of 2 Ph), 129.7 (d, C-3),
128.7 (d, C-4 of 2 Ph), 128.6 (d, C-4), 127.9 (d, C-2/C-6 of 2 Ph), 127.6 (d, C-5),
127.0 (d, C-6), 126.1 (d, CH), 42.2 (t, CH2), 36.2 [q, N(CH3)2].
EI-MS: m/z (%) = 356 (M+, 12), 312 (M+ -  Me2N, 7), 284 (10), 268 (100), 252 (8), 
206 (12), 178 (13), 167 (33), 152 (18), 91 (PhCH2+, 13), 72 (Me2NCO+, 71), 44 (22). 
CI-MS: m/z (%) = 374 (M + N H /, 100), 357 (MH+, 81), 331 (6), 301 (5), 276 (7), 
167 (15), 118 (19), 106 (25), 89 (33), 46 (100).
HRMS: m/z calc, for C24H25N20  (MH+), 357.1961; found, 357.1960.
FT-IR: vmax = 3316 (NH), 2958 (CH), 1637 (C=0), 1538 (aromatic C=C), 1352, 1230 
cm'1.
Anal. calc, for C24H24N20 : C, 80.87; H, 6.79; N, 7.86. Found: C, 80.90; H, 6.89; N,
7.63%.
Selected crystallographic data: C72H76N605, FW = 1105.39, T = 150(2) K, X = 
0.71073 A, Monoclinic, P2i/n, a = 19.0960(3) A, b = 10.8300(2) A, c = 30.7660(5) A, 
a  = 90°, p = 107.7660(10)°, y = 90°, V = 6059.27(18) A3, Z = 4, pcaIc, = 1.212 Mg/m3, 
crystal size = 0.32 x 0.20 x 0.06 mm3, m = 0.076 mm'1, reflections collected = 26316, 
independent reflections = 8712, Rint = 0.0683, parameters = 770, final Ri = 0.0836, 
wR2 = 0.2243 for I >2a(I) and Ri = 0.1130, wR2 = 0.2492 for all data. Full
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crystallographic data for this compound have been deposited with the CCDC, 
reference number 737416, and can be obtained free of charge via 
http://www.ccdc.ac.uk/data_request/cif.
7.35 Synthesis of (/?*)-3-((5'*)-hydroxy(4-methoxyphenyl)methyl)-4- 
methoxyisoindolin-l-one (139)
A solution o f ^-BuLi in heptane (3.9 mL, 1.7 M, 6.6 mmol) was added to a 
cold (0 °C), stirred solution o f A-(2-methoxybenzyl)-A,/V-dimethylurea (111; 0.42 g,
2.0 mmol) in anhydrous THF (20 mL) under N 2. Formation of the monolithium 
reagent 133 was observed as a yellow solution and the dilithium reagent 134 was 
observed as a reddish orange solution, after which the colour changed to deep red. 
The mixture was stirred at 0 °C for 6 h after which 4-anisaldehyde (0.30 g, 2.2 mmol) 
was added. The mixture was stirred for 2 h at 0 °C then the cooling bath was removed 
and the mixture allowed to warm to room temperature. It was then diluted with Et20 
(10 mL) and quenched with aq. sat. N H 4 C I (10 mL). The organic layer was separated, 
washed with H2O (2 x 10 mL), dried (MgSCL), and evaporated under reduced 
pressure. The residue obtained was treated with diethyl ether (20 ml) and gave a white 
solid which was filtered and then washed with diethyl ether. The pure product was 
identified as 139 (0.49 g, 1.63 mmol, 81%).
Compound 139 was found to be identical in all respects with the one produced 
previously in Chapter 3; Section 3.5. See Section 7.23 for spectral data.
7.36 Synthesis of 4-m ethoxyisoindolin-l-one (216)
A solution o f ?-BuLi in heptane (2.6 mL, 1.7 M, 4.4 mmol) was added to a 
cold (0 °C), stirred solution o f Ar-(2-methoxybenzyl)-A,A-dimethylurea (111; 0.42 g,
2.0 mmol) in anhydrous THF (20 mL) under N2. The mixture was stirred at 0 °C for 6 
h then the cooling bath was removed and the mixture allowed to warm to room 
temperature. The mixture was stirred at room temperature overnight. The reaction 
mixture was worked-up and purified as described in Section 7.35 to give 216 (0.25 g,
1.53 mmol, 76%) as a white solid.
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NH
7a.
4 OMe
Mp: 190-192 °C.
'H NMR (500 MHz, DM SO-J6): 5 = 8.60 (s, exch., 1 H, NH), 7.46 (app. t, J  = 8 Hz, 
1 H, H-6), 7.26 (d, J  = 8 Hz, 1 H, H-7), 7.19 (d, J  = 8 Hz, 1 H, H-5), 4.29 (s, 2 H, 
H-3), 3.88 (s, 3 H, OCH3).
,3C NMR (125 MHz, DMSO-</6): 5 = 170.3 (s, C -l), 154.9 (s, C-4), 134.6 (s, C-3a),
131.8 (s, C-7a), 129.9 (d, C-6), 115.2 (d, C-7), 113.5 (d, C-5), 55.8 (q, OCH3), 43.0 (t, 
C-3).
EI-MS: m/z (%) = 163 (M+, 100), 162 (M+ -  1, 42), 135 (M+ -  CO, 12), 134 (M+ -  
CH2NH, 22), 132 (44), 119 (22), 104 (18), 92 (15), 77 (26).
CI-MS: m/z (%) = 327 ( 2 M + + 1, 6), 181 (M + N H /, 14), 164 (MH+, 100), 134 (M+ 
-C H 2NH, 10).
HRMS: m/z calc, for C9H ,0NO2 (MH+), 164.0706; found, 164.0707.
FT-IR: vmax = 3286 (NH and OH), 2870 (CH), 1682 (C=0), 1585 (aromatic C=C), 
1440, 1266, 1052 cm '1.
Selected crystallographic data: C9H9N 0 2, FW = 163.17, T = 150(2) K, X =  0.71073 A, 
Triclinic, PI, a = 7.2640(5) A, b = 7.8940(6) A, c = 8.3280(8) A, a  = 104.845(3)°, p = 
114.462(4)°, y = 103.622(5)°, V = 387.21(5) A3, Z = 2, pcaic. = 1 400 Mg/m3, crystal 
size = 0.25 x 0.24 x 0.18 mm3, m = 0.0301 m m '1, reflections collected = 2379, 
independent reflections = 1714, Rjnt = 0.0301, parameters = 110, final Ri = 0.0512, 
wR2 = 0.1220 for I>2a(I) and Ri = 0.0735, wR2 = 0.1361 for all data. Full 
crystallographic data for this compound have been deposited with the CCDC, 
reference number 737411, and can be obtained free of charge via 
http://www.ccdc.ac.uk/data_request/cif.
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7.37 Synthesis of 3-substituted 4-methoxyisoindolin-l-ones 216-224
The procedure was identical to that described for the synthesis of 139 (Section 
7.35) except that an electrophile (2.2 mmol), in anhydrous THF (8 mL) if solid, 
otherwise neat, was used instead o f 4-anisaldehye. The reaction mixtures were 
worked-up and purified as described in Section 7.35 to give pure products as white 
solids. The yields o f products 216-224 are recorded in Table 6.1.
4-M ethoxyisoindolin-l-one (216)
NH
4 OMe
Yield: 0.27 g (1.65 mmol, 82%).
Mp: 190-192 °C.
Compound 216 produced using the general procedure was found to be identical in all 
respects with the one produced previously using 2.2 mole equivalents of /-BuLi 
(Section 7.36). See Section 7.36 for spectral data.
4-M ethoxy-3-methylisoindolin-l-one (217)
NH
7 a, Me
3a
4 OMe
Yield: 0.28 g (1.58 mmol, 79%).
Mp: 153-154 °C.
'H NMR (500 MHz, CDC13): 5 = 7.26 (br s, exch., 1 H, NH), 7.47 (t, J  = 8 Hz, 1 H, 
H-6), 7.24 (d, J  = 8 Hz, 1 H, H-7), 7.15 (d, J  = 8 Hz, 1 H, H-5), 4.73 (q, J = 7 Hz, 1 H, 
H-3), 3.92 (s, 3 H, OCH3), 1.55 (d, J =  7 Hz, 3 H, CH3).
13C NMR (100 MHz, CDC13): 5 = 171.2 (s, C -l), 155.3 (s, C-4), 136.8 (s, C-7a),
133.9 (s, C-3a), 130.1 (d, C-6), 116.0 (d, C -l), 113.6 (d, C-5), 55.8 (q, OCH3), 52.0 
(d, C-3), 19.3 (q, CH3).
EI-MS: m/z (%) = 177 (M+, 24), 162 (M+ -  Me, 100), 146 (10), 119 (8), 105 (9), 91 
(11), 84 (8), 49 (15).
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CI-M S: m/z (%) = 195 (M + NH4+, 30), 178 (MH+, 100), 162 (M+ -  Me, 8), 94 (11), 
52 (50), 44 (41).
HRMS: m/z calc, for C |0Hi2NO2 (MH*), 178.0863; found, 178.0864.
FT-IR: vmax = 3071 (NH and OH), 2971 (CH), 1680 (C =0), 1602 (aromatic C=C), 
1493, 1267, 1057 cm '1.
3-Ethyl-4-m ethoxyisoindolin-l-one (218)
NH
7 a,
4 OMe
Yield: 0.32 g (1.68 mmol, 84%).
Mp: 150-152 °C.
'H NMR (500 MHz, DMSO-<76): 8 = 7.72 (s, exch., 1 H, NH), 7.44 (app. t, J =  8 Hz, 
1 H, H-6), 7.23 (d, J  = 8 Hz, 1 H, H-7), 7.18 (d, J  = 8 Hz, 1 H, H-5), 4.57 (dd, J=  3 ,7  
Hz, 1 H, H-3), 3.87 (s, 3 H, OCH3), 2.08 (ddq, J =  3, 14, 7 Hz, 1 H, 1 H o f CH2), 1.59 
(app. d quintet, J  = 14, 7 Hz, 1 H, 1 H o f  CH2), 0.73 (app. t, J =  1 Hz, 3 H, CH3).
I3C NMR (125 MHz, DMSO-<4): 5 = 169.7 (s, C -l), 155.1 (s, C-4), 134.8 (s, C-7a),
134.4 (s, C-3a), 130.1 (d, C-6), 115.0 (d, C-7), 113.8 (d, C-5), 56.1 (d, C-3), 55.9 (q, 
OCHj), 25.0 (t, CH2), 9.2 (q, CH3).
EI-MS: m/z (%) =191 (M+, 7), 162 (M+ -  Et, 100), 149 (5), 132 (6).
CI-MS: m/z (%) = 209 (M + NH„+, 9), 192 (MH*, 100), 176 (M+ -  Me, 12), 162 (M+ 
-  Et, 28), 94 (11), 59 (33), 44 (40).
HRMS: m/z calc, for C n H l4N 0 2 (MH+), 192.1019; found, 192.1018.
FT-IR: vmax = 3303 (NH and OH), 2922 (CH), 1679 (C =0), 1602 (aromatic C=C), 
1493, 1271, 1049 cm'1.
3-Butyl-4-methoxyisoindolin-l-one (219)
NH
7 a, Bu
3a
4 OMe
192
Chapter Seven: Experimental
Yield: 0.32 g (1.45 mmol, 72%).
Mp: 130-131 °C.
'H NMR (500 MHz, CDCI3): 5 = 7.57 (s, exch., 1 H, NH), 7.47-7.41 (m, 2 H, H-6 
and H-7), 7.22 (dd, J  = 2, 8 Hz, 1 H, H-5), 4.69 (dd, J  = 3, 7 Hz, 1 H, H-3), 3.91 (s, 
3 H, OCH3), 2.20 (m, 1 H, 1 H o f C //2CH2CH2CH3), 1.65 (m, 1 H, 1 H of 
CW2CH2CH2CH3), 1.39-1.22 (m, 4 H, CH 2 CH 2 CH3), 0.88 (t, J  = 7 Hz, 3 H, CH3).
13C NMR (125 MHz, CDCI3): 5 = 171.5 (s, C -l), 155.3 (s, C-4), 135.6 (s, C-7a),
134.2 (s, C-3a), 130.0 (d, C-6), 116.1 (d, C-7), 113.5 (d, C-5), 56.4 (d, C-3), 55.8 (q, 
OCH3), 32.4 (t, CH2CH2CH2CH3), 27.9 (t, CH2CH2CH3), 23.0 (t, CH2CH3), 14.3 (q, 
CH3).
EI-MS: m/z (%) = 219 (M+, 4), 188 (M+ -  Me, 3), 162 (M+ -  Bu, 100), 148 (4), 132 
(5), 119 (4), 91 (4), 77 (6).
CI-MS: m/z (%) = 237 (M + NH4+, 8), 220 (MH+, 100), 204 (9), 190 (11), 164 (18), 
162 (M+ -  Bu, 17), 86 (17), 72 (38), 58 (41), 44 (39).
HRMS: m/z calc, for C l3H i8N 0 2 (M H3), 220.1332; found, 220.1332.
FT-IR: vmax = 3314 (NH and OH), 2955 (CH), 1678 (C=0), 1600 (aromatic C=C), 
1490, 1276, 1053 c m 1.
3-(l-Hydroxycyclohexyl)-4-m ethoxyisoindolin-l-one (220)
,3 a
Yield: 0.41 g (1.57 mmol, 78%).
Mp: 206-207 °C.
'H NMR (500 MHz, DMSO-</6): § = 8.45 (s, exch., 1 H, NH), 7.43 (app. t, J =  8 Hz, 
1 H, H-6), 7.25 (d, J  = 8 Hz, 1 H, H-7), 7.22 (d, J  = 8 Hz, 1 H, H-5), 4.46 (s, 1 H, 
H-3), 4.32 (s, exch., 1 H, OH), 3.88 (s, 3 H, OCH3), 1.54-0.96 (m, 10 H, cyclohexyl 
group).
13C NMR (125 MHz, DMSO-t/6): 5 = 169.8 (s, C -l), 155.0 (s, C-4), 135.9 (s, C-7a),
132.0 (s, C-3a), 130.2 (d, C-6), 115.5 (d, C-7), 114.6 (d, C-5), 73.5 (s, C-l of 
cyclohexyl group), 65.5 (d, C-3), 56.1 (q, OCH3), 38.8, 33.7 (2 t, C-2/C-6 of
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cyclohexyl group), 25.8 (t, C-4 o f cyclohexyl group), 21.5, 21.4 (2 t, C-3/C-5 of 
cyclohexyl group).
EI-MS: m/z (%) = 262 (MH*, 11), 262 (M 1, 2), 244 (MH+ -  H20 ,  32), 243 (M* -  
H20 ,  100), 214 (33), 212 (21), 188 (M* -  NCO -  OMe, 48), 177 (19), 176 (34), 175 
(55).
CI-MS: m/z (%) = 279 (M + NH4*, 2), 262 (MH*, 29), 244 (MH* -  H20 , 4), 181 (35), 
164 (M* -  C6H i0OH, 100), 134 (12), 116 (88), 98 (12), 55 (13).
HRMS: m/z calc, for C 1 5H 20N O 3 (MH*), 262.1438; found, 262.1435.
FT-IR: vmax = 3301 (NH and OH), 2952 (CH), 1690 (C=0), 1590 (aromatic C=C), 
1470, 1240, 1047 c m 1.
Anal. calc, for C 15H 19NO3: C, 68.94; H, 7.33; N, 5.36. Found: C, 69.13; H, 7.34; N, 
5.48%.
3-(Hydroxydiphenylmethyl)-4-methoxyisoindolin-l-one (221)
N H Ph
Ph
3a OH
Yield: 0.56 g (1.62 mmol, 81%).
Mp: 206-208 °C.
'H NMR (500 MHz, DMSO-r/6): 6 = 7.89 (s, exch., 1 H, NH), 7.52-7.18 (m, 11 H, 
H-6 and 2 Ph), 7.10 (d, J  = 8 Hz, 1 H, H-7), 6.94 (d, J  = 8 Hz, 1 H, H-5), 5.84 (s, 
exch., 1 H, OH), 5.76 (s, 1 H, H-3), 3.19 (s, 3 H, OCH3).
n C NMR (125 MHz, DMSO-r/6): 5 = 169.7 (s, C -l), 155.0 (s, C-4), 145.8, 144.4 (2 s, 
C-l of 2 Ph), 136.2 (s, C-7a), 131.9 (s, C-3a), 130.2 (s, C-6), 128.0, 127.4 (2 d, 
C-3/C-5 o f 2 Ph), 127.1, 126.9 (2 d, C-2/C-6 o f 2 Ph), 127.0, 126.8 (2 d, C-4 o f 2 Ph),
115.0 (d, C-7), 113.9 (d, C-5), 79.7 (s, C-OH), 64.3 (d, C-3), 55.5 (q, OCH3).
EI-MS: m/z (%) = 182 (PhCO*, 22), 163 (12), 105 (100), 77 (Ph*, 89), 51 (33). 
CI-MS: m/z (%) = 346 (MH*, 100).
ES*-MS: m/z (%) = 691 (2 MH* + 1, 12), 346 (MH*, 31), 164 (100).
HRMS: m/z calc, for C22H2oN 03 (MH*), 346.1438; found, 346.1440.
FT-IR: vmax = 3301 (NH and OH), 2981 (CH), 1690 (C=0), 1599 (aromatic C=C), 
1491, 1267, 1038 cm '1.
194
Chapter Seven: Experimental
3-(l-H ydroxy-l-phenylethyl)-4-m ethoxyisoindolin-l-one (222)
N H Me
Ph
J OH 
OMe
Yield: 0.43 g (1.62 mmol, 81%).
Mp: 235-236 °C.
'H NMR (500 MHz, DMSO-cfe): 5 = 8.61 (s, exch., 1 H, NH), 7.32 (app. t, J  = 8 Hz, 
1 H, H-6), 7.26 (d, J  = 7 Hz, 2 H, H-2/H-6 o f Ph), 7.15 (app. t, J =  1  Hz, 2 H, H-3/H-5 
of Ph), 7.11-7.05 (m, 3 H, H-5, H-7 and H-4 o f Ph), 5.42 (s, exch., 1 H, OH), 4.83 (s, 
1 H, H-3), 3.67 (s, 3 H, OCH3), 1.51 (s, 3 H, CH3).
n C NMR (125 MHz, DMSO-r/6): 5 = 169.8 (s, C -l), 154.7 (s, C-4), 154.2 (s, C -l o f  
Ph), 135.5 (s, C-7a), 131.9 (s, C-3a), 130.2 (d, C-6), 127.5 (d, C-3/C-5 o f Ph), 126.8 
(d, C-4 o f Ph), 115.3 (d, C-7), 114.2 (d, C-5), 76.0 (s, C-OH), 65.7 (d, C-3), 56.1 (q, 
OCH3), 26.6 (q, CH3).
EI-MS: m/z (%) = 265 (M+ -  H20 , 100), 238 (22), 187 (35).
CI-MS: m/z (%) = 301 (M + NH4\  3), 284 (MH*, 100), 268 (12).
HRMS: m/z calc, for C i7H l8N 0 3 (MH*), 284.1281; found, 284.1281.
FT-IR: vmax = 3373 (NH and OH), 3010 (CH), 1687 (C =0), 1594 (aromatic C=C), 
1488, 1367, 1263, 1044 c m 1.
Anal. calc, for C ,7H i7N 0 3: C, 72.07; H, 6.05; N, 4.94. Found: C, 71.98; H, 6.03; N, 
4.94%.
3-(2-Hydroxyhexyi)-4-m ethoxyisoindolin-l-one (223)
N  H Me
Bu
Yield: 0.41 g (1.56 mmol, 78%).
Mp: 186-187 °C.
'H NMR (500 MHz, CDCI3): 5 = 7.83 (s, exch., 1 H, NH), 7.54 (dd, 1, 8 Hz, 1 H, 
H-7), 7.49 (app. t , J = 8 Hz, 1 H, H-6), 7.12 (dd, J =  1, 8 Hz, 1 H, H-5), 4.72 (s, exch.,
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1 H, OH), 4.08 (s, 1 H, H-3), 3.99 (s, 3 H, OCH3), 1.34 (s, 3 H, CH3), 1.39-1.33 (m,
2 H, C //2CH2CH2CH3), 1.29-0.94 (tn, 4 H, CH 2 CH 2 CU,), 0.79 (t, J  = 7 Hz, 3 H, 
CH2CH3).
13C NMR (125 MHz, CDC13): 6 = 171.1 (s, C -l), 154.3 (s, C-4), 135.5 (s, C-7a),
132.5 (s, C-3a), 130.6 (d, C-6), 117.5 (d, C-7), 114.2 (d, C-5), 74.7 (s, C-OH), 66.9 (d, 
C-3), 56.5 (q, OCH3), 36.8 (t, CH2CH2CH2CH3), 25.6 (t, CH2CH2CH3), 24.8 (q, CH3),
23.6 (t, CH2CH3), 14.4 (q, CH2CH3).
EI-MS: m/z (%) = 163 (M+ -  BuCOMe, 100), 148 (10), 132 (13), 119 (11), 58 (15), 
43 (18).
CI-MS: m/z (%) = 264 (MH+, 30), 181 (7), 164 (MH* -  BuCOMe, 18), 118 (100). 
HRMS: m/z calc, for C |5H22N 0 3 (MH+), 264.1600; found, 264.1596.
FT-IR: vmax = 3490 (NH and OH), 3073 (CH), 1682 (C =0), 1593 (aromatic C=C), 
1263, 1046 cm '1.
3-(Hydroxy(phenyl)methyl)-4-methoxyisoindolin-l-one (224)
7a
Yield: 0.43 g (1.60 mmol, 80%).
Mp: 213-214 °C.
'H NMR (500 MHz, DMSO-cfe): 6 = 8.79 (s, exch., 1 H, NH), 7.31 (app. t, J =  8 Hz, 
1 H, H-6), 7.16 (d, J  = 8 Hz, 1 H, H-7), 7.03-6.97 (m, 5 H, Ph), 6.91 (d, J  = 8 Hz, 
1 H, H-5), 5.82 (d, J  = 4 Hz, exch., 1 H, OH), 5.43 (app. t, J  = 4 Hz, 1 H, CH), 4.92 
(d, J  = 3 Hz, 1 H, H-3), 3.98 (s, 3 H, OCH3).
I3C NMR (125 MHz, DMSO-cfe): 8 = 175.0 (s, C -l), 160.3 (s, C-4), 144.8 (s, C -l of 
Ph), 140.1 (s, C-7a), 136.8 (s, C-3a), 135.4 (d, C-6), 132.6 (d, C-4 o f Ph), 132.5 (d, 
C-2/C-6 o f Ph), 132.4 (d, C-3/C-5 o f Ph), 120.1 (d, C-7), 118.8 (d, C-5), 77.2 (d,
CHOH), 66.6 (d, C-3), 61.2 (q, OCH3).
EI-MS: m/z (%) = 163 (M+ -  PhCHO, 22), 132 (5), 116 (15), 105 (14), 86 (24), 84 
(30), 51 (56), 49 (100).
CI-M S: m/z (%) = 270 (MH*, 15), 181 (7), 164 (MH* -  PhCHO, 100), 148 (8), 134
(7), 124 (14), 105 (23), 94 (13), 78 (12), 58 (28), 44 (27).
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HRMS: m/z calc, for C ,6H l6N 0 4 (MH*), 270.1125; found, 270.1125.
FT-IR: vmax = 3201 (NH and OH), 3070 (CH), 1672 (C =0), 1603 (aromatic C=C), 
1492, 1269, 1053 c m 1.
7.38 Synthesis of various substituted isoindolin-l-ones 225-245
A solution o f /-BuLi in heptane (3.9 mL, 1.7 M, 6.6 mmol) was added to a 
cold (0 °C), stirred solution o f the appropriate substituted N f-benzy\-N,N- 
dimethylureas 107, 108 and 113 (2.0 mmol) in anhydrous THF (20 mL) under N2. The 
mixture was stirred at 0 °C for 6 h after which an electrophile (2.2 mmol), in 
anhydrous THF (8 mL) if  solid, otherwise neat, was added. The mixture was stirred 
for 2 h at 0 °C then the cooling bath was removed and the mixture allowed to warm to 
room temperature. It was then diluted with Et20 (10 mL) and quenched with aq. sat. 
NH4CI (10 mL). The organic layer was separated, washed with H2O (2 x 10 mL), 
dried (MgSCL), and evaporated under reduced pressure. The residue obtained was 
treated with diethyl ether (20 ml) to give a white solid which was filtered and washed 
with diethyl ether. The pure products were identified as substituted isoindolin-l-ones 
225-245. The yields o f products are recorded in Table 6.2.
Isoindolin-l-one (225)
3a
Yield: 0.19 g (1.43 mmol, 71%).
Mp: 153-154 °C (lit.139 149-151 °C).
'H NMR (500 MHz, CDCI3): 5 = 7.82 (d, J  = 8 Hz, 1 H, H-7), 7.66 (br, exch., 1 H, 
NH), 7.49 (dt, J =  2, 8 Hz, 1 H, H-5), 7.43-7.40 (m, 2 H, H-4 and H-6), 4.41 (s, 2 H, 
H-3).
13C NMR (125 MHz, CDCI3): 5 = 172.0 (s, C -l), 143.7 (s, C-3a), 132.2 (s, C-7a),
131.8 (d, C-5), 128.0 (d, C-4), 123.8 (d, C-7), 123.2 (d, C-6), 45.7 (d, C-3).
APCI-MS: m/z (%) = 134 (MH+, 100).
HRMS: m/z calc, for C8H8NO (MH+), 134.0606; found, 134.0604.
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FT-IR: vmax -  3288 (NH and OH), 2964 (CH), 1676 (C=0), 1570 (aromatic C=C), 
1458, 1272, 1052 cm '1.
3-M ethylisoindolin-l-one (226)
NH
7 a Me
Yield: 0.22 g (1.50 mmol, 75%).
Mp: 117-118 °C (lit.140 115-116 °C).
'H NMR (500 MHz, CDCl3): 8 = 8.35 (br, exch., 1 H, NH), 7.77 (d, J =  8 Hz, 1 H, 
H-7), 7.49 (dt, J  = 2, 8 Hz, 1 H, H-5), 7.38-7.34 (m, 2 H, H-4 and H-6), 4.63 (q, J  = 
7 Hz, 1 H, H-3), 1.43 (d, J =  7 Hz, 3 H, CH3).
I3C NMR (125 MHz, CDC13): 5 = 171.3 (s, C -l), 149.0 (s, C-3a), 131.8 (s, C-7a),
131.7 (d, C-5), 128.0 (d, C-4), 123.6 (d, C-7), 122.2 (d, C-6), 52.8 (d, C-3), 20.2 (q, 
CH3).
ES+-M S: m/z (%) = 295 (2 M+, 9), 189 (M + MeCNH+, 100), 148 (MH*, 34).
HRMS: m/z calc, for C g H ]0N O  (MH*), 148.0762; found, 148.0762.
FT-IR: vmax = 3176 (NH and OH), 2934 (CH), 1678 (C =0), 1602 (aromatic C=C), 
1457, 1265, 1043 c m 1.
3-Ethylisoindolin-l-one (227)
NH
7 a,
3a
Yield: 0.25 g (1.55 mmol, 77%).
Mp: 103-105 °C (lit.140 104-105 °C).
'H NMR (500 MHz, CDCI3): 5 = 8.46 (br, exch., 1 H, NH), 7.76 (d, 7  = 8 Hz, 1 H, 
H-7), 7.46 (app. dt, 7  = 2, 8 Hz, 1 H, H-5), 7.35 (app. t, 7  = 8 Hz, 1 H, H-6), 7.21 (d, 
7 = 8  Hz, 1 H, H-4), 4.52 (dd, 7 =  5, 7 Hz, 1 H, H-3), 1.94 (ddq, 7 =  5, 14, 7 Hz, 1 H, 
1 H o f CH2), 1.62 (app. d quintet, 7 =  14, 7 Hz, 1 H, 1 H of CH2), 0.87 (app. t, 7  = 
7 Hz, 3 H, CH3).
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l3C NMR (125 MHz, CDC13): 5 = 171.6 (s, C -l), 147.6 (s, C-3a), 132.3 (s, C-7a),
131.7 (d, C-5), 128.5 (d, C-4), 123.6 (d, C-7), 122.4 (d, C-6), 58.2 (d, C-3), 27.3 (t, 
CH2), 9.5 (q, CH3).
APCI-MS: m/z (%) = 203 (M + MeCNH+, 37), 162 (MH+, 100).
HRMS: m/z calc, for C l0H |2NO (M+), 162.0913; found, 162.0919.
FT-IR: vmax = 3312 (NH and OH), 2945 (CH), 1677 (C=0), 1589 (aromatic C=C), 
1472, 1267, 1043 cm '1.
3-Butylisoindolin-l-one (228)
NH
7 a, Bu
Yield: 0.29 g (1.53 mmol, 76%).
Mp: 88-89 °C (lit.140 88-89 °C).
'H NMR (500 MHz, CDC13): 8 = 7.77 (d, J  = 8 Hz, 1 H, H-7), 7.66 (br, exch., 1 H, 
NH), 7.49 (app. dt, J =  2, 8 Hz, 1 H, H-5), 7.40-7.36 (m, 2 H, H-4 and H-6), 4.55 (dd, 
J  = 4, 7 Hz, 1 H, H-3), 1.88 (m, 1 H, 1 H o f C //2CH2CH2CH3), 1.59 (m, 1 H, 1 H of 
C //2CH2CH2CH3), 1.30-1.23 (m, 4 H, CH 2 CH 2 CH3), 0.82 ( t ,7 = 7  Hz, 3 H, CH3).
I3C NMR (125 MHz, CDC13): 5 = 171.2 (s, C -l), 147.8 (s, C-3a), 132.0 (s, C-7a),
131.7 (d, C-5), 128.0 (d, C-4), 123.7 (d, C-7), 122.4 (d, C-6), 57.0 (d, C-3), 34.3 (t, 
CH2CH2CH2CH3), 27.6 (t, CH2CH2CH3), 22.6 (t, CH2CH3), 13.9 (q, CH3).
ES+-M S: m/z (%) = 189 (M +, 25), 177 (56), 132 (M+ -  Bu, 100), 104 (23), 72 (32). 
HRMS: m/z calc. fo rC |2H ,5NO (M +), 189.1154; found, 189.1154.
FT-IR: vmax = 3312 (NH and OH), 2960 (CH), 1677 (C=0), 1596 (aromatic C=C), 
1475, 1272, 1045 cm '1.
3-(Hydroxydiphenylmethyl)isoindolin-l-one (229)
N  H Ph
Ph7 a,
Yield: 0.47 g (1.49 mmol, 74%).
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Mp: 189-191 °C.
'H NMR (500 MHz, DMSO-76): 6 = 8.20 (br, exch., 1 H, NH), 7.60 (d, 7  = 8 Hz, 1 H, 
H-7), 7.52 (app. t, 7  = 8 Hz, 1 H, H-5), 7.35 (d, 7  = 8 Hz, 1 H, H-4), 7.30-7.00 (m, 
11 H, H-6 and 2 Ph), 6.44 (d, 7  = 6 Hz, 1 H, H-3), 6.19 (s, exch., 1 H, OH). 
n C NMR (125 MHz, DMSO-76): 8 = 170.3 (s, C -l), 145.2, 145.1 (2 s, C-l o f 2 Ph),
141.2 (s, C-3a), 134.2 (s, C-7a), 130.9 (d, C-5), 129.6 (d, C-4), 128.3, 128.2 (2 d, 
C-3/C-5 o f 2 Ph), 127.4, 127.3 (2 d, C-2/C-6 o f Ph), 126.4, 126.3 (2 d, C-4 o f 2 Ph),
124.6 (d, C-7), 122.8 (d, C-6), 79.1 (s, C-OH), 67.5 (d, C-3).
ES+-M S: m/z (%) = 316 (MH*, 3), 315 (M+, 2), 297 (M+ -  H20 ,  37), 268 (10), 182 
(Ph2CO+, 100), 133 (95), 105 (97).
HRMS: m/z calc, for C2iH i8N 0 2 (M H+), 316.1338; found, 316.1338.
FT-IR: vmax = 3202 (NH and OH), 2990 (CH), 1678 (C=0), 1590 (aromatic C=C), 
1491, 1252, 1025 c m 1.
3-(Hydroxyphenylm ethyl)isoindolin-l-one (230)
7a
3a O H
Yield: 0.35 g (1.46 mmol, 73%).
Mp: 174-175 °C.
'H NMR (500 MHz, CDCI3): S = 8.69 (br, exch., 1 H, NH), 7.48 (d, 7  = 8 Hz, 1 H, 
H-7), 7.31 (app. dt, 7  = 2, 8 Hz, 1 H, H-5), 7.37 (app. t, 7  = 8 Hz, 1 H, H-6), 7.21 (br,
5 H, Ph), 7.07 (d, 7  = 8 Hz, 1 H, H-4), 5.92 (d, 7  = 4 Hz, exch., 1 H, OH), 4.81 (d, 7  =
6 Hz, 1 H, H-3), 4.73 (dd, 7 =  4, 6 Hz, 1 H, CH).
I3C NMR (125 MHz, CDCI3): 5 = 169.5 (s, C -l), 144.5 (s, C -l o f Ph), 141.1 (s, C-3a),
133.6 (s, C-7a), 131.0 (d, C-5), 128.3 (d, C-4), 127.8 (d, C-3/C-5 o f Ph), 127.7 (d, 
C-2/C-6 o f Ph), 127.6 (d, C-4 o f Ph), 124.7 (d, C-7), 122.8 (d, C-6), 74.8 (d, CHOH), 
61.9 (d, C-3).
EI-MS: m/z (%) = 239 (M +, 4), 221 (M+ -  H20 ,  100), 220 (51), 193 (33), 165 (89), 
149 (86).
CI-M S: m/z (%) = 257 (M + NH4+, 12), 240 (MH+, 100), 224 (24).
HRMS: m/z calc, for C |5H i4N 0 2 (MH*), 240.1019; found, 240.1018.
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FT-IR: vmilx = 3237 (NH and OH), 2957 (CH), 1669 (0 = 0 ), 1599 (aromatic C=C), 
1512, 1050 c m 1.
3-(Hydroxy(4-methoxyphenyl)methyl)isoindolin-l-one (231)
OMe
1 H 9
sU n 2 h
7A
w/r
^ 3 a OH
5
Yield: 0.42 g (1.56 mmol, 78%).
Mp: 196-198 °C.
Compound 231 was a mixture o f diastereoisomers, which were not separated; 
however, many individual NM R signals could be identified; 231a:231b = 6:1 (by *H 
NMR).
ES+-M S: m/z (%) = 561 (2 M + Na+, 12), 539 (2 M+ + 1, 100), 311 (M + MeCNNa+, 
17), 270 (M + M eCNH+, 17), 270 (M H+, 100), 252 (M+ -  H20 , 58), 175 (6).
HRMS: m/z calc, for C ,6H ,6N 0 3 (M H+), 270.1130; found, 270.1121.
FT-IR: vmax = 3301 (NH and OH), 2886 (CH), 1678 (C =0), 1602 (aromatic C=C), 
1510, 1271, 1042 cm '1.
Compound 231a:
'H NMR (500 MHz, DM S0 -d 6)\ 5 = 8.55 (br, exch., 1 H, NH), 7.51-7.37 (m, 4 H, 
H-4, H-5, H-6 and H-7), 7.13 (d, J =  9 Hz, 2 H, H-2/H-6 of 4-methoxyphenyl group), 
6.77 (d, J  = 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl group), 5.69 (d, J =  4 Hz, exch., 
1 H, OH), 4.95 (app. t, J =  4 Hz, 1 H, H-3), 4.83 (d, J =  4 Hz, 1 H, C//OH), 3.70 (s, 3 
H, OCH3).
13C NMR (125 MHz, DMSO-<4): 5 = 170.0 (s, C -l), 158.8 (s, C-4 o f
4-methoxyphenyl), 145.1 (s, C-3a), 133.6 (s, C -l o f 4-methoxyphenyl), 133.1 (s, 
C-7a), 131.2 (d, C-5), 128.6 (d, C-2/C-6 o f 4-methoxyphenyl), 128.3 (d, C-7), 124.5 
(d, C-4), 122.9 (d, C-6), 113.3 (d, C-3/C-5 of 4-methoxyphenyl), 73.9 (d, CHOH),
62.5 (d, C-3), 55.4 (q, OCH3).
Compound 231b:
'H NMR (500 MHz, DMSO-d6): § = 8.67 (br, exch., 1 H, NH), 7.51-7.38 (m, 4 H, 
H-4, H-5, H-6 and H-7), 7.06 (d, J  = 9 Hz, 2 H, H-2/H-6 o f 4-methoxyphenyl group),
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6.79 (d, J  — 9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl group), 5.82 (d, J =  4 Hz, exch., 
1 H, OH), 4.77 (d, J =  4 Hz, 1 H, C//OH), 4.66 (app. t, J =  4 Hz, 1 H, H-3), 3.68 (s, 3 
H, OCH3).
13C NMR (125 MHz, DMSO-t/6): 5 = 170.3 (s, C -l), 159.3 (s, C-4 o f
4-methoxyphenyl), 145.0 (s, C-3a), 133.7 (s, C -l o f 4-methoxyphenyl), 133.4 (s, 
C-7a), 131.1 (d, C-5), 128.9 (d, C-2/C-6 o f 4-methoxyphenyl), 128.4 (d, C-7), 124.8 
(d, C-4), 122.9 (d, C-6), 113.4 (d, C-3/C-5 o f 4-methoxyphenyl), 74.7 (d, CHOH), 
62.1 (d, C-3), 55.4 (q, OCH3).
6-M ethoxyisoindoIin-l-one (232)
NH
7a
MeO
Yield: 0.23 g (1.41 mmol, 70%).
Mp: 189-190 °C.
*H NM R (500 MHz, CDC13): 6 = 8.21 (br, exch., 1 H, NH), 7.38 (d, J  = 2 Hz, 1 H, 
H-7), 7.35 (d, J =  8 Hz, 1 H, H-4), 7.14 (dd, J = 2, 8 Hz, 1 H, H-5), 4.42 (s, 2 H, H-3), 
3.87 (s, 3 H, OCH3).
,3C NMR (125 MHz, CDC13): 5 = 172.2 (s, C -l), 160.0 (s, C-6), 135.9 (s, C-3a),
133.5 (s, C-7a), 124.0 (d, C-4), 120.3 (d, C-5), 106.3 (d, C-7), 55.7 (q, OCH3), 45.4 
(d, C-3).
ES+-M S: m/z (%) = 205 (M + M eCNH+, 100), 164 (MH+, 68).
HRMS: m/z calc, for C9H 10NO2 (MH+), 164.0706; found, 164.0709.
FT-IR: vmax = 3294 (NH and OH), 2976 (CH), 1678 (C=0), 1577 (aromatic C=C), 
1472, 1265, 1049 cm '1.
6-M ethoxy-3-methylisoindolin-l-one (233)
NH
7 a Me
3a
MeO'
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Yield: 0.27 g (1.52 mmol, 76%).
Mp: 160-161 °C.
'H NMR (500 MHz, CDC13): 5 = 8.21 (br, exch., 1 H, NH), 7.33 (d, = 2 Hz, 1 H,
H-7), 7.31 (d, J  = 8 Hz, 1 H, H-4), 7.13 (dd, = 2, 8 Hz, 1 H, H-5), 4.66 (q, = 7 Hz, 
1 H, H-3), 3.86 (s, 3 H, OCH3), 1.48 (d, J  = 7 Hz, 3 H, CH3).
I3C NMR (125 MHz, CDCl3): 5 = 171.2 (s, C -l), 160.0 (s, C-6), 141.3 (s, C-3a),
133.0 (s, C-7a), 123.1 (d, C-4), 120.2 (d, C-7), 106.3 (d, C-5), 55.7 (q, OCH3), 52.4 
(d, C-3), 20.4 (q, CHj).
ES+-MS: m/z(%) = 219 (M + MeCNH+, 96), 178 (MH+, 100).
HRMS: m/z calc, for C |0H l2NO2 (MH+), 178.0863; found, 178.0862.
FT-IR: = 3165 (NH and OH), 2979 (CH), 1679 (C=0), 1600 (aromatic C=C),
1487, 1261, 1046 cm '1.
3-Ethyl-6-m ethoxyisoindolin-l-one (234)
NH
MeO
Yield: 0.30 g (1.57 mmol, 78%).
Mp: 137-138 °C.
'H NMR (500 MHz, CDC13): 5 = 8.16 (br, exch., 1 H, NH), 7.33 (d, 8 Hz, 1 H,
H-4), 7.31 (s, 1 H, H-7), 7.12 (dd, J  = 2, 8 Hz, 1 H, H-5), 4.56 (dd, = 5, 7 Hz, 1 H,
H-3), 3.87 (s, 3 H, OCH3), 1.96 (ddq, J  = 5, 14, 7 Hz, 1 H, 1 H of CH2), 1.70 (app. d 
quintet, J =  14, 7 Hz, 1 H, 1 H o f CH2), 0.97 (app. t, 7 Hz, 3 H, CH3).
13C NMR (125 MHz, CDC13): 5 = 171.4 (s, C -l), 160.0 (s, C-6), 139.8 (s, C-3a),
133.6 (s, C-7a), 123.2 (d, C-4), 120.1 (d, C-5), 106.3 (d, C-7), 57.8 (d, C-3), 55.7 (q, 
OCH3), 27.5 (t, CH2), 9.5 (q, CH3).
EI-MS: m/z(%) = 191  (M+, 21), 162 (M+ -  Et, 100), 147 (M+ -  Et -  Me, 13), 134 
(15), 119(16).
HRMS: m/z calc, for C ,iH i3N 0 2 (M+), 191.0946; found, 191.0943.
FT-IR: Vmax = 3300 (NH and OH), 2942 (CH), 1678 (C=0), 1598 (aromatic C=C), 
1475, 1270, 1045 cm '1.
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3-Butyl-6-m ethoxyisoindolin-l-one (235)
NH
7 a, Bu
MeO
Yield: 0.34 g (1.55 mmol, 77%).
Mp: 145-147 °C.
'H NMR (500 MHz, DMSO-t/6): 5 = 8.71 (br, exch., 1 H, NH), 7.44 (d, J  = 8 Hz, 1 H, 
H-4), 7.15-7.03 (m, 2 H, H-5 and H-7), 4.48 (dd, J =  3, 7 Hz, 1 H, H-3), 3.81 (s, 3 H, 
OCHj), 1.84 (m, 1 H, 1 H o f C « 2CH2CH2CH3), 1.48 (m, 1 H, 1 H o f 
C/CCTFCIHCH,), 1.31-1.21 (m, 4 H, CH :CH 2 CH3), 0.84 (t, J =  7 Hz, 3 H, CH3).
I3C NMR (125 MHz, DMSO-r/,,): 5 = 169.6 (s, C -l), 159.5 (s, C-6), 140.4 (s, C-3a),
134.3 (s, C-7a), 124.3 (d, C-4), 119.4 (d, C-5), 106.5 (d, C-7), 56.0 (d, C-3), 55.9 (q, 
OCHj), 34.4 (t, CH2CH2CH2CH3), 27.3 (t, CH2CH2CH3), 22.6 (t, CH2CH3), 14.3 (q, 
CHj).
ES+-M S: m/z (%) = 261 (M + MeCNH+, 100), 220 (MH+, 46), 204 (9), 164 (21) 
HRMS: m/z calc, for C ,3H |gN 02 (M H+), 220.1338; found, 220.1347.
FT-IR: vmax = 3305 (NH and OH), 2967 (CH), 1680 (C=0), 1597 (aromatic C=C), 
1477, 1277, 1051 cm '1.
3-(Hydroxydiphenylmethyl)-6-methoxyisoindolin-l-one (236)
f '
1
7a/
?H Lii > N H Ph
~Y~Ph
7X OH
MeO 6 5 4
Yield: 0.50 g (1.45 mmol, 72%).
Mp: 159-160 °C.
'H NMR (500 MHz, CDC13): 5 = 8.12 (br, exch., 1 H, NH), 7.71-7.16 (m, 10 H, 
2 Ph), 6.93 (d, J  = 2 Hz, 1 H, H-7), 6.75 (s, exch., 1 H, OH), 6.69 (dd, J  = 2, 8 Hz, 
1 H, H-5), 5.78 (d, J =  8 Hz, 1 H, H-4), 5.40 (s, 1 H, H-3), 3.68 (s, 3 H, OCH3).
,3C NMR (125 MHz, CDC13): 5 = 172.0 (s, C -l), 160.0 (s, C-6), 146.5, 144.7 (2 s, 
C-l of 2 Ph), 136.4 (s, C-3a), 135.1 (s, C-7a), 128.6, 128.5 (2 d, C-3/C-5 o f 2 Ph),
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127.4, 127.4 (2 d, C-4 o f 2 Ph), 126.3, 126.2 (2 d, C-2/C-6 of Ph), 124.6 (d, C-4),
119.2 (d, C-5), 106.6 (d, C-7), 78.4 (s, C-OH), 64.4 (d, C-3), 55.7 (q, OCH3).
EI-MS: m/z(%) = 346 (M+ + 1, 33), 345 (M+, 10), 328 (MH* -  H20 , 45), 327 (M+ -  
HzO, 100).
CI-MS: m/z(%) =  346 (MH+, 100).
HRMS: m/z calc, for C22H20NO3 (MH+), 346.1438; found, 346.1443.
FT-IR: vmax = 3205 (NH and OH), 2994 (CH), 1677 (C=0), 1594 (aromatic C=C), 
1493, 1255, 1027 c m '.
3-(Hydroxyphenylm ethyl)-6-m ethoxyisoindolin-l-one (237)
7 a
3a OH
Yield: 0.45 g (1.50 mmol, 75%).
Mp: 164-165 °C.
'H NMR (500 MHz, CDC13): 5 = 7.86 (br, exch., 1 H, NH), 7.32-7.23 (m, 6 H, Ph 
and H-7), 7.16 (d, J =  8 Hz, 1 H, H-4), 6.91 ( d ,J = 8 H z ,  1 H, H-5), 5.82 (d ,J = 4 H z , 
exch., 1 H, OH), 5.43 (app. t, J  = 4 Hz, 1 H, CH), 4.33 (d, 4 Hz, 1 H, H-3), 3.68
(s, 3 H, OCH3).
I3C NMR (125 MHz, CDC13): 5 = 171.0 (s, C -l), 160.2 (s, C-6), 140.8 (s, C-l o f Ph),
135.4 (s, C-3a), 133.7 (s, C-7a), 128.7 (d, C-3/C-5 o f Ph), 128.4 (d, C-4 of Ph), 127.5 
(d, C-2/C-6 o f Ph), 124.9 (d, C-4), 119.6 (d, C-5), 114.0 (d, C-7), 78.6 (d, CHOH),
62.8 (d, C-3), 55.6 (q, OCH3).
ES+-M S: m/z(%) = 561 (2 M + Na+, 23), 539 (2 M+ + 1, 62), 333 (M + MeCNNa+, 
51), 311 (M + MeCNH+, 100), 270 (MH+, 74), 252 (M+ -  H20 , 71), 209 (27).
HRMS: m/z calc, for C i6H |6N 04 (MH+), 270.1130; found, 270.1133.
FT-IR: = 3300 (NH and OH), 2923 (CH), 1679 (C=0), 1600 (aromatic C=C),
1504, 1270, 1052 cm '1.
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6-M ethyIisoindolin-l-one (238)
NH
7 a.
Me
Yield: 0.22 g (1.50 mmol, 75%).
Mp: 211-213 °C.
'H NMR (500 MHz, DMSO-r/6): 5 = 8.51 (br, exch., 1 H, NH), 7.48 (s, 1 H, H-7), 
7.44 (d, J  = 8 Hz, 1 H, H-5), 7.39 (d, J =  8 Hz, 1 H, H-4), 4.32 (s, 2 H, H-3), 2.39 (s, 3 
H, CHj).
I3C NMR (125 MHz, DMSO-<4): 5 = 170.5 (s, C -l), 141.7 (s, C-3a), 137.6 (s, C-6),
133.2 (s, C-7a), 132.6 (d, C-5), 123.8 (d, C-7), 123.4 (d, C-4), 45.1 (t, C-3), 21.3 (q, 
CH3).
ES+-M S: m/z (%) = 295 (2 M + + 1, 41), 189 (M + MeCNH+, 92), 148 (MH+, 100). 
HRMS: m/z calc, for C9H,oNO (M H+), 148.0755; found, 148.0762.
FT-IR: vmax = 3286 (NH and OH), 2972 (CH), 1676 (C=0), 1570 (aromatic C=C), 
1467, 1261, 1047 cm '1.
Anal. calc, for C9H9NO: C, 73.45; H, 6.16; N, 9.52. Found: C, 73.32; H, 6.14; N, 
9.41%.
3,6-D im ethylisoindolin-l-one (239)
NH
Me
Me'
Yield: 0.25 g (1.55 mmol, 78%).
Mp: 161-162 °C.
'H NMR (500 MHz, CDCI3): 5 = 8.59 (br, exch., 1 H, NH), 7.45 (s, 1 H, H-7), 7.44 
(d, J  = 8 Hz, 1 H, H-5), 7.39 (d, J  = 8 Hz, 1 H, H-4), 4.56 (q, J  = 6 Hz, 1 H, H-3), 2.38 
(s, 3 H, CH3), 1.33 (d, J =  6 Hz, 3 H, C //,CH ).
I3C NMR (125 MHz, CDCI3): 5 = 169.4 (s, C -l), 146.9 (s, C-3a), 137.7 (s, C-6),
132.8 (d, C-5), 132.7 (s, C-7a), 123.3 (d, C-7), 122.9 (d, C-4), 51.9 (d, C-3), 21.3 (q, 
CH3), 20.8 (q, CHj).
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ES+-M S: m/z (%) = 323 (2 M + + 1, 22), 203 (M + MeCNH+, 96), 162 (MH+, 100). 
HRMS: m/z calc, for C i0H |2NO (M H+), 162.0925; found, 162.0925.
FT-IR: vmax = 3187 (NH and OH), 2986 (CH), 1677 (C =0), 1598 (aromatic C=C), 
1478, 1266, 1042 c m '1.
3-Ethyl-6-m ethylisoindolin-l-one (240)
NH
7a
Me'
Yield: 0.26 g (1.49 mmol, 75%).
Mp: 165-166 °C.
'H NMR (500 MHz, CDClj): 8 = 8.27 (br, exch., 1 H, NH), 7.58 (s, 1 H, H-7), 7.28 
(d, J =  8 Hz, 1 H, H-5), 7.23 (d, J  = 8 Hz, 1 H, H-4), 4.49 (dd, 7 =  5, 7 Hz, 1 H, H-3), 
2.36 (s, 3 H, CHj), 1.91 (ddq, J =  5, 14, 7 Hz, 1 H, 1 H o f CH2), 1.62 (app. d quintet, 
7 =  14, 7 Hz, 1 H, 1 H o f CH2), 0.89 (app. t, J =  7 Hz, 3 H, CZ/jCH2). 
n C NMR (125 MHz, CDClj): 5 = 171.7 (s, C -l), 144.8 (s, C-3a), 137.9 (s, C-6),
132.7 (d, C-5), 132.4 (s, C-7a), 123.8 (d, C-4), 122.1 (d, C-7), 58.0 (d, C-3), 27.4 (t, 
CH2), 21.3 (q, CH3), 9.5 (q, CH3CH2).
APCI-MS: m/z (%) = 175 ( M \ 11), 146 (M * - Et, 100), 118(12).
HRMS: m/z calc, for C n H ,3NO (M +), 175.0997; found, 175.1000.
FT-IR: vmax = 3307 (NH and OH), 2949 (CH), 1679 (C =0), 1597 (aromatic C=C), 
1470, 1272, 1049 c m 1.
3-(l-H ydroxycyclohexyl)-6-m ethylisoindolin-l-one (241)
/ \
Ho
0 4
7a \
3a
> - J *Me 5
Yield: 0.35 g (1.43 mmol, 72%). 
Mp: 235-237 °C.
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'H NMR (500 MHz, DMSO-</6): 6 = 7.72 (br, exch., 1 H, NH), 6.56 (d, J =  8 Hz, 1 H, 
H-5), 6.53 (s, 1 H, H-7), 6.42 (d, J  = 8 Hz, 1 H, H-4), 4.00 (s, exch., 1 H, OH), 3.42 
(s, 1 H, H-3), 2.27 (s, 3 H, C H 3 ), 0.65-0.33 (m, 10 H, cyclohexyl).
Compound 34 was highly insoluble in DMSO so that its 13C NMR spectrum was not 
recorded.
ES+-M S: m/z (%) = 491 (2 M + + 1, 10), 287 (M + MeCNH+, 79), 246 (MH+, 100), 
228 (M+- H 20 ,  18).
HRMS: m/z calc, for C 15H20NO2 (M H+), 264.1494; found, 246.1498.
FT-IR: vma\ = 3307 (NH and OH), 2943 (CH), 1681 (C =0), 1596 (aromatic C=C), 
1472, 1246, 1043 cm '1.
Anal. calc, for C i5H ,9N 02: C, 73.44; H, 7.81; N, 5.71. Found: C, 73.81; H, 7.85; N, 
5.80%.
3-(Hydroxydiphenylm ethyI)-6-m ethylisoindolin-l-one (242)
N H Ph
Ph
Me
Yield: 0.56 g (1.70 mmol, 85%).
Mp: 236-264 °C.
‘H NMR (500 MHz, DMSO-<4): 5 = 8.12 (br, exch., 1 H, NH), 7.61-7.19 (m, 11 H, 
2 Ph and H-7), 7.11 (d, J  = 8 Hz, 1 H, H-5), 6.26 (d, J  = 8 Hz, 1 H, H-4), 5.81 (s, 
exch., 1 H, OH), 5.72 (s, 1 H, H-3), 2.33 (s, 3 H, CH3).
I3C NMR (125 MHz, DMSO-<4): 5 = 172.40 (s, C -l), 145.5, 145.2 (2 s, C -l o f 2 Ph),
142.4 (s, C-3a), 137.6 (s, C-6), 134.4 (s, C-7a), 131.8 (d, C-5), 128.3, 128.2 (2 d, 
C-3/C-5 o f 2 Ph), 127.3, 127.2 (2 d, C-4 o f 2 Ph), 127.1, 127.0 (2 d, C-2/C-6 o f 2 Ph),
124.3 (d, C-4), 123.0 (d, C-7), 79.0 (s, C-OH), 63.4 (d, C-3), 21.2 (q, CH3).
E S -M S : m/z (%) = 659 (2 M+ + 1, 12), 371 (M + MeCNH+, 71), 330 (MH+, 100), 
312 (M+ -  H20 , 36), 189 (8).
HRMS: m/z calc, for C22H20NO2 (MH ), 330.1494; found, 330.1487.
FT-IR: vmax = 3278 (NH and OH), 3000 (CH), 1678 (C =0), 1591 (aromatic C=C), 
1493, 1251, 1040 c m 1.
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3-(2-H ydroxyhexyl)-4-m ethylisoindolm -l-one (243)
f
1
1/y
2 H u
T 1 Me
■y~Bu
7 U ^ 3 3  a OH11
Me e 5  4
Yield: 0.38 g (1.54 mmol, 77%).
Mp: 88-89 °C.
'H NMR (500 MHz, DMSO-c4): 5 = 8.47 (br, exch., 1 H, NH), 7.53 (d, J =  8 Hz, 1 H, 
H-5), 7.42 (s, 1 H, H-7), 7.35 (d, J  = 8 Hz, 1 H, H-4), 4.79 (s, exch., 1 H, OH), 4.39 
(br, 1 H, H-3), 2.38 (s, 3 H, CH3), 1.33-1.09 (m, 6 H, CH 2 CH 2 CH/CW 3 ), 1.06 (s, 3 H, 
C/fjC-OH), 0.79 (t, J  = 7 Hz, 3 H, C //jC H 2).
I3C NMR (125 MHz, DMSO-c/6): 5 = 170.3 (s, C -l), 142.8 (s, C-3a), 137.7 (s, C-6),
133.9 (s, C-7a), 132.4 (d, C-5), 125.0 (d, C-4), 123.1 (d, C-7), 73.6 (s, C-OH), 65.5 (d, 
C-3), 36.3 (t, CH2CH2CH2CH3), 25.4 (t, CH2CH2CH3), 24.6 (q, CH3), 23.3 (t, 
CH2CH3), 21.3 (q, CH3), 14.5 (q, CH3CH 2).
ES*-MS: m/z (%) = 517 (2 M + N a+, 9), 495 (2 M+ + 1, 44), 289 (M + MeCNH+, 32), 
248 (MH+, 100), 230 (M + -  H20 ,  41), 148 (9), 100 (8).
HRMS: m/z calc. fo rC i5H22NO: (M H+), 248.1651; found, 248.1646.
FT-IR: vnwx = 3467 (NH and OH), 3042 (CH), 1680 (C =0), 1590 (aromatic C=C), 
1269, 1041 c m 1.
3-(H ydroxyphenylm ethyl)-6-m ethylisoindolin-l-one (244)
° ^ U n 2 h Ph
7aJLyT
, n 3a OH
Me 6 5
.
Yield: 0.40 g (1.58 mmol, 79%).
Mp: 228-229 °C.
'H NMR (500 MHz, CDCI3): 5 = 8.01 (br, exch., 1 H, NH), 7.41 (d, J  = 2 Hz, 1 H, 
H-7), 7.31-7.22 (m, 5 H, Ph), 7.03 (dd, J =  2, 8 Hz, 1 H, H-5), 6.33 (d, J =  8 Hz, 1 H, 
H-4), 5.62 (d, J  = 3 Hz, exch., 1 H, OH), 4.67 (d, J  = 8 Hz, 1 H, H-3), 4.39 (dd, J =  3, 
8 Hz, 1 H, C //O H ), 2.32 (s, 3 H, CH3).
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l3C NMR (125 MHz, CDCI3): 5 = 170.3 (s, C -l), 141.1 (s, C-3a), 140.9 (s, C-l of Ph),
137.9 (s, C-6), 133.3 (s, C-7a), 131.9 (d, C-5), 128.2 (d, C-7), 128.1 (d, C-3/C-5 of 
Ph), 127.7 (d, C-2/C-6 o f Ph), 124.1 (d, C-4 o f Ph), 123.2 (d, C-4), 76.9 (d, CHOH),
62.7 (d, C-3), 21.3 (q, CH3).
APCI-MS: m/z(%) = 529 (2 M + Na+, 61), 507 (2 M+ + 1, 93), 317 (M + MeCNNa+, 
15), 295 (M + MeCNH+, 22), 254 (M H \ 89), 236 (M+ -  H2Os 100), 100 (22).
HRMS: m/z calc, for C ,6H i6N 0 2 (MH+), 254.1181; found, 254.1182.
FT-IR: Vna, = 3312 (NH and OH), 2943 (CH), 1678 (C=0), 1602 (aromatic C=C), 
1500, 1272, 1045 cm '1.
3-(Hydroxy(4-m ethoxyphenyl)m ethyl)-6-m ethylisoindolin-l-one (245)
OMe
3a OH
Yield: 0.47 g (1.66 mmol, 83%).
Mp: 211-213 °C.
'H NMR (500 MHz, DMSO-cfe): 8 =  8.47 (br, exch., 1 H, NH), 7.31-7.29 (m, 3 H, 
H-4, H-5 and H-7), 7.12 (d, J  = 9 Hz, 2 H, H-2/H-6 o f 4-methoxyphenyl), 6.76 (d,
9 Hz, 2 H, H-3/H-5 o f 4-methoxyphenyl), 5.65 (d, = 4 Hz, exch., 1 H, OH), 4.92
(app. t, J  = 4Hz, 1 H, C //OH), 4.77 (d, 7 = 4  Hz, 1 H, H-3), 3.69 (s, 3 H, OCH3), 2.33 
(s, 3 H, CHj).
I3C NMR (125 MHz, DMSO-cfe): 8 = 170.1 (s, C -l), 158.8 (s, C-4 of
4-methoxyphenyl), 142.3 (s, C-3a), 137.7 (s, C-6), 133.8 (s, C-7a), 133.2 (s, C -l of
4-methoxyphenyl), 132.1 (d, C-5), 128.6 (d, C-2/C-6 of 4-methoxyphenyl), 124.2 (d, 
C-7),123.1 (d, C-4), 113.3 (d, C-3/C-5 o f 4-methoxyphenyl), 73.9 (d, CHOH), 62.3 
(d, C-3), 55.4 (q, OCHj), 21.3 (q, CH3).
ES+-M S: m/z(%) = 589 (2 M + Na+, 37), 567 (2 M+ + 1, 64), 325 (M + MeCNH+, 
65), 284 (M H \ 100), 266 (M H+ -  H20 ,  46).
HRMS: m/z calc. fo rC ,7Hl8N 0 3 (MH+), 284.1287; found, 284.1290.
FT-IR: Vmax = 3301 (NH and OH), 2896 (CH), 1677 (C=0), 1601 (aromatic C=C), 
1519, 1271, 1042 c m 1.
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3,3-Dibutylisoindolin-l-one (246)
NH Bu
3a Bu
Yield: 25 mg (0.10 mmol, 5%).
Mp: 88-89 °C.
1H NMR (500 MHz, CDC13): 8 = 7.74 (d, J  = 8 Hz, 1 H, H-7), 7.47 (app. t, J  = 8 Hz,
1 H, H-5), 7.36 (app. t, J  = 8 Hz, 1 H, H-6), 7.23 (d, J  = 8 Hz, 1 H, H-4), 7.16 (br s, 
exch., 1 H, NH), 1.85-1.72 (m, 4 H, 2 C //2CH2CH2CH3), 1.18-1.09 (m, 8 H,
2 CH 2 CH 2 CH}), 0.74 (t, J=  7 Hz, 6 H, 2 CH3).
n C NMR (125 MHz, CDC13): 5 = 170.6 (s, C -l), 150.8 (s, C-3a), 133.3 (s, C-7a),
131.8 (d, C-5), 127.8 (d, C-4), 123.7 (d, C-7), 121.2 (d, C-6), 65.1 (s, C-3), 39.0 (t, 
2 CH2CH2CH2CH3), 25.6 (t, 2 CH2CH2CH 3), 22.8 (t, 2 CH2CH3), 13.8 (q, 2 CH3). 
ES+-M S: m/z (%) = 513 (2 M + N a+, 12), 491 (2 M + + 1, 3), 309 (M + MeCNNa+, 
24), 287 (M + M eCNH+, 97), 246 (M H+, 100).
HRMS: m/z calc, for C l6H24NO (M H+), 246.1858; found, 246.1858.
FT-IR: vmax = 3300 (NH and OH), 2960 (CH), 1681 (C =0), 1591 (aromatic C=C), 
1473, 1273, 1046 c m 1.
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Final conclusion and future work
F IN A L  C O N C L U S IO N  A N D  F U T U R E  W O R K
A simple, efficient and high yielding lithiation procedure that allows 
electrophilic substitution o f various A-benzylpivalamides and A-benzyl-A,A- 
dimethylureas has been demonstrated to provide various substituted derivatives. 
Catalytic cyclization reactions o f some o f  the products with TFAA, via dehydration 
from the OH and hydrogen from the NH, takes place to give the corresponding 
isoindolines and tetrahydroisoquinolines in excellent yields.
Also, a lithiation procedure has been developed that allows the production of 
3-substituted isoindolin-l-ones in high yields in only one step via lithiation o f various 
substituted A -benzyl-A A -dim ethylureas with /-BuLi (3.3 mole equivalents) in THF 
at 0 °C followed by reactions with various electrophiles. The procedure has been 
proven to be simple, efficient and general.
However, A-(2-(2-hydroxy-2-arylalkyl)benzyl)pivalamides are not cyclised to 
produce the corresponding tetrahydroisoquinolines on reaction with TFAA under the 
conditions tried. Therefore, future w ork could aim for the production of such 
compounds via lithiation procedures as shown in the Scheme below. It is hoped that 
lithiation o f A-substituted 2-arylethylam ines 252 would give the corresponding 
dilithium reagents 253 which on reaction with carbonyl compounds would give the 
corresponding or//?o-substituted derivatives 354 (Route a). Catalytic cyclization o f 
254 with TFAA could produce 255 w hich on reaction with TFA could give the 
corresponding 256 (Route a). Also, isoquinolin-l-ones 257 and 258 could be 
synthesized via Routes b and c.
Y  2 BuLi 
O Route a
1—L
OH
254253252
3 BuLi 
Route c
TFAARoute b
NH
255257
i, 2 BuLi
ii, Electrophile
iii, H30 +
OLi TFA259
NH
NH
256258 o
1—L
1_L
1_L
1_L
R 1 = alkyl, alkoxy, halogen 
R2 = Bu', OBu', NM e2 
R3, R4 = H, alkyl, aryl
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